# Gmt database for MulEA software (http://www.mulea.org/)
# taxon_name: Homo sapiens
# taxid: 9606 
# ID_type: Uniprot
# source_URL: www.pathwaycommons.org/
# source_PMID: 21071392
# source_version: Version 12 
# source_last_update: 18-09-2019
# gmt_download_date: 24-09-2020
# gmt_file_version: 2 
# gmt_entry_names: Pathway ID
# Pathway ID	Pathway	Gene set (Uniprot)
# Pathway ID	Pathway	Gene set (Uniprot)
PC_1	Glycolysis / Gluconeogenesis	3098	5236	5315	4967	2597	2821	5232	669	2203	1738	230	1737	5162	10327	218	2645	224	8382	7167	5214	5106	2645	2026	128	160287	130	130589	83440	57818	55902
PC_2	Citrate cycle (TCA cycle)	8803	4967	1431	3417	2271	1738	1737	5162	5091	6389	1743	4190	47	5106	48
PC_3	Pentose phosphate pathway	5236	25796	9563	2821	2203	230	2539	5634	6888	22934	5226	5214	9104	729020	84076	64080	51071
PC_4	Pentose and glucuronate interconversions	7358	9942	2990	231	224	7360	729020	54575	51181	27294	51084
PC_5	Fructose and mannose metabolism	3098	9108	8790	57016	2762	2203	230	231	4351	3795	7167	6652	5214	7264	5210	197258	5372	29925
PC_6	Galactose metabolism	3098	5236	2717	2592	3938	6476	231	2683	2720	2645	5214	2582	7360	2645	2595	57818	2584
PC_7	Ascorbate and aldarate metabolism	7358	224	9104	54575	55586
PC_8	Fatty acid biosynthesis	2194	31	27349	79071	55301	54995	54898
PC_9	Fatty acid elongation	2182	34	38	1892	3030	10449	36	37	10965	5538	1962	570	3033	51102
PC_10	Fatty acid degradation	8310	2182	10455	34	35	38	33	1892	218	3030	10449	36	37	224	1962	3033	284541	128	1374	2639
PC_11	Synthesis and degradation of ketone bodies	38	3155	622	64064
PC_12	Steroid biosynthesis	1594	6309	7108	6646	2222	3988	4047	51478	6713	10682	1718	50814	1595	120227	10826	1717
PC_13	Primary bile acid biosynthesis	9420	9023	1109	6342	1581	3295	6718	1593	570	8309	80270	51302	23600	1582	10998	10858
PC_14	Ubiquinone and other terpenoid-quinone biosynthesis	2806	2805	6898	3242	84274	27235	10229	51805	51004
PC_15	Steroid hormone biosynthesis	6820	8630	9420	1543	1586	1583	1589	412	1588	3283	1584	1109	1585	1312	1581	3293	6783	6718	3291	6822	1545	54575	79644	64816
PC_16	Purine metabolism	646625	3614	5236	5315	5136	1716	51292	5198	109	956	957	9060	10380	4860	3251	100	353	5634	1890	2618	10606	5167	270	6240	205	1633	159	158	471	7498	2272	8833	318	10914	132	8382	3000	5471	5426	2987	1716	58497	55821	30833	87178	131870	84284	3704	5980	11164	9615	51728	954	56985
PC_17	Caffeine metabolism	9	1544	7498	64816
PC_18	Pyrimidine metabolism	10587	956	957	151531	4860	7298	7372	1503	1890	1841	6240	1633	790	51727	978	1635	1854	318	8382	1723	5426	1806	1807	23318	30833	87178	139596	3704	83549	51733	5980	50808	51728
PC_19	Alanine, aspartate and glutamate metabolism	2744	2806	445	435	440	2752	6898	189	790	8659	159	158	1373	443	2747	7915	18	5471	2673	84706	132789	259307	8528	56954
PC_20	Glycine, serine and threonine metabolism	1757	26227	23464	1738	1610	10993	189	2731	1491	6470	102724560	275	501	2628	5723	2593	27232	8639	4128	132158	55349	635	63826	51268	29958	1757	29968
PC_21	Cysteine and methionine metabolism	10768	2806	262	6898	6723	10993	4357	1491	102724560	6611	4507	1036	160287	635	51074	259307	4548	84245	55256	27430	58478	29947
PC_22	Valine, leucine and isoleucine degradation	4967	587	5095	1738	1629	34	35	4594	38	3712	1892	11112	3155	10449	36	224	18	4329	316	549	593	26275	84693	259307	3028	64064	64087	27034
PC_23	Valine, leucine and isoleucine biosynthesis	587	5162	7407	23395	3376
PC_24	Lysine biosynthesis	501	51166	10157
PC_25	Lysine degradation	4967	8985	8424	38	1892	1743	223	501	224	51111	51166	2639	55217	51268	10157	8985
PC_26	Arginine and proline metabolism	57571	5625	2744	5009	2806	445	4942	435	383	4953	1610	2752	1160	262	6723	26	51056	4846	8659	1373	2747	2628	224	6611	5832	95	8974	2593	65263	4128	162417	113451	112483	79814	58510
PC_27	Histidine metabolism	57571	10841	3067	26	1644	218	3034	443	3176	224	4128	131965	84735	55748	131669	144193
PC_28	Tyrosine metabolism	2954	2806	7054	7173	1621	5409	4282	7299	2184	2805	7306	6898	1644	1312	218	3242	1638	316	8639	4128	128	131965	3081	259307
PC_29	Phenylalanine metabolism	5053	2806	4282	6898	1644	9588	218	3242	8639	4128	259307
PC_30	Tryptophan metabolism	4967	8564	11185	847	1544	1738	26	1644	38	1892	1743	438	23498	6999	224	316	15	8942	883	4128	125061	169355	130013	2639	259307	10352
PC_31	Phenylalanine, tyrosine and tryptophan biosynthesis	5053	2806	2805	6898	259307
PC_32	beta-Alanine metabolism	57571	23417	34	6723	26	1892	218	224	6611	18	1806	1807	8639	26275	84735	51733
PC_33	Taurine and hypotaurine metabolism	2687	570	1036	51380	84890	51380
PC_34	Selenocompound metabolism	10587	11185	9060	1491	22929	4141	883	56267	118672	51540	4548	51091
PC_35	Cyanoamino acid metabolism	6470	2687	57733
PC_36	D-Glutamine and D-glutamate metabolism	2744	2747
PC_37	D-Arginine and D-ornithine metabolism	1610
PC_38	Glutathione metabolism	26873	79017	3417	9563	51060	2936	2539	4953	290	6723	6240	51056	2687	2879	2730	2937	5226	6611	257202	2946	290
PC_39	Starch and sucrose metabolism	3098	5236	11181	8972	7358	256281	2821	2990	5837	6476	5167	2645	178	2998	2632	7360	2645	54575	276	283209	80146	2595	57733	57818
PC_40	N-Glycan biosynthesis	8703	8813	8818	6480	4245	4122	1603	4248	4249	4247	7841	23193	440138	84920	8813	57171	201595	10195	199857	56052	79087	79053	2530	1798	85365	79796	79868	54344	25834	11253	22845	11282	29929	29880
PC_41	Mucin type O-Glycan biosynthesis	9334	9245	2650	6482	192134	100528030	56913	55808
PC_42	Other types of O-glycan biosynthesis	8473	8703	8985	6480	146664	283464	145173	56983	3955	55624	23509	10585
PC_43	Amino sugar and nucleotide sugar metabolism	3098	5236	8790	2762	7358	5238	2821	3073	2592	4351	2645	5973	2673	7264	2582	6675	7360	27159	2645	197258	80146	55907	140838	132789	5372	64841	80896	54187	51706	55577	10020	51005	29925	2584
PC_44	Butirosin and neomycin biosynthesis	3098	2645
PC_45	Glycosaminoglycan degradation	3073	2990	2799	411	2720	3423	2588	3425	6448	4669	3373	60495	138050	10855
PC_46	Glycosaminoglycan biosynthesis - chondroitin sulfate	64132	22856	55454	126792	135152	54480	11285
PC_47	Glycosaminoglycan biosynthesis - heparan sulfate	64132	2137	2131	2134	126792	135152	11285
PC_48	Glycerolipid metabolism	8613	2717	4023	10327	231	224	5408	2712	26007	84803	55750	346606	132158	11343	10554
PC_49	Inositol phosphate metabolism	79837	5288	3613	10423	8395	8871	8821	3707	3633	3628	7167	5728	4329	3705	27124	5289	253430	64768	51477	51196	5298	55586	9562	200576
PC_50	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	9091	8818	23556	5277	51227	2822	5281	5283	84992	54872	5281	284098	80235	54965	84720	9488	5279	9091	93183	55650	9487
PC_51	Glycerophospholipid metabolism	151056	8613	10423	8443	3931	590	43	1119	2820	9791	5130	5337	6901	9489	56985	84803	1103	10162	154141	23171	162466	9926	1040	79143	5833	10554	81490	10400	23761	54675
PC_52	Ether lipid metabolism	151056	8540	8613	5320	5337	5168	254531	133121	54947	5051
PC_53	Arachidonic acid metabolism	151056	9536	247	27306	242	1571	240	4048	873	239	6916	2053	5743	2687	8644	1573	257202	1579	4051	5740	4056	284541	1562	113612	874
PC_54	Linoleic acid metabolism	151056	57016	246	64816
PC_55	alpha-Linolenic acid metabolism	151056	8310	9415
PC_56	Sphingolipid metabolism	8613	8560	10558	8879	2629	2717	3938	410	2720	6609	2581	2531	427	7357	7368	4758	259230	166929	64781	9514	81537	56848	55331	9331
PC_57	Glycosphingolipid biosynthesis - lacto and neolacto series	2524	11041	8707	8703	8702	8704	2683	28	2525	2526	2527	2529	6487	6484	2651	6489	84002	10690	10402	10331	10317	8708
PC_58	Glycosphingolipid biosynthesis - globo series	2524	8706	2717	3073	4668	6482	26301	53947	10690	10317
PC_59	Glycosphingolipid biosynthesis - ganglio series	27090	29906	8705	3073	2720	2583	6482	256435	6489	30815	81849	8869
PC_60	Pyruvate metabolism	5315	4967	1738	1737	5162	5091	98	231	4200	38	218	4190	224	8382	2739	31	3029	5106	10873	160287	197257	134526	55902	9380
PC_61	Glyoxylate and dicarboxylate metabolism	283871	1431	5095	4594	38	4190	47	81888	125061	132158	84693	48	51179	9380
PC_62	Propanoate metabolism	8803	23417	5095	34	4594	38	1892	224	18	4329	31	26275	160287	84693	79611	55902
PC_63	Butanoate metabolism	57016	5162	35	38	1892	3155	36	7915	18	622	54988	65985	64064	79944
PC_64	One carbon pool by folate	25902	10841	1719	7298	4522	2618	471	6470	4524	275	10588	160428	635	123263	4548	441024
PC_65	Thiamine metabolism	84284	79178	27010	9054
PC_66	Riboflavin metabolism	7299	5167	645	80308	55312	51205
PC_67	Vitamin B6 metabolism	8566	316	57026	55163	29968
PC_68	Nicotinate and nicotinamide metabolism	65220	4860	5167	952	4837	10135	316	23530	23475	55191	65220	93100	30833	349565	83594	54981
PC_69	Pantothenate and CoA biosynthesis	587	8875	5167	1806	80347	1807	80025	60490	79717	60496	51733
PC_70	Biotin metabolism	686	3141
PC_71	Lipoic acid metabolism	387787	11019	51601
PC_72	Folate biosynthesis	4338	1719	5860	248	2643	6697	5805	2356	8836	4337
PC_73	Retinol metabolism	317749	9227	216	1543	1544	8228	6121	1553	54575	284541	158835	128	54884	340665	195814	51109	53630	64816
PC_74	Porphyrin and chlorophyll metabolism	7389	2990	3145	7390	210	2235	645	1371	5498	3052	1352	54575	124454	3162	1355	94033	326625
PC_75	Terpenoid backbone biosynthesis	9453	3156	2224	38	4597	4598	3422	10654	23590	79947
PC_76	Nitrogen metabolism	2744	759	440	1738	2752	2731	1373	1491	3034	275	2747
PC_77	Sulfur metabolism	6820	9060	10380	6783	445329	6821	50515
PC_78	Aminoacyl-tRNA biosynthesis	57038	4677	1615	7407	2617	5859	23438	4141	6301	23395	3735	124454	57505	25973	3376	118672	123263	80222	79587	51091	10352	2193	51067
PC_79	Metabolism of xenobiotics by cytochrome P450	1544	1571	2052	1109	218	2946	54575	128	64816
PC_80	Drug metabolism - cytochrome P450	1544	1571	1565	1555	218	316	2946	1553	4128	54575	128	1562	2327	64816
PC_81	Drug metabolism - other enzymes	3614	9	8824	151531	3251	2990	7372	1890	978	7498	8833	7172	1806	1807	1553	54575	221223	3704	83549	64816	51733
PC_82	Biosynthesis of unsaturated fatty acids	9200	8310	2182	9415	30	3030	10965	5538	570	51144	79966	122970	79071	54995	54898	9524
PC_83	Metabolic pathways	283871	646625	387787	2524	1757	3098	27090	9091	25902	151056	3614	5236	5315	64132	317749	8803	1716	4967	5288	9	8540	8824	8566	8613	9536	3613	10423	8630	8790	8395	8871	5198	8560	8564	8310	10558	247	8821	587	29906	1594	26227	5625	8972	11041	2954	11019	8707	10768	2137	57016	2182	8703	8702	2762	7358	27306	8813	8704	9942	242	1431	8706	6309	3417	7108	8818	2744	151531	25796	9060	9245	23556	23483	8879	9563	65220	9453	23417	10380	10841	8705	4338	216	1719	5053	5009	4860	3251	2806	100	445	3156	2629	4942	2597	435	1543	7298	383	1586	1583	5095	1544	1571	7389	2821	3073	7054	7173	5232	669	353	2592	2271	2990	440	3145	1589	1621	5860	2203	1738	3938	240	248	4048	230	7390	5409	7372	5162	1629	34	2539	5091	1588	4522	128	5634	4953	210	3283	2224	6476	10327	5320	7299	1610	2752	231	290	2683	1584	2799	411	6480	246	873	35	2720	28	2184	2805	6609	1109	1160	7306	262	6898	1503	239	1585	3067	6723	1890	10993	1644	2525	189	1312	4594	2526	2618	10606	3423	6342	5167	1581	2235	270	4200	2731	1841	6240	6916	38	4357	3712	4245	205	5444	10715	1633	790	3707	33	51056	952	4846	8659	9588	1892	51727	159	158	2643	218	6389	1373	11112	471	3633	978	1635	3242	1491	1854	2588	6470	2053	4351	6697	5743	3425	102724560	2645	178	1119	3155	2687	1371	1743	3293	2222	5277	6888	1638	4837	4190	3030	3034	10449	4524	686	36	438	23498	5859	7498	4047	2730	2937	9791	275	6999	22934	2194	501	3628	2747	5130	4122	37	10965	22929	10588	8833	3795	5498	2628	3141	5538	10914	1573	224	7915	3295	6448	6718	5226	6611	47	4597	11145	5408	4669	2581	5832	132	8382	51478	51227	7167	1603	5723	3291	18	6652	2583	5214	1723	4329	1593	622	2650	1579	95	5805	4598	2632	2356	8974	2531	5471	2673	316	5281	5426	1962	4051	4248	4249	4247	2527	2529	6482	6487	6484	3373	1806	80347	31	4507	10549	5337	23530	4534	427	3705	7264	7841	549	3422	570	1807	2593	2582	2712	5283	6713	23193	10682	10654	23475	1718	9104	27124	50814	6675	2131	15	5740	8942	7357	883	2987	10873	5106	3033	1595	7360	8639	1716	4056	1036	7368	60495	729020	440138	9489	26007	84992	84803	55750	65263	2645	4128	290	593	84920	54575	84274	124454	8813	81888	23318	284541	125061	254531	138050	2026	55191	5281	128	276	221223	54988	26275	80025	65220	10873	120227	93100	192134	160287	169355	54947	1562	113612	51181	284098	374569	51380	346606	259230	22856	130	27349	132158	2651	197258	162417	195814	100528030	26301	51166	55454	55821	80146	256435	5289	80308	55907	166929	140838	54965	51109	30833	201595	162466	84706	132789	130013	84720	2595	6489	9488	5279	10195	5372	1040	2134	2639	635	3081	55312	30815	113451	139596	60490	134147	326625	112483	199857	57026	51074	27235	51540	10826	84735	55748	126792	131669	144193	84693	259307	84890	349565	8309	5833	5051	11343	4548	3028	10229	10554	9514	9091	83440	84284	79814	56052	79178	79087	84245	55256	51102	81490	81849	79053	3704	2530	84002	84076	80270	54802	1798	27010	93183	85365	79611	79796	64768	441024	83549	79717	53630	64816	48	64087	79868	53947	51477	135152	57818	55902	54187	56848	56913	55808	55650	55301	55163	54995	51179	4337	51805	27430	51268	51196	54480	54344	5298	10400	1717	25834	9380	51733	11285	9331	10157	58510	5980	23761	23600	29958	54675	29947	11253	27034	1757	8869	1582	22845	11282	10020	10690	51601	10855	10402	10331	9487	10317	10998	51084	9615	51728	51004	29925	8708	51380	29968	29929	29880	874	2584
PC_84	Adrenaline and noradrenaline biosynthesis	8773	8417	11185	9342	7054	1621	5409	1644	4128	1312	6843	6530	4129	4837	6570	6616	6844	6531	6571	340024	23673	348932	28968	388662	55117	54716	10490
PC_85	Alpha adrenergic receptor signaling pathway	8773	10228	8677	5582	150	5578	151	152	6843	2767	148	147	6616	6844	5330	5331	5581	5580	3708	5332	9341	23236	51196
PC_86	Alzheimer disease-amyloid secretase pathway	102	5603	778	9546	351	5582	5579	1129	1132	1133	5045	1128	5126	5578	1131	5583	5595	5594	5122	5046	5596	1139	5584	5599	5601	5663	5664	6300	5602	23621	6868	776	5581	320	782	5588	5590	5580	3831	783	5598	8754	779	775	5600	5585	5586	1432	9159	5597	89832	147700	29941	54760	225689	83464	23385	10524	321	64837	89953	55851	25825
PC_87	Alzheimer disease-presenilin pathway	8326	7480	7476	1855	1856	7483	7484	8323	9313	4037	8324	4038	4041	10612	2081	4040	8510	11143	10307	7481	4312	7471	351	4313	4316	7472	5045	999	4318	3728	960	5126	1001	4317	5122	5046	1499	7474	4322	4851	7220	5663	5664	2932	4323	4324	4325	4301	7473	89780	54361	7477	23621	60	10097	59	71	72	70	58	6868	4036	4853	3516	4035	11167	7855	2535	5818	2066	9159	345651	54760	118856	83464	23385	323	10524	1857	7482	7479	4855	4327	23321	80326	7478	81029	64066	8325	83439	57113	64386	7976	6934	55851	53353	11317	7223	51384	51176	7224	8322	11211	4326	4854	8321	7225	10893	25825	7475
PC_88	Angiogenesis	5293	5286	5296	28514	7480	5287	7476	1855	1856	5338	285	8312	332	7041	10817	8440	9046	9404	5063	23683	10297	2353	4893	3265	5155	102724652	1410	5894	5154	7471	3315	5582	2246	3725	5579	389	2155	7472	5159	100137049	369	2260	6714	2152	2113	673	7422	5156	4690	5336	5578	5335	5921	3716	5787	5583	324	2149	5595	5295	5594	2042	2048	6464	4846	207	208	1499	3791	6932	5605	6774	7474	5584	6772	5290	5291	5599	6416	1398	1399	4851	5321	5294	5829	9261	2932	1948	2049	2047	842	7477	387	388	182	8788	23779	55615	25759	1947	5581	5604	7010	4853	5588	5747	5590	5580	3516	6654	6655	392	5058	5062	4214	5337	7855	10750	2535	2888	2886	5587	284	1432	7867	3091	79930	283748	5289	10818	8503	1857	7482	4855	1796	25865	80310	80326	81029	9047	7976	6934	54567	56848	56034	8877	10683	11317	8321	8605	3714	10000
PC_89	Apoptosis signaling pathway	8797	5293	317	5609	8795	8794	3551	1147	8837	10018	8575	9530	9531	9448	9131	2353	4049	7124	7157	5582	1965	3725	5579	3303	3303	3002	596	3309	3312	3482	1386	3310	5578	11016	466	467	468	22926	7132	5610	4790	7133	2999	5583	355	4792	5595	5594	207	208	3305	5290	5291	836	5599	5601	6416	5606	356	5294	8743	5602	3306	7009	840	842	8738	331	54205	4791	5971	5581	1390	5970	5588	5966	5580	4050	581	598	4170	5871	7186	8772	4214	638	330	329	8737	2021	841	8717	578	8491	8567	122953	599	843	9020	4217	1388	10017	56616	8793	1616	666	10000
PC_90	Axon guidance mediated by semaphorins	10570	8829	5364	2534	2242	5880	2444	387	5879	1020	5058	1807	1400	10371	1808	10507	9138	56896	5361
PC_91	Axon guidance mediated by Slit/Robo	4917	6585	6586	9353	9423	25	389	5880	1630	6387	998	7852	5879	57522	84628	59277	22854	6091
PC_92	Axon guidance mediated by netrin	5293	5286	5296	4917	5287	3983	8633	9423	5880	5336	5335	5295	5290	5291	1630	5294	7408	998	5879	4775	4773	4776	137970	58480	219699	23533	8503	84628	59277	22854
PC_93	B cell activation	5293	3551	1147	5603	2353	4893	3265	5894	3725	5579	4067	5788	801	369	973	5880	930	7409	5532	5336	933	4792	5595	5594	5777	5605	974	5290	5291	6850	5599	5601	5294	7410	6300	5602	2885	5879	5604	5580	695	6654	6655	5530	3709	3710	3708	5600	1432	29760	4215	4795	10451	10746
PC_94	Blood coagulation	2157	2147	2158	2159	5340	2161	5328	5327	462	5265	3827	2243	2244	2266	3818	5624	7450	351	5055	5054	2165	7056	5627	2811	3674	5345	2155	7035	2812	2152	2815	8858	2149	2814	5329	9002	51156	10544
PC_95	Cadherin signaling pathway	8326	7480	7476	7483	7484	5099	26025	8323	1500	8324	1014	5100	7481	1956	2064	7471	2534	7525	4067	7472	999	6714	2241	5770	1000	1459	2065	1001	1003	1499	7474	2444	2932	1002	1004	1006	1009	1010	1012	1013	7473	89780	54361	7477	60	10097	59	71	72	1460	70	58	5097	11167	1015	7855	1016	2535	2195	2066	345651	64403	64881	283106	57526	120114	7482	7479	92211	8642	65217	54825	27328	83259	80326	56135	28513	7478	81029	64072	8325	28316	5101	54510	83439	1952	7976	51294	6934	57717	9620	1951	2196	57575	51384	64405	51176	1007	1005	8322	11211	56128	56126	5098	8641	56141	56142	56144	56137	8321	1501	56129	56130	26167	56131	56132	56133	56121	56122	56123	56124	56125	29930	56097	56098	56099	56100	56103	56104	9708	56108	56109	56110	56112	56113	56105	56106	56114	9752	56140	56143	56145	56146	56136	56138	56139	56147	56134	7475	1008
PC_96	Cell cycle	5717	5718	10213	5709	9134	898	894	896	6119	5713	5710	10197	51550	5719
PC_97	Cholesterol biosynthesis	9453	3156	2224	2222	4047	4597	3157	4598	6713	10654	23590	91734
PC_98	Circadian clock system	406	8864	9575	5187	1453	102800317	8863	1407	1408
PC_99	Cytoskeletal regulation by Rho GTPase	57644	8976	10095	10109	10094	10092	1729	1730	9475	5063	10298	10382	203068	5216	389	4621	4619	4625	4624	4626	5880	3925	1072	5217	4627	4628	4629	7408	3984	10093	345456	60	998	59	5879	71	72	70	58	10383	23779	392	5058	5062	6093	10381	7280	4638	91807	347688	345651	58480	79784	55740	53904	140469	54434	10552	9138	84617	347733	81551	85366	81027	106821730	57144	4620	8735	1073	4622
PC_100	DNA replication	246243	5422	7150	7153	5111	6118	5424	5984	5982	5981	5985	5983	5425	5557	1763	7155	8290	440093
PC_101	EGF receptor signaling pathway	5293	5286	5287	9542	5609	22808	2069	5603	10156	10253	10252	10251	23683	1956	4893	3265	1950	7039	5894	2064	5582	5579	6237	369	673	5880	374	5336	5578	5335	5921	4763	2065	867	5583	10971	5595	5594	6464	5037	207	208	7529	2810	685	5605	6774	5584	6772	6778	6776	5290	5291	5599	5601	6416	5606	5294	6777	5608	6773	6300	5602	10718	7532	22800	7531	5516	5879	7534	5515	25759	5581	3084	5604	5588	7533	5590	5580	6654	6655	868	5527	2549	10750	5528	6775	5587	5525	5526	5922	2066	5600	5529	1432	153090	90102	5289	145957	139716	23533	53358	157310	1839	4217	4215	25865	81848	9462	23624	9846	10000	10746	4216
PC_102	untitled	112	109	115	111	9427	9630	5894	5582	1906	5579	5045	110599583	369	5573	5576	1908	5578	5566	1907	5568	5567	1910	5583	1909	5595	5594	5122	4846	2767	5575	5577	207	208	2977	5743	5605	2774	114	5584	1889	5321	2776	113	23478	5330	5331	2982	2983	5581	5604	5588	5590	5580	108	107	5593	5592	3709	3710	3708	5332	2778	196883	55811	90701	23236	10000
PC_103	FAS signaling pathway	317	8837	1677	1956	4000	2064	3725	2934	2735	1537	142	2737	4001	2065	355	822	836	5599	5601	6416	356	5602	840	842	839	84823	8772	841	2066	843	4217	1616	10038	143	11124	10039	85477
PC_104	FGF signaling pathway	5293	5286	5287	5609	5603	2255	10156	10817	10253	10252	10251	8822	8817	9064	4893	3265	5894	5582	2246	5579	2249	369	2251	2260	2248	2250	5880	5336	5578	5335	5921	2252	2263	2264	2261	5583	10971	5595	5594	5777	6464	5037	5518	5519	2254	207	208	7529	2810	5605	5584	5290	5291	5599	5601	6416	5606	5294	5608	6300	5602	2253	2257	7532	7531	5516	5879	7534	5520	5515	5521	5581	5604	5588	5590	5580	6654	6655	5527	10750	5528	5525	5526	5922	5600	5529	1432	55844	5289	10818	53358	2258	2256	2259	4217	4215	81848	27006	26281	10000	5522	10746	4216
PC_105	General transcription by RNA polymerase I	51082	7343	6908	5440	9519	7270	9013	9015	9014	284119	387332	129685	84172	54700	29893
PC_106	General transcription regulation	6874	2963	5432	2960	2961	2965	2962	6878	5437	2957	2958	5435	9519	2959	2967	7270	6882	6879	9013	6883	6880	80298	6873	129685	2968	2972	55290	51616	11036	29105
PC_107	Glycolysis	5230	226	2597	2023	2821	669	5213	2026	5315	5224	5211	3098	5313	3099	7167	80201	441531
PC_108	Hedgehog signaling pathway	51366	2735	2737	5573	5576	5575	5577	1452	102800317	2932	5727	6469	122011	1387	6608	27148	23291	51684	8945
PC_109	Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway	2918	2793	6003	6002	2916	6004	8490	112	10636	6001	10488	2788	109	115	8787	8786	111	2771	5836	154	1129	1132	153	2773	3350	1133	1211	1212	140	801	5573	5834	5837	1128	2997	5576	155	1813	5261	1385	5566	151	152	1131	1812	1815	1816	5568	5567	3274	156	146	3352	3351	3356	3358	3354	135	136	134	6751	6752	3355	2798	5575	5577	6754	2868	6753	2869	3363	6755	148	3269	147	4988	157	2774	114	4985	4986	4987	5997	2915	3357	2870	5256	5255	3361	4543	3763	3762	3760	4544	9628	10287	5998	5999	6000	2931	2932	2786	2790	3362	113	8218	2998	85397	54331	5908	5906	2782	2783	2770	2792	2785	2787	29899	1213	9586	1390	5996	108	107	2033	2911	9248	3360	2912	2917	2913	2914	6011	5260	84699	64764	26086	196883	148327	131890	1387	3765	5257	90993	59340	64407	55970	26575	94235	11255
PC_110	Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway	2918	773	2793	6003	6002	2916	6004	8490	10636	6001	2788	8787	8786	10125	9630	5582	5579	1129	1132	1133	2775	1211	1212	140	1128	1813	2784	5578	1131	1812	1815	1816	5583	156	135	136	2767	624	134	2769	6751	6752	2798	6754	2868	6753	2869	6755	4988	157	4985	4986	4987	5997	2915	5584	2870	623	5909	3763	3762	3760	9628	10287	5998	5999	6000	2776	2786	2790	8218	85397	54331	5908	387	5906	2782	2783	2792	2785	2787	29899	1213	5330	774	5331	5581	5588	5590	5580	5996	2911	2912	3709	3710	3708	2917	2913	2914	5332	777	84253	10235	26086	25780	115727	131890	3765	9138	59345	23236	64407	51277	51764	55970	26575	94235	11250
PC_111	Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction	2793	10681	2788	8787	6010	801	2779	5145	5566	5148	5132	5568	5567	810	1259	5957	5158	2786	2790	54331	2782	2783	2792	2785	2787	1258	6011	1261	59345	54714	51764	55970	94235
PC_112	Huntington disease	6874	3092	8976	26330	1780	317	5609	10753	10095	7161	2906	726	10092	1783	8867	8997	9026	161	25816	160	10126	2353	10382	2597	826	7157	3725	823	203068	6667	1537	1212	5880	23433	824	378	6908	825	627	207	208	2897	400	10124	836	3064	5601	6416	379	23647	9001	10123	60	998	4218	10097	377	382	59	5879	8655	71	72	70	58	10383	1742	375	381	391	4294	2902	2033	2903	2898	2899	2904	1781	10381	7280	1639	1778	841	2905	2900	2901	347688	345651	147968	23191	79659	116443	55567	1767	56171	10552	1387	10133	26999	140735	1769	84290	6457	81873	84617	347733	29993	64446	8626	81027	57381	11132	55081	11131	10000	51143	827	23473
PC_113	Hypoxia response via HIF activation	2861	5071	9283	7295	405	207	208	7428	2475	6097	7179	5728	3091	1387	112398	25828	54583	112399	10000
PC_114	Inflammation mediated by chemokine and cytokine signaling pathway	57644	5293	9034	10663	6366	6367	30837	9306	3551	6003	8573	1147	10095	10109	10094	3636	10092	5170	112	2788	3717	9655	5063	10725	111	4772	9630	10298	4893	3845	3458	5196	3627	5894	7450	2771	3725	3688	5579	389	2773	2775	3576	6348	6237	369	5197	4621	1291	1292	1293	4619	4625	388372	6347	6352	4624	4626	5880	7409	246	2784	414062	5336	3454	3726	3727	5566	239	5335	241	3683	2357	728	5568	5567	5742	3577	3579	2359	3695	5595	5594	6464	2767	2769	207	208	1230	1236	643	5743	4627	4628	4629	6774	729230	5290	5291	2870	2826	2829	5321	5294	1524	2833	5999	2776	2786	2790	5333	6356	1232	1233	1234	1235	1237	10803	5613	6362	54331	10093	5728	60	998	7852	387	59	5879	2770	2785	2787	71	72	70	58	6376	6364	6355	6354	391	4791	5330	5971	5331	5581	5970	5590	7373	6654	108	4775	5058	5062	6093	4773	817	10750	2185	3709	3710	3708	4776	5334	5332	4638	91807	345651	79784	89869	53904	388372	57580	122809	140469	10552	6357	1303	81873	84812	85366	56413	23236	106821730	51196	57642	57144	55970	94235	4620	8735	815	10000	10344	10850	4622
PC_115	Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade	8471	9252	8986	2353	3630	3481	5894	3479	3643	3480	3482	3645	2002	5921	6198	5595	5594	3667	5605	5606	6197	5604	6654	6655	6196	6195	6199	27330	8660
PC_116	Insulin/IGF pathway-protein kinase B signaling cascade	8471	4194	3636	5170	2309	3630	3481	3479	3643	3480	3482	3645	3667	5290	7249	2931	2932	7179	5728	4193	2308	7248	8660
PC_117	Integrin signalling pathway	79658	22798	5293	5286	5296	5287	10095	10109	10094	3911	5603	10092	81	2317	8515	9358	4893	3265	1277	1280	1281	1282	2335	5894	3689	3688	1290	2534	3685	3912	1278	389	3674	1284	3678	5911	6237	369	3915	3684	1301	1291	1292	1293	87	6714	3676	1302	673	5880	3691	3673	3693	7414	3694	3683	3687	1297	1289	2316	3655	3908	1296	284217	50509	3675	3695	3696	5595	1295	5295	6464	1287	88	5605	3682	1306	400	1445	5290	5291	5599	5601	6416	1398	1399	5606	3987	5294	5829	7408	8153	1286	8516	5602	3913	3672	9564	60	998	5908	5912	387	390	382	388	5906	5879	71	375	1285	5604	857	1300	5782	5747	7373	1307	6654	6655	3681	3611	3679	3914	3918	3680	2889	1288	1299	1298	1793	2185	3910	5597	3909	345651	1305	55679	85301	85377	55738	5289	9844	8503	27289	10552	63916	4217	1303	4215	81873	59277	29780	55742	51277	57642	1755	22801	50807	1308	23092	10746	57826	7094	10319	4216
PC_118	Interferon-gamma signaling pathway	8835	30837	9021	9306	5603	3717	9655	8554	9063	3458	3459	3716	5595	5594	5777	3460	6772	5599	5601	6300	5602	5600	1432	51588	225689	122809	1154	10401
PC_119	Interleukin signaling pathway	3551	1147	5170	2309	2353	4609	4893	3552	3559	5894	3565	3569	3570	3576	369	6722	3560	673	3578	6688	2002	3589	5921	3566	3577	3579	3563	5595	2005	5594	6464	4846	207	208	3667	1026	3572	6774	3600	2004	6772	6778	6776	5290	5291	2475	3594	1027	9261	2932	6777	6197	3718	6773	3597	3568	6654	6655	3588	5598	3601	3587	3590	3598	6775	6196	6195	5597	121599	225689	3595	8569	84174	59067	2872	51561	53832	27330	10000	8660
PC_120	Ionotropic glutamate receptor pathway	8773	6512	2906	8676	9342	6843	2897	2890	2891	2892	6507	6506	6505	4905	2893	6511	6616	6844	2902	2903	2898	2899	2904	816	817	2912	2913	2905	9341	2900	2901	415117	246213	116443	8673	9463	57084	27091	815	50944	10369
PC_121	JAK/STAT signaling pathway	8651	3717	8554	9063	5788	3716	6774	6772	6778	6776	6777	3718	6775	1432	10401
PC_122	Metabotropic glutamate receptor group III pathway	8773	2918	6512	773	2793	10681	2916	2906	2788	9342	2771	2773	5573	5576	2784	5566	5568	5567	6843	5575	5577	2897	2915	2890	2891	2892	6507	6506	6505	2893	6511	2786	2790	5613	6616	112755	2782	2783	6844	2770	2785	2787	774	782	2902	2903	2898	2899	2904	2911	2917	2914	2905	9341	777	2900	2901	6804	116443	143187	55811	8673	59345	57030	94235
PC_123	Metabotropic glutamate receptor group II pathway	8773	773	2793	10681	2788	9342	2771	2773	2775	5573	5576	2784	5566	2780	5568	5567	6843	5575	5577	2786	2790	5613	6616	112755	2791	2782	2783	6844	2770	2785	2787	774	782	2912	2913	9341	777	6804	55811	8673	59345	94235
PC_124	Metabotropic glutamate receptor group I pathway	2906	5579	5573	5566	5568	5567	2767	2769	5575	2897	2915	2776	5613	2902	2903	2904	2911	3708	2905	5332	2901	2907	9456	116443
PC_125	Muscarinic acetylcholine receptor 1 and 3 signaling pathway	8773	2793	10681	2906	2788	9342	9630	5582	5579	590	1128	2784	5578	1131	43	6843	5583	1103	2767	5584	2776	2786	2790	6616	112755	2791	2782	2783	6844	2785	2787	5581	5588	5590	2902	5580	2903	2904	3709	3710	3708	2905	5332	9341	5585	5586	6572	6804	29941	116443	8673	60482	59345	94235
PC_126	Muscarinic acetylcholine receptor 2 and 4 signaling pathway	8773	2793	8675	10681	2788	8676	9342	2771	590	1129	1132	2773	2775	5573	2779	5576	2784	5566	2780	43	5568	5567	6843	1103	5575	5577	6535	3763	3762	3760	2786	2790	5613	6616	112755	2791	2782	2783	6844	2770	2785	2787	6810	9341	6572	6804	415117	3765	55811	8673	60482	59345	94235
PC_127	Nicotinic acetylcholine receptor signaling pathway	441294	643854	57644	64005	4649	4641	4542	8773	8675	4430	8676	4642	9342	1134	590	1146	4621	1140	4619	4625	4624	4626	1141	43	6843	1103	1138	1143	1136	4627	4628	4629	1139	10120	1137	6535	60	6616	10121	112755	59	6844	71	72	70	58	1145	1142	1144	6810	4643	4647	1135	8973	9341	6572	6804	89832	345651	4648	79784	79990	84700	100128553	415117	126969	53904	140469	399687	80179	8673	60482	57053	4651	55930	4640	55584	51168	4620	8735	4645	4646	22989	4644	4622	23026
PC_128	Notch signaling pathway	4242	102	9148	4851	8650	5663	182	6868	8788	4853	3516	9541	222484	3955	84708	23385	9794	55294	84461	4855	140825	2530	23509	54567	10683	11317	4854	3714	9612
PC_129	Oxidative stress response	29904	5603	11072	4609	3725	596	7295	2002	1843	1649	6772	5599	5601	6416	5606	5321	1845	5608	6300	4149	1844	4208	1846	1850	5600	1432	1847	1848	1849	92235	338599	150290	142679	6815	1852	8569	78986	80824	128853	63904	2872	56940	51207	11266	11221
PC_130	PDGF signaling pathway	79658	143872	5293	5296	3551	1147	5170	395	9901	10156	8440	3717	4983	9252	8986	9402	8518	25803	2353	4609	4893	3265	5155	5894	5154	3725	5159	369	2078	6722	2113	673	7409	5156	4690	5336	5578	5335	2002	5921	6198	3716	5595	5295	2005	5594	6464	208	1997	5605	6774	2117	6772	6778	6776	5290	5291	5599	5294	9261	2931	2932	2077	6777	6197	3718	6773	7410	5602	2885	1999	23779	25759	393	2313	5604	2551	6654	6655	392	394	5598	2549	10750	3709	3710	3708	6775	5157	5922	6196	6195	1998	7392	9230	5586	5597	55843	57522	94134	51199	5289	225689	23533	53358	8503	85004	26750	26292	54738	2000	64333	8569	2872	26298	6199	27330	10451	2001	23092	9846	22981	10746	4216
PC_131	PI3 kinase pathway	5296	2793	10681	3636	5170	2309	3717	9630	4893	2771	3643	2773	2784	2780	6198	5295	4846	2767	207	208	5731	3667	5290	5291	2932	2776	842	5728	2782	2783	2770	7534	2792	4303	6654	6655	2308	3632	23533	8503	59345	6199	10000
PC_132	Parkinson disease	1861	5688	9246	8573	5338	2861	8417	5414	5071	9283	6623	9134	3932	2534	7054	7525	4067	3055	2268	7345	3303	3303	3309	3312	6714	3310	4729	2002	1459	5689	898	156	5682	5683	5684	5685	10971	5595	5686	5594	7529	2810	3305	157	6622	3313	5699	1445	2444	5599	5601	1452	1453	102800317	5691	640	6300	5602	3306	5687	7532	7531	7534	1460	7332	1455	6531	7533	5598	8454	4735	6620	1432	3091	27433	23673	118424	122011	283106	143471	225689	1731	55294	5695	5413	23291	10273	9627	1456
PC_133	Plasminogen activating cascade	5340	5328	5327	2243	2244	2266	4312	5055	5054	4314	4018	5345	4318	4322	5329	1361
PC_134	TCA cycle	1431	2271	5160	5161	4190	8802	4967	5164	6391	50
PC_135	TGF-beta signaling pathway	658	7044	2660	4092	4093	5603	6885	4091	7092	2661	8928	10637	10220	27302	9372	9210	4893	3265	3725	3624	3625	6237	7043	650	652	651	6497	6498	649	1386	8061	3726	3727	655	653	654	2286	92	5595	2657	5594	656	657	91	7046	94	7048	2668	8200	5599	5601	6300	5602	3626	2662	56911	83729	7042	2280	2281	4088	90	2033	25805	4089	93	659	10454	5600	4087	4086	1432	269	392255	9765	151449	353500	196513	130399	79753	1387	4838	4090	4435	10370	9518	64750	57154	9573	2658	7093
PC_136	T cell activation	5293	5296	3551	1147	27040	8440	9402	5063	2353	4893	3265	5894	915	3725	3932	916	5788	917	801	369	940	673	7409	5532	4690	5335	919	4792	5595	5295	5594	207	208	941	5605	1445	942	5290	5291	7454	7535	5599	5601	5533	5294	7410	998	5879	5604	5588	6654	6655	5530	3937	5058	5062	4214	3708	5289	8503	10451	10000
PC_137	Toll receptor signaling pathway	7099	4794	3551	1147	7098	6885	7097	3725	929	2002	7128	4792	5595	5605	1326	5599	5601	5606	3654	114609	7334	5604	387522	9641	3661	10454	1432	389898	100302736	148022	10010	4615	51295	81793	54472	54106	51311	51135	51284	29110	10333	7189	11213	23643
PC_138	Transcription regulation by bZIP transcription factor	6874	5573	5576	2963	5432	5434	6908	2960	2961	5575	5577	2965	2962	6878	5437	2957	2958	5435	9519	5441	2959	9586	2033	2967	7270	6882	6879	9013	6883	6880	80298	84699	6873	387332	64764	129685	148327	2968	1387	2972	90993	55290	51616	29893	11036	8458	29105
PC_139	VEGF signaling pathway	5293	5286	5296	5287	7041	9404	23683	4893	3265	102724652	1410	5894	3315	5582	5579	369	2113	673	5880	7422	5336	5578	5335	5583	5595	5295	5594	4846	207	3791	5605	5584	5290	5291	5321	5294	5829	9261	842	5881	5879	23779	55615	25759	5581	5604	5588	5747	5590	5580	392	5587	1432	7867	3091	5289	8503	25865	9047	56848	8877
PC_140	Wnt signaling pathway	8326	658	607	7480	7476	8289	1855	1856	7483	7484	8312	8841	6478	6885	5099	2788	8467	26025	8323	6907	8324	4041	1014	4040	5100	4772	9350	9630	7481	7471	5582	5579	7472	6295	999	5532	2784	5578	1000	1459	1001	5583	1496	6594	2767	2769	409	1003	1495	1499	407	657	91	7046	7474	5584	5533	1452	1453	408	102800317	2932	2776	2786	2790	6595	6597	1002	1004	1006	1009	1010	1012	1013	1488	7473	89780	54361	7477	56911	54331	5516	2782	2783	5534	2785	2787	5515	1460	1455	5330	5331	5581	7088	7089	7090	7091	5588	5590	5580	166	5097	5530	2033	6598	11167	1015	4775	5527	1487	7855	4773	4089	3065	1016	2535	2195	6596	3709	3710	3708	5528	4776	5332	5525	5526	4086	5529	6425	6424	6604	10847	64403	9557	6477	6422	64881	122011	79412	130399	283106	57526	6601	120114	2487	3066	1387	6599	6603	1857	7482	7479	85409	6605	85407	6602	6423	92211	8642	57634	5535	83999	65217	4090	90665	90780	55869	54825	27328	83259	79718	80326	56135	28513	7478	81029	64072	8325	79816	59345	28316	5101	54510	83439	1952	7976	51294	23236	6934	57717	3070	51339	9620	1951	2196	50485	57575	51764	51701	55970	8727	51384	29119	64405	51176	94235	23291	1007	1005	54617	8322	11211	56128	56126	5098	8641	56141	56142	56144	56137	8321	8945	22881	26108	56129	56130	26167	56131	56132	56133	56121	56122	56123	56124	56125	29930	56097	56098	56099	56100	56103	56104	9708	56108	56109	56110	56112	56113	56105	56106	56114	9752	56140	56143	56145	56146	56136	56138	56139	56147	56134	7475	1456	1008
PC_141	mRNA splicing	9129	6629	6626	8233	9410
PC_142	p53 pathway	4194	7161	5170	4616	9219	10912	11200	7157	983	3146	891	1647	898	1017	5371	995	207	208	2810	1026	5290	6612	7179	5728	6613	5516	7341	5515	4193	2033	7186	472	545	3065	7486	23522	1387	8850	23411	25942	8626	51512	10000
PC_143	Ubiquitin proteasome pathway	55236	11060	10213	11065	9246	10533	7317	7318	5704	7319	5713	7321	7324	5710	7327	7323	3093	7334	7326	7322	7320	7332	4193	7337	5708	9690	7336	27338	389898	89910	9039	10477	83737	7325	5707	11219	11059	64750	57154	29089	10055	10054	5719	51619
PC_144	ATP synthesis	506	509
PC_145	Acetate utilization	79611	55902	84532
PC_146	Adenine and hypoxanthine salvage pathway	4860	3251	100	353	7498	56952
PC_147	Alanine biosynthesis	587	586
PC_148	Allantoin degradation	55821
PC_149	Aminobutyrate degradation	18
PC_150	Androgen/estrogene/progesterone biosynthesis	8630	8435	1588	3292	6646	3293	3294	3988	51478
PC_151	Arginine biosynthesis	5009	445	435	790	1373	162417
PC_152	Ascorbate degradation	6120
PC_153	Asparagine and aspartate biosynthesis	440
PC_154	Coenzyme A biosynthesis	53354	79877	80025	79646	79717	55229
PC_155	Cysteine biosynthesis	102724560
PC_156	De novo purine biosynthesis	4833	10201	203	3615	4830	2618	4831	6240	205	159	158	6241	471	8833	204	8382	5471	4832	2987	50484	122622	57453	158067	50808	29922	26289
PC_157	De novo pyrimidine deoxyribonucleotide biosynthesis	4833	7298	4830	4831	1841	6240	6241	1854	4832	50484	134637	57453
PC_158	De novo pyrimidine ribonucleotides biosythesis	4833	4830	1503	4831	790	1373	1723	4832	57453	56474
PC_159	Flavin biosynthesis	80308	55312
PC_160	Tetrahydrofolate biosynthesis	1719	7298	2643	2356	200895
PC_161	Formyltetrahydroformate biosynthesis	1719	7298	10797	25902	200895	4548
PC_162	Fructose galactose metabolism	226	229	2592	230	3098	3795	3099	2582	80201
PC_163	Glutamine glutamate conversion	2746	2752	2747	51557
PC_164	Heme biosynthesis	7389	2058	3145	210	2235	1371	5859	5498	1352	124454	55316
PC_165	Isoleucine biosynthesis	10994	587	586
PC_166	Leucine biosynthesis	587	586
PC_167	Lipoate_biosynthesis	11019
PC_168	Mannose metabolism	5373	2762	4351	5372	29926	29925
PC_169	Methionine biosynthesis	4548
PC_170	Methylcitrate cycle	48	3658
PC_171	Methylmalonyl pathway	5095	5096	4594	84693
PC_172	N-acetylglucosamine metabolism	9945	10007	2673	132789	80896	51005
PC_173	O-antigen biosynthesis	9945	23483	2673
PC_174	Ornithine degradation	51582	4953	113451
PC_175	Pyridoxal-5-phosphate biosynthesis	55163	29968
PC_176	Pentose phosphate pathway	2821	3098	7086	6888	22934	5226	3099	80201
PC_177	Phenylethylamine degradation	314	26	8639
PC_178	Purine metabolism	4907	7498	272	9615
PC_179	Pyridoxal phosphate salvage pathway	8566	55163
PC_180	Pyrimidine Metabolism	4907	978	18	4329	1806	1807	1809	1808	56896	51733
PC_181	Pyruvate metabolism	1431	5160	5091	5315	5161	5313	5105	4199	47	171425
PC_182	S-adenosylmethionine biosynthesis	4144	4143	4548
PC_183	Salvage pyrimidine deoxyribonucleotides	7083	978	134637
PC_184	Salvage pyrimidine ribonucleotides	4833	151531	4831	4832	7378	134637	7371	83549	54963
PC_185	Serine glycine biosynthesis	26227	5723	29968
PC_186	Succinate to proprionate conversion	5096	4594	55862
PC_187	Thiamine metabolism	79178	27010
PC_188	Threonine biosynthesis	79896
PC_189	Triacylglycerol metabolism	3990	3991
PC_190	Valine biosynthesis	10994	587	586
PC_191	Vitamin B6 metabolism	8566	55163	29968
PC_192	Xanthine and guanine salvage pathway	4860	3251	56952	9615
PC_193	5-Hydroxytryptamine biosynthesis	7166	1644	121278
PC_194	5-Hydroxytryptamine degredation	10840	8854	216	217	4128	4129	8659	219	218	220	223	501	224	160428	126133	259307	64577
PC_195	5HT1 type receptor mediated signaling pathway	8773	2793	3777	10681	2788	9342	2771	2773	3350	2775	5576	2784	5566	5568	5567	6843	3352	3351	3354	3355	5577	6532	2786	2790	5613	113	54331	6616	2791	2782	2783	6844	2770	2785	2787	108	6809	9341	59345	51305	55970	94235
PC_196	5HT2 type receptor mediated signaling pathway	2793	3777	10681	2788	9630	5582	5579	2784	5336	5578	5335	5583	3356	3358	2767	6532	3357	5584	2776	2786	2790	5333	6570	54331	2791	2782	2783	2785	2787	5330	5331	5581	5588	5590	5580	6571	5334	5332	89869	84812	59345	51305	23236	51196	55970	94235
PC_197	5HT3 type receptor mediated signaling pathway	8773	3777	9342	6843	6532	6570	6616	6844	6571	6809	9341	8673	51305
PC_198	5HT4 type receptor mediated signaling pathway	8773	2793	3777	10681	2788	9342	2784	6843	6532	2774	2786	2790	113	6570	54331	6616	2782	2783	6844	2785	2787	6571	108	6809	3360	9341	8673	59345	51305	55970	94235
PC_199	Beta1 adrenergic receptor signaling pathway	8773	2793	10681	2788	9342	153	5576	2784	5566	5568	5567	6843	5577	2774	2786	2790	5613	113	54331	6616	2782	2783	6844	2785	2787	108	6809	9341	8673	59345	55970	94235
PC_200	Beta2 adrenergic receptor signaling pathway	2793	10681	2788	154	5576	2784	5566	5568	5567	5577	2774	2786	2790	5613	113	54331	2782	2783	2785	2787	108	59345	55970	94235
PC_201	Beta3 adrenergic receptor signaling pathway	8773	2793	10681	2788	9342	155	2784	6843	2774	2786	2790	113	54331	6616	2782	2783	6844	2785	2787	108	6809	9341	8673	59345	55970	94235
PC_202	Cortocotropin releasing factor receptor signaling pathway	8773	2793	10681	2788	9342	9630	5443	1392	2784	6843	2767	104909134	2774	2776	2786	2790	54331	6616	2782	2783	6844	2785	2787	6809	1395	9341	8673	59345	55970	94235
PC_203	Gamma-aminobutyric acid synthesis	7915	18	2572	2571	51380
PC_204	Histamine H1 receptor mediated signaling pathway	2793	10681	2788	9630	5582	5579	2784	5336	5578	5335	5583	2767	3269	5584	2776	2786	2790	5333	54331	2782	2783	2785	2787	5330	5331	5581	5588	5590	5580	3709	3710	3708	5334	5332	89869	84812	59345	23236	51196	55970	94235
PC_205	Histamine H2 receptor mediated signaling pathway	2793	10681	2788	5576	2784	5566	5568	5567	3274	5577	2774	2786	2790	5613	113	54331	2782	2783	2785	2787	108	59345	55970	94235
PC_206	Histamine synthesis	3067
PC_207	Oxytocin receptor mediated signaling pathway	8773	2793	10681	2788	9342	9630	5582	5579	2784	5336	5578	5335	6843	5583	2767	5021	5584	2776	2786	2790	5333	54331	6616	2782	2783	6844	2785	2787	5330	5331	5581	5588	5590	5580	6809	5334	5332	9341	89869	84812	8673	59345	23236	51196	55970	94235
PC_208	P53 pathway feedback loops 1	4194	7161	7157	4193	64326	8626
PC_209	Ras Pathway	5293	5609	5338	5863	5603	5170	5063	4893	3265	3845	5894	3725	389	369	5898	5899	6722	2113	673	5880	1386	2002	5595	5594	6464	207	5605	6774	6772	5290	5291	5599	5601	6416	5606	5294	9261	2931	2932	6197	5608	6300	5602	56911	5881	998	387	388	2885	5879	5604	6654	6655	5900	7074	5058	5062	4214	5337	6196	6195	5600	1432	7867	5289	55770	23179	27330	10000	4216
PC_210	Thyrotropin-releasing hormone receptor signaling pathway	8773	785	773	2793	10681	2788	9342	9630	1081	7252	5582	5579	2784	5336	5578	5335	7200	6843	5583	2767	7201	5584	2776	2786	2790	5333	784	54331	6616	2782	2783	6844	2785	2787	5330	774	5331	5581	782	5588	5590	5580	783	6809	5334	5332	9341	777	89869	84812	8673	59345	23236	51196	55970	94235
PC_211	Vasopressin synthesis	5020	551	1363	5066	5550	60559	23478	9789	9581	387921	90701
PC_212	Vitamin D metabolism and pathway	1594	2638	2165	5914	7421	6256	1593	339761
PC_213	p53 pathway by glucose deprivation	7161	5565	7157	6198	207	208	7249	5571	5563	5516	5515	3476	5562	1978	6009	6794	7248	8626	6199	10000	5564
PC_214	p53 pathway feedback loops 2	5293	5286	5296	5287	5603	7161	5170	5288	4609	4893	3265	3845	7157	5925	890	898	1017	5295	5933	207	208	1499	1026	5290	5291	5294	900	6300	7179	5728	5516	5515	8900	472	545	5600	1432	6477	5289	23533	8503	8626	10000
PC_215	5-arachidonylglycerol_biosynthesis	4023	5330	5331	51365	200879	23236	747
PC_216	Anandamide_degradation	2166
PC_217	Bupropion_degradation	1555
PC_218	Endogenous_cannabinoid_signaling	773	2793	8913	2788	2773	2775	2784	1268	4792	2915	2786	2791	2782	2783	2770	2785	2787	5330	774	5331	2911	59345	23236	94235
PC_219	GABA-B_receptor_II_signaling	773	2793	112	8913	2788	115	9568	111	2773	2775	5573	5576	2784	5566	5568	5567	5575	5577	114	3760	2786	113	2791	2782	2783	2770	2785	2787	774	108	107	196883	59345	2550	94235
PC_220	Synaptic_vesicle_trafficking	6861	10497	9066	5864	6857	6843	2054	4905	6616	112755	6812	6804	148281	201294	22999	91683	127833	440279	84258	102724488	23208
PC_221	Angiotensin_II-stimulated_signaling_through_G_proteins_and_beta-arrestin	2793	10681	2788	183	5894	2784	5578	1958	2002	156	5595	5594	185	409	2869	157	5605	2870	408	2776	2786	2790	2791	2782	2783	2785	5330	5331	5604	3709	3710	3708	59345	23236	94235
PC_222	PNAT	8773	3777	2037	9342	2771	7054	2773	1621	2035	5576	1813	2784	5566	2781	1644	2316	4128	1812	1815	1816	1312	5568	5567	6843	4129	5577	5501	2786	5613	113	6616	2791	5499	2782	2783	6844	2770	2785	6531	6571	108	6809	9341	54102	8673	2036	59345	51305	84152	94235	23136
PC_223	Enkephalin release	2793	10681	2788	5179	5173	2771	2773	2775	5576	1385	2784	5566	5568	5567	5577	4988	2774	4985	2786	2790	5613	113	54331	2782	2783	2770	2785	2787	1390	108	59345	55970	94235
PC_224	Nicotine_degradation	11185	1548	1549	2328	1553
PC_225	Opioid proenkephalin pathway	8773	2793	10681	2788	9342	5179	5173	2771	2773	2784	6843	4985	2786	2790	113	54331	6616	2782	2783	6844	2770	2785	2787	108	6809	9341	8673	59345	55970	94235
PC_226	untitled	8773	2793	10681	2788	9342	5020	551	5173	2771	2773	2775	2784	6843	4986	2786	2790	113	54331	6616	2782	2783	6844	2770	2785	2787	108	6809	9341	8673	59345	55970	94235
PC_227	Opioid proopiomelanocortin pathway	8773	2793	10681	2788	9342	5443	2771	2773	2775	2784	6843	4985	2786	2790	113	54331	6616	2782	2783	6844	2770	2785	2787	108	6809	9341	8673	59345	55970	94235
PC_228	p38 MAPK pathway	29904	5603	6885	9252	8986	3315	1977	6722	3554	466	2002	1647	1843	6416	9261	5608	6300	100271849	4294	4208	4209	10454	5600	1432	7867	4217	8569	2872	23118	7189	4216	11221
PC_229	Nicotine pharmacodynamics pathway	3777	2037	8913	7054	2035	1813	5566	1141	1644	2316	1815	1138	1143	1136	1137	54331	5499	2782	2770	1142	6571	108	775	8973	54102	2036	51305	84152
PC_230	untitled	6498	5970	7050
PC_231	Gastrin_CCK2R_240212	4221	5170	9314	2309	8460	3717	6615	5328	2353	2520	5894	3315	3725	3688	5579	885	1977	3685	7525	4067	6667	4314	801	3576	369	596	1191	1071	6722	4953	999	6714	673	1386	6925	1385	1363	5578	5566	1958	5335	2002	6261	5568	5567	6198	5583	4792	5595	5295	2005	5594	952	6464	4842	207	7529	409	887	1499	5743	3667	5605	5468	6774	5997	1445	5291	836	5599	5601	6416	1398	8870	5321	1452	1453	5829	7182	102800317	2932	6197	5608	5602	5136	9564	54331	5728	998	387	6194	2782	2885	5879	393	100271849	5581	6670	5604	3000	1390	5588	1759	5747	5580	6571	5781	4208	581	598	6654	5530	107	2308	5058	5607	5598	6093	4773	1978	5592	2185	3708	4209	5587	6009	6263	6195	1994	1432	814	4296	64283	84254	219931	51564	8165	6262	572	10256	84335	1173	1839	9020	25865	53373	7189
PC_232	Interleukin-6 signaling	9021	3717	3569	3570	867	3716	7297	3572	6774	6772	5781
PC_233	PI3K Cascade	5296	2255	8823	8822	8817	9965	2246	2249	2247	2251	2260	2248	2250	2252	2263	2264	2261	5295	2254	3667	2322	5290	5291	2323	2253	2885	5781	2549	152831	5289	10818	30849	8074	27006	26281	54106	9365	9846	8660
PC_234	MAPK3 (ERK1) activation	3717	3569	983	3570	3716	5595	7297	3572	5604	5781
PC_235	Translesion synthesis by REV1	5980	7314	7316	5111	6118	6117	6119	5984	5982	5981	5985	5983	6233	7311	51455	10459
PC_236	Recognition of DNA damage by PCNA-containing replication complex	7398	7314	7316	5111	6118	6117	5424	6119	5984	5982	5981	5985	5983	5425	5427	9978	6233	7311	7320	5426	8451	8450	10714	1642	57599	57804	56655	54107	56852	51514
PC_237	Translesion Synthesis by POLH	7314	7316	5111	6118	6117	6119	5984	5982	5981	5985	5983	7415	6233	7311	55666	7353	25898	83932	5429
PC_238	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	4968	85236	8930	3012	8970	3015	474382	7374	3014	3013	8348	3018	7013	102724334	3017	121504	3017	4913	6996	7014	8290	8338	8349	23583	723790	94239	128312	55247	8334	8345	252969	255626	65057	79661	8341	8331	8342	8340	26277	55766	25913	54386
PC_239	Cleavage of the damaged pyrimidine	4968	85236	8930	3012	8970	3015	474382	7374	3014	3013	8348	3018	7013	102724334	3017	121504	3017	4913	6996	7014	8290	8338	8349	23583	723790	94239	128312	55247	8334	8345	252969	255626	65057	79661	8341	8331	8342	8340	26277	55766	25913	54386
PC_240	Recognition and association of DNA glycosylase with site containing an affected purine	4968	85236	3012	8970	3015	474382	3014	3013	8348	4350	3018	7013	102724334	3017	121504	3017	7014	8290	8338	8349	723790	94239	128312	55247	8334	8345	255626	65057	8341	8331	8342	8340	26277	55766	25913	54386	4595
PC_241	Cleavage of the damaged purine	4968	85236	3012	8970	3015	474382	3014	3013	8348	4350	3018	7013	102724334	3017	121504	3017	7014	8290	8338	8349	723790	94239	128312	55247	8334	8345	255626	65057	8341	8331	8342	8340	26277	55766	25913	54386	4595
PC_242	Displacement of DNA glycosylase by APEX1	4968	8930	7374	328	4350	4913	6996	23583	4595
PC_243	POLB-Dependent Long Patch Base Excision Repair	5423	142	3978	328	2237	670	54936	10038
PC_244	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	5423	328
PC_245	Resolution of AP sites via the single-nucleotide replacement pathway	5423	7515	3980
PC_246	SLBP independent Processing of Histone Pre-mRNAs	6628	22916	6635	6636	6637	6634	134353	4686	25888	84967
PC_247	Activation of BIM and translocation to mitochondria	10018	5599	8655
PC_248	Activation of BAD and translocation to mitochondria	596	10971	207	208	7529	2810	5533	637	7532	7531	5534	7534	7533	572	10000
PC_249	Activation of NOXA and translocation to mitochondria	7157	1869	5366	7027	7029
PC_250	Activation and oligomerization of BAK protein	637	578
PC_251	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	10018	596	6774	637	598	5366	572	90427	27113
PC_252	Release of apoptotic factors from the mitochondria	5414	54205	581	578	56616
PC_253	Formation of apoptosome	317	842	54205	51074	57099	22900
PC_254	Activation of caspases through apoptosome-mediated cleavage	317	836	840	842	331	54205
PC_255	SMAC (DIABLO) binds to IAPs	317	836	840	842	331	54205	56616
PC_256	SMAC(DIABLO)-mediated dissociation of IAP	317	836	840	842	331	54205	56616
PC_257	Apoptotic cleavage of cellular proteins	324	836	2339	10134	660	840	839	6304	5588	5747	5580	6093	329	841	63967	51765	22985	8428
PC_258	SMAC, XIAP-regulated apoptotic response	5414	836	840	331	56616
PC_259	Opioid Signalling	5443	5173	4988
PC_260	PKA-mediated phosphorylation of CREB	1385	5566	5568	5567	5613
PC_261	CaMK IV-mediated phosphorylation of CREB	801	1385	3838	816	818	817	814	84254	10645	815
PC_262	Calmodulin induced events	5582	801	5578	156	5580
PC_263	Cam-PDE 1 activation	801	5136	5153	5137
PC_264	phospho-PLA2 pathway	5594	5321
PC_265	CaM pathway	801
PC_266	PLC beta mediated events	346562	10768	2771	2773	2775	2779	2781	2780	2770	5330	5331	3709	3710	3708	5332	23236
PC_267	ALKBH2 mediated reversal of alkylation damage	121642
PC_268	ALKBH3 mediated reversal of alkylation damage	10973	51008	221120	84164
PC_269	Electric Transmission Across Gap Junctions	10052	84694	56666	24145	57369
PC_270	Presynaptic depolarization and calcium channel opening	785	773	784	774	782	783	777	55799	9254	27092	11094	781	10369
PC_271	Neurotransmitter release cycle	27163
PC_272	Neurotransmitter clearance	6582	6580	590	43
PC_273	Neurotransmitter receptors and postsynaptic signal transmission	285242	8001	9177	2741	2742	3359	2743	200909	170572
PC_274	Formation of RNA Pol II elongation complex	6829	5433	904	905	8812	2963	2068	7936	5432	5434	2071	6917	5430	5431	2965	2962	5438	4300	1022	1025	902	4331	22916	5437	5439	5440	8178	5435	5436	5441	6827	4298	6749	4686	2966	2967	6924	6921	6923	79577	9646	404672	6830	51497	51224	54623	123169	25920	23168	2968	55840	85403	55677	80349	7469	27125	9150	11198
PC_275	IRS-mediated signalling	5296	5295	3667	5290	5291	8660
PC_276	RAF-independent MAPK1/3 activation	5595	5594	1843	1844	1846	1850	8682	1847	1848	1849	1852	80824	11221
PC_277	MAPK1 (ERK2) activation	3717	3569	3570	3716	5594	7297	5605	3572	5781
PC_278	SOS-mediated signalling	4893	3265	3845	3667	2885	6654	8660
PC_279	Formation of the Early Elongation Complex	6829	5433	2963	2068	7936	5432	5434	2071	5430	5431	2965	2962	5438	1022	902	4331	22916	5437	5439	5440	5435	5436	5441	6827	4686	2966	2967	404672	51497	25920	2968	7469	9150
PC_280	Inhibition of replication initiation of damaged DNA by RB1/E2F1	5925	5422	5518	5519	5557	5558	5516	5515	1869	23649	7027	7029	28227
PC_281	E2F-enabled inhibition of pre-replication complex formation	5001	5000	983	891	4998	4999	23595	84515	23594
PC_282	Activation, translocation and oligomerization of BAX	637	581
PC_283	Effects of PIP2 hydrolysis	9162	10125	1606	5583	1608	8526	1609	5581	5588	5580	7222	8525	3709	3710	3708	8527	139189	10235	160851	57113	7225	1607
PC_284	Disinhibition of SNARE formation	6814	5582	5579	5578	6810
PC_285	GPVI-mediated activation cascade	5296	5170	27040	80739	3932	2534	4067	5880	7409	5336	5295	5777	2207	5290	5291	6850	5294	7410	998	387	388	5879	391	5590	5781	3937	146850	10630	23533	8503	51206	51266	10451
PC_286	Platelet degranulation	5874	7044	5768	3671	10257	81	813	2277	5099	9948	9749	23052	6647	2157	2162	1675	5340	5265	12	2	7076	3827	5155	1950	7040	3481	335	2243	2244	2266	350	2335	5004	197	213	5473	5196	7018	226	5154	3273	1	7450	3479	351	3690	5054	710	7123	5627	5660	5216	7057	3674	5341	5345	308	967	6678	801	5552	7043	1191	3309	2153	87	3920	3082	7422	6403	5175	948	7414	5005	2316	928	1072	5267	88	7078	8407	7423	7424	6414	7873	1521	7042	7114	5478	7277	10487	3699	334	3959	6694	22915	2621	3700	6813	1893	22927	259215	139322	135228	10184	55664	83706	374354	78991	51097	29106	7273	10447	94121	54495	5919	66005	54676	29789	51571	54863	10490	51706	27154	10916	7094	51368
PC_287	Activation of NF-kappaB in B cells	122706	4794	5717	5718	5715	10213	5688	3551	1147	5709	6885	5716	8915	5579	7314	7316	5702	4790	5689	5682	5683	5684	5685	4792	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	6500	5970	5966	5720	5708	8454	23198	9861	4793	5711	143471	9491	5695	5707	84433	10892	23291	5721	5719	8945	8517
PC_288	Activation of RAS in B cells	10125	4893	3265	3845	25780
PC_289	ISG15 antiviral mechanism	402569	3839	3840	9246	3841	11097	8672	9470	2317	5495	9631	23586	9636	1977	3434	7314	7316	7175	5335	5610	4599	4600	3716	5595	8021	23636	9775	7318	6772	4734	9972	5903	7324	3838	3836	4928	6396	57122	1973	7334	6233	7311	1982	8480	1981	23279	5300	1974	7706	3661	3837	23511	53371	9688	317649	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	51191	10762	11274	25820
PC_290	Prolactin receptor signaling	3717	5617	2688	2689	1442	2690	5618	6776	6777	9978	6500	5781	8454	25970	8945
PC_291	Signaling by NODAL	7044	2309	8928	10637	9350	5045	55997	6997	92	2657	5046	91	4088	4089	93	10589	4087	199699	130399	4838
PC_292	Meiotic synapsis	644186	5885	85236	8468	23353	9985	4000	3012	8970	3015	474382	3014	3013	4001	8348	3018	672	7013	3306	102724334	3017	121504	3017	7329	545	8243	6847	7014	8290	8338	8349	723790	256126	94239	50511	93426	128312	10735	27127	23345	10274	23224	8334	8345	255626	65057	8341	8331	8342	8340	26277	11083	55766	10388	56158	25913	54386	25777	10734	9126
PC_293	Mtb iron assimilation by chelation	4057
PC_294	ROS and RNS production in phagocytes	8992	9550	534	1536	1535	653361	5880	525	4688	526	528	527	4846	4842	4843	529	523	6556	9114	10312	4689	9296	245972	245973	155066	535	90423	84329	127124	533	50617	51606	23545	51382
PC_295	Signaling by ERBB2	9542	2069	1956	1950	2064	2534	3320	7525	6714	2065	685	10718	3084	2066	11140	145957	55914	1839
PC_296	Regulation of gene expression by Hypoxia-inducible Factor	2056	7422	405	2033	3091	768	1387	2034	10370	25994	64344
PC_297	Cellular response to hypoxia	3091	2034	55662
PC_298	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	122706	126374	5717	5718	5715	10213	5688	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	7428	5704	5714	5691	5690	5713	7321	5710	7979	5687	7323	10197	5700	5705	5706	7322	9978	6233	7311	5720	5708	8453	23198	9861	6921	6923	5711	3091	143471	9491	84962	112398	5695	5707	2034	54583	112399	8994	5721	5719	64344
PC_299	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	1956	4893	3265	3845	1950	3320	7314	7316	5335	867	5295	6464	5290	6233	7311	2885	6654	2549	11140
PC_300	Signaling by ERBB4	9542	2069	1956	1950	2554	2560	2566	2065	2562	685	2561	10718	1742	3084	2066	145957	1839	2567	55879
PC_301	Cross-presentation of particulate exogenous antigens (phagosomes)	1536	3685	1535	653361	948	3693	4688	4689
PC_302	ER-Phagosome pathway	122706	8773	7099	5717	5718	5715	10213	5688	3551	1147	6892	5709	7097	9554	5716	3106	3105	3105	3106	3107	3105	3105	929	7314	7316	3105	3105	3106	3107	3105	3133	3105	3105	3105	948	3135	5702	3105	3106	3106	3106	5689	5682	5683	5684	5685	811	5696	5698	5686	5692	5694	5693	2923	3105	3105	3105	3105	3105	3105	3105	3105	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3107	3107	3107	3107	3107	3107	3134	3105	3106	5701	5699	5704	5714	5691	5690	5713	5710	114609	23480	10952	7979	5687	10197	29927	567	5700	5705	5706	6233	7311	6890	6891	3106	695	5720	3107	3105	6810	5708	23198	9861	7096	9341	5711	3106	3106	3107	3106	3107	3107	3106	3106	143471	9491	3106	3107	5695	5707	4615	8673	55176	3107	5721	5719	10333	8517	23643
PC_303	Endosomal/Vacuolar pathway	1515	3106	3105	3105	3106	3107	3105	3105	1514	3105	3105	3106	3107	3105	3133	3105	3105	3105	3135	3105	3106	3106	3106	1520	3105	3105	3105	3105	3105	3105	3105	3105	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3107	3107	3107	3107	3107	3107	3134	3105	3106	567	3106	3107	3105	3106	3106	3107	3106	3107	3107	3106	3106	3106	3107	3107	4012
PC_304	Cross-presentation of soluble exogenous antigens (endosomes)	122706	5717	5718	5715	10213	5688	5709	5716	2209	5702	5689	4360	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	5720	5708	23198	9861	5711	143471	9491	5695	5707	9902	50489	5721	5719
PC_305	Erythrocytes take up carbon dioxide and release oxygen	759	760	6521	762	358	3043	3039	6005	51700	606495	51167	51706
PC_306	Methionine salvage pathway	2805	4507	51074	84245	55256	58478
PC_307	Erythrocytes take up oxygen and release carbon dioxide	759	760	6521	762	358	3043	3039	6005
PC_308	SHC1 events in ERBB2 signaling	9542	2069	1956	4893	3265	3845	1950	2064	5578	2065	6464	685	10718	2885	5581	3084	5782	5580	6654	2066	145957	1839
PC_309	PI3K events in ERBB4 signaling	9542	2069	5295	685	5290	10718	3084	2066	145957	1839
PC_310	SHC1 events in ERBB4 signaling	9542	2069	4893	3265	3845	6464	685	10718	2885	3084	6654	2066	145957	1839
PC_311	PLCG1 events in ERBB2 signaling	1956	1950	2064	5335
PC_312	Nuclear signaling by ERBB4	9542	2069	9611	11033	348	2099	6285	1447	5241	6678	6714	2670	3925	685	6776	10413	6387	5663	5664	10718	6868	3084	10608	2066	83464	145957	23385	51107	1839	23118	55851	51741
PC_313	Downregulation of ERBB4 signaling	7314	7316	6714	4734	6233	7311	2066	83737	11059
PC_314	PI3K/AKT Signaling	5293	5296	9542	2069	2255	5170	8823	6801	8822	8817	9965	90865	1956	5155	1950	7039	2099	5154	2064	2246	3932	2534	4233	2249	2247	5159	3815	940	2251	2260	2248	2250	6714	3082	5880	930	7409	374	5156	4254	2252	2263	2065	2264	2261	5295	2254	207	208	941	685	3667	942	5290	5291	2475	3654	2253	10718	2885	5879	391	55615	9173	3084	5781	2549	2066	117145	50852	253260	255324	118788	152831	10818	145957	8503	2100	57761	1839	4615	79109	64223	8074	27006	26281	3556	51135	9365	10000	8660	7189	29851
PC_315	Interleukin-7 signaling	5296	8835	8651	3574	3082	5896	3575	3716	5295	3561	3667	6774	6776	6597	6777	3718	5897	8350	126961	8503	85480	64109	1154	54014	8660
PC_316	Mitochondrial protein import	100287932	10469	1678	10245	1431	10651	9512	8604	9868	4714	10452	5009	516	506	1537	3329	291	293	7416	498	3313	3421	2671	100272147	26519	23203	4580	10063	9804	2395	6901	92609	90639	10531	388753	197257	150274	401505	131474	134266	400916	100188893	131118	27235	10440	50	84269	79145	29090	80273	56942	56993	54927	51287	54543	10165	617	51025	25813	29928	26515	26520	26521	26517	51142
PC_317	Spry regulation of FGF signaling	10253	7314	7316	6714	673	867	5595	5594	5518	5516	6233	7311	2885	5515	5781	8569
PC_318	ATP sensitive Potassium channels	10060	6833	3767	3764
PC_319	Activation of G protein gated Potassium channels	2793	2788	9568	2784	3761	3763	3762	3760	2786	2790	54331	2782	2783	2792	2785	2787	3759	3766	3768	3765	3772	3773	55970	2550	94235
PC_320	Ca activated K+ channels	3783	3778	3779	27345	3780	3781	27094	3782	10242
PC_321	Classical Kir channels	3761	3759	3768	3770
PC_322	HCN channels	348980	57657	610	10021
PC_323	Potassium transport channels	3758	3766	3773
PC_324	Voltage gated Potassium channels	9196	3786	3785	3756	3737	3742	3738	3739	3741	3746	3784	9132	3749	3736	3757	8514	3748	3745	7881	3744	27012	27133	170850	93107	169522	9312	3787	131096	3747	3743	3790	81033	3754	56479	90134	3750	3751	3755	26251	3752	23416	3788	23415
PC_325	Tandem pore domain halothane-inhibited K+ channel (THIK)	56659
PC_326	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	3775	9424	10089
PC_327	TWIK-releated acid-sensitive K+ channel (TASK)	3777	51305
PC_328	TWIK-related spinal cord K+ channel (TRESK)	338567
PC_329	TWIK-related alkaline pH activated K+ channel (TALK)	89822	83795
PC_330	TWIK related potassium channel (TREK)	3776	54207	50801
PC_331	Sperm Motility And Taxes	157855	57828	378807	257062	347732	117144	84329	117155	79820
PC_332	Acrosome Reaction and Sperm	49	928	113177	126123	284359
PC_333	GRB7 events in ERBB2 signaling	9542	2064	2065	3084	2886
PC_334	betaKlotho-mediated ligand binding	9965	2264	152831
PC_335	Downregulation of ERBB2	9542	2064	7314	7316	2065	207	208	9101	6233	7311	3084	10193	10000
PC_336	Transcription of E2F targets under negative control by DREAM complex	4609	7153	5111	5933	993	4149	1869	5934	5928	3065	7027	7029	1875	1874	91750	286826	132660	55957	990
PC_337	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	983	4605	890	5933	1869	5934	5928	3065	7027	7029	1875	1874	91750	286826	132660	55957
PC_338	Mitochondrial iron-sulfur cluster biogenesis	2230	2395	112812	51218	122961	150274	81894	81689	23479	57128	51312	9054
PC_339	NR1D1 (REV-ERBA) represses gene expression	8841	9611	9572	83401
PC_340	RORA activates gene expression	6907	6256	6095	6720	1374	5465	2033	23054	10499	5469	8648	80205	6604	10498	1387	96764	85441	79718
PC_341	BMAL1	406	8553	9575	6907	551	5054	2155	6256	10135	5465	1628	23054	10499	5469	8648	80205	6604	10498	56938	1387	96764	4862	85441	79718	79365	28999	25819
PC_342	Mitochondrial ABC transporters	22	10058	23456	11194
PC_343	ABC transporters in lipid homeostasis	335	5825	215	5824	9619	8504	26154	10350	10347	23460	10349	23461	21	20	64137	64241	64240	225
PC_344	Elevation of cytosolic Ca2+ levels	9127	5023	5024	7222	6786	3709	3710	3708	5026	84876	80228	5025	5027	57113	22953	7225
PC_345	Activation of BMF and translocation to mitochondria	5599	140735	90427
PC_346	Activation of PUMA and translocation to mitochondria	7161	7157	1869	7159	7027	7029	23368	27113	27113	8626
PC_347	COX reactions	5742
PC_348	Apoptosis induced DNA fragmentation	1676	1677	3005	3146	3008	3009	3007	3006	3148	836	3836	3024	3837
PC_349	Ligand-dependent caspase activation	7099	8797	8795	929	355	356	8743	7186	8772	8737	841	8717	100302736	148022	23643
PC_350	Extrinsic Pathway of Fibrin Clot Formation	2158	2159	2155	7035	2152
PC_351	Intrinsic Pathway of Fibrin Clot Formation	2157	2147	2158	2159	2161	462	2	3827	2160	3818	5624	7450	5104	710	3053	5270	2811	2812	2815	6470	2814	5547	708	6469
PC_352	Common Pathway of Fibrin Clot Formation	2157	2162	2147	2159	462	2243	2244	2266	5196	5624	5104	2165	3053	5270	7056	5627	5197	2153	5657	2149	6470	6469	57126	10544
PC_353	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	4128	4129
PC_354	PAOs oxidise polyamines to amines	196743	54498
PC_355	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	991	4085
PC_356	Inactivation of APC/C via direct inhibition of the APC/C complex	11065	9184	701	996	7321	7324	25906	991	8881	4085	246184	119504	64682	51529	8697	51434	51433	29945	29882	10393
PC_357	Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal	3796	1780	10403	7514	332	1783	9183	699	9184	701	23122	11130	5518	5519	6249	5501	6232	5048	5905	1058	1063	5903	9735	4928	5347	6396	57122	5516	8655	5515	1062	1060	23279	991	4085	23421	5527	1781	9793	1778	5528	5525	5526	22919	5529	54821	55143	151246	151648	401541	100527963	79682	55166	57551	23332	91687	100526739	84643	147841	348995	79023	57082	81930	55746	348235	25909	2491	220134	80152	54908	81929	140735	9212	55839	25936	11004	80776	64105	79172	79902	83540	81565	79003	64946	79980	55055	57405	3619	79019	54820	55920	10726	8379	51143
PC_358	Signaling by SCF-KIT	5296	1111	3717	9402	4893	3265	3845	3932	2534	2242	7525	4067	3815	6714	4318	7409	2241	5578	4254	1215	5295	6774	6772	6776	5290	7006	6777	2885	5879	5781	6654	2887	10750	2886	8503	10076	9846
PC_359	Regulation of KIT signaling	10603	9306	8651	3932	2534	7525	4067	3815	6714	5578	4254	867	5777	2885	6654	10019
PC_360	Regulation of signaling by NODAL	7044	10637	9350	55997	6997	92	91	93	199699	130399	4838
PC_361	Collagen degradation	102	9313	4312	1509	5645	1514	1508	1991	4313	4314	4316	4319	5045	4318	1297	4317	4320	1306	80781	4321	1513	4322	4323	4324	6868	7373	1307	8754	1299	1298	1310	1305	91522	164656	85007	136227	4327	1303	84570	1308
PC_362	Translocation of SLC2A4 (GLUT4) to the plasma membrane	4641	8773	6814	10640	9371	5565	9882	11336	801	5898	6517	23433	5867	10971	207	208	7529	2810	4627	5872	5571	5563	4218	10890	51552	7532	7531	8766	5879	6844	7534	7533	6810	57186	23216	57148	9847	149371	54536	22920	60412	55770	79058	55763	53632	51422	4012	23265	5564	11127	4644
PC_363	Beta defensins	100289462	7097	100133267	100133267	729230	1235	644414	1672	414325	7096	613210	613209	245930	245929	245928	245927	245913	613211	245934	400830	245939	245910	245909	245938	245936	245932	245937	245911	245908	140596	117285	81623	140881	140850
PC_364	Defensins	100289462	100133267	100133267	1669	1667	1668	644414	1672	414325	1670	1671	613210	613209	245930	245929	245928	245927	245913	613211	245934	400830	245939	245910	245909	245938	245936	245932	245937	245911	245908	140596	117285	81623	140881	140850
PC_365	Alpha-defensins	920	5645	1669	5646	417	1667	1668	1670	1671
PC_366	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1719	3320	801	4846	2644	2643	207	6697	5805	5593
PC_367	Degradation of the extracellular matrix	388743	440854	102	10753	3911	726	7092	9313	1515	9507	6650	5340	2	4312	826	823	1634	1514	3912	1991	4313	4314	1511	4316	4319	6696	3915	999	649	4811	4318	960	176	824	825	831	4317	4320	1520	682	4321	836	1513	4322	5663	5650	4323	4324	101	3339	8751	3914	3918	3909	92291	147968	164656	80274	222663	170690	170692	23385	5654	63827	84290	4327	11132	56999	26254	9510	11131	11096	11095	7093	827	23473
PC_368	Extracellular matrix organization	2335
PC_369	Reversible hydration of carbon dioxide	771	759	760	761	762	765	763	766	768	377677	23632	11238
PC_370	Acyl chain remodelling of PC	8399	8398	5319	100137049	5320	5322	5321	11145	22925	123745	254531	255189	10162	151056	79887	129642	54947	283748	255043	79888	81579	64600	50640	50487	30814	26279	8605
PC_371	Acyl chain remodeling of CL	8398	3030	5321	3032	6901	253558
PC_372	Acyl chain remodelling of PS	8399	5319	100137049	5320	5322	5321	11145	22925	123745	51365	254531	255189	10162	154141	283748	114884	114882	81579	64600	114879	30814	26279
PC_373	Acyl chain remodelling of PE	8399	8398	5319	100137049	5320	5322	5321	11145	22925	123745	254531	255189	10162	79887	154141	129642	283748	63874	117245	81579	64600	57110	50640	54979	50487	30814	5920	26279	8605
PC_374	Acyl chain remodeling of DAG and TAG	8694	158835	347516	57104	84649	11343	80339
PC_375	Acyl chain remodelling of PI	8399	5319	5320	5322	5321	11145	22925	123745	255189	79887	283748	79143	81579	64600	30814	26279	8605
PC_376	Acyl chain remodelling of PG	8399	5319	100137049	5320	5322	5321	22925	254531	255189	283748	79888	9926	81579	64600	50487	30814	54675	26279
PC_377	Synthesis of CL	54675
PC_378	Synthesis of PS	9791	81490
PC_379	Hydrolysis of LPC	100137049	5321	123745	255189	79887	283748	23659	56261	8605
PC_380	Synthesis of PG	5338	8760	5337	9489	23646	201164	114971	122618
PC_381	Hydrolysis of LPE	56261	8605
PC_382	Synthesis of PA	5338	10555	8443	8399	23259	5319	248	100137049	5320	2819	5322	2820	5321	22925	5337	84803	254531	150763	253558	149998	84895	137964	283748	201164	23171	374986	80821	79888	200879	10554	81579	64600	57678	51205	56895	56894	55326	30814	26279
PC_383	Synthesis of PC	590	1459	43	1103	1119	5130	1460	1457	23175	80736	57153	126969	84879	204962	79888	162466	171586	56994	23446	9663	64900	56910	10400	58488	1120	10809	9468	10390
PC_384	PI and PC transport between ER and Golgi membranes	23760
PC_385	Glycerophospholipid biosynthesis	8895	9362	55750	8904	27132
PC_386	Synthesis of PE	1119	23175	64850	162466	9663	5833	64900	85465	55500	55224	23761	1120	10390
PC_387	Synthesis of PI	9600	10423	1040	83394	57605
PC_388	Synthesis of PIPs at the ER membrane	6305	5297	8898	55300	22908
PC_389	PI Metabolism	25816	388121	79626	126282
PC_390	DAG and IP3 signaling	10768	5335	5581	5580	3709	3710	3708
PC_391	Signaling by Activin	8928	3624	3625	92	91	4088	4089	93	10589	4087	130399
PC_392	G0 and Early G1	9134	890	898	1017	5933	8900	5934	5928	3065	1859	7027	7029	1875	1874	91750	286826	132660	55957
PC_393	Methylation	1544	1312	191	4144	4837	7172	9446	4143	4548	57412	27430	4552	51504	29104
PC_394	Acetylation	10	9
PC_395	Cytosolic sulfonation of small molecules	6820	6819	27284	8460	8459	27233	10380	445329	445329	6783	6817	6799	6822	391365	84836	25830	54928	50512
PC_396	Glucuronidation	54600	10720	7367	7363	7364	54578	54658	54657	54659	54579	7365	7366	167127	133688	79799	54490	54577	54575	54576	55347	10941
PC_397	Glutathione conjugation	4259	2941	2954	27306	2938	2939	2950	2944	2953	653689	4257	2098	10327	2947	2946	2952	2949	9446	2948	2940	221357	4258	119391	373156
PC_398	Elastic fibre formation	3690	3688	3685	3678	5045	2006	3694	4015	2200	2201	4237	84695	4016	8076	84467	84171	10516	4017
PC_399	Fibronectin matrix formation	2335	3688	3678	634	1088	4680
PC_400	Polo-like kinase mediated events	9133	4605	891	7465	993	995	1063	5347	2305	5928	2033	91750	286826	132660	55957	9088
PC_401	L13a-mediated translational silencing of Ceruloplasmin expression	8665	8664	8667	8666	8669	1356	1965	6176	6181	6175	1977	6218	3921	26986	6187	6165	6129	6139	8894	6192	6188	1975	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	1968	6232	11224	6157	6125	6144	6158	6203	6193	6204	1964	6159	6164	9045	8662	3646	1973	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	6152	6173	6143	6142	6128	1981	6141	8668	8661	1974	7458	200916	51065	10480	140032	6123	6166	116832	140801	8663	27335	51121	51386	25873
PC_402	Eukaryotic Translation Elongation	1933	1937	1936	1915	1917
PC_403	Peptide chain elongation	6176	6181	6175	6218	3921	1938	6187	6165	6129	6139	6192	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	1915	6152	6173	6143	6142	6128	6141	200916	51065	140032	6123	6166	116832	140801	51121	25873
PC_404	Transport of the SLBP independent Mature mRNA	11097	9631	1977	7175	8021	23636	9972	5903	22916	4928	6396	57122	8480	4686	23279	23511	53371	10189	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10482	10762
PC_405	Transport of the SLBP Dependant Mature mRNA	11097	9631	1977	7175	8021	23636	9972	5903	22916	4928	6396	57122	8480	4686	23279	7884	23511	53371	10189	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10482	10762
PC_406	Transport of Mature mRNA Derived from an Intronless Transcript	11097	9631	10898	1977	7175	8021	23636	9972	5903	22916	4928	6396	57122	8480	4686	29894	23279	23511	81608	53371	10189	9688	348995	79023	129401	23225	55746	23165	8189	81929	9883	4927	55706	9818	79902	55339	8086	53981	10482	51692	10762
PC_407	Transport of Mature mRNA derived from an Intron-Containing Transcript	10212	22794	11097	51362	9877	9631	10569	7175	11338	8021	23636	9775	9972	5903	22916	4928	6396	57122	4116	8480	84324	6428	102724594	6427	9295	6426	6429	4686	23279	8683	6430	6431	8563	7919	10921	6432	2733	23511	80145	53371	10189	79228	10250	9688	348995	79023	129401	57187	23225	199746	55746	9785	23165	55110	81929	9984	9883	84321	84248	4927	55706	9818	79902	84271	65109	56001	8086	51213	10482	29107	10762	26097	9939
PC_408	Activation of Matrix Metalloproteinases	1515	5340	7076	3818	4312	5644	5645	1991	4313	4314	1511	4316	4319	5045	4318	7077	1504	3817	4317	1215	4320	80781	1513	4322	4323	4324	4325	7177	440387	50859	64386	4326	10893
PC_409	Recycling of bile acids and salts	8714	8647	213	6256	6579	2172	6555	570	6554	10499	8648	9971	28234	80765	10998	10599
PC_410	Gamma-carboxylation of protein precursors	2147	2158	2159	632	5624	5627	2155	8858	2677	2621
PC_411	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	2147	2158	2159	632	5624	5627	2155	8858	2621
PC_412	Removal of aminoterminal propeptides from gamma-carboxylated proteins	2147	2158	2159	632	5624	5627	2155	5045	8858	2621
PC_413	ZBP1(DAI) mediated induction of type I IFNs	81030
PC_414	IRF3 mediated activation of type 1 IFN	3661	147945	81030	29110	23220
PC_415	Sulfide oxidation to sulfate	23474	6821	7263	100131187	1468	58472
PC_416	Degradation of cysteine and homocysteine	2806	4357	1491	7263	1036	339896	84890	25828	51380
PC_417	Cysteine formation from homocysteine	1491	102724560
PC_418	Sulfur amino acid metabolism	191	4143	635	4548	23743	4552
PC_419	Uncoating of the HIV Virion	5478
PC_420	Budding and maturation of HIV virion	55048	27243	9525	7314	7316	5478	6233	7311	155382	137492	10015	91782	92421	93343	79643	23327	7251	29082	128866	89853	79720	51534	51271	51510	51160	27183	25978	100526767
PC_421	Integration of provirus	11168	8815	3159	3836	5478
PC_422	Early Phase of HIV Life Cycle	3978	2237	5478
PC_423	Late Phase of HIV Life Cycle	4836
PC_424	Golgi Cisternae Pericentriolar Stack Reorganization	8615	9133	983	891	5595	5594	5347	5862	5861	2801	64689	81876	8548	26003
PC_425	Synthesis of dolichyl-phosphate mannose	8813	8818	54344
PC_426	Synthesis of glycosylphosphatidylinositol (GPI)	8818	23556	5277	51227	5281	5283	84992	54872	284098	80235	54965	84720	9488	5279	9091	93183	55650	9487
PC_427	Attachment of GPI anchor to uPAR	8733	5329	80055	10026	51604	94005	128869
PC_428	Post-translational modification	390243	8000	7512	2215	7007	4062	53942	27076	8876	8875	80740	58530	8434	7070	249	1048	4241	248	251	2350	1368	1043	2813	2822	683	10232	4045	419	1087	8581	4978	4061	54742	123904	503542	154064	353091	349633	147719	284348	646627	137797	135228	146183	257194	161357	146760	349667	338328	152330	116372	266727	130576	171169	420	84628	6975	83639	80328	51299	50863	5067	23627	22854	10942
PC_429	Formation of ATP by chemiosmotic coupling	10476	10632	4508	4509	516	506	522	515	498	513	509	539	518	9551	514	521	517	27109
PC_430	Mitochondrial transcription initiation	5442	7019	64216
PC_431	Macroautophagy	10542	27243	5565	9776	8408	9140	11337	10533	2475	7249	5571	5563	11345	8655	389541	5562	8897	8678	6009	56270	55062	10325	285973	55054	55004	22863	10670	79065	84971	57521	153129	64419	5289	9821	91782	115201	7248	92421	84938	140735	79643	30849	60673	64223	440738	29082	55626	81631	23710	83734	9474	128866	84557	58528	64422	7405	53632	51422	8649	25978	28956	100526767	5564	11152	23192	26100
PC_432	Mitochondrial transcription termination	7978
PC_433	PKA-mediated phosphorylation of key metabolic factors	5207	5566	5568	5567	51085
PC_434	Glucagon signaling in metabolic regulation	112	2788	109	115	111	2641	2784	114	2642	2786	2790	113	54331	2791	2782	2783	2778	2785	2787	108	107	2778	196883	59345	51764	55970	94235
PC_435	Triglyceride catabolism	646486	2173	5346	10226	2170	2168	2169	2167	5566	5568	5567	5501	8228	2820	2172	5499	5500	2171	857	3991	646480	150379	51099	11343
PC_436	PKA activation	112	109	115	111	801	5573	5576	5566	5568	5567	5575	5577	114	113	108	107	196883
PC_437	AMPK inhibits chREBP transcriptional activation activity	5565	5563	6794	9370	79602	51094	51085	51422
PC_438	Integration of energy metabolism	5518	5519	5516	5515	5528
PC_439	Insulin effects increased synthesis of Xylulose-5-Phosphate	7086	6888
PC_440	ChREBP activates metabolic gene expression	32	5313	2194	47	31	10554	51085	6945
PC_441	PP2A-mediated dephosphorylation of key metabolic factors	5207	5518	5519	5516	5515	5528	51085
PC_442	Gamma carboxylation, hypusine formation and arylsulfatase activation	23463	64122	79672
PC_443	PKA activation in glucagon signalling	112	109	115	111	5573	5576	5566	5568	5567	5575	5577	114	113	2778	108	107	2778	196883
PC_444	Minus-strand DNA synthesis	5478
PC_445	Plus-strand DNA synthesis	5478
PC_446	2-LTR circle formation	11168	8815	2547	7520	3159	3981	7518
PC_447	Nef mediated downregulation of CD28 cell surface expression	940	1173
PC_448	Nef mediated downregulation of MHC class I complex cell surface expression	164	3105	8905	567	1174	162	55690	130340	8907	10053
PC_449	Nef and signal transduction	3932	2534	3055	919	5879	5062	9844	1794
PC_450	Rev-mediated nuclear export of HIV RNA	7514	11097	9631	7175	1104	8021	23636	5902	5905	9972	5903	4928	6396	57122	5901	8480	23279	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_451	Collagen biosynthesis and modifying enzymes	131873	256076	5352	9508	8974	7092	8985	10491	9509	1277	1280	1281	1282	1290	5034	1278	1284	1301	1291	1292	1293	649	5033	1302	1297	1289	5479	1296	50509	1295	1287	1306	80781	871	1286	1285	1294	5351	1300	7373	1307	1288	1299	1298	1310	5118	255631	340267	64175	1305	283208	91522	55214	10536	23127	85301	79709	169044	140766	136227	81578	1303	84570	57642	26577	1308	7093
PC_452	Activation of PKB	5170	208	117145	57761
PC_453	mTOR signalling	10542	207	7529	2475	389541	6009	10325	55004	10670	57521	153129	84335	64223	58528	8649	28956
PC_454	PDE3B signalling	208	5140
PC_455	Inhibition of TSC complex formation by PKB	208	7249	7248
PC_456	Regulation of cholesterol biosynthesis by SREBP (SREBF)	3638	51360	9871	10802	10427	6720	9632	5901	22937	6721	8720	3837	10484	51141	51128
PC_457	Toll Like Receptor 4 (TLR4) Cascade	7099	9450	3689	929	3684	5336	671	3929	5775	1785	1759	100302736	4064	26052	23643
PC_458	Transfer of LPS from LBP carrier to CD14	929	3929
PC_459	Synthesis of PIPs at the plasma membrane	5293	5286	5296	5287	8395	8871	8821	3636	8867	23396	5288	5867	5868	5295	5290	5291	5305	5294	660	5728	51552	8396	375	4952	5783	4534	8776	8898	8897	27124	146850	81846	64419	79837	55300	23533	8503	3635	55613	84725	3631	66036	80230	8394	51763	55361	57664	54477	59339	65977	59338	9107	22874
PC_460	Synthesis of PIPs at the Golgi membrane	5286	5288	5297	7179	377	375	4952	55697	93492	5289	55300	9896	30849	55361	56623	22908	5298	200576
PC_461	Synthesis of PIPs at the early endosome membrane	5286	8821	55697	4534	8898	5289	55300	9896	3631	30849	55361	54545	54893	9110	22876	200576
PC_462	Synthesis of PIPs at the late endosome membrane	5286	55697	4534	8898	5289	9896	66036	30849	9110	9108	200576
PC_463	MyD88	7099	8651	3656	7097	929	948	3654	114609	695	4214	7096	59307	4615	51295	51135	10333	7189	11213	23643
PC_464	Sphingolipid de novo biosynthesis	8611	8613	8560	10558	9517	8612	23683	9217	8879	5007	10715	221	224	1455	2531	5587	29095	340485	151742	123099	253782	79152	259230	204219	130367	94103	91012	165679	166929	125981	171546	29956	142891	81537	25865	79603	56848	55331	55304	8877	9218	94101	10087
PC_465	Glycosphingolipid metabolism	57488	83850	6610	8706	2629	2717	3073	5660	3074	412	5476	410	411	2720	6609	2760	414	415	416	2581	2583	427	7357	7368	347527	79642	340075	80772	79411	339221	153642	25870	285362	64781	129807	22901	4758	23344	57733	57704	56624	55627	55512	51228	10825	4759
PC_466	MyD88-independent TLR4 cascade	7099	929	23098	100302736	148022	23643
PC_467	mTORC1-mediated signalling	29904	10542	1977	6198	1975	7529	2475	6194	1981	389541	1978	6009	10325	55004	10670	57521	153129	84335	64223	58528	8649	28956
PC_468	The activation of arylsulfatases	412	410	411	414	415	416	347527	79642	340075	153642	25870	285362	22901
PC_469	Lectin pathway of complement activation	10747	2219	8547	4153	5648	2220	78989	10584
PC_470	Initial triggering of complement	10747	2219	8547	715	712	713	714	717	716	720	100293534	4153	5648	2220	78989	10584
PC_471	Terminal pathway of complement	727	735	731	732	733	730	1191	729
PC_472	PLC-gamma1 signalling	4803	4914	5335
PC_473	Signalling to RAS	4893	3265	3845	4803	4914	6464	2885	25759	6654	53358
PC_474	NGF processing	4803	5045	5046	5125
PC_475	Formation of HIV elongation complex in the absence of HIV Tat	6829	5433	904	905	8812	2963	2068	7936	5432	5434	2071	6917	5430	5431	2965	2962	5438	1022	1025	902	4331	22916	5437	5439	5440	8178	5435	5436	5441	6827	6749	4686	2966	2967	6924	6921	6923	404672	51497	51224	25920	2968	7469	9150	11198
PC_476	Formation of the HIV-1 Early Elongation Complex	6829	5433	2963	2068	7936	5432	5434	2071	5430	5431	2965	2962	5438	1022	902	4331	22916	5437	5439	5440	5435	5436	5441	6827	4686	2966	2967	404672	51497	25920	2968	7469	9150
PC_477	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	6829	5433	8731	8732	2963	2068	5432	5434	2071	5430	5431	2965	2962	5438	1022	902	4331	5437	5439	5440	5435	5436	5441	2966	2967	404672	2968
PC_478	HIV Transcription Initiation	6874	5433	2963	2068	5432	5434	2071	6908	6872	5430	2960	2961	5431	2965	2962	5438	6878	1022	902	4331	5437	5439	2957	2958	5440	5435	5436	5441	2959	6881	2966	2967	6877	6884	6882	6879	6883	6880	54457	83860	6873	404672	138474	6875	2968	8148	51616
PC_479	RNA Polymerase II HIV Promoter Escape	6874	5433	2963	2068	5432	5434	2071	6908	6872	5430	2960	2961	5431	2965	2962	5438	6878	1022	902	4331	5437	5439	2957	2958	5440	5435	5436	5441	2959	6881	2966	2967	6877	6884	6882	6879	6883	6880	54457	83860	6873	404672	138474	6875	2968	8148	51616
PC_480	Transcription of the HIV genome	6874	5433	2963	2068	5432	5434	2071	6908	6872	5430	2960	2961	5431	2965	2962	5438	6878	1022	902	4331	5437	5439	2957	2958	5440	5435	5436	5441	2959	6881	2966	2967	6877	6884	6882	6879	6883	6880	54457	83860	6873	404672	138474	6875	2968	8148	51616
PC_481	Formation of HIV-1 elongation complex containing HIV-1 Tat	6829	5433	904	2963	2068	7936	5432	5434	2071	6917	5430	5431	2965	2962	5438	1022	1025	902	4331	22916	5437	5439	5440	8178	5435	5436	5441	6827	6749	4686	2966	2967	6924	6921	6923	404672	51497	51224	25920	2968	7469	9150	11198
PC_482	Pausing and recovery of Tat-mediated HIV elongation	6829	5433	904	2963	7936	5432	5434	6917	5430	5431	2962	5438	1025	5437	5439	5440	8178	5435	5436	5441	6827	6749	6924	6921	6923	51497	51224	25920	7469	9150	11198
PC_483	Abortive elongation of HIV-1 transcript in the absence of Tat	6829	5433	2963	7936	5432	5434	5430	5431	2962	5438	22916	5437	5439	5440	5435	5436	5441	6827	4686	51497	25920	7469	9150
PC_484	Tat-mediated HIV elongation arrest and recovery	6829	5433	904	2963	7936	5432	5434	6917	5430	5431	2962	5438	1025	5437	5439	5440	8178	5435	5436	5441	6827	6749	6924	6921	6923	51497	51224	25920	7469	9150	11198
PC_485	Tat-mediated elongation of the HIV-1 transcript	6829	5433	904	2963	2068	7936	5432	5434	2071	6917	5430	5431	2965	2962	5438	1022	1025	902	4331	5437	5439	5440	8178	5435	5436	5441	6827	6749	2966	2967	6924	6921	6923	404672	51497	51224	25920	2968	7469	9150	11198
PC_486	HIV elongation arrest and recovery	6829	5433	904	905	8812	2963	7936	5432	5434	6917	5430	5431	2962	5438	1025	5437	5439	5440	8178	5435	5436	5441	6827	6749	6924	6921	6923	51497	51224	25920	7469	9150	11198
PC_487	Pausing and recovery of HIV elongation	6829	5433	904	905	8812	2963	7936	5432	5434	6917	5430	5431	2962	5438	1025	5437	5439	5440	8178	5435	5436	5441	6827	6749	6924	6921	6923	51497	51224	25920	7469	9150	11198
PC_488	Nef Mediated CD4 Down-regulation	161	160	920	3932	1175	163	375	1173	51606
PC_489	The fatty acid cycling model	9016	9481	7350	7351	7352
PC_490	The proton buffering model	9016	9481	7350	7351	7352
PC_491	Trafficking and processing of endosomal TLR	7098	1515	1514	1508	7184	1520	1513	5641	10695	81622	54106	51311	51284
PC_492	Toll Like Receptor 9 (TLR9) Cascade	8411	5289	30849	64145	54106
PC_493	Toll Like Receptor 10 (TLR10) Cascade	81793
PC_494	Toll Like Receptor 3 (TLR3) Cascade	7098	23098	148022
PC_495	Toll Like Receptor 5 (TLR5) Cascade	7100
PC_496	Toll Like Receptor TLR1	7097	929	7096
PC_497	Toll Like Receptor 7/8 (TLR7/8) Cascade	51311	51284
PC_498	Toll Like Receptor TLR6	7097	929	948	10333
PC_499	Transport of Ribonucleoproteins into the Host Nucleus	11097	9631	7175	8021	23636	9972	5903	3836	4928	6396	57122	8480	23279	3837	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_500	Entry of Influenza Virion into Host Cell via Endocytosis	1211	1213
PC_501	NS1 Mediated Effects on Host Pathways	402569	3839	3840	3841	11097	9631	9636	7175	8021	23636	9972	5903	3838	3836	4928	6396	57122	8480	23279	3837	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_502	Influenza Virus Induced Apoptosis	7040	293
PC_503	Inhibition of Host mRNA Processing and RNA Silencing	10898	8106
PC_504	Assembly of Viral Components at the Budding Site	811	821
PC_505	Viral Messenger RNA Synthesis	11097	5433	9631	7175	2963	5432	5434	5430	5431	2962	8021	5438	23636	9972	5903	5437	5439	4928	5440	6396	57122	5435	5436	5441	8480	23279	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_506	Viral RNP Complexes in the Host Cell Nucleus	3303
PC_507	NEP/NS2 Interacts with the Cellular Export Machinery	7514	11097	9631	7175	8021	23636	9972	5903	4928	6396	57122	5901	8480	23279	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_508	NOD1/2 Signaling Pathway	3551	1147	5603	3656	6885	8767	7128	834	835	837	3654	5608	6300	842	7334	387522	330	329	841	10454	5600	1432	257397	83737	64170	64127	1540	23118	10392	7189	8517
PC_509	TICAM1, RIP1-mediated IKK complex recruitment	3551	1147	7098	7314	7316	7321	7323	7334	7322	6233	7311	387522	330	329	8737	148022	7189	11035	8517
PC_510	DDX58/IFIH1-mediated induction of interferon-alpha/beta	9246	23586	9636	7318	7706	26007	57506	79671	84166	84282	79132	64135	51191
PC_511	Inhibition of PKR	5610
PC_512	Regulation of Apoptosis	4976	115209
PC_513	Phosphorylation of proteins involved in the G2/M transition by Cyclin A	983	890	8900
PC_514	Adenylate cyclase activating pathway	112	109	115	111	2774	114	113	108	107	196883
PC_515	Adenylate cyclase inhibitory pathway	346562	112	109	115	111	2771	2773	2774	114	113	2770	108	107	196883
PC_516	Regulation of Glucokinase by Glucokinase Regulatory Protein	11097	9631	7175	2645	8021	23636	9972	5903	4928	6396	57122	8480	23279	2646	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_517	Frs2-mediated activation	4803	4914	673	5595	5594	7529	1399	5906	2889	10818
PC_518	ARMS-mediated activation	4803	4914	673	7529	1398	5906	57498
PC_519	p38MAPK events	5603	4893	3265	3845	5898	5899	6714	9261	6300	5900	5600	1432	7867
PC_520	Synthesis and processing of ENV and VPU	5045
PC_521	Packaging Of Telomere Ends	85236	3012	8970	3015	474382	3014	3013	8348	3018	7013	102724334	3017	121504	3017	7014	8290	8338	8349	723790	94239	128312	8334	8345	255626	65057	8341	8331	8342	8340	26277	55766	25913	54386
PC_522	Telomere Extension By Telomerase	7015	1736	55135	55651	10856	8607
PC_523	Binding and entry of HIV virion	920	1234	7852	5478
PC_524	Formation of the active cofactor, UDP-glucuronate	7358	7360	23169
PC_525	Classical antibody-mediated complement activation	715	1401	712	713	714	716
PC_526	Alternative complement activation	1675	629	718	3004
PC_527	APC/C	11065	983	7314	7316	891	996	7321	7324	25906	6233	7311	991	8881	246184	119504	64682	51529	8697	51434	51433	29945	29882	10393
PC_528	Autodegradation of Cdh1 by Cdh1	5717	5718	5715	10213	11065	5688	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	996	5701	5699	5704	5714	5691	5690	5713	7321	7324	5710	25906	7979	5687	10197	5700	5705	5706	6233	7311	5720	8881	5708	9861	5711	246184	9491	119504	5695	5707	64682	51529	8697	51434	51433	29945	29882	5721	51343	10393	5719
PC_529	SCF-beta-TrCP mediated degradation of Emi1	122706	5717	5718	5715	10213	5688	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	6500	5720	991	5708	8454	23198	9861	5711	143471	9491	5695	5707	26271	5721	51343	5719	8945
PC_530	APC/C	122706	5717	5718	5715	10213	11065	5688	5709	5716	9232	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	996	5701	5699	5704	5714	5691	5690	5713	7321	7324	5710	25906	7979	5687	10197	5700	5705	5706	6233	7311	5720	991	8881	5708	23198	9861	5711	246184	143471	9491	119504	5695	5707	64682	51529	8697	51434	51433	29945	29882	5721	10393	5719
PC_531	APC/C	122706	5717	5718	5715	10213	11065	5688	6790	5709	5716	9232	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	996	5701	5699	5704	5714	5691	5690	5713	7321	7324	5347	5710	25906	7979	5687	10197	5700	5705	5706	6233	7311	5720	991	8881	5708	6502	23198	9861	5711	246184	143471	9491	119504	9212	5695	5707	64682	51529	8697	51434	51433	29945	29882	5721	51343	10393	5719
PC_532	Cdc20	122706	5717	5718	5715	10213	11065	5688	5709	9184	701	5716	983	7314	7316	5702	890	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	996	5701	5699	5704	5714	5691	5690	5713	7321	7324	5710	25906	7979	5687	10197	5700	5705	5706	6233	7311	8900	5720	991	8881	5708	4085	23198	9861	5711	246184	143471	9491	119504	5695	5707	64682	51529	8697	51434	51433	29945	29882	5721	10393	5719
PC_533	Transport and synthesis of PAPS	9061	9060	1836	347734	51000	10861
PC_534	Glutathione synthesis and recycling	26873	79017	2678	2687	2729	2730	2937	124975	494143	55748	79094	2686
PC_535	Polymerase switching on the C-strand of the telomere	5422	5111	5424	5984	5982	5981	5985	5983	5425	5557	5558	23649	10714	57804
PC_536	Processive synthesis on the C-strand of the telomere	5111	3978	5424	5425	10714	57804
PC_537	Telomere C-strand (Lagging Strand) Synthesis	5111	5424	5425	10714	57804
PC_538	Telomere C-strand synthesis initiation	5422	5557	5558	5427	5426	23649	56655	54107
PC_539	Removal of the Flap Intermediate from the C-strand	5111	6118	6117	5424	6119	2237	5425	1763	10714	57804
PC_540	Membrane binding and targetting of GAG proteins	55048	9397	7314	7316	6233	7311	155382	137492	93343	7251	89853	79720	51271	51160
PC_541	Activation of C3 and C5	629	718	727	717	720	100293534
PC_542	Assembly Of The HIV Virion	7314	7316	5478	6233	7311
PC_543	Integration of viral DNA into host genomic DNA	11168	8815	3159
PC_544	Interactions of Tat with host cellular proteins	904	1025
PC_545	Activation of ATR in response to replication stress	8317	1111	5001	5000	5810	3364	8318	5884	6118	1017	4172	6117	993	995	4173	4174	4176	6119	5984	5982	5985	5983	4171	4998	4999	545	4175	144715	55388	84126	5883	990	63967	23595	10926	84515	23594
PC_546	Conversion from APC/C	11065	996	7321	7324	25906	991	8881	246184	119504	64682	51529	8697	51434	51433	29945	29882	51343	10393	8556
PC_547	Regulation of APC/C activators between G1/S and early anaphase	11065	983	891	890	1017	996	7321	7324	25906	8900	991	8881	246184	119504	64682	51529	8697	51434	51433	29945	29882	26271	51343	10393
PC_548	APC/C	11065	9184	701	996	7321	7324	25906	991	8881	4085	246184	119504	64682	51529	8697	51434	51433	29945	29882	10393
PC_549	Phosphorylation of the APC/C	11065	983	891	996	7321	7324	5347	25906	8881	246184	119504	64682	51529	8697	51434	51433	29945	29882	10393
PC_550	Phosphorylation of Emi1	983	891	5347	991	26271	51343
PC_551	Unwinding of DNA	8318	4172	4173	4174	4176	4171	4175	9837	84296	64785	84515	51659
PC_552	Conjugation of salicylate with glycine	341392	123876	389396	348158	10249	54988	219970	92292
PC_553	Conjugation of benzoate with glycine	116285	389396	348158	10249	219970	92292
PC_554	Conjugation of phenylacetate with glutamine	116285	348158
PC_555	Retrograde neurotrophin signalling	161	160	10126	4803	4914	1211	1785	1175	163	1213	1759	1173	6456	26052
PC_556	Autointegration results in viral DNA circles	11168	8815	3159
PC_557	Signaling by EGFR	102	2069	8038	1956	1950	7039	6714	374	685	6868	255324	26018	1839
PC_558	APC-Cdc20 mediated degradation of Nek2A	11065	9184	701	7314	7316	996	7321	4751	7324	25906	6233	7311	991	8881	4085	246184	119504	64682	51529	8697	51434	51433	29945	29882	10393
PC_559	GRB2 events in EGFR signaling	2069	1956	4893	3265	3845	1950	7039	374	685	2885	6654	255324	1839
PC_560	SRP-dependent cotranslational protein targeting to membrane	6731	6184	6185	6176	6181	6175	6734	6218	3921	6728	6187	6165	6129	6139	6192	6188	6206	6137	6134	6136	6133	6146	6124	6727	6223	6122	1650	23521	6232	11224	6745	6746	6157	6125	6144	6158	6203	6193	6204	6159	6164	6726	9045	6748	23480	10952	6224	60559	6729	6189	6154	6138	6155	6168	29927	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	23478	6152	6173	6143	6142	6128	6141	9789	23471	200916	51065	140032	6123	6166	116832	140801	90701	55176	6730	6747	51121	25873	58477	28972
PC_561	DARPP-32 events	801	5573	5576	5532	5566	5568	5567	5141	5518	5519	5575	5577	5533	5499	5516	5534	5515	1020	5142	5530	5143	5144	5528	84152
PC_562	GAB1 signalosome	2069	1956	1950	7039	6714	374	5295	685	1445	5290	5829	2885	5781	2549	255324	1839	55824
PC_563	SHC1 events in EGFR signaling	2069	1956	4893	3265	3845	1950	7039	374	6464	685	2885	6654	255324	1839
PC_564	Vpu mediated degradation of CD4	122706	5717	5718	5715	10213	5688	5709	5716	920	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	6500	5720	5708	23198	9861	5711	143471	9491	5695	5707	5721	5719	8945
PC_565	Vif-mediated degradation of APOBEC3G	122706	5717	5718	5715	10213	5688	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	5720	5708	23198	9861	6921	6923	5711	143471	9491	8065	5695	5707	60489	5721	5719
PC_566	APOBEC3G mediated resistance to HIV-1 infection	11168	8815	3159	5478	60489
PC_567	Nuclear import of Rev protein	11097	9631	4869	7175	1104	8021	23636	9972	5903	4928	6396	57122	5901	8480	23279	3837	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_568	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	292	291	293
PC_569	Vpr-mediated nuclear import of PICs	11097	11168	8815	9631	7175	3159	8021	23636	9972	5903	3836	4928	6396	57122	8480	23279	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_570	RIP-mediated NFkB activation via ZBP1	3551	1147	7098	4790	4792	4791	5970	1660	8737	4793	148022	4615	81030	28511	28512	11035	8517
PC_571	Serotonin Neurotransmitter Release Cycle	10497	10815	8224	8541	8499	8497	9256	6853	5864	6857	6616	6812	6844	6571	8500	6804	22999	6854
PC_572	Norepinephrine Neurotransmitter Release Cycle	10497	10815	6582	6580	8541	8499	8497	9256	5864	4128	6857	6616	6812	6844	6571	8500	6804	22999
PC_573	Nef Mediated CD8 Down-regulation	161	160	926	1175	163	1173	51606
PC_574	EGFR downregulation	2069	9146	10253	10252	10254	1956	1950	7039	7314	7316	374	867	5774	685	2060	998	6233	7311	2885	5782	8874	5796	255324	8027	30011	1839	6455	6456	6457	58513	29924
PC_575	STING mediated induction of host immune responses	6737	3428	340061	115004	51428
PC_576	Cytosolic sensors of pathogen-associated DNA	11128	9533	10622	27297	661	51082	2547	7520	5434	4361	5437	5440	5435	5441	5591	84265	10623	10621	55718	55703	51728	171568
PC_577	Signaling by cytosolic FGFR1 fusion mutants	8805	11116	613	5295	1523	6774	6772	6776	5290	6777	2885	11052	9208	11064	399687	26127	7750	9846
PC_578	Signaling by FGFR1 amplification mutants	2260
PC_579	Signaling by activated point mutants of FGFR1	8822	2246	2249	2247	2251	2260	2250	2254	2253	8074	26281
PC_580	FGFR4 mutant receptor activation	2264
PC_581	Signaling by activated point mutants of FGFR3	8823	8822	8817	2246	2249	2247	2250	2261	2254	2253	8074	26281
PC_582	Synthesis of pyrophosphates in the cytosol	23262	11165	3705	9677	170685	9807	55190	117283	64768	11163
PC_583	Synthesis of IP2, IP, and Ins in the cytosol	3613	8821	8867	3612	3633	3628	4952	3632	27124	3631	66036	51477	55586	9108
PC_584	Synthesis of IPs in the nucleus	253430	9807	64768	51447
PC_585	Synthesis of IP3 and IP4 in the cytosol	3636	8867	9651	801	5336	5335	3706	3707	3633	5333	5728	5330	4952	5331	3705	5332	27124	23007	89869	113026	3635	122618	80271	84812	23236	51196
PC_586	Synthesis of IPs in the ER lumen	9562
PC_587	Downstream signal transduction	5296	8440	4893	3265	3845	5155	5154	5159	6714	5156	4690	5335	5921	5295	6774	6772	6778	6776	5290	5291	1398	1399	6777	9564	2885	5781	6654	2889	2886
PC_588	Signaling by PDGF	131873	256076	5340	5327	5155	1282	5154	7057	1284	5159	5045	6696	1291	1292	1293	5156	1297	1287	7058	7060	7059	1286	1285	5782	1299	1298	80310	56034
PC_589	NGF-independant TRKA activation	4914	116	135	117	4915
PC_590	TRKA activation by NGF	4803	4914
PC_591	SCF(Skp2)-mediated degradation of p27/p21	5717	5718	5715	10213	5688	5709	5716	9134	7314	7316	1019	5702	890	5689	595	898	1017	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	1026	5699	5704	1027	5714	5691	5690	5713	5710	7979	5687	1163	10197	5700	5705	5706	6233	7311	6500	8900	5720	5708	6502	8454	5753	9861	5711	9491	5695	5707	5721	5719
PC_592	Signalling to p38 via RIT and RIN	4803	4914	673	6016	6014
PC_593	Digestion of dietary carbohydrate	11181	8972	276	279	3938	6476	280	1118	27159
PC_594	Cellular hexose transport	125206	81031	6513	6514	6515	6523	6517	6524	200010	91749	155184	154091	144195	85414	55974	66035	56606	26291	29988	6527	11182
PC_595	Heme biosynthesis	7389	3145	7390	211	210	212	2235	1371	5498	1352	1355
PC_596	Heme degradation	3162	54657	645	3163	644
PC_597	FGFR4 ligand binding and activation	8823	8822	8817	9965	2246	2249	2247	2251	2264	2254	2253	8074	26281
PC_598	FGFR1b ligand binding and activation	2255	2246	2247	2260	2248	27006
PC_599	FGFR3b ligand binding and activation	8822	8817	2246	2261	2254	2253	26281
PC_600	FGFR3c ligand binding and activation	8823	8822	8817	2246	2249	2247	2250	2261	2254	2253	2591	8074	26281
PC_601	FGFR1c ligand binding and activation	8822	2246	2249	2247	2251	2260	2250	3730	2254	2253	8074	26281
PC_602	FGFR1c and Klotho ligand binding and activation	2260	8074	9365
PC_603	FGFR2c ligand binding and activation	8823	8822	8817	2246	2249	2247	2251	2250	2263	2254	2253	8074	26281
PC_604	FGFR2b ligand binding and activation	2255	2246	2247	2248	2252	2263	9982	143282	83888	27006
PC_605	Oligomerization of connexins into connexons	2705	2697	2706
PC_606	Transport of connexins along the secretory pathway	2705	2697	2706
PC_607	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	2697
PC_608	Gap junction assembly	2707	2709	10804	2705	2697	2706	2701	2702	10052	2703	81025	57165	375519	125111	84694	219770	127534	57369	2700
PC_609	Transport of connexons to the plasma membrane	2706
PC_610	Gap junction degradation	1211	1212	2697	1785	8218	1601	1213	1759	1173	4646
PC_611	Pre-NOTCH Processing in the Endoplasmic Reticulum	4851	4853	56983	4855	23509	4854
PC_612	Pre-NOTCH Transcription and Translation	1871	85236	7157	3012	3725	8970	3015	474382	3014	3013	8348	595	3018	5584	4851	102724334	3017	121504	3017	8350	1999	3020	1869	861	4853	3516	2033	10046	22938	7027	7029	8338	8349	723790	126961	94239	84441	128312	51548	27327	9794	1387	2648	8850	8334	8345	255626	55534	4855	8341	8331	8342	8340	55766	192669	4343	57690	192670	27161	26523	4854	23112
PC_613	Pre-NOTCH Processing in Golgi	4242	487	5045	2683	488	5870	4851	4853	6487	6484	10959	3955	489	4855	6400	4854	10402	5986
PC_614	Cholesterol biosynthesis	7108	9453	3156	2224	2222	4047	4597	51478	3157	4598	3422	6713	3930	10654	50814	6307	1595	403313	39	91734	64801
PC_615	Regulation of gap junction activity	6714	2697	7082
PC_616	snRNP Assembly	10419	8487	11097	9631	10073	7175	6628	8021	23636	9972	5903	22916	4928	1207	6396	50628	57122	6635	6636	6637	6632	6633	6634	8480	4686	23279	6606	23511	53371	9688	348995	79023	129401	23225	25929	55746	79833	23165	81929	9883	96764	4927	79084	55706	9818	79902	51808	79760	8086	54960	11218	10762
PC_617	Synthesis of bile acids and bile salts	9420	9023	6256	5007	1581	10499	8648	9971	114883	114876	114881	114880	9885	26031
PC_618	Digestion of dietary lipid	1208	8513	5406	5407	5408	119548
PC_619	Viral mRNA Translation	6176	6181	6175	6218	3921	6187	6165	6129	6139	6192	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	6152	6173	6143	6142	6128	6141	2926	5611	200916	51065	140032	6123	6166	116832	140801	51121	25873
PC_620	vRNP Assembly	3843	3320
PC_621	Androgen biosynthesis	5443	1081	3972	1586	3283	6715	3284	6716	3293	51144	79644
PC_622	Estrogen biosynthesis	441282	1588	3292	3294	51170	51171
PC_623	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	10005	11001	9420	8647	1109	6256	6342	1581	8644	3295	6718	1646	1593	1645	570	10499	8648	5740	9971	8309	80270	23600	1582	10998
PC_624	Axonal growth inhibition (RHOA activation)	4804	4168	4099	4974	396	387	84894	57142
PC_625	NRAGE signals death through JNK	389337	445328	100271715	5924	9639	23263	9826	23229	10018	8997	7204	57449	22899	4803	4804	4168	7409	5599	7410	5879	2245	6654	6655	7984	11214	29	7074	8874	10672	9459	6453	89846	84033	27237	23370	10276	221472	26230	128272	84904	25791	57580	55701	9138	572	9181	26084	121512	9828	64857	1894	55160	50649	50650	54848	26574	23365	10451	9500
PC_626	p75NTR negatively regulates cell cycle via SC1	8841	4803	4804	3065	3066	11108
PC_627	Ceramide signalling	6610	4803	4804
PC_628	Regulated proteolysis of p75NTR	4804	4790	5663	5664	6868	5970	83464	23385	51107	55851	7189
PC_629	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	11001	1109	8644	6718	1646	1593	1645	5740	80270	51302	23600	1582	10998	10858
PC_630	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	9420	1109	6256	1581	8644	6718	1646	1593	1645	10499	8648	5740	9971	80270	1582
PC_631	Mineralocorticoid biosynthesis	1081	3972	1589	3283	1585	3284
PC_632	Glucocorticoid biosynthesis	5443	1586	1589	3283	1584	1585	3284	3290	3291
PC_633	Neurophilin interactions with VEGF and VEGFR	8829	8828	2321	3791
PC_634	VEGF ligand-receptor interactions	2277	7422	5228	7423	7424
PC_635	Rho GTPase cycle	79658	389337	445328	143872	9743	100271715	4649	29984	5296	115703	5924	9639	23263	9826	395	9901	23229	8997	4983	23380	7204	57449	9886	10144	22899	2	389	4168	613	5880	7409	1123	23433	2664	3633	9938	2665	396	397	7410	1124	5881	998	387	388	5879	391	23779	393	2245	4952	6654	6655	392	7984	11214	29	7074	394	4650	8874	10672	84986	9459	10928	9322	399	6453	9912	57514	89839	9411	55843	89846	57584	84033	84144	27237	55114	9824	158763	23370	201176	85360	58480	58504	10276	57522	257106	221472	26230	128272	94134	89941	55288	117289	83478	93663	84904	25791	57580	55701	55789	64411	116984	9754	23526	9138	9181	26084	171177	121512	116985	9828	10395	91614	398	64333	23221	80728	29127	57381	64857	1894	54509	55160	50649	50650	2909	54848	51306	23365	51291	57636	57569	10451	23092	90627
PC_636	Degradation of beta-catenin by the destruction complex	122706	5717	5718	5715	10213	5688	8312	5709	5716	7314	7316	5702	5689	324	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5518	5519	1499	5701	5699	5704	5714	1452	5691	5690	2932	5713	5710	7979	5687	10197	5700	5705	5706	5516	9978	6233	7311	6500	5515	5720	5708	5527	8454	5528	23198	9861	5525	5526	5711	5529	139285	143471	9491	5695	5707	5721	5719	8945
PC_637	VEGF binds to VEGFR leading to receptor dimerization	2277	7422	2321	2324	3791	5228	7423	7424
PC_638	Formation of annular gap junctions	1211	1212	2697	1785	8218	1601	1213	1759	1173
PC_639	Pregnenolone biosynthesis	9256	83930	1583	2230	231	2232	706	6770	147323	10948	112812	134429
PC_640	Beta-catenin phosphorylation cascade	8312	23401	324	5518	5519	1499	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285	10023
PC_641	GRB2 events in ERBB2 signaling	9542	2069	1956	4893	3265	3845	1950	2064	685	10718	2885	3084	6654	2066	145957	1839
PC_642	PI3K events in ERBB2 signaling	9542	2069	1956	1950	2064	2065	5295	685	5290	10718	2885	3084	2549	2066	145957	1839
PC_643	Cobalamin (Cbl, vitamin B12) transport and metabolism	5826	8029	5644	1504	6947	6948	4594	2694	4363	5646	440387	166785	326625	4548	11330	81693	27249	51293	55788	4552	25974
PC_644	Metabolism of folate and pterines	10840	1719	4522	10797	2350	6470	6472	6573	4524	10588	2356	160428	25902	200895	113235	81034	441024
PC_645	Biotin transport and metabolism	32	5095	5096	5091	686	3141	31	51248	56922	64087	8884
PC_646	Coenzyme A biosynthesis	8034	80347	53354	60490	80025	79646	79717	55229
PC_647	Vitamin D (calciferol) metabolism	1594	8029	2638	7421	6613	7329	4036	1591	120227	51588	5641
PC_648	Nicotinate metabolism	65220	4907	952	683	23475	133686	55191	349565	23057	64802	27231	54981
PC_649	Vitamin B1 (thiamin) metabolism	10560	79178	80704	27010	60386
PC_650	Vitamin C (ascorbate) metabolism	1528	1727	6513	6515	9446	119391	9962	9963
PC_651	Vitamin B2 (riboflavin) metabolism	54	5167	80308	55312	79581	113278	55065
PC_652	A tetrasaccharide linker sequence is required for GAG synthesis	375790	1463	9672	2239	26229	10675	1634	1462	6382	633	6385	6383	2817	2719	2262	3339	1464	64131	221914	63827	126792	64132	135152	27087	11285	10082
PC_653	Nicotinamide salvaging	5743	4837	10135	5740	56965	54625	84875	55328	93100	55739	83666	79668	54956	160728	128240	83594	143	1582	9390
PC_654	PI3K/AKT activation	5296	4803	4914	5295	3667	5290	5291	387	8660
PC_655	AKT phosphorylates targets in the cytosol	1147	207	208	1026	1027	7249	2931	2932	842	4193	572	84335	23608	10000
PC_656	AKT phosphorylates targets in the nucleus	2309	1385	3164	207	208	4303	2308	6199	10000
PC_657	Signalling to STAT3	4803	4914	6774
PC_658	ERK/MAPK targets	9252	2002	5595	5594	5518	5519	6197	5516	5515	4205	4208	5598	5528	6196	6195	5600	1432
PC_659	Signalling to ERK5	5607	5598
PC_660	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	353514	124599	117157	259197	8778	946	7305	4068	11024	102725035	10990	9437	56253	9436	11126	718	925	3106	3105	3105	3106	3107	915	3105	3689	3383	3105	3688	909	916	2214	917	3105	3105	3106	3107	926	2209	999	8519	3384	3676	3105	3133	6402	4267	5817	930	912	3105	3105	3105	3135	3105	3106	3106	3106	7412	945	933	3683	919	958	3695	3821	100528032	947	910	911	959	3105	3105	3105	3105	3105	3105	3105	3105	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3107	3107	3107	3107	3107	3107	3134	3105	3106	2213	3385	10225	4345	3802	3803	3804	3811	3812	100132285	23547	975	567	1525	3106	3107	10871	3105	3820	3824	8174	3386	3806	10666	3106	3106	3107	3106	3107	3107	4277	100507436	3106	3106	342510	81035	79865	374383	3903	3904	339390	146894	285852	100131439	120425	340205	196500	126014	11027	10288	11026	11006	10859	135250	131450	146722	9976	5819	3106	3107	114836	10219	89790	89858	114132	3805	79465	80329	6614	54210	57823	56654	27181	54209	51348	3107	10870	11314	29121	29990	29992	7087	27036	27180
PC_661	PPARA activates gene expression	219541	57491	406	8841	9575	9443	9282	3992	54600	6907	8800	9611	9862	27242	10001	9441	19	183	335	336	3156	1543	2168	6667	34	2101	211	948	6256	9572	5244	1581	4800	1376	892	4801	50486	405	6257	2180	6095	196	6720	5468	2222	11010	4199	1024	1374	3158	7376	3157	1579	6822	5465	2033	6721	10062	2874	9412	4802	2274	23054	4520	51	27063	6837	10499	5469	8648	4899	7296	80205	9442	376497	116519	6604	23389	81857	10498	133522	26230	1387	9968	84498	112950	90390	9971	51586	96764	57761	123	4862	84246	54797	23097	51129	85441	79718	80306	9477	9915	29079	9440	55090	55588	29841	23179	400569	10891	9969	9439	9967	10025	51003	9612	8202
PC_662	Vitamin B5 (pantothenate) metabolism	5169	8876	8875	5167	2194	5168	51248	60496	8884
PC_663	Negative regulation of the PI3K/AKT network	23239	207	208	5728	117145	23035	57761	10000
PC_664	CREB phosphorylation	9252	1385	466	9261	6197	6196	6195
PC_665	trans-Golgi Network Vesicle Budding	8773	6845	6844	375	6810	8729	8673
PC_666	Import of palmitoyl-CoA into the mitochondrial matrix	5565	788	6584	6256	1376	1374	5563	5467	1375	7069	58526	51422
PC_667	Signaling by BMP	658	4092	4093	4091	27302	9350	268	650	6497	92	657	94	7321	7323	11167	9241	4089	93	659	4086	269	9765	4090	91851	64388	64750	57154	2658
PC_668	TCF dependent signaling in response to WNT	1855	1856	7483	8312	4041	4040	22943	8658	7471	7314	7316	6259	1499	7474	7473	89780	54361	6233	7311	2535	9736	6422	79412	1857	7479	6423	83999	50964	7478	80351	81847	27121	27123	8321	8313	11197
PC_669	WNT mediated activation of DVL	1855	1856	8395	1459	102800317	1460	1457	1857
PC_670	Formation of the beta-catenin	4221	607	8085	7015	85236	4609	3012	8970	3015	474382	6925	3014	3013	8348	3018	1499	6932	6597	102724334	3017	121504	3017	8350	3020	7088	7089	7090	7091	2033	3065	5929	8290	8338	8349	723790	79577	126961	94239	283149	128312	123169	1387	10524	8334	8345	255626	8341	8331	8342	8340	90780	55766	83439	6934	9070	51176	8607	26108	8295
PC_671	G-protein activation	346562	2793	10681	2788	5443	5173	2771	2773	2775	2779	2784	2781	2780	4988	2786	2790	54331	2791	2782	2783	2770	2792	2785	2787	59345	51764	55970	94235
PC_672	Assembly of collagen fibrils and other multimeric structures	131873	256076	9313	1515	1277	1280	1281	1282	1290	1514	1508	1278	4314	1284	4316	1301	1291	1292	1293	1302	4318	3691	1297	1289	3655	1296	1520	50509	1295	1287	1306	80781	4322	977	1286	1285	667	1300	3914	3918	1299	1298	5339	3909	255631	85301
PC_673	Metabolism of Angiotensinogen to Angiotensins	10159	5972	183	1509	1511	4311	1636	1360	1359	290	2999	1066	1215	2028	84909	1361	59272	1522
PC_674	Keratan sulfate biosynthesis	9334	11041	8534	8703	8702	8704	11081	2683	176	4969	4060	5549	2331	6482	6487	6484	6483	11046	93010	4958	79369	23563	4166	10678	9331	10402	10331	9435
PC_675	Keratan sulfate degradation	11081	3073	3074	2799	176	2720	4969	4060	5549	2331	79411	4958
PC_676	Chondroitin sulfate biosynthesis	1463	10675	1634	1462	633	1464	337876	83539	51363	9469	22856	79586	55454	166012	55790	63827	50515	55501	56548	54480
PC_677	Dermatan sulfate biosynthesis	1463	10675	1634	1462	633	1464	92126	113189	63827	29940	10090
PC_678	HS-GAG biosynthesis	375790	9957	9394	9672	2239	26035	9348	6382	6385	6383	2817	2719	3340	8509	2262	3339	2131	11046	9653	266722	222537	221914	2132	90161	64711	64579	9956	10082	9951	9953	9955
PC_679	Signaling by FGFR2 amplification mutants	2263
PC_680	HS-GAG degradation	375790	9672	2239	2990	2720	6382	3423	6385	6383	2817	3425	2719	6448	4669	2262	3339	79411	221914	60495	10855	10082
PC_681	CS/DS degradation	1463	8372	10675	3073	1634	3074	1462	411	633	3423	3425	3373	1464	63827
PC_682	Downstream TCR signaling	122706	5717	5718	5715	5296	10213	5688	3551	1147	5170	5709	6885	8767	5716	8915	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	917	7314	7316	3123	3123	3126	5702	4790	3113	3123	5689	919	5682	5683	5684	5685	4792	5295	5696	5698	5686	5692	5694	5693	5701	5699	5290	5291	5704	5714	997	5691	5690	5713	7321	5710	5728	7979	5687	7334	10197	5700	5705	5706	7322	6233	7311	6500	3125	5970	5588	5720	5708	387522	8454	23198	9861	5711	3123	3123	3127	3123	3123	50852	143471	9491	3635	3123	5695	5707	84433	3123	23118	3123	10892	23291	5721	5719	8945	7189	8517
PC_683	Phosphorylation of CD3 and TCR zeta chains	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	5788	917	3123	3123	3126	3113	3123	919	1445	3125	5795	3123	3123	3127	3123	3123	3123	3123	55824	3123	26191
PC_684	Translocation of ZAP-70 to Immunological synapse	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	917	3123	3123	3126	3113	3123	919	7535	3125	3123	3123	3127	3123	3123	3123	3123	3123	26191
PC_685	Generation of second messenger molecules	2533	27040	9402	5063	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	917	3123	3123	3126	4690	5335	3113	3123	919	7454	7535	7408	3125	3702	3937	5058	5062	3123	3123	3127	3123	3123	55740	9398	3123	3123	3123	51466
PC_686	Calcineurin activates NFAT	4772	801	5532	5478	2280	5534	5530	4775	4773
PC_687	ERKs are inactivated	5595	5594	5518	5519	1845	5516	5515	1846	5598	5528	1848	1849	51231
PC_688	Cell surface interactions at the vascular wall	8797	8795	9672	2147	7040	3512	2993	2335	5196	5624	338	972	2995	3689	3688	2994	2534	914	1048	7056	5627	4067	3678	962	5197	3684	5669	5670	7441	3676	634	6402	4282	4267	3543	960	6403	6693	5175	4072	6401	6382	965	3683	3687	2207	6385	1088	6383	2817	1084	4680	7102	58494	1525	140885	4973	5678	5672	5675	961	10461	5676	6404	2621	5673	5671	120425	57126	83692	83953	2734	90952	83700	51744	51206	54210	9463	55423	8793	8832	29802	10544	5680	440533	50848
PC_689	Signaling by Hippo	1856	261734	9113	7529	836	10413	7531	7082	6789	6788	154796	92597	23286	154810	25937	60485	55233	26524	9414	51421
PC_690	FCGR activation	2534	7525	4067	3055	2214	917	2268	2209	2212	6714	919	6850
PC_691	Regulation of actin dynamics for phagocytic cup formation	644150	4641	8976	10095	10109	10094	10092	7456	25	3320	3326	2214	917	2209	2212	7409	4690	919	1072	5595	5594	4771	4627	7454	6850	1398	7410	3984	3071	10093	60	998	10096	10097	2885	5879	71	5747	695	5058	4650	1793	23191	10006	147179	55845	9844	8936	10552	26999	63916	4651	10152	51517	10451	4620	10810	10458	10787	4644	10163
PC_692	Role of phospholipids in phagocytosis	5296	5338	10768	8398	2214	917	2209	2212	5336	5335	919	5295	5290	5291	6850	5581	5580	5337	3709	3710	3708	196051	23646	84513	122618
PC_693	YAP1- and WWTR1 (TAZ)-stimulated gene expression	4878	7003	1490	2626	10413	1482	860	7004	8463	204851	8850	6910	7005	25937	28996
PC_694	FGFR3 mutant receptor activation	8823	8822	8817	2246	2249	2247	2250	2261	2254	2253	8074	26281
PC_695	t(4	2261
PC_696	Activated point mutants of FGFR2	2255	8823	8822	8817	2246	2249	2247	2251	2248	2250	2252	2263	2254	2253	8074	27006	26281
PC_697	eNOS activation	10434	23576	23564	3320	801	4846	207	6697	857	340481	114757
PC_698	NOSTRIN mediated eNOS trafficking	8976	4846	1785	857	115677
PC_699	NOSIP mediated eNOS trafficking	4846	51070
PC_700	MicroRNA (miRNA) biogenesis	5433	8575	5432	5434	5430	5431	5438	5437	5439	5440	5435	5436	5901	5441	6895	144233	54487	192669	57510	192670	29102	27161	26523	23405
PC_701	COPII-mediated vesicle transport	5537	9570	9919	23243	10282	10652	27095	8615	9554	79090	9871	22872	10175	10802	10427	2157	5265	7039	6399	2153	966	2348	374	2890	4905	7109	1453	3998	10972	1075	9632	8775	6396	55014	5861	1294	2801	10960	6811	10959	10484	55291	254263	122553	126003	90411	149111	23256	10342	128637	26984	89866	83696	8774	64689	9117	81876	81562	63908	79748	10113	1522	51693	22870	51399	58485	51128	11196
PC_702	Regulation of pyruvate dehydrogenase (PDH) complex	8050	2954	5160	1738	1737	5162	6256	5161	5467	5163	5164	5165	5166	55066	54704	57546
PC_703	Linoleic acid (LA) metabolism	3992	9415	2180	215	64834	83401	54898	60481
PC_704	alpha-linolenic acid (ALA) metabolism	10005	3992	9415	30	6342	2180	215	3295	51	64834	83401	54898	60481
PC_705	Hypusinylation	1725	1984	83475	56648
PC_706	NFG and proNGF binds to p75NTR	4803	4804
PC_707	NADE modulates death signalling	4803	4804	836	835	7531	27018
PC_708	NRIF signals cell death from the nucleus	4803	4804	7314	7316	5599	5663	5664	6233	7311	23421	8878	83464	23385	51107	55851	7189
PC_709	p75NTR recruits signalling complexes	3551	8767	4803	4804	7314	7316	5584	3654	6233	7311	8878	4615	7189
PC_710	NF-kB is activated and signals survival	3551	4803	4804	7314	7316	4790	4792	3654	6233	7311	5970	8878	7189
PC_711	Axonal growth stimulation	4803	4804	396	387
PC_712	Glycoprotein hormones	1081	7252	2488	3972	3623	3624	3625	1082	3626	83729
PC_713	Catecholamine biosynthesis	7054	1621	5409	1644
PC_714	Serotonin and melatonin biosynthesis	7166	1644	438	15	121278
PC_715	Peptide hormone biosynthesis	5443	5122
PC_716	Thyroxine biosynthesis	1081	7252	7173	389434	6528	50506	53905
PC_717	Astrocytic Glutamate-Glutamine Uptake And Metabolism	2752	6507	6506	81539
PC_718	Glutamate Neurotransmitter Release Cycle	6512	10497	10815	8541	8499	8497	10550	2744	9256	5864	6857	6507	6506	6505	6511	6616	6812	6844	8500	6804	22999	54407	57030	27165
PC_719	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	390874	6928	4851	3516	2033	10046	22938	3280	84441	9794	1387	2648	8850	55534	3175	50674
PC_720	Regulation of gene expression in beta cells	4821	3630	3375	6514	6927	5080	5313	2645	3172	3651	3171	4825	2308	4760	3174	222546	389692	3170
PC_721	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	4821	3642	4760	50674
PC_722	Regulation of gene expression in early pancreatic precursor cells	2494	2255	390874	6928	3651	4825	256297	3175
PC_723	PECAM1 interactions	3690	3932	2534	3685	7525	4067	6714	5175	5335	5777	5781	3635
PC_724	Basigin interactions	9123	23539	4312	481	3688	6520	482	6693	4099	3655	3675	3897	682	6566	483	5478	11136	8140	857	23759	9057	56301	23428	9056	23657
PC_725	Tie2 Signaling	5296	285	9046	4893	3265	3845	5295	6464	5290	5291	2885	7010	5781	6654	2888	2886	284	51378
PC_726	AKT-mediated inactivation of FOXO1A	207	208	2308	10000
PC_727	Regulation of PAK-2p34 activity by PS-GAP/RHG10	79658	5062
PC_728	Regulation of activated PAK-2p34 by proteasome mediated degradation	122706	5717	5718	5715	10213	5688	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5062	5708	23198	9861	5711	143471	9491	5695	5707	5721	5719
PC_729	Stimulation of the cell death response by PAK-2p34	836	5062
PC_730	Cytochrome P450 - arranged by substrate type	5447
PC_731	Vitamins	1594	1592	1591	340665	120227	56603
PC_732	Fatty acids	1565	1580	1555	1549	1572	1573	8529	11283	1579	4051	1553	284541	126410	57834	66002
PC_733	Phase I - Functionalization of compounds	57491	8824	80777	314	874	1727	2052	4835	26	13	1066	405	218	196	8639	64757	23491	670	54996	134147	9915
PC_734	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	1544
PC_735	Miscellaneous substrates	1565	1580	8529	1579	4051	284541	126410	113612	54905	29785	64816	57834
PC_736	Endogenous sterols	57491	9420	5443	1583	1589	2230	1588	1584	1585	6256	2232	1581	405	196	1593	10499	8648	1545	1595	112812	285440	9971	9915	51302	10858
PC_737	Eicosanoids	1580	6916	8529	11283	1579	4051	5740	284541	126410	57834	66002	1582
PC_738	Xenobiotics	57491	1543	1571	1576	1558	1565	1548	1559	1555	1577	1549	100861540	1572	405	1562	1557	196	1573	1553	54905	29785	64816	9915
PC_739	Sterols are 12-hydroxylated by CYP8B1	5740	1582
PC_740	CYP2E1 reactions	1571	1558	1565	1548	1559	1555	1549	1572	1557	1553	29785
PC_741	NOTCH1 Intracellular Domain Regulates Transcription	8841	6907	9611	4609	7314	7316	892	4851	1024	9759	9978	6233	7311	6500	7088	7089	7090	7091	3516	2033	10046	3065	22938	8454	3280	3091	388585	84441	51564	9794	3066	1387	2648	8850	55294	83933	79885	55534	55869	79718	26508	10013	23493	9734	10014	23462	9612
PC_742	Activated NOTCH1 Transmits Signal to the Nucleus	54492	28514	102	9148	7314	7316	409	4851	408	8650	5663	5664	6233	7311	182	6868	8788	1272	113878	1840	57534	92737	83464	23385	142678	51107	83737	54567	55851	3714	23220
PC_743	PRC2 methylates histones and DNA	5252	85236	8726	3012	8970	3015	474382	3014	3013	8348	1786	3018	102724334	3017	121504	3017	8350	3020	5928	23512	2146	5931	8338	8349	26147	723790	121536	126961	94239	128312	3720	8334	8345	255626	8341	8331	8342	8340	55766	1789	22823	1788
PC_744	Generic Transcription Pathway	162967	219578	84626	344787	353355	100287226	730087	441234	55778	146540	442319	100131980	100131539	7652	728927	654254	7748	10168	7760	10127	9422	7757	388567	9443	9282	26048	6940	56242	100129842	9534	9862	25799	10001	7743	9668	7753	7755	9441	91120	146542	730291	728957	284459	58500	7559	7561	7562	7565	7566	7567	7568	7571	7586	219749	7574	7587	7576	7551	7594	90075	7556	892	1024	7712	7592	7626	7692	7695	7699	7694	7697	353274	7752	7596	168374	7581	7582	90317	125919	55786	7711	7710	10155	10520	10781	10308	10795	10780	9310	10794	10793	169841	5469	7745	7700	58492	7633	7678	7625	374879	79755	163049	126375	84436	255403	284307	374900	339559	92285	84124	63934	282890	55634	83744	440515	148266	127396	90874	26149	90333	51058	284309	199777	400720	388569	285349	388566	54989	155054	221785	155061	342132	27300	79175	57711	9442	162239	199704	348327	256051	79898	388536	374928	54811	100129543	158431	340385	390927	80108	440077	619279	253639	162966	284443	389114	285268	81857	51333	199692	124411	90233	162972	51276	100289635	115196	339327	51385	353088	7770	388561	342926	30832	126231	201514	284306	152687	126070	163227	168417	80778	94039	163081	374655	285267	136051	144348	93134	79027	163059	163223	81856	349075	80110	284370	126068	163051	79230	285676	147929	162963	163087	163071	220992	90594	163255	57209	283337	147694	340252	148254	140612	147837	92283	147923	147687	79891	162655	163050	169270	57541	171392	170960	170959	158399	147686	146198	25888	147657	80095	9968	387032	84924	79862	285971	286075	115509	112950	10782	90576	90649	92595	79744	90390	90589	84838	90827	84449	79759	84874	117608	146434	147741	197320	7627	148213	148206	121274	147949	148156	147948	148268	26974	148103	114026	57693	91975	51586	84671	84775	84914	84911	7738	84527	80317	65251	93474	7549	84765	84246	55657	79088	65988	55659	57573	100131827	80818	59348	90592	79818	79973	79788	80139	79943	80264	9477	80032	57336	57335	90338	57677	57343	55713	29079	11105	55422	58491	55900	55762	9440	55663	54925	54807	7769	7767	23619	55888	57615	57547	7621	7988	8427	9969	7773	65243	7771	7733	7768	7766	7673	7638	7762	7761	27153	9439	57474	10224	22835	22869	23660	10172	113835	10025	51003	26152	7552	7728	51123	7539
PC_745	Dopamine Neurotransmitter Release Cycle	10497	10815	8825	8573	8224	8541	8499	8497	9256	6853	5864	6857	6616	6812	6844	320	6571	8500	6804	22999	6854	64130	55327
PC_746	EGFR interacts with phospholipase C-gamma	2069	1956	1950	7039	374	5335	685	255324	1839
PC_747	Molecules associated with elastic fibres	27302	30008	7040	7448	3690	3688	3685	7043	650	652	655	3693	3694	2192	3696	8200	8516	4237	4236	4238	4239	7042	2199	2202	8076	4052	4053	8425	4054	10516
PC_748	MHC class II antigen presentation	3796	10671	1780	3797	6712	9371	1783	164	1515	11258	9871	161	22872	10112	24137	10802	10427	160	3122	3118	3117	3123	3123	3119	3123	972	3115	3120	3111	1509	1514	1508	1211	1512	5476	10437	3123	3123	3126	3112	1510	3902	3113	3123	1520	821	3109	3799	10120	1519	1513	830	832	1785	7879	3832	829	1075	1175	9632	6396	8905	10121	1174	163	8655	3125	375	1213	1062	9493	1759	3831	162	3798	1781	10540	1639	1778	3835	10484	3123	285643	3123	3127	3123	3123	147700	84643	81930	22920	3123	1173	140735	93661	83547	130340	5641	11004	6456	84516	8907	114876	3123	64837	29127	56992	89953	55860	3123	8722	51164	26153	26052	11127	51128	51143	10053
PC_749	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	1543	1544	1558	1559	1557	2053	1573	1545
PC_750	Synthesis of 5-eicosatetraenoic acids	2876	240	2877	241	5444	2879	5445	5446	4056
PC_751	Synthesis of Leukotrienes (LT) and Eoxins (EX)	240	4048	1580	246	1800	2678	241	4363	2687	9261	8529	11283	1579	4051	22949	4056	284541	126410	64174	64180	57834
PC_752	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	239
PC_753	Synthesis of Lipoxins (LX)	240	3248	239	241	22949	4056
PC_754	Synthesis of 12-eicosatetraenoic acid derivatives	242	2876	246	239	2877	2879	59344
PC_755	Arachidonic acid metabolism	2166	5321	158833	158584
PC_756	Synthesis of 15-eicosatetraenoic acid derivatives	247	2876	246	2877	5743	2879
PC_757	Ubiquinol biosynthesis	57017	84274	23590	57107	27235	10229	51805	51004
PC_758	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	1543	1544	1558	1559	1557	8529	1579	1545	113612
PC_759	Hyaluronan biosynthesis and export	3038	10057	57214	3037	3036
PC_760	Transcriptional activation of mitochondrial biogenesis	5442	8841	6907	9611	2746	6648	506	801	2101	211	1386	1385	6256	9572	3418	2747	3054	64854	54205	7019	6742	4208	2551	2553	5465	23054	4209	10499	5469	8648	814	4899	80205	200186	84808	23082	6604	64784	23373	10498	133522	51106	1387	56652	96764	7978	85441	79718	64216	55902	23410	23408	10891	11232	23409
PC_761	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	5565	6300	5571	5563	5600	1432	10891	53632	51422	5564
PC_762	Phenylketonuria	5053
PC_763	Integrin cell surface interactions	375790	8515	1282	2243	2244	2266	2335	7448	3690	3689	3383	3688	3685	7057	3674	1284	3678	6696	3684	999	3384	3676	960	5175	3673	3693	3694	7412	3683	3687	1297	3381	3655	3371	3675	3695	3696	3385	2200	682	3791	3682	80781	1311	4060	1286	8516	3672	58494	3339	1285	1307	961	3681	8174	3679	3680	1299	1298	3386	1305	91522	83700	22801	7087	50848
PC_764	Hyaluronan uptake and degradation	8372	3161	3073	3074	2990	960	6548	3373	8692	55576	11261	10894
PC_765	Abacavir transmembrane transport	6582	6580	6581	5243	9429
PC_766	Abacavir metabolism	124	5105	22978	2987	161823
PC_767	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	9536	27306	3248	873	5742	6916	5743	5730	8644	10728	5740	145482	127281	80142	1582
PC_768	Scavenging of heme from plasma	8542	3240	3250	3512	335	259	213	3263	3043	3039	4035	9332
PC_769	DAP12 interactions	124599	10326	7305	9436	3107	3133	3822	100528032	3107	100132285	3809	567	100049587	3824	3813	3810	342510	284266	3106	54210	23601	54209
PC_770	FMO oxidises nucleophiles	2328	2326	2327
PC_771	Downregulation of TGF-beta receptor signaling	7514	4092	23645	9372	7040	7314	7316	5501	7046	7048	5499	5500	6233	7311	4088	25805	4087	56937	23327	64750	57154	9110	10273	11171	9958	51377
PC_772	TGF-beta receptor signaling activates SMADs	9372	7040	5045	867	7046	7048	9040	2280	4088	4089	4087	4738
PC_773	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	7040	7314	7316	7046	7048	387	2280	6233	7311	5590	23370	56288	57154	50855	57530	50848
PC_774	Downregulation of SMAD2/3	9611	142	7314	7316	6497	6498	5494	7321	7323	6233	7311	4088	4089	3065	7050	4087	54778	8239	23327	60436	64750	51592	9612
PC_775	SMAD2/SMAD3	4221	4092	904	905	8812	4609	5054	6667	7314	7316	3726	892	5933	1030	1024	1025	6233	7311	4088	4089	3065	22938	7027	7029	1875	7050	4087	1874	54778	60436	25937	23439
PC_776	EGFR Transactivation by Gastrin	1956	4893	3265	3845	4314	5578	2885	6654	1839
PC_777	The retinoid cycle in cones (daylight vision)	9249	611	5956	101060233	5949	6017	158835
PC_778	NOTCH2 intracellular domain regulates transcription	2208	3002	1385	4853	3516	2033	10046	3280	388585	84441	9794	55534
PC_779	MPS IX - Natowicz syndrome	3373
PC_780	MPS IIIB - Sanfilippo syndrome B	4669
PC_781	MPS VI - Maroteaux-Lamy syndrome	411
PC_782	MPS IV - Morquio syndrome A	2588
PC_783	MPS IIIC - Sanfilippo syndrome C	138050
PC_784	MPS VII - Sly syndrome	2990
PC_785	MPS II - Hunter syndrome	3423
PC_786	MPS I - Hurler syndrome	3425
PC_787	MPS IIID - Sanfilippo syndrome D	2799
PC_788	MPS IIIA - Sanfilippo syndrome A	6448
PC_789	MPS IV - Morquio syndrome B	2720
PC_790	Anchoring fibril formation	7092	649	1294	3914	3918	3909	7093
PC_791	Constitutive Signaling by Aberrant PI3K in Cancer	5293	5296	9542	2069	2255	8823	6801	8822	8817	9965	1956	5155	1950	7039	2099	5154	2064	2246	3932	2534	4233	2249	2247	5159	3815	940	2251	2260	2248	2250	6714	3082	5880	930	7409	374	5156	4254	2252	2263	2065	2264	2261	5295	2254	941	685	3667	942	5290	5291	2253	10718	2885	5879	391	3084	5781	2549	2066	50852	255324	118788	152831	10818	145957	8503	2100	1839	8074	27006	26281	9365	8660	29851
PC_792	Crosslinking of collagen fibrils	7092	649	4015	84695	4016	5118	7837	84171	4017	7093
PC_793	Condensation of Prophase Chromosomes	85236	10592	3012	5925	983	8970	3015	474382	891	3014	3013	8348	3018	23310	5347	102724334	3017	121504	3017	8350	3020	6418	8290	8338	8349	723790	29781	126961	94239	54892	128312	79648	8334	8345	255626	8341	8331	8342	8340	55766	387893	10051	23133
PC_794	Phosphate bond hydrolysis by NUDT proteins	4521	56985	79873	131870	53343	55270	11164
PC_795	Electron transport from NADPH to Ferredoxin	2230	2232	112812
PC_796	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	8483	3481	3479	3480
PC_797	Metabolism of ingested SeMet, Sec, MeSec into H2Se	191	1491	102724560	4837	3176	4143	27232	51540
PC_798	Selenoamino acid metabolism	9521	2058	1615	3376	5859	5917	4141	9255	7965	3735	51520
PC_799	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	9061	9060	2936	7296
PC_800	Methylation of MeSeH for excretion	11185
PC_801	Selenocysteine synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6192	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	6301	9045	60678	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	6152	6173	6143	6142	6128	6141	200916	51065	118672	140032	6123	6166	116832	140801	79048	22928	51091	51121	25873
PC_802	DAP12 signaling	5296	27040	7305	9402	4893	3265	3845	3932	2534	3133	5336	5335	3822	100528032	5295	6464	5290	5291	6850	7410	567	2885	5879	695	6654	3937	3824	54209	10451
PC_803	Activation of gene expression by SREBF (SREBP)	32	6319	6907	6309	7108	9453	3156	6667	2224	6256	4800	4801	6720	2222	4047	2194	4597	3157	4598	5465	6721	31	3422	4802	6713	23054	4520	10654	10499	5469	8648	1595	80205	6604	10498	1387	96764	85441	79718	79071	57678	1717
PC_804	IRS-related events triggered by IGF1R	8471	3481	3479	3480	3667	8660
PC_805	SHC-related events triggered by IGF1R	4893	3265	3845	3481	3479	3480	6464	2885	6654
PC_806	Retinoid cycle disease events	9227	5950	7276	611	5956	101060233	5947	6017	24	5959	145226	64220
PC_807	The canonical retinoid cycle in rods (twilight vision)	8630	8608	9227	5950	7276	6010	5947	5949	6017	3292	24	4647	6121	285440	157506	121214	51109	5959	145226	10170	64220	50700
PC_808	Fc epsilon receptor (FCERI) signaling	27040	4067	2205	2207	6850	2206
PC_809	MASTL Facilitates Mitotic Progression	2029	983	891	5518	5519	10776	5516	5515	55844	84930
PC_810	Biosynthesis of A2E, implicated in retinal degradation	222236
PC_811	Separation of Sister Chromatids	122706	3796	5717	5718	5715	10213	11065	1780	10403	5688	7514	332	1783	5709	9183	699	9184	5885	701	23122	5716	11130	9232	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5518	5519	996	6249	5701	5501	5699	6232	5048	5704	5905	5714	1058	1063	5691	5690	5903	9735	5713	7321	7324	4928	5347	5710	6396	57122	25906	7979	5687	10197	5700	5705	5706	5516	6233	7311	8655	5515	1062	1060	5720	23279	991	8881	5708	4085	23421	5527	1781	9793	1778	9700	8243	5528	23198	9861	5525	5526	22919	5711	5529	23244	54821	55143	151246	151648	401541	100527963	79682	55166	57551	23332	23063	91687	100526739	10735	84643	147841	348995	79023	57082	246184	81930	143471	55746	348235	10274	25909	9491	2491	220134	80152	119504	54908	81929	113130	140735	9212	55839	25936	5695	5707	11004	80776	64105	79172	79902	55869	83540	81565	79003	64682	64946	79980	55055	57405	3619	79019	23047	54820	51529	55920	8697	51434	51433	29945	29882	5721	10393	5719	9126	10726	8379	51143
PC_812	Establishment of Sister Chromatid Cohesion	5885	8243	23244	157570	114799	23063	10735	10274	113130	23047	9126
PC_813	Cohesin Loading onto Chromatin	5885	8243	23244	25836	23063	10735	10274	23047	9126	23383
PC_814	Antagonism of Activin by Follistatin	10272	3624	3625	10468
PC_815	Activation of the phototransduction cascade	9187	6010	6295	2779	5145	5148	1259	5158	2782	2792	1258
PC_816	Resolution of Sister Chromatid Cohesion	3796	1780	10403	7514	332	1783	9183	699	9184	5885	701	23122	9133	11130	983	891	5518	5519	6249	5501	6232	5048	5905	1058	1063	5903	9735	4928	5347	6396	57122	5516	8655	5515	1062	1060	23279	991	4085	23421	5527	1781	9793	1778	8243	5528	5525	5526	22919	5529	23244	54821	55143	151246	151648	401541	100527963	79682	55166	57551	23332	23063	91687	100526739	10735	84643	147841	348995	79023	57082	81930	55746	348235	10274	25909	2491	220134	80152	54908	81929	113130	140735	9212	55839	25936	11004	80776	64105	79172	79902	55869	83540	81565	79003	64946	79980	55055	57405	3619	79019	23047	54820	55920	9126	10726	8379	51143
PC_817	Condensation of Prometaphase Chromosomes	9133	10592	983	891	1459	1460	1457	23397	9918	64151	10051
PC_818	Inactivation, recovery and regulation of the phototransduction cascade	10681	5475	9397	8787	9626	6010	801	6295	2779	5145	5578	5148	1259	4836	2868	5957	5158	118142757	2339	100529261	10988	2986	23173	2782	2792	3000	5588	1258	6011	388531	79823	131890	2979
PC_819	Interaction With Cumulus Cells And The Zona Pellucida	8748	2683	7784	6677	22917	7783	57829	5016	2515	11085	8747
PC_820	Oxidative Stress Induced Senescence	8535	1871	5609	23135	4194	85236	8726	23466	9448	2353	3456	7157	3012	3725	8970	3015	474382	7314	7316	7295	1019	3014	3013	8348	5595	5594	3018	100532731	1029	1030	1031	5599	5601	6416	5606	9261	5608	5602	1032	102724334	3017	121504	3017	6233	7311	8350	1911	3020	1021	4193	1869	6015	5928	7027	7029	1870	84733	23512	5600	2146	1432	5931	7867	8338	8349	723790	126961	94239	8550	1912	128312	50488	1029	27327	80012	8334	8345	255626	22955	6045	4217	8341	8331	8342	8340	55766	192669	57332	4343	57690	192670	23043	26523	23112
PC_821	Senescence-Associated Secretory Phenotype (SASP)	11065	85236	2353	3552	3012	3569	3725	8970	3015	474382	7314	7316	3576	1019	3014	1051	4790	890	3013	8348	1017	5595	5594	996	3018	1026	6774	1029	1030	1031	1027	7321	6197	7324	1032	102724334	3017	25906	121504	3017	6233	7311	8350	8900	3020	1021	5970	8881	5598	6196	6195	3490	8338	8349	723790	126961	94239	128312	246184	8334	8345	255626	119504	10919	8341	8331	8342	8340	55766	64682	79813	51529	8697	51434	51433	29945	29882	51343	10393
PC_822	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	7157	5925	3005	3008	3009	3007	3006	3159	4001	1026	8091	7290	3024	57634	29855	25842	23523
PC_823	Oncogene Induced Senescence	1871	4194	7157	5925	6667	7314	7316	1019	2113	2114	5595	5594	3397	1029	1030	1031	2077	1032	6233	7311	1021	4193	1869	7027	7029	1870	1029	27327	192669	4343	57690	192670	26523	23112
PC_824	DNA Damage/Telomere Stress Induced Senescence	85236	4683	9134	7157	3012	8970	3015	474382	3014	890	3013	8348	898	1017	3018	1026	1027	4361	7013	102724334	3017	121504	3017	8900	472	7014	8290	8338	8349	723790	94239	128312	10111	10524	8334	8345	255626	65057	57634	8341	8331	8342	8340	26277	55766	25913	54386
PC_825	TRIF-mediated programmed cell death	7099	929	8772	8737	841	100302736	148022	11035	23643
PC_826	Cytosolic iron-sulfur cluster assembly	22	9391	2068	5424	4682	57019	64210	83990	64428	51750	27158	51647	10101
PC_827	Regulation of PLK1 Activity at G2/M Transition	9814	10733	6790	4659	80184	9738	8636	4660	8481	11258	23354	22995	9133	5116	11116	10382	983	203068	3320	7314	7316	891	5566	7283	5518	5577	1069	5048	1453	102800317	4751	5347	4218	10121	7532	5500	7531	6233	7311	8655	6500	7277	10383	1781	10540	8454	9793	1639	1778	5108	22919	4957	84131	9662	79441	79866	7846	23332	54801	11064	10806	9702	80321	121441	79959	7840	55125	115106	10133	84962	80254	55755	55559	10142	93323	11190	95681	54930	55835	55142	54820	55722	23291	22994	22897	8945	22981
PC_828	Signaling by Leptin	9021	3717	3667	6774	3952	6776	3953	6777	5781	25970	8660
PC_829	Constitutive Signaling by NOTCH1 PEST Domain Mutants	54492	28514	102	8841	6907	9611	9148	4609	7314	7316	892	4851	1024	5663	5664	9759	9978	6233	7311	6500	182	6868	3516	2033	10046	3065	22938	8454	3280	388585	57534	84441	51564	83464	23385	9794	3066	1387	2648	8850	55294	83933	142678	51107	79885	55534	55869	79718	26508	54567	55851	10013	23493	9734	10014	3714	23462	9612
PC_830	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	4851	9978	6500	8454	55294
PC_831	Acetylcholine Neurotransmitter Release Cycle	10497	10815	8541	8499	8497	9256	5864	6857	1103	6616	6812	6844	8500	6572	6804	22999	60482
PC_832	Caspase-mediated cleavage of cytoskeletal proteins	2620	2934	7431	4137	118	836	840	839	6709	841	5339	28988
PC_833	Insulin processing	10640	3800	11336	3630	5126	1363	5122	3799	5873	6844	3798	6804	55676	56605	169026	149371	148867	25924	64924	54536	60412	30001	55770	57393	55763	23265	4644
PC_834	Constitutive Signaling by NOTCH1 t(7	28514	102	4851	182	6868	54567	3714
PC_835	Stimuli-sensing channels	338440	1179	6446	10786	1193	7439	5894	7314	7316	801	6261	2040	6717	1180	6337	6338	6340	6339	1181	1182	1183	1184	1185	1186	1187	1188	6233	7311	2281	41	444	10345	22802	6263	40	121601	285335	196527	150159	284525	55107	50636	203859	133308	28962	259232	144453	285175	266675	54831	219931	161003	7809	6262	100533105	55515	65266	23327	1831	94015	65267	63982	80727	11059	57348	65125	10110	57719	57101	55129	51802	57578	9311	53373	9635	65268
PC_836	EPH-Ephrin signaling	2051	1943	2534	7525	4067	6714	1942	2041	1969	2042	2046	2048	1944	1945	1948	1946	2049	2044	2050	2047	2043	1947	2045	1949	284656	285220
PC_837	Constitutive Signaling by NOTCH1 HD Domain Mutants	54492	28514	102	9148	7314	7316	4851	6233	7311	182	6868	57534	142678	54567	3714
PC_838	Role of LAT2/NTAL/LAB on calcium mobilization	5296	5170	2534	4067	5295	6464	5290	5291	6850	2885	6654	7462	9846
PC_839	Ficolins bind to repetitive carbohydrate structures on the target cell surface	10747	2219	8547	5648	2220
PC_840	FCERI mediated MAPK activation	5609	27040	9402	2353	4893	3265	3845	3725	4067	7409	5336	5335	5595	5594	6464	6850	5599	5601	6416	7410	5602	2885	5879	6654	3937	5058	5062	4214	10451
PC_841	FCERI mediated Ca+2 mobilization	27040	10768	9402	4772	4067	801	7409	5532	5336	5335	6464	7006	7294	6850	7410	2885	5534	695	6654	5530	3702	4775	3937	4773	3709	3710	3708	10451
PC_842	FCERI mediated NF-kB activation	122706	5717	5718	5715	10213	5688	3551	1147	5170	5709	6885	5716	10125	8915	4067	7314	7316	5702	4790	5689	5682	5683	5684	5685	4792	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	997	5691	5690	5713	7321	5710	7979	5687	7334	10197	5700	5705	5706	7322	6233	7311	6500	5970	5588	5720	5708	387522	8454	23198	9861	10454	5711	10235	257397	143471	115727	9491	5695	5707	84433	23118	10892	23291	5721	5719	8945	7189	8517
PC_843	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	22943	8320	6657	145258	5460	3087	8848	2627	1045	79923
PC_844	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	7547	2247	6997	2041	6774	6657	5460	2649	55211	79923	6299	57167	27022
PC_845	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	54492	28514	102	8841	6907	9611	9148	4609	7314	7316	892	4851	1024	5663	5664	9759	9978	6233	7311	6500	182	6868	3516	2033	10046	3065	22938	8454	3280	388585	57534	84441	51564	83464	23385	9794	3066	1387	2648	8850	55294	83933	142678	51107	79885	55534	55869	79718	26508	54567	55851	10013	23493	9734	10014	3714	23462	9612
PC_846	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	3417
PC_847	NOTCH2 Activation and Transmission of Signal to the Nucleus	54492	28514	102	9148	7314	7316	4192	5663	5664	6233	7311	182	4853	1272	57534	83464	23385	142678	51107	54567	55851	3714
PC_848	Nuclear Envelope Breakdown	8815	7112	2010	7444	221496	7443	23592
PC_849	Activation of NIMA Kinases NEK9, NEK6, NEK7	9133	983	891	5347	91754	140609	10783
PC_850	Initiation of Nuclear Envelope Reformation	8815	4000	4001	5518	7112	2010	5520	5515	23141	7444	221496	7443	23592
PC_851	Laminin interactions	3911	3688	3685	3912	3915	4811	3691	3673	3655	3908	284217	3675	80781	3913	3672	3339	3679	3914	3918	22795	3910	3909	10319
PC_852	Syndecan interactions	8573	9672	7040	7448	3690	3688	3685	7057	2247	87	3691	5578	3673	3693	6382	3655	3371	6385	6383	51399
PC_853	Non-integrin membrane-ECM interactions	375790	3911	5155	7276	5154	3912	2247	3915	1756	3908	284217	3913	3339	780	3914	3918	1605	3910	3909	4921	59277	9378	10319
PC_854	ECM proteoglycans	375790	1463	4593	3911	4148	4038	8785	7040	7448	3690	5054	3688	3685	1634	3912	3674	6678	7043	1404	3915	4684	1462	176	3673	3693	3694	3687	1297	633	3381	4146	7148	3908	3371	284217	1311	4060	8516	3913	7042	3339	2331	1758	5802	3679	3680	1299	1298	1605	3910	3909	7143	63827	54829	1834	63923
PC_855	Scavenging by Class B Receptors	284297	335	338	6288	948	949
PC_856	Scavenging by Class A Receptors	1277	1281	1282	335	348	2512	2495	338	1278	1284	7184	4481	811	5648	81035	286133	117156	78989	8685
PC_857	Scavenging by Class F Receptors	338	3320	811	8578	10808	10525
PC_858	Scavenging by Class H Receptors	338	6678	55576	23166
PC_859	SUMO is conjugated to E1 (UBA2	6612	6613	7341	10055	10054
PC_860	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	6612	6613	7341	7329	10055	10054	25950
PC_861	SUMO is proteolytically processed	6612	6613	7341	205564	59343	29843
PC_862	SUMOylation of DNA damage response and repair proteins	8535	11097	5885	9631	8554	9063	8924	142	7175	6672	6117	5371	100532731	7703	8021	23636	672	1069	5893	9972	5903	4928	641	6396	6612	57122	6613	7341	7329	1911	8480	7508	6015	23279	7518	6996	7486	9656	8243	84733	23511	53371	1912	23137	165918	493861	9688	51588	10735	1029	80012	348995	79023	129401	23225	51564	55746	197370	10274	23165	81929	22955	9883	286053	56160	79677	6045	4927	55706	9818	79902	57332	8086	54780	10762	9126
PC_863	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	4790	4791	5970	1660	3665	4615	170506
PC_864	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	1499	2033	3661	9208	1387
PC_865	Regulation of innate immune responses to cytosolic DNA	7314	7316	6737	6233	7311	22954	3661	340061	147945	81844	81030	29110	51428	23220
PC_866	HDACs deacetylate histones	10284	8841	23028	85236	6907	9611	8819	9219	53615	3012	8970	8329	3013	8348	5926	3018	3017	121504	3017	8350	5928	1107	5978	2874	9112	3065	1108	5931	8338	8349	51742	440689	723790	126961	92815	54815	317772	128312	57459	3066	8334	8345	83933	255626	51317	85235	221613	8341	8331	8342	8340	57504	55869	79718	64426	79685	25855	10362	23186	9612
PC_867	PKMTs methylate histone lysines	8085	9739	6839	8726	7468	4790	11091	121504	8350	4791	2122	4297	5970	5928	23512	9869	5929	2146	5931	51111	55729	121536	126961	84193	84787	55904	58508	79918	84444	80854	10919	64324	83852	29072	54904	84661	79723	64754	79813	63976	387893	56979	55870	56950	9070	9757	23067
PC_868	HDMs demethylate histones	7404	23135	7403	23028	5253	9682	23030	5927	8242	121504	8350	84159	55693	23210	80853	126961	51780	84864	221656	84678	8284	23081	10765	23133	22992	55818
PC_869	HATs acetylate histones	8520	6314	8473	9575	85236	6871	8464	10474	27097	9913	8518	11143	8089	23774	86	3012	8970	8329	1386	3013	8348	5077	3018	3054	7862	3017	60	11091	121504	3017	8350	1810	2033	54859	6881	56970	9643	10499	8648	6944	6883	5931	6880	8338	8349	440689	339287	723790	55250	79960	126961	92815	284058	93624	317772	26009	128312	10943	55578	23587	23522	84289	9767	1387	7994	2648	8850	10524	8334	8345	255626	117143	26610	112869	10445	85235	57634	221613	8341	8331	8342	8340	51230	79595	10902	80314	84148	57325	54934	55140	64769	55167	56943	55929	23338	51562	55257	54556	55683	10933	27154	55689	51147	23326	10856	8607	8295	10629
PC_870	RMTs methylate histone arginines	8289	10419	3717	10196	51412	86	3012	3015	8329	474382	1019	6187	3014	3013	595	6595	6597	11091	121504	8350	6598	5931	8338	196528	723790	6604	126961	94239	92815	55193	10498	317772	57492	6601	6599	6603	8334	6605	6602	85235	55170	221613	3276	8331	79084	55766	55352	54496	1788
PC_871	GSD Ib	2542
PC_872	SUMOylation of transcription factors	4286	8554	9063	7157	7020	6612	668	6613	7341	7329	4193	6670	7158	9112	3090	51588	1029	7021	7022	10401
PC_873	SUMOylation of ubiquitinylation proteins	11097	9631	8554	9063	7175	5987	5371	8021	23636	7428	9972	5903	4928	6396	57122	7341	7329	8480	4193	23279	23511	53371	9688	51588	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_874	WNT ligand biogenesis and trafficking	7480	7476	7483	7484	8724	9559	7481	7471	7472	7474	7473	89780	54361	7477	79971	7482	7479	55737	80326	7478	81029	64840	51699	51384	50999	7475
PC_875	Chromatin modifying enzymes	6597	8350	353238	126961	54014	29943	51702	23569	11240
PC_876	Regulation by TREX1	11277
PC_877	STAT6-mediated induction of chemokines	6778	340061	29110
PC_878	IRF3-mediated induction of type I IFN	2547	7520	4361	5591	3661	3428	197358	340061	147945	11277	29110	51428	23220
PC_879	GSD Ia	2538
PC_880	SCN4	92579
PC_881	TRP channels	8989	7226	7220	7222	79054	4308	255231	7442	162514	54795	55283	26133	54822	140803	57192	55503	59341	80036	57113	56302	29850	7223	7224	7225	51393
PC_882	Hydroxycarboxylic acid-binding receptors	8843	338442	27198
PC_883	Detoxification of Reactive Oxygen Species	475	9973	2880	343	2936	6647	847	6648	1536	2876	5034	6649	2950	7295	1535	653361	2877	4688	2878	9588	25824	10935	7001	318	257202	54205	538	5052	4689	7296	493869	30001	79400	2882	25828	10587	50507
PC_884	Nuclear Pore Complex (NPC) Disassembly	11097	9631	9133	983	7175	891	8021	23636	9972	5903	4928	6396	57122	8480	23279	23511	53371	9688	348995	79023	129401	91754	140609	23225	55746	23165	81929	9883	4927	55706	9818	79902	10783	8086	10762
PC_885	SMAD2/3 Phosphorylation Motif Mutants in Cancer	9372	7040	7046	7048	4088	4087
PC_886	SMAD4 MH2 Domain Mutants in Cancer	4088	4089	4087
PC_887	SMAD2/3 MH2 Domain Mutants in Cancer	4088	4089	4087
PC_888	Glycogen synthesis	8908	7957	7314	7316	2997	5236	2992	2998	6233	7311	2632	7360	283209	378884	55276	5507
PC_889	Defective TCN2 causes hereditary megaloblastic anemia	6948
PC_890	Defective GIF causes intrinsic factor deficiency	2694
PC_891	Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF	55788
PC_892	Defective AMN causes hereditary megaloblastic anemia 1	8029	2694	81693
PC_893	Defective CUBN causes hereditary megaloblastic anemia 1	8029	2694	81693
PC_894	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	4548	4552
PC_895	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	4548	4552
PC_896	Defective MMAB causes methylmalonic aciduria type cblB	326625
PC_897	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	27249	25974
PC_898	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	25974
PC_899	Defective MMAA causes methylmalonic aciduria type cblA	4594	166785
PC_900	Defective MUT causes methylmalonic aciduria mut type	4594	166785
PC_901	Defective CD320 causes methylmalonic aciduria	6948	51293
PC_902	Regulation by c-FLIP	8797	8795	8837	355	356	8743	7186	8772	8737	841	8717
PC_903	Regulation of HSF1-mediated heat shock response	11097	259217	10049	27242	9631	9530	22824	9532	9531	3315	6013	7314	3303	3303	3309	3312	7175	6118	3310	3337	5595	6117	5594	3305	3308	6119	8021	23636	3313	6782	9261	9972	5903	2932	871	6767	4928	1413	3306	6396	57122	7531	8480	3297	2288	51182	23279	472	545	1288	3316	51501	23511	53371	91582	57805	9688	348995	79023	129401	23225	55746	162989	10808	23165	23411	81929	9883	116835	2765	27000	4927	7266	573	55706	9818	79902	8086	10762	9529
PC_904	HSP90 chaperone cycle for SHRs	10671	1780	1783	10294	11258	2908	5241	3320	4306	3326	3303	3303	367	3312	3337	3301	10963	3305	830	832	829	3306	10121	8655	2288	1781	2289	10540	1639	1778	10728	55466	140735	93661	84516	55860	51164	51143
PC_905	HSF1 activation	10049	3281	27242	3315	6013	3320	3326	7314	3303	3303	6118	3310	3337	6117	3305	6119	871	1413	7415	7531	1915	3297	2288	1288	10728	3316	162989	10808	2765	10013
PC_906	Attenuation phase	10049	3281	27242	3315	6013	3320	3326	7314	3303	3303	3312	3310	3337	3305	871	1413	3306	3297	2288	2033	1288	10728	3316	162989	10808	1387	2765
PC_907	HSF1-dependent transactivation	10049	3281	27242	1410	3315	6013	3320	3326	7314	3303	3303	3312	3310	3337	3305	2475	871	1413	3297	2288	816	818	817	1288	3316	57521	162989	10808	84335	2765	64223	26353	815
PC_908	Defective BTD causes biotidinase deficiency	686
PC_909	Defective HLCS causes multiple carboxylase deficiency	5095	5096	5091	3141	31	56922	64087
PC_910	Autodegradation of the E3 ubiquitin ligase COP1	122706	5717	5718	5715	10213	5688	5709	5716	7157	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	472	23198	9861	5711	64326	143471	9491	5695	5707	5721	5719
PC_911	Notch-HLH transcription pathway	8841	6907	9611	4851	9759	4853	3516	10046	3065	22938	84441	51564	9794	3066	1387	2648	8850	83933	79885	55534	4855	55869	79718	10013	9734	4854	10014	9612
PC_912	Regulation of ornithine decarboxylase (ODC)	122706	5717	5718	5715	10213	5688	51582	5709	5716	4947	4953	1728	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	4946	5710	7979	5687	10197	5700	5705	5706	5720	5708	23198	9861	5711	143471	9491	5695	5707	5721	51686	5719
PC_913	Regulation of thyroid hormone activity	1733	1735	1734
PC_914	Agmatine biosynthesis	113451	79814
PC_915	Interconversion of polyamines	6303	196743	54498
PC_916	Metabolism of polyamines	4953	262	6723	6611
PC_917	Apoptotic cleavage of cell adhesion proteins	999	1832	1830	1499	836	1828	7082	5317	1829	100506658	9414
PC_918	Amino acid transport across the plasma membrane	8501	6520	6541	6533	6509	6539	6542	11136	8140	6519	6510	153201	340024	120103	206358	124935	123096	117247	92745	84889	9057	55089	348932	54407	10991	81539	55117	54716	56301	23428	9056	11254	23657
PC_919	Breakdown of the nuclear lamina	4000	4001	839
PC_920	Integrin alphaIIb beta3 signaling	5170	10125	10411	2243	2244	2266	2335	7450	3690	3674	6714	5770	6464	207	1445	6850	5908	5906	5747	10235	54518	11069	7094
PC_921	GRB2	2243	2244	2266	2335	7450	3690	3674	6714	5908	5906	2885	5747	6654	54518	7094
PC_922	Defective B4GALT7 causes EDS, progeroid type	375790	1463	9672	2239	10675	1634	1462	6382	633	6385	6383	2817	2719	2262	3339	1464	221914	63827	11285	10082
PC_923	Defective SLC26A2 causes chondrodysplasias	1836
PC_924	Defective PAPSS2 causes SEMD-PA	9060
PC_925	Defective B3GAT3 causes JDSSDHD	375790	1463	9672	2239	26229	10675	1634	1462	6382	633	6385	6383	2817	2719	2262	3339	1464	221914	63827	10082
PC_926	Defective CHST3 causes SEDCJD	1463	10675	1634	1462	633	1464	9469	63827
PC_927	Defective CHST14 causes EDS, musculocontractural type	1463	10675	1634	1462	633	1464	113189	63827
PC_928	Defective CHSY1 causes TPBS	1463	10675	1634	1462	633	1464	22856	63827
PC_929	TGFBR2 MSI Frameshift Mutants in Cancer	7040	7048
PC_930	TGFBR2 Kinase Domain Mutants in Cancer	7040	7046	7048
PC_931	Defective CHST6 causes MCDC1	11081	176	4969	4060	5549	2331	4958	4166
PC_932	Defective HEXA causes GM2G1	3073
PC_933	Defective EXT2 causes exostoses 2	375790	9672	2239	6382	6385	6383	2817	2719	2262	3339	2131	221914	2132	10082
PC_934	Defective ST3GAL3 causes MCT12 and EIEE15	11081	176	4969	4060	5549	2331	6487	4958
PC_935	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	11081	2683	176	4969	4060	5549	2331	4958
PC_936	Defective HEXB causes GM2G2	3074
PC_937	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	375790	9672	2239	6382	6385	6383	2817	2719	2262	3339	2131	221914	2132	10082
PC_938	TGFBR1 KD Mutants in Cancer	9372	7040	7046	7048	4088	4087
PC_939	TGFBR1 LBD Mutants in Cancer	7040	7046	7048	2280
PC_940	p130Cas linkage to MAPK signaling for integrins	2243	2244	2266	2335	7450	3690	3674	6714	1398	9564	5908	5906	5747	54518	7094
PC_941	Class A/1 (Rhodopsin-like receptors)	2863	1268	5724	1880	1269	2828	4543	4544	2841	8111	8477	338442	151306	27199	1240	56670	2859	29933	9290
PC_942	Class B/2 (Secretin family receptors)	8326	7480	7476	7483	7484	50846	8323	8324	7481	5741	7471	1392	1604	7472	5744	1393	104909134	7474	976	5746	7349	7473	89780	54361	7477	5745	1395	7855	5727	2015	2535	3549	6469	7482	7479	114131	113091	90226	6608	84658	80326	7478	8325	7976	51384	30817	8322	11211	8321	8643	7475
PC_943	Netrin-1 signaling	6478	6585	6586	9353	9423	7430	1630	5588	285704	90249	148738	6477	219699	4756	56963	116986	59277	4651	6091
PC_944	Nephrin family interactions	8976	5296	8573	8440	81	4868	2534	87	4690	5295	88	5290	5291	8826	6711	89	6709	84063	9863	84623	55243	23607
PC_945	SDK interactions	54549	221935
PC_946	L1CAM interactions	1463	11313	3912	3915	2596	100133941	284217	2048	3897	6900	1272	214	10048
PC_947	NCAM signaling for neurite out-growth	6712	9252	4893	3265	3845	6708	2534	6710	2260	6714	4684	1385	5786	5595	5594	2885	6711	5747	6654	6709	57731	51332
PC_948	Peptide ligand-binding receptors	1325	2151	2861	2862	8811	8484	9283	10911	23620	2147	183	718	727	3827	5443	5179	5173	5539	4852	1906	885	2922	5660	4828	594857	110599583	5697	3576	4295	1908	5367	7200	1907	728	51083	3792	1910	1909	2149	4886	4829	624	2925	185	6751	6752	4923	4922	6754	886	887	4160	680	6753	4161	7201	6755	4988	187	4985	4986	4987	4159	1889	623	2587	2831	2832	10874	4887	2834	186	100996758	7504	2150	84432	6750	51052	4158	4157	5368	3814	4889	2532	719	129521	387129	257313	283869	128674	256933	10887	2693	84634	84539	9002	2852	2847	57486	56923	10316	60675	27202	51738	2837	8862
PC_949	Amine ligand-binding receptors	9038	4935	83551	319100	134860	134864	9287
PC_950	Hormone ligand-binding receptors	2797	2796	1081	7252	2488	3972	7253	3973	2492	2798	122876	170589
PC_951	DSCAM interactions	5603	1826	9423	1630	5599	6300	5879	5058	5600	1432	57453
PC_952	Signaling by ROBO receptors	8829	6585	6586	9353	5216	2817	5217	6387	7408	7852	55740	6092	23767	51466	6091
PC_953	Deactivation of the beta-catenin transactivating complex	4221	607	8085	7514	7314	7316	324	207	208	1499	55553	6932	6658	6657	6662	6233	7311	7534	331	7088	7089	7090	7091	6736	6659	1487	3065	5929	283149	90780	83595	64321	57680	83439	6934	56998	9070	51176	9580	8945	25776	26108
PC_954	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	7483	4041	4040	22943	7474	89780	54361	6422	79412	6423	83999	50964	27121	27123	11197
PC_955	Myoclonic epilepsy of Lafora	7957	7314	7316	2997	2992	6233	7311	378884	5507
PC_956	Enzymatic degradation of dopamine by COMT	4128	1312	220074
PC_957	Enzymatic degradation of Dopamine by monoamine oxidase	4128	1312
PC_958	Clearance of dopamine	6531
PC_959	Cytosolic tRNA aminoacylation	9521	4677	2058	3035	1615	7453	6897	7407	2617	3376	5859	16	833	6301	5917	8565	4141	9255	7965	3735	5464	10056	51520	2193
PC_960	Mitochondrial tRNA aminoacylation	10667	2617	5859	23438	23395	3735	124454	57505	57176	57038	55157	25973	92935	79731	80222	27068	79587	54938	55699	10352	51067
PC_961	Tachykinin receptors bind tachykinins	6863	6865	6869	6870	6866
PC_962	Chemokine receptors bind chemokines	9034	10663	6366	6373	6370	6360	10563	5473	5196	3627	2919	3576	6352	2920	2921	6346	3577	3579	57007	1230	1236	643	729230	6374	2826	2829	6375	6387	1524	2833	1232	1233	1234	1235	1237	10803	7852	6376	6364	6372	4283	6357	6363	58191	51554	56477	6846	10850
PC_963	Loss of Nlp from mitotic centrosomes	9814	10733	80184	9738	8636	8481	11258	23354	22995	5116	11116	10382	983	203068	3320	5566	7283	5518	5577	1069	5048	1453	102800317	4751	5347	10121	7532	7531	8655	7277	10383	1781	10540	9793	1639	1778	5108	22919	4957	84131	9662	79441	7846	23332	54801	11064	10806	9702	80321	121441	79959	7840	55125	115106	80254	55755	55559	10142	93323	11190	95681	54930	55835	55142	54820	55722	22994	22897	22981
PC_964	Recruitment of mitotic centrosome proteins and complexes	9814	10733	80184	9738	8636	8481	11258	23354	22995	5116	11116	10382	983	203068	3320	5566	984	7283	5518	5577	1069	5048	1453	102800317	4751	5347	10121	7532	7531	8655	7277	10383	440145	1781	10540	9793	1639	1778	5108	22919	4957	84131	9662	79441	80097	653784	7846	23332	54801	11064	10806	9702	80321	121441	79959	7840	55125	115106	10426	80254	85378	114791	55755	55559	10142	10844	93323	11190	95681	54930	55835	27175	55142	54820	55722	27229	22994	22897	728642	22981	29922
PC_965	Loss of proteins required for interphase microtubule organizationfrom the centrosome	9814	10733	80184	9738	8636	8481	11258	23354	22995	5116	11116	10382	983	203068	3320	5566	7283	5518	5577	1069	5048	1453	102800317	4751	5347	10121	7532	7531	8655	7277	10383	1781	10540	9793	1639	1778	5108	22919	4957	84131	9662	79441	7846	23332	54801	11064	10806	9702	80321	121441	79959	7840	55125	115106	80254	55755	55559	10142	93323	11190	95681	54930	55835	55142	54820	55722	22994	22897	22981
PC_966	Recruitment of NuMA to mitotic centrosomes	9814	10733	80184	9738	8636	8481	11258	23354	22995	5116	11116	10382	983	203068	3320	5566	7283	5518	5577	1069	5048	1453	102800317	4751	5347	10121	7532	7531	8655	7277	10383	440145	1781	10540	9793	1639	1778	4926	5108	22919	4957	84131	9662	79441	80097	653784	7846	23332	54801	11064	10806	9702	80321	121441	79959	7840	55125	115106	10426	80254	85378	114791	55755	55559	10142	10844	93323	11190	95681	54930	55835	27175	55142	54820	55722	27229	22994	22897	22981	29922
PC_967	Metabolism of serotonin	217	4128
PC_968	Clearance of seratonin	6532
PC_969	Energy dependent regulation of mTOR by LKB1-AMPK	10542	5565	5494	2475	7249	5571	5563	389541	5562	6009	6794	10325	55004	10670	92335	57521	153129	7248	64223	55437	81617	58528	53632	51422	8649	28956	51719	5564
PC_970	ATF4 activates genes in response to endoplasmic reticulum stress	5073	440	3484	3576	6347	467	468	22926	4800	4801	1649	1054	5393	23404	4802	9709	23016	118460	167227	8570	11340	54512	56915	51010	22894	51013
PC_971	ATF6 (ATF6-alpha) activates chaperones	51360	3309	22926	8720
PC_972	XBP1(S) activates chaperone genes	10106	9570	1200	11015	2137	7466	22872	10897	4000	6734	100137049	445329	7494	6464	118	6745	37	2931	3068	9114	2673	7709	5611	1639	10954	9820	10130	5526	55062	84447	55738	9695	2134	9797	56005	1663	116138	64061	10113	55033	30827	2135	4189	51726	7094	10525	58477	27230
PC_973	PERK regulates gene expression	1965	3309	468	8894	1968	9451
PC_974	IRE1alpha activates chaperones	2081	3309	7494
PC_975	ATF6 (ATF6-alpha) activates chaperone genes	3309	7184	7494	468	22926	4800	4801	811	1649	4802
PC_976	Transcriptional regulation of white adipocyte differentiation	219541	7480	8841	9314	9443	5346	9282	6907	9611	9862	10001	9441	7040	7124	7471	4023	1959	1019	6517	2167	948	1051	6256	4790	7026	892	896	5105	6720	5468	3952	1024	1050	1052	5970	5465	2033	6721	9412	688	23054	27332	6837	10499	5469	8648	10974	9370	80205	9442	6604	23389	81857	168544	10498	1387	9968	84498	112950	90390	51586	96764	84246	54797	23097	51129	85441	79718	80306	9477	29079	9440	55090	55588	400569	10891	1879	9969	9439	9967	10025	51003	9612	8202
PC_977	Regulation of IGF Activity by IGFBP	4221	5768	3491	102	8542	4148	7425	10618	813	7466	8614	11098	10272	9210	1356	2147	5340	462	5265	718	7076	1471	3827	5179	3481	335	348	336	2243	2266	2335	197	213	174	7018	4312	5624	338	3479	1114	351	3569	3053	3816	5034	354	3912	4313	1511	4241	3484	3956	1435	720	6696	3915	2153	652	7857	1462	5589	7184	3486	3485	1000	3698	3817	2999	3487	3270	3489	3488	3371	6383	2200	3483	2719	3913	4924	334	10970	4240	11167	6694	5611	5069	1758	10232	2621	8404	8720	4052	10130	5954	3490	54972	375056	147111	64856	116519	401138	3895	56975	51246	80341	51280	255738	29106	57104	54757	265	54587	2519	91851	60676	8074	84141	57719	258	56955	10117	51156	26085	11320
PC_978	GSD XV	2997	2992
PC_979	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	2793	10681	112	2788	10411	111	2641	5573	5576	2784	5566	5568	5567	9495	5575	5577	114	2740	8826	2786	2790	54331	2791	5906	2782	2783	2778	2792	2785	2787	3709	3710	3708	3745	2778	11069	3747	3790	59345	51764	55970	26251	94235
PC_980	Olfactory Signaling Pathway	127059	392138	254783	401994	403274	403284	403277	283365	441932	343172	119749	403273	390327	403282	26341	390323	219968	338755	390326	403278	403257	341152	26333	4992	26696	26538	26532	26658	126370	442184	442186	26707	26664	390892	135948	135946	441308	79541	338674	8590	4993	7932	79482	26687	283110	504189	504190	390084	8387	26476	4991	2774	4994	8388	8392	8390	4995	8386	26212	124538	26496	26529	132112	2782	2792	7905	10798	26211	285093	158131	26689	26494	26188	26493	26659	127623	441911	344892	391211	390167	219429	26683	401993	401992	26492	442361	120787	403253	391107	390079	389090	26648	221035	343171	390437	102723532	120586	219447	390152	346517	390151	284521	81472	390155	391195	127064	219865	81466	391196	127062	391191	391192	347468	81061	390883	284383	125958	390882	125962	125963	126541	284433	81099	79346	256148	390538	390649	390648	390445	390439	26534	26533	390436	122748	390441	390442	441670	390429	390431	79317	79544	122740	121275	341418	121129	121130	121364	441639	390199	219957	340980	119695	390038	338675	81341	219965	119765	119764	81168	219464	390154	219469	390157	219858	390275	390271	120775	120796	338751	120793	390081	390077	390072	387748	219986	390197	390201	390195	219981	219982	219983	390067	79296	119678	119682	401666	401667	119692	401665	81282	79324	119774	390036	119772	390037	390144	26338	219438	219437	219436	390142	81328	81300	219428	81309	390261	338662	219875	219874	219873	390264	219870	219869	390265	283092	219477	390162	219482	219484	390168	219493	283189	219952	219958	219960	219956	219954	79290	392390	392392	392391	254973	347169	138881	138882	138883	26219	26740	347168	138805	138804	138803	138802	138799	392376	286362	26248	392309	135924	346525	346528	130075	134083	286365	79295	79310	150681	128371	391189	127068	403244	128360	391109	343406	391112	128366	128367	128368	81448	391114	128372	81442	391190	441933	81469	81470	343169	127069	127074	127077	343563	343173	403239	441669	79334	341568	219417	26246	282775	282770	79501	256144	341799	81127	390433	122742	441608	390113	219453	219473	79473	390083	390075	390061	119679	119694	401663	119687	143502	390148	81327	219432	219431	390093	196335	390260	81318	219479	390174	390181	219959	26735	26737	81392	26693	26339	402135	127385	284532	127066	254879	143503	283159	120065	120066	64108	92840	442194	390191	390190	26245	391194	285659	401427	135941	393046	283093	26682	162998	219487	283162	26595	390321	255725	390078	83597	51308	81697	26716	442185	26531	283160	144125	144124	341276	283297	120776	81285	390054	283111	282763	390058	390059	79470	390063	390064	390066	80346	65055	56656	254786	341416	81050	8383	442191	81696	81797	23538	26692	26539	26189	79339	79345
PC_981	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	346562	2864	2641	2922	2784	5080	1803	5122	1499	3952	60559	23478	9789	338557	139760	1045	90701	6934	51764	28972
PC_982	ABC-family proteins mediated transport	122706	5717	5718	5715	10213	5688	8714	10257	10057	5709	10060	10613	5716	11160	10351	368	1965	5243	7314	7316	1080	5702	8894	5689	5244	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	4363	5701	5699	1968	5704	5714	5691	5690	5713	5710	7415	7979	5687	10197	5700	5705	5706	6233	7311	24	5720	5708	10956	3767	23198	9861	5711	340273	89845	23	143471	9491	1244	27248	91445	85320	91319	5695	5707	6048	79139	51009	23457	6400	5721	5719
PC_983	GSD 0 (muscle)	2997	2992
PC_984	Nuclear Receptor transcription pathway	2494	9611	8856	2103	2099	2908	5241	4306	367	5914	2063	7025	5915	7067	7068	7421	2101	7181	5916	6256	9572	3164	6257	6095	5468	3172	4929	6258	7182	6097	190	7376	2104	5467	5465	10062	2516	3174	9970	9975	2649	8431	5469	126382	8013	2100	29982	9971	29959	7101	10002	9612
PC_985	GSD 0	8908	2998
PC_986	GSD IV	8908	2998	2632
PC_987	Vasopressin-like receptors	5020	551	554	5021	552	553
PC_988	Costimulation by the CD28 family	5296	23308	5295	5777	5290	2885	5781	151888	8503	8764	29851
PC_989	Receptor-type tyrosine-protein phosphatases	8541	8499	8497	22865	26050	5792	5789	8500	5802	4916	8496	139065	8495	114798	84631	84189	26280	3556	94030	11141
PC_990	CD28 co-stimulation	9402	3932	2534	7525	4067	940	6714	941	942
PC_991	CD28 dependent PI3K/Akt signaling	5296	5170	3932	2534	940	5295	207	208	941	1326	942	5290	2475	55615	117145	253260	8503	57761	9020	79109	64223	10000
PC_992	CD28 dependent Vav1 pathway	5063	3932	2534	940	7409	941	942	998	2885	5879	5058	5062
PC_993	Orexin and neuropeptides FF and QRFP bind to their respective receptors	8620	3060	3061	3062	347148	84109	64106	10886
PC_994	CTLA4 inhibitory signaling	3932	2534	7525	4067	6714	1493	5518	5519	207	208	941	942	5516	5515	5781	5527	5528	5525	5526	5529	10000
PC_995	NADPH regeneration	3417
PC_996	Alpha-oxidation of phytanate	5264	11001	10478	224	55825	26061
PC_997	Glyoxylate metabolism and glycine degradation	387787	8050	4706	11019	2806	5160	1738	1737	5162	1629	593	1610	189	594	2653	5161	8659	1743	4967	27232	112817	55526	8528	64902	5827	9380	58510	54363	51601
PC_998	Beta-oxidation of pristanoyl-CoA	10005	8310	6342	1384	3295	8309	55289	23600	54677
PC_999	SUMOylation of transcription cofactors	8535	8554	9063	4869	1655	100532731	7703	8204	7690	6612	6613	7341	7329	1911	6015	2033	10155	1487	84733	6294	10499	8648	1912	51588	80012	1387	10521	57591	22955	115426	25942	6045	11315	59348	3622	28996	57332	10210	10891	1616	4152	9994	9612	10401
PC_1000	PD-1 signaling	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	917	3123	3123	3126	3113	3123	919	5777	1445	3125	5781	5133	3123	3123	3127	3123	3123	3123	80380	3123	29126	3123
PC_1001	Prefoldin mediated transfer of substrate to CCT/TriC	10471	5201	10382	7278	113457	6950	908	22948	7203	10694	10575	60	7411	7277	10383	10576	10381	7280	7846	10693	5204	10574	84790	84617	347733	81027	5203	5202
PC_1002	Formation of tubulin folding intermediates by CCT/TriC	79861	10382	7278	113457	6950	908	22948	7203	10694	10575	10376	7277	10383	10576	10381	7280	112714	7846	10693	10574	84790	84617	347733	81027	51807
PC_1003	Post-chaperonin tubulin folding pathway	79861	6902	10382	7278	113457	402	10376	7277	10383	10381	7280	6905	6903	112714	7846	1155	84790	6904	84617	347733	81027	51807
PC_1004	Beta-oxidation of very long chain fatty acids	10005	10455	23417	30	215	3295	1962	51	641372	122970	26063
PC_1005	Folding of actin by CCT/TriC	6950	908	22948	7203	10694	10575	60	10576	10693	10574
PC_1006	Association of TriC/CCT with target proteins during biosynthesis	10528	26330	8841	11328	9134	2629	7157	6950	898	908	6774	22948	7203	10694	10575	8237	6468	10238	10576	6499	84261	10517	83752	10693	55294	54461	10574	55135	3801	22803	63971	26270	8877	26234	26272	26224	26190	26985	10564
PC_1007	Striated Muscle Contraction	8557	7125	4632	7170	7169	4634	7431	7168	4633	4621	1756	4635	4624	4626	7138	1674	7135	7137	4703	7111	88	7140	7139	7136	7134	7171	4604	89	4606	4607	7273	29766	29765	29767
PC_1008	Muscarinic acetylcholine receptors	1129	1132	1133	1128	1131
PC_1009	Histamine receptors	3274	3269	59340	11255
PC_1010	Dopamine receptors	1813	1812	1815	1816	1814
PC_1011	Serotonin receptors	3350	3352	3351	3356	3358	3354	3355	3363	3357	3361	3362	3360
PC_1012	Adrenoceptors	154	153	150	155	151	152	146	148	147
PC_1013	Peroxisomal lipid metabolism	390916	283927	91452	79777	51179
PC_1014	Signal regulatory protein family interactions	10326	2533	7305	8935	6714	5777	2885	140885	5747	5781	961	2185	55423
PC_1015	Eicosanoid ligand-binding receptors	165140
PC_1016	Leukotriene receptors	2840	1241	56413	57105	10800
PC_1017	Prostanoid ligand receptors	6915	5731	5734	5737	5733	5732	5739	5729	11251
PC_1018	Adrenaline signalling through Alpha-2 adrenergic receptor	150	151	152
PC_1019	Nitric oxide stimulates guanylate cyclase	4846	4842	2977	4843	2982	2983
PC_1020	ADP signalling through P2Y purinoceptor 12	346562	2793	10681	2788	2771	2773	2784	2786	2790	54331	2791	2782	2783	2770	2792	2785	2787	64805	59345	51764	55970	94235
PC_1021	G beta	2793	10681	5170	2788	2784	207	208	5294	2786	2790	54331	387	2791	2782	2783	2792	2785	2787	146850	23533	59345	51764	55970	94235	10000
PC_1022	Rap1 signalling	10125	10411	5894	5566	5568	5567	7529	5909	5908	5906	7534	5592	23108	10235	11069	6494
PC_1023	Prostacyclin signalling through prostacyclin receptor	2793	10681	2788	2784	5739	2786	2790	54331	2791	2782	2783	2778	2792	2785	2787	2778	59345	51764	55970	94235
PC_1024	EPHB-mediated forward signaling	8976	10095	10109	10094	10092	8997	9475	3265	2534	7525	4067	6714	5921	1072	6383	3984	3985	10093	60	998	10096	10097	387	5879	71	5747	2902	7074	5058	2904	6093	6453	64283	10552
PC_1025	EPHA-mediated growth cone collapse	103910	9475	2534	7525	4067	6714	10398	4627	4628	4629	4637	387	6093	79784	25791
PC_1026	Ephrin signaling	6386	2051	8440	5063	2534	6714	10627	2048	1948	2049	2050	2047	5879	1947	5058	5062	8874	1949	28964
PC_1027	EPH-ephrin mediated repulsion of cells	102	2051	1943	161	160	2534	7525	4067	4313	1211	1212	6714	4318	1942	2041	1969	2042	2046	2048	5663	5664	7410	1944	1945	1948	1946	8218	1175	2049	2044	2050	2047	2043	5879	163	1947	1213	1759	7074	2045	1949	284656	83464	23385	51107	1173	55851	285220	10451
PC_1028	Activation of AMPA receptors	2890	2891	2892	2893
PC_1029	Trafficking of AMPA receptors	10368	9495	2890	2892	2893	1742	4193	1739	816	818	817	59283	2036	27092	4646	815	10369
PC_1030	Sema3A PAK dependent Axon repulsion	8829	5362	5063	2534	2242	3320	3326	1072	55558	3984	5879	5058	5062	10371	91584	5361
PC_1031	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	8829	23396	5362	9855	2534	2242	6237	55558	5879	10371	27289	91584	5361	7094
PC_1032	CRMPs in Sema3A signaling	10570	8829	5362	2534	2242	2932	55558	1020	1400	1809	10371	8851	1808	56896	91584	5361
PC_1033	Acetylcholine regulates insulin secretion	9630	5578	1131	4082	2767	2769	2776	5330	5331	23236
PC_1034	Adrenaline,noradrenaline inhibits insulin secretion	2793	10681	112	2788	111	2771	150	2784	152	2786	2790	784	54331	2791	2782	2783	2770	2792	2785	2787	776	783	775	59345	9254	51764	55970	94235
PC_1035	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	8841	6907	23309	9611	2168	6256	5465	23054	10499	5469	8648	80205	6604	10498	1387	96764	25942	85441	79718	9612
PC_1036	Circadian Clock	406	8864	8841	9575	5187	6907	9611	2908	7314	7316	1386	1385	6256	9572	6095	5501	8204	1453	102800317	102724428	64854	5499	5500	6233	7311	6500	1390	4208	5465	2033	8454	23054	4209	10499	5469	8648	1407	4783	3091	80205	1408	200186	6604	64784	23373	10743	10498	1387	23411	96764	4862	5936	85441	79718	79365	10891	26224	8945
PC_1037	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	2864	2695	5080	1803	5122	2626	60559	3670	23478	9789	139760	90701	28972
PC_1038	Defective PMM2 causes PMM2-CDG (CDG-1a)	5373
PC_1039	Defective MPI causes MPI-CDG (CDG-1b)	4351
PC_1040	Sialic acid metabolism	29906	51046	5476	6480	2720	338596	10559	6482	6487	6484	6483	256435	55907	140838	129807	6489	8128	7903	30815	84620	4758	81849	80896	27090	54187	26503	55808	10610	8869	10825	10020	10402	4759
PC_1041	Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2	10020
PC_1042	Defective GFPT1 causes CMSTA1	2673
PC_1043	SUMOylation of SUMOylation proteins	11097	9631	7175	8021	23636	9972	5903	4928	6396	57122	6613	7341	7329	8480	23279	23511	53371	9688	51588	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10210	10762
PC_1044	Ca2+ pathway	2793	10681	6885	2788	8323	4772	7481	4609	2775	801	5532	5145	2784	5578	5148	2780	1499	5158	6932	7474	2786	2790	54331	2791	2782	2783	5534	2792	2785	2787	5330	5331	5530	5593	7855	5592	2535	3709	3710	3708	27327	192669	59345	4343	57690	192670	83439	7976	23236	6934	51764	51701	55970	51176	94235	27161	26523	8322	23112	815	8313
PC_1045	PCP/CE pathway	1855	1856	8323	8324	7481	7471	5216	5880	6259	7474	54361	5881	387	5879	4920	1857	81029	7976	57216	8321	23002
PC_1046	SUMOylation of intracellular receptors	2494	8856	8554	9063	2099	2908	5241	4306	367	5914	7067	7068	7421	7181	6256	6095	5468	4929	7376	6612	9759	6613	7341	7329	5465	10062	2516	51588	9971	10401
PC_1047	G alpha (q) signalling events	353299	2151	27334	5296	2793	10681	2864	2865	6003	8620	6004	8490	2867	2862	2863	2797	3060	3061	3062	8997	2788	7204	10911	23620	9630	2147	183	3827	2796	5020	551	2641	2520	301	351	1906	885	2922	1133	4828	594857	6288	1128	4295	1908	2784	1131	6863	5367	7200	1907	6865	6915	1910	2358	156	146	1909	6869	5724	2149	5295	3356	3358	4829	6870	2767	624	2925	185	5021	2769	2798	4923	4922	886	887	680	2869	7201	5731	148	3269	147	552	846	5997	5029	2915	3357	5290	5737	10161	2828	2829	623	2642	5028	553	6375	10874	10287	5998	5999	2776	2786	2790	4935	2150	6368	84432	54331	2791	2782	2783	2792	2785	2787	347148	5330	5331	695	5996	2911	2840	5031	5332	1241	3814	8111	431704	129521	338557	222545	387129	257313	115557	8477	128674	10887	8503	1902	2693	84634	84539	5032	84109	9002	2846	2847	56923	64106	57121	59345	10316	9170	60675	56413	23236	64407	57105	51764	6846	55970	51738	23566	26575	6866	94233	94235	2837	29933	10800	10886
PC_1048	G alpha (12/13) signalling events	389337	445328	100271715	2793	10681	5924	9639	23263	9826	5364	23229	8997	2788	9475	7204	57449	22899	389	4168	7409	2784	6915	146	148	147	2786	2790	7410	54331	387	2791	388	2782	2783	2792	2785	2787	2245	2768	695	6654	6655	7984	11214	29	7074	6093	8874	10672	9459	6453	89846	84033	27237	23370	10276	221472	26230	128272	84904	25791	57580	55701	9138	9181	26084	121512	9828	64857	1894	59345	55160	50649	50650	54848	23365	51764	55970	94235	10451
PC_1049	Sema4D mediated inhibition of cell attachment and migration	5364	4233	6237	387	5879	27289	10507	2909
PC_1050	Sema4D induced cell migration and growth-cone collapse	103910	9826	5364	9475	2064	389	10398	4627	4628	4629	3984	3985	4637	387	388	6093	79784	27289	10507	23365
PC_1051	Other semaphorin interactions	9723	7305	10154	5362	8482	3688	5788	971	3672	9037	80031	10507	57556	64218	91584	54209	5361	5365	23129
PC_1052	Trafficking of GluR2-containing AMPA receptors	161	160	5582	5579	5578	7102	2890	2891	2892	4905	2893	1175	163	1173	80852	9463	23426
PC_1053	P2Y receptors	27334	5029	10161	5028	5030	2840	5031	9934	5032	2846	53829	64805
PC_1054	Adenosine P1 receptors	140	135	136	134
PC_1055	G beta	2793	10681	2788	2784	2786	2790	54331	2791	2782	2783	2792	2785	2787	5330	5331	59345	23236	51764	55970	94235
PC_1056	Platelet homeostasis	9127	5023	5024	5026	5051	5025	5027	22953
PC_1057	Reduction of cytosolic Ca++ levels	487	801	488	490	493	6717	6546	6547	491	492	489	6543
PC_1058	cGMP effects	5138	8654	5152	5136	5153	3778	5593	5592	3708	3779	27345	50940	27094	10846	10242	10335
PC_1059	G alpha (s) signalling events	346562	2848	5138	2793	10681	9038	2863	112	2788	109	115	5151	10267	10266	10268	2854	8622	111	9340	551	5443	1081	7252	2488	3972	796	5741	2641	7432	2691	6019	2771	1392	796	154	153	2773	2695	6343	594857	797	3375	5744	6714	155	7253	2784	116	2781	1812	1816	3973	2492	3274	156	5141	135	136	554	799	409	7433	4160	4161	2869	3363	104909134	133	5734	157	114	117	7434	4159	5732	5739	2740	2870	2642	6344	2696	5746	408	2838	2786	2790	3362	3640	113	5136	54331	2791	2782	2783	2778	2770	2792	2785	2787	5153	4158	4157	2692	5745	108	5143	5144	107	5729	1395	5140	3360	5150	5139	11245	10203	2778	387129	79924	122876	196883	285601	151306	122042	117579	83551	113091	5032	319100	134860	134864	170589	2843	59345	59350	50940	27115	53831	2850	10888	9287	51764	55970	94235	10846	11250
PC_1060	ADP signalling through P2Y purinoceptor 1	2793	10681	2788	9630	6714	2784	2767	2769	5321	5028	2776	2786	2790	54331	2791	2782	2783	2792	2785	2787	1432	59345	51764	55970	94235
PC_1061	G alpha (i) signalling events	353299	346562	2918	1325	2853	10663	6366	2793	6373	10692	10681	6003	6002	2916	2861	6370	6360	6004	8490	112	10636	8811	6001	10563	2788	109	115	8484	9283	9568	8787	8601	8786	9294	111	8698	183	718	727	3827	5443	5179	5173	5539	4852	5473	5196	3627	611	5956	101060233	301	2771	351	5660	6010	1129	1132	2773	3350	150	2919	6288	140	5697	3576	2779	6714	388372	6352	1813	2784	151	152	2781	2780	2920	2921	5367	1901	2357	1268	728	1815	6346	51083	3577	3579	2359	2358	57007	4886	3352	3351	3354	624	134	6751	6752	3355	6754	1230	1236	1880	643	6753	1269	6755	4988	187	1814	114	4985	4986	4987	846	729230	6374	5733	2826	623	2587	5995	3361	4543	6387	2831	2832	10874	8843	4887	1524	4544	2833	9628	10287	5998	5999	6000	186	2786	2790	100996758	5030	1232	1233	1234	1235	1237	10803	113	6368	85397	5726	259285	259286	259287	259289	259290	259292	259293	259294	259295	259296	338398	54331	7852	6750	2791	2782	2783	2778	2770	2792	2785	2787	6376	6364	6372	29899	4283	5996	108	107	2840	5368	2841	2912	2917	2913	2914	9934	4889	719	431704	129521	2778	221391	83756	80835	26086	126006	283869	26166	196883	256933	388372	338442	165140	339403	80834	117579	1902	84539	27199	1903	2852	6357	2847	6363	53829	56670	27198	56923	57121	23596	53637	64805	58191	59340	59345	10316	9170	56477	50865	64407	51289	50833	50840	50838	50839	50835	50836	50837	54429	50832	50831	50834	51764	55970	2550	23566	26575	94235	8862	9290	63940	10850	11255	10022	11251
PC_1062	G alpha (z) signalling events	353299	346562	2793	10681	6004	112	2788	109	115	8601	111	2771	5582	5579	2773	150	2784	5578	151	152	2781	5583	114	10287	5999	2786	2790	113	54331	2791	2782	2783	2778	2770	2792	2785	2787	5581	5588	5580	108	107	2778	196883	59345	51764	55970	26575	94235
PC_1063	DCC mediated attractive signaling	8976	3983	7204	22885	9423	2534	6714	4690	1630	998	5879	5747	1793	84448
PC_1064	Netrin mediated repulsion signals	8633	9423	6714	1630	5781	137970	90249	219699
PC_1065	Ligand-independent caspase activation via DCC	1613	836	1630	1612	842	90249	219699	23604	26060	9500
PC_1066	Role of second messengers in netrin-1 signaling	9423	5335	1630	7220	5306	7222	57113	7223	7224	7225
PC_1067	Adherens junctions interactions	1500	283	999	3728	1000	1001	1003	1495	1499	4301	1002	1004	1006	1009	1010	1012	1013	1015	1016	5818	64403	57863	253559	5819	81607	23705	25945	1007	1005	1008
PC_1068	NCAM1 interactions	131873	256076	785	2675	375790	1463	8913	5623	8912	1282	5621	1284	1291	1292	1293	4684	1297	1287	2668	1286	784	2674	776	1285	6900	782	783	779	775	1299	1298	9048	8128	7903	4902	64096	8911
PC_1069	Lysosphingolipid and LPA receptors	9294	8698	1901	163404	79948	9890	54886	1902	64748	1903	57121	53637	9170	23566
PC_1070	Opsins	10692	611	5956	101060233	6010	5995	221391	23596	94233
PC_1071	Calcitonin-like ligand receptors	10267	10266	10268	796	796	797	3375	799	133	10203	79924
PC_1072	Tight junction interactions	7122	1364	1365	5010	1366	9080	23562	9076	5584	24146	9074	9073	9069	26285	51208	49861	9075	9071	64398	149461	53842	56288	137075	92359	84552	84612	50855	10686	50848
PC_1073	Glucagon-type ligand receptors	2793	10681	2788	9340	2641	7432	2691	2695	6343	2784	116	7433	117	7434	2740	2642	6344	2696	2786	2790	54331	2791	2782	2783	2778	2792	2785	2787	2692	2778	59345	51764	55970	94235
PC_1074	Class C/3 (Metabotropic glutamate/pheromone receptors)	2918	2916	9568	846	2915	5726	259285	259286	259287	259289	259290	259292	259293	259294	259295	259296	338398	2911	2912	2917	2913	2914	222545	83756	80835	80834	50833	50840	50838	50839	50835	50836	50837	54429	50832	50831	50834	2550
PC_1075	Nectin/Necl trans heterodimerization	5817	5818	57863	5819	81607	23705	25945
PC_1076	Synthesis, secretion, and deacylation of Ghrelin	9314	2688	2641	3630	3479	590	43	5122	3952	7349	60559	23478	7941	1395	9789	619373	90701	51738	28972
PC_1077	Regulation of insulin secretion	6861	773	10768	10411	3630	2771	6513	6514	5566	5568	5567	784	6616	6812	6844	2770	776	783	6833	775	3709	3710	3708	3767	777	6804	11069	9254
PC_1078	Transport of bile salts and organic acids, metal ions and amine compounds	6563	8170	345274	80736	146802	57153	126969	204962	23446	55244	60482
PC_1079	Bicarbonate transporters	6521	6522	6508	9498	57282	23382	83697	57835	9497	8671
PC_1080	Transport of inorganic cations/anions and amino acids/oligopeptides	6512	1497	6507	6506	6505	6511	115286	140679
PC_1081	Transport of vitamins, nucleosides, and related molecules	9197	51248	8884
PC_1082	Metal ion SLC transporters	1317	1356	6556	4891	55532	254428	84102	9843	30061
PC_1083	Sodium/Calcium exchangers	9187	801	6717	6546	6547	80024	283652	123041	57419	25769	6543
PC_1084	Sodium/Proton exchangers	6548	6550	6553	389015	285195	10479	84679	6549	23315
PC_1085	Arachidonate production from DAG	26090	221955	11343	57406	747
PC_1086	Cation-coupled Chloride cotransporters	6558	6559	6557	57468	9990	6560	10723
PC_1087	Small interfering RNA (siRNA) biogenesis	8575	7247	6895	7257	192669	192670	27161	26523	23405
PC_1088	Post-transcriptional silencing by small RNAs	27327	192669	57690	192670	27161	26523	23112
PC_1089	SIRT1 negatively regulates rRNA expression	23378	6839	85236	3012	8970	3015	474382	3014	6908	3013	8348	3018	102724334	3017	121504	3017	8350	3020	9013	9015	8338	8349	9014	723790	126961	94239	128312	8334	8345	255626	23411	8341	8331	8342	8340	55766	79101
PC_1090	Activation of rRNA Expression by ERCC6 (CSB) and EHMT2 (G9a)	85236	9219	53615	3012	8970	3015	474382	3014	3013	8348	3018	102724334	3017	121504	3017	8350	3020	2074	5928	1107	11335	9112	3065	1108	7270	5931	8338	8349	723790	126961	94239	54815	128312	57459	3066	8334	8345	255626	10919	8341	8331	8342	8340	57504	55766
PC_1091	NoRC negatively regulates rRNA expression	10284	9533	10849	8467	85236	23309	8819	25885	3012	8970	3015	474382	51082	3014	7343	2068	5434	2071	6908	3013	8348	1786	2965	3018	1022	902	4331	5437	5440	102724334	3017	5435	121504	3017	5441	8350	3020	3065	2966	2967	7270	9013	9015	8338	8349	221830	51742	9014	723790	404672	126961	94239	128312	2968	3066	8334	8345	255626	25942	8341	8331	8342	8340	55766	64425	79595	79101	64426	84172	79685	30834	8932	1789	29115	11176
PC_1092	Type II Na+/Pi cotransporters	10568	6569	142680
PC_1093	Multifunctional anion exchangers	5172	1811	1836	159963	115019	284129	115111	65010	10861
PC_1094	Sodium-coupled phosphate cotransporters	6575	6574
PC_1095	Proton/oligopeptide cotransporters	6564	6565	51296	121260
PC_1096	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	10643	4609	3481	960	60	10642	10644
PC_1097	Activation of RAC1	8440	5063	9353	10298	4690	5879	6654	6655	5058	5062	106821730	57144	6091
PC_1098	Regulation of commissural axon pathfinding by SLIT and ROBO	6585	6586	9353	9423	6714	1630	64221	4753	6092	6091
PC_1099	Inactivation of CDC42 and RAC1	9901	23380	9353	998	5879	57522	80728	6091
PC_1100	Proton-coupled neutral amino acid transporters	153201	206358
PC_1101	Organic anion transporters	6568	160728	246213	6528	83733	79751	26503	57030	57084	1468
PC_1102	Role of ABL in ROBO-SLIT signaling	23122	9353	25	10486	27	10487	23332	6091
PC_1103	Thromboxane signalling through TP receptor	2793	10681	2788	9630	2784	6915	2767	2769	2776	2786	2790	54331	2791	2782	2783	2792	2785	2787	10672	59345	51764	55970	94235
PC_1104	Inositol transporters	115584	114134
PC_1105	Deadenylation of mRNA	23019	4849	5073	4850	1977	26986	1975	9775	1973	1981	1974	9924	255967	23318	79670	9125	246175	85456	10605	25904	4848	9337	29883	55571
PC_1106	mRNA decay by 3' to 5' exoribonuclease	5393	23404	23016	6499	118460	9652	115024	11340	28960	80349	54512	56915	51010	22894	51013	10767
PC_1107	mRNA decay by 5' to 3' exoribonuclease	27257	1656	27258	11157	23644	219988	167227	196513	54464	80153	55802	51690	57819	23658	25804
PC_1108	GP1b-IX-V activation signalling	5894	7450	2811	6714	2812	2815	2316	5295	2814	7534
PC_1109	Transport of glycerol from adipocytes to the liver by Aquaporins	364	366
PC_1110	Vasopressin regulates renal water homeostasis via Aquaporins	2793	10681	112	2788	109	115	111	551	5573	5576	2784	5566	5568	5567	358	554	5575	5577	114	359	2786	2790	113	361	54331	2791	8766	2782	2783	2778	2792	2785	2787	108	107	2778	22841	196883	360	59345	51764	55970	94235	4645
PC_1111	Passive transport by Aquaporins	364	366	343	358	4284	359	362	361	363	375318	282679	360	89872
PC_1112	Platelet sensitization by LDL	338	2268	5175	5777	5518	5519	5321	5516	5515	5781	5527	7804	5528	5525	5526	5529	1432
PC_1113	Lysosome Vesicle Biogenesis	1777	9179	9146	27243	164	9829	8906	351	1211	1212	3312	2799	4074	408	1785	6845	8905	1174	6844	2647	375	1213	162	134829	157807	81567	130340	6456	8673	8907	1522	23431	11154	10717	10053
PC_1114	Golgi Associated Vesicle Biogenesis	8546	5286	2580	10618	164	6643	9829	9026	1362	23557	7037	2512	2495	1211	3312	3482	408	1785	5878	6845	8775	7163	8905	1174	6844	2647	375	1213	4952	54885	162	8301	9698	9685	2804	7164	152503	388552	81567	25977	1176	286451	84062	130340	6272	6456	8673	8907	64746	55330	26258	23431	51429	27131	10717	10053
PC_1115	Sodium-coupled sulphate, di- and tri-carboxylate transporters	9058	284111	64849	6561	26266
PC_1116	Proton-coupled monocarboxylate transport	9123	9194	23539	682	6566	133418
PC_1117	Defective NEU1 causes sialidosis	5476	2720	4758
PC_1118	Intracellular metabolism of fatty acids regulates insulin secretion	2182	2181	948
PC_1119	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	2864	9630	2767	2769	2776	5330	5331	23236
PC_1120	Zinc efflux and compartmentalization by the SLC30 family	55676	169026	148867	64924	7781	7780	7779
PC_1121	Recycling pathway of L1	57698	9252	8986	161	24137	160	1211	6714	7430	4478	5594	3897	5962	8650	1785	6197	1175	163	1213	1759	6196	6195	1808	285643	1173	6456	27330	26052
PC_1122	Unblocking of NMDA receptors, glutamate binding and activation	2906	4747	801	88	2890	2891	2892	2893	1742	2902	2903	1739	2904	816	818	817	2905	1740	1741	815
PC_1123	Binding of TCF/LEF	4609	1499	6932	864	83439	6934	51176	8313
PC_1124	Depolymerisation of the Nuclear Lamina	23399	4000	5579	983	891	5578	4001	7112	2010	23175	255919	221496	9663	64900	23592
PC_1125	VEGFA-VEGFR2 Pathway	5296	5603	8440	9475	3315	1536	3690	2534	3685	3320	6714	1535	653361	7409	7422	4690	5566	4688	5568	5567	5295	558	3791	5290	5291	1398	5829	9261	7410	6300	3071	9564	998	387	5879	25759	5747	5062	6093	1793	2185	4689	6461	5600	1432	7867	23191	10006	55845	9844	8936	26999	63916	9047	10152	10451	10810	10458	10787	10163
PC_1126	Defective B3GALT6 causes EDSP2 and SEMDJL1	375790	1463	9672	2239	10675	1634	1462	6382	633	6385	6383	2817	2719	2262	3339	1464	221914	63827	126792	10082
PC_1127	Zinc influx into cells by the SLC39 gene family	25800	23516	55630	283375	7922	29985	64116	29986	27173	57181
PC_1128	Na+/Cl- dependent neurotransmitter transporters	6582	6580	6530	6529	6533	6539	6538	6536	6570	6531	6571	340024	348932	6534	55117	54716	6540	11254	9152
PC_1129	CREB1 phosphorylation through the activation of Adenylate Cyclase	801	5573	5576	1385	5566	5568	5567	5575	5577	114	5613	107
PC_1130	CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde	801	1385	3838	816	818	814	84254	10645
PC_1131	CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling	1385	6197	6196	6195	27330
PC_1132	Ras activation upon Ca2+ influx through NMDA receptor	5924	2906	4893	3265	3845	4747	801	88	1742	2902	1739	2904	816	818	817	5923	1740	1741	815
PC_1133	Free fatty acid receptors	2853	2864	2865	2867	338557
PC_1134	RSK activation	5170	5595	5594	6197	6196	6195	27330
PC_1135	Rhesus glycoproteins mediate ammonium transport.	6005	57127	51458
PC_1136	Formyl peptide receptors bind formyl peptides and many other ligands	301	351	6288	2357	2359	2358	6368	50865
PC_1137	Relaxin receptors	6019	3640	339403	122042	117579	59350	51289	10022
PC_1138	Interaction between L1 and Ankyrins	6712	3786	3785	6327	23114	6708	6710	286	3897	6323	6329	6711	6332	287	6324	288	6709	6331	6335	6330	4897	6326	57731	51332	6328	55800	11280	6334	6336
PC_1139	Signal transduction by L1	8829	1956	3690	3688	3685	3674	3678	2260	4684	1459	5595	5594	3897	5605	7410	5879	1460	1457	5604	5058	3680
PC_1140	Smooth Muscle Contraction	103910	10174	8291	301	7170	302	7169	309	7168	801	140465	3693	7414	10627	10398	25802	2977	4629	5829	3672	859	4637	59	72	7171	58498	4636	2982	2983	800	5058	5062	4638	493829	29895	93408	10580	7094
PC_1141	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	3551	1147	3656	6885	8767	6285	351	3146	6288	4790	4792	3654	7334	6283	4791	5970	387522	177	4793	10454	257397	64127	23118	28511	28512	10392	7189	8517
PC_1142	Type I hemidesmosome assembly	3691	3655	977	667	3914	3918	5339	3909	1308
PC_1143	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	9526	440138	84920	144245	10195	91869	199857	56052	79087	79053	1798	85365	79796	79868	29929
PC_1144	Synthesis of Dolichyl-phosphate	4597	79947	57171	116150	79644	22845
PC_1145	Asparagine N-linked glycosylation	6184	6185	432	433	7369	1650	3703	1603	7991	124872	84061
PC_1146	Synthesis of GDP-mannose	5373	4351	5372	29926	29925
PC_1147	Synthesis of UDP-N-acetyl-glucosamine	9945	5238	5973	2673	6675	64841	55577	51005
PC_1148	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	3688	5829	3611	55742
PC_1149	Cell-extracellular matrix interactions	2316	3987	7408	3611	2318	55679	54751	10979	29780	55742
PC_1150	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	87	3987	5829	9459	6251	7016	29780	55742
PC_1151	NrCAM interactions	8828	286	1742	6900	1739	1741	4897
PC_1152	CHL1 interactions	10752	8829	8515	3688	3312	286	3673	3672	27255
PC_1153	Neurofascin interactions	6386	1641	23114	286	8506	1272	4897
PC_1154	Interleukin-17 signaling	3605	84818	132014	23765	112744	64806	55540	27189
PC_1155	Interleukin-1 processing	3552	3553	1511	4790	834	4791	5970	3606
PC_1156	Other interleukin signaling	920	1436	1435	1440	6382	3716	5803	9235	5657	7297	200081	836	6616	6844	3588	6810	6809	3603	6813	6804	146433	282618	163702	1441
PC_1157	activated TAK1 mediates p38 MAPK activation	3656	6885	8767	5606	9261	3654	5608	7334	387522	10454	5600	1432	7867	257397	64127	23118	10392	7189	8517
PC_1158	JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1	5609	3656	6885	8767	5599	5601	6416	3654	5602	7334	387522	10454	257397	64127	23118	10392	7189	8517
PC_1159	Activation of the AP-1 family of transcription factors	2353	3725	1386	5595	5594	5599	5601	5602	5600	1432
PC_1160	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	207	7529	9261	5393	677	23404	23016	118460	167227	54464	11340	54512	55802	56915	51010	22894	51013
PC_1161	AUF1 (hnRNP D0) binds and destabilizes mRNA	122706	5717	5718	5715	10213	5688	5709	5716	3315	7314	7316	3303	3312	26986	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	1981	5720	5708	3184	23198	9861	5711	143471	9491	5695	5707	5721	5719
PC_1162	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	7538	7529	9261	5393	23404	23016	118460	167227	54464	3842	11340	54512	55802	56915	51010	22894	51013
PC_1163	HuR (ELAVL1) binds and stabilizes mRNA	7514	8741	5578	8021	8125	6418	5580	1994	9052
PC_1164	KSRP (KHSRP) binds and destabilizes mRNA	5073	207	7534	5393	23404	23016	5600	1432	118460	167227	8570	11340	54512	56915	51010	22894	51013
PC_1165	Activation of Na-permeable kainate receptors	2897	2898
PC_1166	Activation of Ca-permeable Kainate Receptor	801	2897	83988	1742	1739	2898	2899	2900	2901	1741
PC_1167	Interleukin-2 family signaling	3965	84868
PC_1168	Transcriptional regulation of pluripotent stem cells	9314	7547	5087	6774	6657	5460	2516	4089	4087	84891	2034	63978	27086	79923	79727	57167	64344
PC_1169	Defective ALG2 causes ALG2-CDG (CDG-1i)	85365
PC_1170	Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2	1798
PC_1171	Defective ALG1 causes ALG1-CDG (CDG-1k)	56052
PC_1172	Defective ALG11 causes ALG11-CDG (CDG-1p)	440138
PC_1173	SUMOylation of chromatin organization proteins	8535	11097	9631	8554	9063	9189	7175	100532731	7703	8021	23636	23468	9972	5903	4928	6396	6612	9759	57122	6613	121504	7341	7329	1911	8480	6304	6015	23279	1107	3065	84733	23512	23511	53371	1912	9688	80012	348995	79023	129401	23225	55746	23165	3066	83746	81929	22955	9883	6045	4927	55706	9818	79902	57332	8086	10762	23314
PC_1174	Thrombin signalling through proteinase activated receptors (PARs)	2151	2793	10681	2788	9630	2147	6714	2784	2149	5595	5594	2767	2769	409	408	2776	2786	2790	54331	2791	2782	2783	2792	2785	2787	2768	10672	9002	59345	51764	55970	94235
PC_1175	SUMOylation of RNA binding proteins	8535	11097	9631	3183	7175	100532731	7703	8021	23636	9972	5903	4928	6396	57122	6613	3190	7341	7329	1911	8480	6015	23279	84733	23511	53371	1912	9688	80012	348995	79023	129401	23225	55746	23165	81929	22955	9883	6045	4927	55706	9818	79902	57332	8086	10762	51602
PC_1176	Defective RFT1 causes RFT1-CDG (CDG-1n)	91869
PC_1177	Asymmetric localization of PCP proteins	122706	5717	5718	5715	10213	1856	5688	5709	8324	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	7474	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	7855	23513	2535	23198	9861	5711	143471	9491	144165	5695	5707	8325	64750	57154	50855	7976	5721	57216	8322	5719	8321
PC_1178	SUMOylation of DNA replication proteins	6790	332	11097	9631	7150	7153	5111	7175	8021	23636	5905	9972	5903	4928	6396	6612	57122	6613	7341	7329	8480	7155	23279	55143	23511	53371	9688	51588	348995	79023	129401	23225	55746	23165	81929	9212	9883	4927	55706	9818	79902	3619	8086	10762	10401
PC_1179	Degradation of AXIN	122706	5717	5718	5715	10213	5688	8312	5709	5716	8658	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	23198	9861	5711	143471	9491	5695	5707	80351	64750	81847	5721	5719	8313
PC_1180	Degradation of DVL	122706	5717	5718	5715	10213	1855	1856	5688	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	5720	5708	8452	23198	9861	5711	59349	23072	143471	9491	1857	5695	5707	51339	5721	5719
PC_1181	Disassembly of the destruction complex and recruitment of AXIN to the membrane	1855	1856	8312	4041	23401	4040	7471	324	5518	5519	1499	1452	2932	89780	5516	5515	1455	857	5527	7855	2535	5528	5525	5526	5529	139285	10023	1857	7479	7478	8321
PC_1182	Regulation of FZD by ubiquitination	8323	4041	8549	4040	7314	7316	9101	89780	6233	7311	7855	343637	284654	54894	340419	55366	84870	8325	59352	84133	8322
PC_1183	Repression of WNT target genes	4609	6932	1488	7088	7089	7090	7091	166	1487	3065	83439	6934	51176	8313
PC_1184	SUMOylation of DNA methylation proteins	8535	1786	100532731	7703	7341	7329	1911	6015	84733	1912	80012	22955	6045	57332	1789	1788
PC_1185	Defective MPDU1 causes MPDU1-CDG (CDG-1f)	9526
PC_1186	Defective DPM1 causes DPM1-CDG (CDG-1e)	8813	8818	54344
PC_1187	Defective DPM3 causes DPM3-CDG (CDG-1o)	8813	8818	54344
PC_1188	Defective DPM2 causes DPM2-CDG (CDG-1u)	8813	8818	54344
PC_1189	Defective ALG9 causes ALG9-CDG (CDG-1l)	79796
PC_1190	Defective ALG3 causes ALG3-CDG (CDG-1d)	10195
PC_1191	Defective ALG12 causes ALG12-CDG (CDG-1g)	79087
PC_1192	Defective ALG6 causes ALG6-CDG (CDG-1c)	29929
PC_1193	Defective ALG8 causes ALG8-CDG (CDG-1h)	79053
PC_1194	SUMOylation of immune response proteins	4792	6612	7341	7329	4791	5970	9641	51588	10210	8517	10401
PC_1195	Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ	79644
PC_1196	Defective DOLK causes DOLK-CDG (CDG-1m)	22845
PC_1197	Defective DHDDS causes retinitis pigmentosa 59	79947	116150
PC_1198	Defective MAN1B1 causes MRT15	11253
PC_1199	Defective MGAT2 causes MGAT2-CDG (CDG-2a)	4247
PC_1200	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	2683
PC_1201	Defective MOGS causes MOGS-CDG (CDG-2b)	7841
PC_1202	Synthesis of dolichyl-phosphate-glucose	256281	29880
PC_1203	Interconversion of nucleotide di- and triphosphates	4833	2936	203	7298	7295	4830	1503	4831	1841	6240	205	51727	6241	1635	1854	2745	204	4832	2987	7296	221264	50484	25961	122481	158067	79077	56474	102157402	26289
PC_1204	Presynaptic function of Kainate receptors	2793	10681	2788	2784	2786	2790	54331	2791	2782	2783	2792	2785	2787	5330	5331	2899	59345	23236	51764	55970	94235
PC_1205	Pyrimidine biosynthesis	7372	790	1723
PC_1206	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	4582	4586	4584	2591	394263	140453	4588	283463	200958	143662	4589	94025	118430	4585	56667	727897	10071
PC_1207	Defective LARGE causes MDDGA6 and MDDGB6	11041	9215
PC_1208	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	1605	55624
PC_1209	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	1605	29954	10585
PC_1210	Defective LFNG causes SCDO3	4851	4853	3955	4855	4854
PC_1211	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	4582	4586	4584	394263	140453	4588	283463	200958	143662	4589	94025	118430	29071	4585	56667	727897	56913	10071
PC_1212	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	1605	29954	10585
PC_1213	Defective B3GALTL causes Peters-plus syndrome (PpS)	9508	9507	9509	7057	5199	7058	81792	80070	57188	9037	54507	145173	339366	79875	11093	9719	157869	92949	170691	170690	170689	171019	170692	140766	10417	80731	81794	10418	55901	54437	56999	9510	11173	11174	11096	11095	221981
PC_1214	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	4582	4586	4584	394263	140453	4588	283463	79695	200958	143662	4589	94025	118430	4585	56667	727897	10071
PC_1215	WNT5A-dependent internalization of FZD4	1856	161	160	5582	5579	1211	1212	5578	409	7474	1175	163	1213	1173	8322
PC_1216	Interleukin-3, Interleukin-5 and GM-CSF signaling	5293	5296	3717	1437	3567	3562	7409	1438	5566	3563	5295	5777	6464	1439	6776	5290	5291	7006	6777	2885	7534	3568	5781	8503
PC_1217	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	161	160	1211	1212	7474	1175	163	1213	4919	4920	7855	2535	1173
PC_1218	O-linked glycosylation	11041	9215	1605	120071	84892	148789	55624	84197	29954	10585
PC_1219	O-glycosylation of TSR domain-containing proteins	9508	9507	9509	7057	5199	7058	81792	80070	57188	9037	54507	145173	339366	79875	11093	9719	157869	92949	170691	170690	170689	171019	170692	140766	10417	80731	81794	10418	55901	54437	56999	9510	11173	11174	11096	11095	221981	23275
PC_1220	Pink/Parkin Mediated Mitophagy	5071	9140	9868	9927	10452	7314	7316	7416	6233	7311	8878	9804	55669	401505	100188893	51001	65018	81631	9474	84557	56993	54543
PC_1221	Uptake and function of anthrax toxins	5609	5045	801	5605	6416	5606	5608	118429	5604	10015	84168
PC_1222	RIPK1-mediated regulated necrosis	8797	8795	8837	355	356	8743	331	7186	8772	330	329	8737	841	8717	197259	11035
PC_1223	CASP8 activity is inhibited	8797	8795	8837	355	356	8743	7186	8772	8737	841	8717
PC_1224	VEGFR2 mediated vascular permeability	5170	1500	5063	3320	801	3728	7409	4846	207	208	1003	1495	1499	2475	7410	5879	55615	857	5058	5062	117145	253260	57761	79109	64223	10451	10000
PC_1225	VEGFR2 mediated cell proliferation	5170	10768	4893	3265	3845	5579	801	6714	7422	5578	5335	5921	3791	5590	5580	3709	3710	3708	8877
PC_1226	Oxidative demethylation of DNA	200424	6996	54790	80312
PC_1227	Miscellaneous transport and binding events	1497	5304	563	118	119	2039	348938	7991	80131	152519	57185	23507	54896	55144	123606	56262	93380	81614	84230	84061	79815	56172	57380	120
PC_1228	B-WICH complex positively regulates rRNA expression	4641	9533	10849	8467	85236	23451	25885	3012	8970	3015	474382	51082	3014	5434	6908	3013	8348	3018	7913	2932	5437	5440	102724334	3017	60	5435	121504	3017	5441	8350	3020	2074	2033	9013	9015	8338	8349	221830	9014	723790	126961	94239	128312	2648	8850	8334	8345	255626	8341	8331	8342	8340	10514	55766	64425	79101	84172	9188	30834	9031
PC_1229	Toxicity of botulinum toxin type D (BoNT/D)	6843	6844	22987	9900	9899
PC_1230	Toxicity of botulinum toxin type B (BoNT/B)	6857	6844	127833
PC_1231	Toxicity of botulinum toxin type A (BoNT/A)	6616	22987	9900	9899
PC_1232	Toxicity of botulinum toxin type C (BoNT/C)	6616	112755	6804
PC_1233	Toxicity of botulinum toxin type F (BoNT/F)	6843	6844	22987	9900	9899
PC_1234	Toxicity of tetanus toxin (TeNT)	6844
PC_1235	Toxicity of botulinum toxin type G (BoNT/G)	6857	6843	6844
PC_1236	Toxicity of botulinum toxin type E (BoNT/E)	6616	9900	9899
PC_1237	Myogenesis	4917	9043	25	4617	4654	4656	6925	6929	1000	4618	1496	1495	1499	5608	6300	1002	1013	998	4205	100271849	4208	663	4209	5600	1432	50937	4756	6938	91653
PC_1238	Metabolism of ingested MeSeO2H into MeSeH	7296
PC_1239	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	7314	7316	5589	5887	7415	5700	6233	7311	51035	7841	9761	23193	64772	55768	79139	267
PC_1240	DNA methylation	85236	3012	8970	3015	474382	3014	3013	8348	1786	3018	102724334	3017	121504	3017	8350	3020	8338	8349	723790	126961	94239	128312	8334	8345	255626	29128	8341	8331	8342	8340	55766	1789	29947	1788
PC_1241	Uptake and function of diphtheria toxin	3320	3326	1938	928	7296	1839
PC_1242	TCF7L2 mutants don't bind CTBP	1488	1487	6934
PC_1243	Misspliced GSK3beta mutants stabilize beta-catenin	8312	324	5518	5519	1499	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285
PC_1244	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	4041	22943	79412	83999	27121	27123
PC_1245	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	64840
PC_1246	RNF mutants show enhanced WNT signaling and proliferation	8323	4041	4040	89780	7855	54894	8325	8322
PC_1247	GSD II	2548	2992
PC_1248	TNFR1-induced proapoptotic signaling	9099	7124	7132	7128	7186	7375	8772	8737	841	8717	56957	1540	27005
PC_1249	Regulation of TNFR1 signaling	3551	1147	9099	7124	7314	7316	7132	7128	6233	7311	10399	331	7186	7185	7375	330	329	8737	841	8717	56957	8887	56928	84888	8567	90268	25999	55072	10616	81858	1540	27005	8517
PC_1250	TNFR1-induced NFkappaB signaling pathway	3551	1147	6885	9099	7124	7132	7128	10399	331	7186	7185	7375	330	329	8737	8717	10454	56957	257397	55072	10616	81858	1540	23118	27005	8517
PC_1251	Hedgehog ligand biogenesis	122706	5717	5718	5715	10213	5688	5709	50846	5716	5034	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7415	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	10956	3549	23198	9861	6469	5711	55733	84447	143471	9491	27248	5695	5707	51009	6400	5721	5719
PC_1252	Synthesis of diphthamide-EEF2	1938	120526	89978	285381	1802	92715	1801	51611
PC_1253	Mismatch repair (MMR) directed by MSH2	5111	6118	3978	6117	5424	6119	4292	4436	5425	2956	5395	10714	57804	9156
PC_1254	Mismatch repair (MMR) directed by MSH2	5111	6118	3978	4437	6117	5424	6119	4292	4436	5425	5395	10714	57804	9156
PC_1255	S33 mutants of beta-catenin aren't phosphorylated	8312	324	5518	5519	1499	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285
PC_1256	S37 mutants of beta-catenin aren't phosphorylated	8312	324	5518	5519	1499	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285
PC_1257	S45 mutants of beta-catenin aren't phosphorylated	8312	324	5518	5519	1499	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285
PC_1258	T41 mutants of beta-catenin aren't phosphorylated	8312	324	5518	5519	1499	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285
PC_1259	Signaling by Retinoic Acid	8050	5160	1738	5914	1737	5915	5162	5916	6256	6257	1382	5161	6258	1374	2171	5467	5163	5164	5165	5166	1375
PC_1260	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	122706	5717	5718	5715	10213	5688	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7415	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	10956	23198	9861	6469	5711	84447	143471	9491	27248	5695	5707	51009	6400	5721	5719
PC_1261	Release of Hh-Np from the secreting cell	85455	50846	2262	6868	3549	6469	147111	57758
PC_1262	RA biosynthesis pathway	1592	8608	9249	8854	126	216	124	127	1381	8644	220	340665	157506	195814	112724	51109	5959	10170	10901	64577	57665	56603
PC_1263	Mitochondrial translation initiation	6183	63931	9553	26284	11222	4528	9801	7818	6182	56945	64432	55173	60488	64969	92259	64963	64960	54460	65993	64968	64965	10573	740	3396	5018	6150	51258	51069	116541	64928	219927	128308	124995	122704	64975	54534	84545	90480	51263	23107	10240	79590	118487	123263	64978	64951	116540	55037	51642	64981	78988	64983	55052	28998	65005	51073	65008	64949	51253	29074	219402	26589	65080	57129	10884	64976	63875	55168	54998	29093	54948	54148	51318	29088	64979	51264	51650	28957	51373	51081	51116	65003	51021	51023	51649	28973	28977
PC_1264	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	1855	1856	1857	440193
PC_1265	Mitochondrial translation elongation	6183	63931	9553	26284	11222	10102	9801	7284	7818	6182	56945	64432	55173	60488	64969	92259	64963	64960	54460	65993	64968	64965	10573	740	3396	5018	6150	51258	51069	116541	64928	219927	128308	124995	122704	64975	54534	84545	90480	51263	23107	10240	79590	118487	64978	64951	116540	55037	51642	85476	64981	78988	64983	55052	28998	65005	51073	65008	64949	51253	29074	26589	65080	57129	10884	64976	63875	55168	54998	29093	54948	54148	51318	29088	64979	51264	51650	28957	51373	51081	51116	65003	51021	51023	51649	28973	28977
PC_1266	Mitochondrial translation termination	6183	63931	9553	26284	11222	9801	7818	6182	56945	64432	55173	60488	64969	92259	64963	64960	54460	65993	64968	64965	10573	740	3396	5018	6150	51258	51069	116541	64928	219927	128308	124995	122704	64975	54534	84545	90480	51263	23107	10240	84340	79590	118487	64978	92399	64951	116540	55037	51642	64981	78988	64983	55052	28998	65005	51073	65008	64949	51253	29074	26589	65080	57129	10884	64976	63875	55168	54998	29093	54948	54148	51318	29088	64979	51264	54516	51650	28957	51373	51081	51116	65003	51021	51023	51649	28973	28977
PC_1267	Aflatoxin activation and detoxification	4259	8574	22977	1544	1576	4257	1800	2678	1577	2687	95	1553	124975	246181	91703	4258	64174	64180	2686
PC_1268	APC truncation mutants are not K63 polyubiquitinated	324
PC_1269	APC truncation mutants have impaired AXIN binding	8312	324	5518	5519	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285
PC_1270	AXIN missense mutants destabilize the destruction complex	8312	324	5518	5519	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285
PC_1271	Deletions in the AMER1 gene destabilize the destruction complex	139285
PC_1272	Deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling	8312
PC_1273	Truncations of AMER1 destabilize the destruction complex	8312	324	5518	5519	1452	2932	5516	5515	5527	5528	5525	5526	5529	139285
PC_1274	Organic cation transport	6582	6580	6581	6584	861	85413	55356	6248	5002	6583
PC_1275	Defective Mismatch Repair Associated With MLH1	4292	5395
PC_1276	XAV939 inhibits tankyrase, stabilizing AXIN	8658	80351
PC_1277	Phase 4 - resting membrane potential	3775	3777	3776	8645	3761	54207	3759	3768	338567	89822	83795	60598	56659	56660	51305	50801	3770	9424	10089
PC_1278	Phase 3 - rapid repolarisation	3753	3784	3757	23704	10142	23630	10008	9992
PC_1279	Phase 0 - rapid depolarisation	785	10368	778	6327	801	6323	6329	784	781	2257	59284	6332	776	782	786	6324	783	816	818	817	779	775	6331	6335	93589	6330	55799	59283	2258	2256	2259	6326	59285	29098	6328	9254	55800	27092	27091	11280	781	6334	815	6336	10369
PC_1280	Phase 2 - plateau phase	785	10368	778	3753	3784	784	781	59284	776	782	786	783	779	775	93589	55799	23704	59283	10142	59285	9254	27092	27091	781	23630	10369	10008	9992
PC_1281	Phase 1 - inactivation of fast Na+ channels	80333	30819	3750	30820	3751	3752	30818
PC_1282	Transcriptional regulation by small RNAs	10526	11097	5433	85236	9631	3012	8970	3015	474382	7175	3014	5432	5434	3013	8348	5430	5431	3018	8021	5438	23636	9972	5903	5437	5439	4928	5440	6396	102724334	57122	3017	5435	5436	121504	3017	5901	5441	8350	8480	3020	23279	8338	8349	23511	723790	126961	94239	53371	9688	128312	27327	348995	79023	129401	23225	55746	23165	8334	8345	255626	81929	9883	4927	8341	8331	8342	8340	55766	55706	9818	79902	8086	27161	10762	26523
PC_1283	Physiological factors	4878	4881	4882	4880	2626	1482	204851	8850	6910	25937	28996	10699
PC_1284	Ion homeostasis	5348	6588	487	1193	10768	10060	476	481	801	478	482	488	5566	7137	490	6261	493	5350	4842	6717	6546	7220	477	483	486	6547	53822	53828	2281	491	1760	444	10345	816	818	817	6786	480	3709	3710	3708	3767	5349	6263	492	6262	489	84876	80228	53826	6543	815
PC_1285	Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)	7172
PC_1286	Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)	1593
PC_1287	Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)	191
PC_1288	Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)	26873
PC_1289	Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)	2729	2730
PC_1290	Defective CYP1B1 causes Glaucoma	1545
PC_1291	Defective UGT1A1 causes hyperbilirubinemia	54658
PC_1292	Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)	340665
PC_1293	Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)	126410
PC_1294	Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)	2937
PC_1295	Defective ACY1 causes encephalopathy	95
PC_1296	Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)	1585
PC_1297	Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)	1591
PC_1298	Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)	113612
PC_1299	Defective MAOA causes Brunner syndrome (BRUNS)	4128
PC_1300	Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)	9420
PC_1301	Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)	1594
PC_1302	Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)	56603
PC_1303	Defective UGT1A4 causes hyperbilirubinemia	54657
PC_1304	Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)	1584
PC_1305	Defective FMO3 causes Trimethylaminuria (TMAU)	2328
PC_1306	Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)	23169
PC_1307	Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)	1589
PC_1308	Defective GGT1 causes Glutathionuria (GLUTH)	2678
PC_1309	Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)	4143
PC_1310	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	1583	2230	2232	112812
PC_1311	Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)	120227
PC_1312	Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)	1586
PC_1313	Defective CYP19A1 causes Aromatase excess syndrome (AEXS)	1588
PC_1314	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	5443	4158
PC_1315	Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)	6916
PC_1316	PIWI-interacting RNA (piRNA) biogenesis	5433	221400	8468	3320	4603	5432	5434	5430	5431	5438	5437	5439	5440	5435	5436	5441	91646	113802	143689	201164	122402	55124	136991	9271	84944	56165	54456	54514	11022
PC_1317	TLR3 deficiency - HSE	7098
PC_1318	UNC93B1 deficiency - HSE	7098	81622
PC_1319	MyD88 deficiency (TLR2/4)	7099	7097	929	948	114609	695	7096	4615	10333	23643
PC_1320	TICAM1 deficiency - HSE	7098	148022
PC_1321	TRAF3 deficiency - HSE	7098	7187	148022
PC_1322	IKBKB deficiency causes SCID	3551	1147	8517
PC_1323	MyD88 deficiency (TLR5)	7100	4615
PC_1324	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	3551	1147	8517
PC_1325	IkBA variant leads to EDA-ID	3551	1147	4790	4792	4791	5970	8517
PC_1326	IRAK4 deficiency (TLR5)	7100	4615	81793	51135
PC_1327	IRAK4 deficiency (TLR2/4)	7099	7097	929	948	114609	695	7096	4615	51135	10333	23643
PC_1328	Dectin-1 mediated noncanonical NF-kB signaling	122706	5717	5718	5715	10213	6367	5688	1147	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	9040	10197	5700	5705	5706	6233	7311	6500	4791	5971	5970	5720	5708	8454	23198	9861	5711	143471	9039	9491	6361	5695	5707	9020	23291	5721	5719	8945
PC_1329	CLEC7A (Dectin-1) induces NFAT activation	10768	4772	801	5532	5534	5530	4775	4773	3709	3710	3708
PC_1330	CLEC7A (Dectin-1) signaling	122706	5717	5718	5715	10213	5688	3551	1147	5170	5709	6885	5716	8915	7314	7316	6714	5336	5702	4790	5689	5682	5683	5684	5685	4792	5696	5698	5686	5692	5694	5693	5701	5699	6850	5704	5714	997	5691	5690	5713	7321	5710	7979	5687	7334	10197	5700	5705	5706	7322	6233	7311	6500	5970	5580	5720	5708	387522	8454	23198	9861	10454	5711	257397	143471	9491	5695	5707	84433	64581	64170	23118	10892	23291	5721	5719	8945	7189	8517
PC_1331	Defective PGM1 causes PGM1-CDG (CDG1t)	5236
PC_1332	Defective GALK1 can cause Galactosemia II (GALCT2)	2584
PC_1333	Defective GALE can cause Epimerase-deficiency galactosemia (EDG)	2582
PC_1334	Defective GALT can cause Galactosemia	2592
PC_1335	Organic anion transport	9356	9376	116085	55867	10864
PC_1336	Degradation of GLI1 by the proteasome	122706	5717	5718	5715	10213	5688	5709	5716	2735	7314	7316	5566	5702	5689	5568	5567	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	8650	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	6500	5720	5708	8454	23198	9861	5711	143471	9491	83737	5695	5707	5721	51684	5719	8945
PC_1337	Degradation of GLI2 by the proteasome	122706	5717	5718	5715	10213	5688	5709	5716	7314	7316	2736	5566	5702	5689	5568	5567	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	1452	5691	5690	2932	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	6500	5720	5708	8454	23198	9861	5711	143471	9491	5695	5707	5721	51684	5719	8945
PC_1338	GLI3 is processed to GLI3R by the proteasome	122706	5717	5718	5715	10213	5688	5709	5716	7314	7316	2737	5566	5702	5689	5568	5567	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	1452	5691	5690	2932	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	6500	5720	5708	8454	23198	9861	5711	143471	9491	5695	5707	5721	51684	5719	8945
PC_1339	Hedgehog 'off' state	112	109	115	7289	8481	111	2735	2736	2737	5573	5576	5566	5568	5567	5575	5577	114	113	2778	108	107	8100	5727	374654	2778	23322	79809	23432	79659	57728	196883	55811	9742	6608	80199	55764	55081	54903	57539	26160	27152	51684	51098	11127
PC_1340	Activation of anterior HOX genes in hindbrain development during early embryogenesis	4211	8085	8841	5433	7403	3199	3200	85236	9611	8726	9063	3012	3725	8970	3233	3221	3015	474382	5914	5915	1959	5916	3213	3212	3211	3014	3214	5432	5434	6256	3013	8348	5430	7528	5080	5431	3232	3018	7703	5438	5087	3198	10664	5437	5439	5440	5316	102724334	3017	5435	11091	5436	121504	3017	5441	8350	3020	3201	5928	2033	23054	23512	5929	2146	5931	8338	8349	723790	22976	126961	94239	128312	58508	9125	1387	8334	8345	255626	84962	8341	8331	8342	8340	79447	55766	3231	63925	9070	9935	8202
PC_1341	Cilium Assembly	79969	10013
PC_1342	Defective SLC17A5 causes Salla disease (SD) and ISSD	26503
PC_1343	Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6)	283652
PC_1344	Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)	10559
PC_1345	Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)	9990
PC_1346	Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1)	6569
PC_1347	Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG)	153201
PC_1348	Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN)	6005
PC_1349	Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)	6513
PC_1350	Defective SLC6A19 causes Hartnup disorder (HND)	340024
PC_1351	Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)	10568
PC_1352	Defective SLC26A4 causes Pendred syndrome (PDS)	5172
PC_1353	Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)	56606
PC_1354	Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)	4891
PC_1355	Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)	1356	30061
PC_1356	Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)	6521
PC_1357	Defective SLC9A9 causes autism 16 (AUTS16)	285195
PC_1358	Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP)	6584
PC_1359	Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)	8671
PC_1360	Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)	123041
PC_1361	Defective HK1 causes hexokinase deficiency (HK deficiency)	3098
PC_1362	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	213	28234
PC_1363	Defective CP causes aceruloplasminemia (ACERULOP)	1356	30061
PC_1364	Defective SLC33A1 causes spastic paraplegia 42 (SPG42)	9197
PC_1365	Defective SLC1A3 causes episodic ataxia 6 (EA6)	6507
PC_1366	Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS)	55315
PC_1367	Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)	5002
PC_1368	Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)	6505
PC_1369	Defective SLC2A10 causes arterial tortuosity syndrome (ATS)	81031
PC_1370	Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)	682	6566
PC_1371	Defective SLC22A12 causes renal hypouricemia 1 (RHUC1)	116085
PC_1372	Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)	7355
PC_1373	Defective GCK causes maturity-onset diabetes of the young 2 (MODY2)	2645
PC_1374	Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25)	246213
PC_1375	Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D)	9187
PC_1376	Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)	55343
PC_1377	Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria	348932
PC_1378	Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)	6531
PC_1379	Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)	23443
PC_1380	Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1)	1811
PC_1381	Defective SLC12A3 causes Gitelman syndrome (GS)	6559
PC_1382	Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)	55630
PC_1383	Defective SLC6A5 causes hyperekplexia 3 (HKPX3)	9152
PC_1384	Defective SLC9A6 causes X-linked, syndromic mental retardation,, Christianson type (MRXSCH)	10479
PC_1385	Variant SLC6A14 may confer susceptibility towards obesity	11254
PC_1386	Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)	6578
PC_1387	Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1)	6528
PC_1388	Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH)	142680
PC_1389	Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS)	6514
PC_1390	Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)	551	552	553
PC_1391	Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)	54716
PC_1392	Defective SLC12A1 causes Bartter syndrome 1 (BS1)	6557
PC_1393	Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)	11097	9631	7175	2645	8021	23636	9972	5903	4928	6396	57122	8480	23279	2646	23511	53371	9688	348995	79023	129401	23225	55746	23165	81929	9883	4927	55706	9818	79902	8086	10762
PC_1394	Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS)	10999
PC_1395	Defective SLC6A2 causes orthostatic intolerance (OI)	6530
PC_1396	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	213	10599
PC_1397	Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1)	6575
PC_1398	Defective SLC3A1 causes cystinuria (CSNU)	11136	6519
PC_1399	Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)	60482
PC_1400	Anchoring of the basal body to the plasma membrane	9814	10733	80184	4867	9738	8636	261734	8481	11258	23354	22995	5116	11116	10382	983	203068	3320	5566	7283	5518	5577	1069	5048	1453	102800317	4751	5347	4218	10121	7532	7531	8766	8655	7277	10383	1781	10540	9793	1639	1778	4735	9657	5108	22919	79600	26005	4957	91147	84131	347240	22832	9662	23322	79441	146057	26123	7846	23332	54801	11064	10806	9702	79598	54806	80321	121441	79959	7840	55125	85302	115106	79867	57787	80254	132320	117177	55755	84902	55559	10142	80776	93323	11190	95681	54930	55835	55142	54903	54820	51259	55722	57545	27077	22994	22897	22981	51134
PC_1401	VxPx cargo-targeting to cilium	10640	11336	9727	6010	378	4218	8766	5310	5311	1258	1260	1262	149371	54536	8729	60412	55770	117177	55763	50807	23265
PC_1402	BBSome-mediated cargo-targeting to cilium	92482	6950	6753	22948	7203	10694	10575	10576	27241	166379	55212	129880	582	79738	123016	117177	585	2847	6608	583	84100	8195	54585
PC_1403	Intraflagellar transport	79989	3797	9371	8655	8100	9321	79809	92104	90410	6991	150737	200132	79659	57728	51626	26146	83657	55112	255758	28981	22920	3842	23059	89891	140735	112752	80173	9742	11020	64792	55764	83658	56912	55081	57576	57560	57539	26160	51098	11127	51668
PC_1404	Dectin-2 family	2534	4067	4582	5336	2207	6850	4586	4584	394263	140453	93978	4588	283463	10462	200958	143662	4589	170482	94025	338339	118430	4585	56667	727897	10071	26253	50856
PC_1405	CD209 (DC-SIGN) signaling	9252	5063	4893	3265	3845	5894	2534	4067	3384	5566	4790	5568	5567	3385	5971	5970	2033	5058	5062	1387	30835
PC_1406	Trafficking of myristoylated proteins to the cilium	84747	6102	403	192668	27031
PC_1407	ARL13B-mediated ciliary trafficking of INPP5E	5147	200894	56623
PC_1408	RHO GTPases activate PKNs	103910	4659	5170	4660	389	10398	10971	995	7529	2810	4627	4628	4629	4637	387	7532	5500	7531	388	5879	7534	7533	5058	5585	5586	29941	79784	94274
PC_1409	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	23028	85236	3012	8970	354	3015	474382	367	3014	3817	3013	8348	3018	102724334	3017	121504	3017	8350	3020	10499	5585	8338	8349	723790	126961	94239	128312	8334	8345	255626	8341	8331	8342	8340	55766	23081
PC_1410	RHO GTPases activate CIT	11113	103910	4659	9055	4660	389	10398	4627	4628	4629	1027	4637	387	5500	388	5879	1742	9928	79784
PC_1411	RHO GTPases activate KTN1	3799	998	387	5879	391	3831	3798	147700	3895	64837	89953
PC_1412	RHO GTPases activate IQGAPs	4221	801	999	6249	1495	1499	8826	998	5879	10788	128239
PC_1413	TNFR1-mediated ceramide production	6610	7124	7132	10399	8439	55512
PC_1414	RHO GTPases regulate CFTR trafficking	1080	23433	57120
PC_1415	RHO GTPases Activate ROCKs	103910	4659	4660	9475	389	1072	10398	4627	4628	4629	3984	3985	4637	387	5500	388	5058	6093	79784
PC_1416	RHO GTPases activate PAKs	103910	4659	4660	5063	801	2316	10398	4771	4627	4628	4629	3984	4637	998	5500	5879	5058	5062	2017	4638	79784
PC_1417	TP53 Regulates Metabolic Genes	4697	9167	10542	5565	9997	6341	2744	2936	4512	4513	4514	7157	2821	1345	1351	7295	1329	2539	1337	1327	1340	1350	2877	9377	1349	10971	25824	207	208	7529	2810	7001	2475	10128	7249	5571	5563	83667	143686	5728	7532	7531	7534	54205	7533	5052	389541	5562	6009	6834	7296	116228	10325	55004	10670	50484	57521	285521	153129	27327	7248	84987	51204	64223	8626	192669	4343	57690	192670	57103	58528	54541	51241	53632	51422	8649	27165	27161	26523	23112	10000	28956	5564	1353	27244
PC_1418	Ligand-receptor interactions	50846	2619	5727	3549	6469	50937	64399	91653
PC_1419	Hedgehog 'on' state	122706	5717	5718	5715	10213	5688	5709	50846	8405	5716	2735	7314	7316	2736	2737	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	8650	5713	5710	2121	7979	5687	10197	5700	5705	5706	9978	6233	7311	5720	5708	8452	5727	3549	23198	9861	6469	5711	374654	339745	79577	25989	132884	22873	23432	143471	9491	83737	5695	5707	6608	64750	57154	5721	51684	5719
PC_1420	Defective Mismatch Repair Associated With MSH3	4437	4436
PC_1421	Defective Mismatch Repair Associated With MSH2	4437	4436	2956
PC_1422	Defective Mismatch Repair Associated With MSH6	4436	2956
PC_1423	Defective Mismatch Repair Associated With PMS2	4292	5395
PC_1424	Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)	199857	79868
PC_1425	Activation of SMO	84455	50846	2622	156	409	1452	408	2619	2121	5727	3549	6469	50937	23288	132884	6608	91653	11127
PC_1426	GLI proteins bind promoters of Hh responsive genes to promote transcription	2735	2736	2737	5727	64399	91653	8643
PC_1427	Constitutive Signaling by EGFRvIII	1956	4893	3265	3845	1950	3320	5335	867	5295	6464	5290	2885	6654	2549	11140
PC_1428	Inhibition of Signaling by Overexpressed EGFR	2069	1956	1950	7039	374	685	6882	255324	1839
PC_1429	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	4968	5423	7515	3980	252969	79661	11284
PC_1430	PCNA-Dependent Long Patch Base Excision Repair	5423	5111	6118	3978	6117	328	5424	6119	5984	5982	5981	2237	5985	5983	5425	5427	5426	10714	57804	56655	54107
PC_1431	Fructose biosynthesis	231	6652
PC_1432	Lactose synthesis	3906	6513	2683
PC_1433	Phospholipase C-mediated cascade	2255	8822	2246	2249	2247	2251	2260	2248	2250	5335	2254	2253	8074	27006	26281	9365
PC_1434	Phospholipase C-mediated cascade	2255	8823	8822	8817	2246	2249	2247	2251	2248	2250	5335	2252	2263	2254	2253	8074	27006	26281
PC_1435	Phospholipase C-mediated cascade	8823	8822	8817	2246	2249	2247	2250	5335	2261	2254	2253	8074	26281
PC_1436	Phospholipase C-mediated cascade	8823	8822	8817	9965	2246	2249	2247	2251	5335	2264	2254	2253	152831	8074	26281
PC_1437	Downstream signaling of activated FGFR1	2255	23768	8822	2246	2249	2247	2251	2260	2248	2250	2254	2253	8074	27006	26281	23767	23769	9365
PC_1438	SHC-mediated cascade	2255	8822	4893	3265	3845	2246	2249	2247	2251	2260	2248	2250	6464	2254	2253	2885	6654	8074	27006	26281	9365
PC_1439	PI-3K cascade	2255	8822	2246	2249	2247	2251	2260	2248	2250	5295	2254	5290	2253	2885	5781	2549	10818	8074	27006	26281	9365
PC_1440	FRS-mediated FGFR1 signaling	2255	10817	8822	4893	3265	3845	2246	2249	2247	2251	2260	2248	2250	2254	2253	2885	5781	6654	10818	8074	27006	26281	9365
PC_1441	PI-3K cascade	2255	8823	8822	8817	2246	2249	2247	2251	2248	2250	2252	2263	5295	2254	5290	2253	2885	5781	2549	10818	8074	27006	26281
PC_1442	SHC-mediated cascade	2255	8823	8822	8817	4893	3265	3845	2246	2249	2247	2251	2248	2250	2252	2263	6464	2254	2253	2885	6654	8074	27006	26281
PC_1443	FRS-mediated FGFR2 signaling	2255	8823	10817	8822	8817	4893	3265	3845	2246	2249	2247	2251	2248	2250	2252	2263	2254	2253	2885	5781	6654	10818	8074	27006	26281
PC_1444	SHC-mediated cascade	8823	8822	8817	4893	3265	3845	2246	2249	2247	2250	2261	6464	2254	2253	2885	6654	8074	26281
PC_1445	FRS-mediated FGFR3 signaling	8823	10817	8822	8817	4893	3265	3845	2246	2249	2247	2250	2261	2254	2253	2885	5781	6654	10818	8074	26281
PC_1446	PI-3K cascade	8823	8822	8817	2246	2249	2247	2250	2261	5295	2254	5290	2253	2885	5781	2549	10818	8074	26281
PC_1447	FRS-mediated FGFR4 signaling	8823	10817	8822	8817	9965	4893	3265	3845	2246	2249	2247	2251	2264	2254	2253	2885	5781	6654	152831	10818	8074	26281
PC_1448	SHC-mediated cascade	8823	8822	8817	9965	4893	3265	3845	2246	2249	2247	2251	2264	6464	2254	2253	2885	6654	152831	8074	26281
PC_1449	PI-3K cascade	8823	8822	8817	9965	2246	2249	2247	2251	2264	5295	2254	5290	2253	2885	5781	2549	152831	10818	8074	26281
PC_1450	Negative regulation of FGFR1 signaling	2255	8822	2246	2249	2247	7314	7316	2251	2260	2248	2250	867	3730	5595	5594	2254	2253	6233	7311	2885	5781	10818	8074	27006	26281	9365
PC_1451	Negative regulation of FGFR2 signaling	2255	8823	8822	8817	2246	2249	2247	7314	7316	2251	2248	2250	2252	2263	867	5595	5594	2254	2253	6233	7311	2885	5781	10818	8074	27006	26281
PC_1452	Negative regulation of FGFR3 signaling	8823	8822	8817	2246	2249	2247	7314	7316	2250	2261	867	5595	5594	2254	2253	6233	7311	2885	5781	10818	8074	26281
PC_1453	Negative regulation of FGFR4 signaling	8823	8822	8817	9965	2246	2249	2247	7314	7316	2251	2264	867	5595	5594	2254	2253	6233	7311	2885	5781	152831	10818	8074	26281
PC_1454	Signaling by FGFR2 in disease	2255	8823	8822	8817	4893	3265	3845	2246	2249	2247	2251	2248	2250	5335	2252	2263	5295	2254	5290	2253	2885	6654	2549	10818	8074	27006	26281
PC_1455	Signaling by FGFR4 in disease	4893	3265	3845	5335	2264	5295	5290	2885	6654	2549	10818
PC_1456	Signaling by FGFR1 in disease	8805	8822	11160	9530	11116	4893	3265	3845	2246	2249	2247	2251	613	2260	2250	5335	5295	2254	1523	5290	2253	2885	6654	2549	11052	9208	11064	10818	399687	8074	26281	26127	7750
PC_1457	Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)	9843	30061
PC_1458	Translesion synthesis by POLK	5980	7314	7316	5111	6118	6117	6119	5984	5982	5981	5985	5983	6233	7311	51426	51455	10459
PC_1459	Translesion synthesis by POLI	5980	7314	7316	5111	6118	6117	6119	5984	5982	5981	5985	5983	6233	7311	51455	10459	11201
PC_1460	Termination of translesion DNA synthesis	9246	9636	7314	7316	5111	6118	6117	5424	6119	5984	5982	5981	5985	5983	7318	5425	5427	6233	7311	5426	7706	9100	9768	10714	124739	57804	56655	54107	51426	51455	11201	5429
PC_1461	Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)	6523
PC_1462	Hereditary fructose intolerance	229
PC_1463	Essential fructosuria	3795
PC_1464	MGMT-mediated DNA damage reversal	4255
PC_1465	HHAT G278V abrogates palmitoylation of Hh-Np	50846	3549	6469	55733
PC_1466	Defective SLC5A2 causes renal glucosuria (GLYS1)	6524
PC_1467	Regulation of RAS by GAPs	122706	5717	5718	5715	10213	5688	5709	10156	5716	8437	4893	3265	3845	7314	7316	5702	5689	5921	4763	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	5720	5708	8452	22821	23198	9861	5922	5711	399473	153090	200734	161742	64926	143471	84078	9491	8831	5695	5707	9462	5721	5719
PC_1468	Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)	60482
PC_1469	FGFRL1 modulation of FGFR1 signaling	2255	8822	8817	2249	2247	2248	2250	2253	200734	161742	53834	8074	27006
PC_1470	Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria	348932
PC_1471	Defective SLC6A19 causes Hartnup disorder (HND)	340024
PC_1472	Intestinal saccharidase deficiencies	3938	6476
PC_1473	RPIA deficiency	22934
PC_1474	MTF1 activates gene expression	1465	4520	6620
PC_1475	CLEC7A/inflammasome pathway	3553	4790	5970	841	10892	29108
PC_1476	Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)	54716
PC_1477	Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)	6531
PC_1478	Defective SLC7A7 causes lysinuric protein intolerance (LPI)	6520	9056
PC_1479	Defective SLC7A9 causes cystinuria (CSNU)	11136	6519
PC_1480	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	10599
PC_1481	Metallothioneins bind metals	4502	4489	4493	4494	4490	4495	4504	84560	4496	4501	4499
PC_1482	Formation of xylulose-5-phosphate	9942	10327	6652	51181	51084
PC_1483	Melanin biosynthesis	7299	7306	1638	4948	51151
PC_1484	Essential pentosuria	51181
PC_1485	Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)	10559
PC_1486	RHO GTPases Activate WASPs and WAVEs	644150	8976	10095	10109	10094	10092	7456	25	4690	5595	5594	7454	3071	10093	60	998	10096	10097	2885	5879	71	5747	695	23191	10006	147179	55845	8936	10552	26999	10152	51517	10810	10458	10787	10163
PC_1487	RHO GTPases Activate Formins	3796	29984	1780	1855	1856	10403	7514	332	1783	9183	699	9184	701	1729	1730	23380	23122	11130	752	3688	5216	389	6722	6714	5518	5519	6249	5217	5501	6232	5048	5905	1058	1063	5903	9735	4928	5347	6396	57122	60	998	387	5516	388	5879	8655	71	5515	1062	1060	23279	991	4085	23421	5527	1781	9793	1778	5528	5525	5526	22919	5529	54821	55143	151246	151648	401541	100527963	79682	55166	57551	23332	91010	91687	100526739	84643	286205	147841	348995	79023	57082	81930	55746	348235	25909	2491	1857	57591	220134	80152	54908	81929	140735	9212	55839	25936	114793	11004	80776	64105	79172	79902	83540	81565	79003	64946	79980	55055	57405	3619	79019	81624	54820	55920	51466	10726	23002	8379	51143
PC_1488	RHO GTPases Activate Rhotekin and Rhophilins	30851	389	387	388	85415	114822	6242	64130	54763
PC_1489	TNFR2 non-canonical NF-kB pathway	122706	5717	5718	5715	10213	8600	5688	5709	407977	8740	5716	4049	7124	5702	7133	5689	5682	5683	5684	5685	958	5696	5698	5686	5692	5694	5693	959	5701	4055	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	5720	4050	7186	7187	5708	330	329	23198	9861	5711	143471	9491	115650	5695	5707	9020	51330	5721	5719	10673	8792
PC_1490	RHO GTPases Activate NADPH Oxidases	1536	6279	5579	6280	1535	653361	5880	5578	4688	5595	5594	5879	5590	5580	5300	4689	5600	1432	10811	5289	124056	30849	50508	27035
PC_1491	TNFs bind their physiological receptors	4982	8600	23495	8740	8741	9966	8771	4049	7132	7133	7292	939	943	970	944	8744	7293	608	3604	356	128178	1896	8764	8718	60401	10913	8995	10673	8784
PC_1492	RAF activation	3717	4893	3265	3845	5894	801	369	6714	673	4140	5518	5519	7529	5245	5605	5516	5515	5604	5527	816	818	817	5528	5525	5526	5529	4296	8315	8844	815
PC_1493	RAF/MAP kinase cascade	2675	9542	5924	2069	6712	2906	2255	8823	10817	27040	8822	5623	2676	3717	8817	10125	9965	1956	4893	3265	3845	5155	1950	7039	3559	6708	5154	1437	2064	3567	2246	2534	4747	5979	4233	2249	3562	2247	5159	801	3815	2251	6710	2260	2248	2250	4684	3082	3560	1438	374	5156	5786	4254	2252	2263	2065	2264	2261	3716	3563	5595	5594	6464	2254	3561	1439	685	3667	88	2322	2668	2323	3718	2253	2674	10718	3558	2885	1742	25759	6711	3568	3084	7010	5747	2902	6654	1739	2904	816	818	817	6709	5923	8682	2066	284	1740	9048	255324	152831	25780	221002	115727	10818	145957	53358	1741	10048	1839	4902	8074	64096	57731	27006	26281	51332	9365	815	9693	8660
PC_1494	MAP2K and MAPK activation	4893	3265	3845	2243	2244	2266	2335	5894	7450	3690	3674	369	6714	673	7414	5595	4140	5594	5037	7529	409	5605	1445	8826	408	5908	5906	5604	283455	54518	8844	54756	22866	10256	84292	8649	28956	7094
PC_1495	Constitutive Signaling by AKT1 E17K in Cancer	1147	5170	2309	1385	3164	207	208	1026	2475	1027	7249	2931	2932	842	55615	4303	4193	2308	253260	572	84335	79109	64223	6199	10000
PC_1496	PTEN Loss of Function in Cancer	5728
PC_1497	Negative feedback regulation of MAPK pathway	5894	673	5595	5594	5605	5604
PC_1498	Negative regulation of MAPK pathway	4893	3265	3845	5894	7314	7316	369	673	5595	4140	5594	1843	5037	5518	5519	7529	5536	5516	6233	7311	5515	1844	1846	1850	5527	5528	5525	5526	5529	1847	1848	1849	152559	8315	8844	1852	80824	11221
PC_1499	Regulation of necroptotic cell death	331	7186	330	329	8737	841	8717
PC_1500	NIK-->noncanonical NF-kB signaling	122706	5717	5718	5715	10213	5688	1147	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	9040	10197	5700	5705	5706	6233	7311	6500	4791	5971	5720	5708	8454	23198	9861	5711	143471	9039	9491	5695	5707	9020	23291	5721	5719	8945
PC_1501	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	8600	407977	8740	4049	958	959	4055	4050	7186	7187	330	329	115650	9020	51330	10673	8792
PC_1502	Protein repair	7295	5110	253827	51734	4482	22921
PC_1503	Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia	10060	3767
PC_1504	Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2	8647
PC_1505	Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1	5244
PC_1506	Defective CFTR causes cystic fibrosis	122706	5717	5718	5715	10213	5688	5709	10613	5716	11160	7314	7316	1080	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7415	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	10956	23198	9861	5711	143471	9491	27248	91445	91319	5695	5707	6048	79139	51009	6400	5721	5719
PC_1507	Defective ABCC2 causes Dubin-Johnson syndrome	1244
PC_1508	Defective ABCG8 causes gallbladder disease 4 and sitosterolemia	64241	64240
PC_1509	Defective ABCG5 causes sitosterolemia	64241	64240
PC_1510	Defective ABCA1 causes Tangier disease	19	335
PC_1511	Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B	26154
PC_1512	LGI-ADAM interactions	10368	8745	4185	9211	112755	1742	6804	55203	163175	203190	59283	53616	27092	10369
PC_1513	Defective ABCC8 can cause hypoglycemias and hyperglycemias	6833	3767
PC_1514	Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)	5826
PC_1515	Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7)	10058
PC_1516	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	21
PC_1517	Surfactant metabolism	10568	9476	6439	150	1512	643847	643834	5222	6440	1438	152	135	136	1439	6441	5029	6569	10970	7270	729238	653509	221395	2627	21	51816	29995	29080	1755	51201
PC_1518	Defective ABCD1 causes adrenoleukodystrophy (ALD)	215
PC_1519	MAP3K8 (TPL2)-dependent MAPK1/3 activation	3551	1147	7314	7316	4790	1326	6416	6233	7311	6500	5604	8454	79155	23291	8945	8517
PC_1520	HDR through Single Strand Annealing (SSA)	5810	3364	4683	5884	25	2067	6118	6117	6119	5984	5982	672	5985	5983	5893	4361	1763	641	5888	472	7156	545	7486	144715	84126	11073	10111	2072	10524	116028	5883	5932	580	83695	83990	80010	9156
PC_1521	HDR through MMEJ (alt-NHEJ)	4683	10721	142	7515	2237	3980	4361	10111	5932	10038
PC_1522	HDR through Homologous Recombination (HRR)	5890	5889	7517	7516	4683	5892	7314	7316	5111	6118	6117	5424	6119	5984	5982	5981	672	5985	5983	5425	4361	1763	675	641	5427	6233	7311	5888	5426	472	7156	7486	10714	79728	10111	10524	10635	116028	5932	580	83990	80010	57804	56655	54107	51426	9156	5429
PC_1523	Regulation of TLR by endogenous ligand	7099	7097	2243	2244	2266	338	6279	6280	929	3146	948	3929	6271	7096	10333	23643
PC_1524	MAPK6/MAPK4 signaling	122706	5717	5718	5715	10213	10435	5688	7514	5709	2309	8997	8555	5716	5063	4609	3315	3725	983	4313	4319	7314	7316	5896	5566	5702	5689	5568	5567	3337	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	896	5596	5701	5699	2118	5704	5714	5691	5690	5713	5710	5897	7979	5687	998	10197	5700	5705	5706	6233	7311	5879	5720	2308	5058	5062	5708	23198	9861	989	5711	5597	148170	8550	27327	143471	9491	5695	5707	192669	4343	57690	192670	10642	10602	27161	26523	5721	8556	5719	23112	8202
PC_1525	Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)	10568
PC_1526	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	729238
PC_1527	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	6439
PC_1528	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	6440
PC_1529	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3)	21
PC_1530	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	6439	6440	1438	1439	6441	729238	653509
PC_1531	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	6439	6440	1438	1439	6441	729238	653509
PC_1532	UCH proteinases	122706	5717	5718	5715	10213	5688	4092	8473	5709	5716	86	7040	3012	7345	8329	29844	7314	7316	7347	5702	5689	3013	7528	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	7046	7048	5699	5704	5714	5691	5690	3054	5713	5710	60	7979	5687	10197	5700	5705	5706	6233	7311	221937	3607	5720	5708	23198	9861	4738	11047	5711	8338	54891	723790	4798	125476	55252	92815	317772	171023	221656	283899	143471	9491	8314	8334	114785	10445	85235	123228	221613	5695	5707	580	8331	83444	93973	79913	55777	5721	54617	5719	8607	9958	51377
PC_1533	Josephin domain DUBs	5071	7314	7316	4287	5886	5887	7415	6233	7311	9929	126119	92552
PC_1534	Ub-specific processing proteases	122706	645836	645402	728386	100287144	100287238	100287205	100287178	100287478	100287364	100287513	100287327	100287404	100287441	5717	5718	5715	10213	5688	9146	4092	4194	8312	6314	5709	6478	9738	6885	8724	85236	219333	10474	9099	5716	10254	9868	10869	8658	90865	23586	4609	7157	3012	5423	8970	154	8329	392188	7314	7316	367	1080	3416	5702	890	5689	3013	7416	8348	2625	5682	5683	5684	5685	4792	5696	5698	5686	5692	5694	5693	993	409	3018	5701	7046	5699	9101	5704	7417	8078	5714	408	5691	5690	5713	8237	9097	5710	3017	5728	7979	5687	10197	5700	5705	5706	3017	6233	7311	8900	4088	4303	4193	5720	728369	991	7186	6881	7375	5708	6502	4089	330	329	8737	9817	23770	8678	9100	23198	9861	9804	10454	4087	4086	11047	5711	3091	8338	8349	440689	63891	723790	377630	25862	9736	84749	92815	401447	57695	93624	84196	317772	55288	128312	143471	57599	91833	79589	23032	1643	9491	2648	7353	8975	8239	7874	8334	8345	79594	255626	55611	55031	85235	221613	57646	5695	5707	8341	8331	8342	8340	83844	64135	84101	80351	64426	84132	64750	63967	51616	1540	81847	27430	29761	27005	5721	11274	5719	23326	23358	9986	8607	7419	10868	8313	51651	8295	9958	7189	10600	9960	8517
PC_1535	Ovarian tumor domain proteases	8767	23586	2099	7157	983	7314	7316	7128	324	7321	7415	5728	387	6233	7311	7187	8737	7706	10318	23252	55432	56957	57506	84282	79155	161725	79589	78990	55611	55593	80124	79931	64135	64127	54764	10392	7189	8517
PC_1536	Metalloprotease DUBs	10213	10617	3012	8329	7314	7316	3013	672	79184	6233	7311	2033	23172	8338	114803	723790	84142	92815	317772	8027	8850	8334	57559	85235	114548	221613	51720	580	8331	29086	9577
PC_1537	Defective ABCC6 causes pseudoxanthoma elasticum (PXE)	368
PC_1538	CD22 mediated BCR regulation	4067	973	933	5777	974
PC_1539	Sensing of DNA Double Strand Breaks	4683	4361	3838	472	10111	10524
PC_1540	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	5890	5889	7517	7516	4683	5892	672	4361	1763	675	641	5888	472	7156	7486	79728	10111	10524	10635	116028	5932	580	83990	80010	51750	9156
PC_1541	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	2139	322	8467	85236	4683	9682	9025	23030	2070	8924	11200	7468	25	7157	8970	7314	7316	3014	8348	3018	672	5599	79184	4361	5536	102724334	3017	7334	121504	3017	6233	7311	7341	7329	7158	472	9656	7336	8290	8349	84142	165918	128312	51588	8314	10111	10524	8345	255626	51720	2138	2140	580	8341	8342	8340	29086	9577	9031
PC_1542	Resolution of D-loop Structures through Holliday Junction Intermediates	197342	5890	5889	7517	7516	4683	5892	672	4361	1763	675	641	5888	472	7156	23514	7486	348654	79728	84464	10111	10524	146956	10635	116028	80198	5932	580	548593	83990	80010	9156
PC_1543	Nonhomologous End-Joining (NHEJ)	85236	4683	9025	51567	8924	7468	8970	2547	7520	3014	8348	3018	672	79184	3981	4361	102724334	3017	7334	121504	3017	7341	5591	7158	472	7518	9656	7336	8290	8349	55183	84142	22976	165918	128312	51588	10111	10524	8345	255626	51720	64421	580	8341	8342	8340	79840	27434	55775	29086	9577	27343
PC_1544	Homologous DNA Pairing and Strand Exchange	5890	5889	7517	7516	4683	5892	672	4361	1763	675	641	5888	472	7156	7486	79728	10111	10524	10635	116028	5932	580	83990	80010	9156
PC_1545	Processing of DNA double-strand break ends	1111	5810	85236	3364	4683	5884	9025	8924	7468	8970	7314	7316	6118	3014	890	8348	1017	6117	3018	6119	5984	5982	672	5985	5983	79184	4361	1763	641	102724334	3017	5531	7334	6613	121504	3017	6233	7311	7341	7329	6047	8900	7158	472	7156	545	7486	9656	7336	8290	8349	84142	144715	165918	128312	51588	51548	84126	11073	10111	10524	8345	255626	116028	51720	5883	5932	580	8341	8342	8340	83695	54962	83990	80010	63967	29086	9577	151987	8914	9156
PC_1546	Presynaptic phase of homologous DNA pairing and strand exchange	1111	5890	5889	7516	5810	3364	4683	5892	5884	6118	6117	6119	5984	5982	672	5985	5983	4361	1763	675	641	5888	472	7156	545	7486	144715	84126	11073	10111	10524	116028	5883	5932	580	83695	83990	80010	9156
PC_1547	Cargo concentration in the ER	9570	9554	9871	10175	10802	10427	2157	5265	7039	2153	966	2348	374	2890	3998	10972	1075	9632	1294	10960	6811	10959	10484	375056	254263	90411	149111	4253	81562	79748	10113	1522	51128
PC_1548	DNA Damage Recognition in GG-NER	86	142	29844	7314	7316	7528	1069	5886	5887	60	9318	9978	6233	7311	7508	2873	8451	8450	1642	54891	4798	125476	10980	283899	1643	10987	10445	10920	51138	83444	93973	79913	64708	50813	10038	54617	8533	8607
PC_1549	Formation of Incision Complex in GG-NER	8554	2067	142	7314	7316	6118	2068	2071	7507	6117	2073	2965	6119	1069	1022	902	4331	5886	5887	6612	7334	6613	9978	6233	7311	7341	7329	7508	8451	8450	2966	2967	7336	1642	54778	404672	85015	9557	1643	2968	2072	10038	10401
PC_1550	Gap-filling DNA repair synthesis and ligation in GG-NER	7314	7316	5111	6118	3978	7515	6117	5424	6119	5984	5982	5981	5985	5983	5425	3980	5427	6233	7311	5426	10714	57804	56655	54107	51426
PC_1551	Dual Incision in GG-NER	2067	142	7314	7316	5111	6118	2068	2071	7507	6117	5424	2073	2965	6119	5984	5982	5981	5985	5983	5425	5427	9978	6233	7311	5426	8451	8450	2966	2967	10714	1642	404672	9557	1643	2968	2072	57804	56655	54107	51426	10038
PC_1552	Deposition of new CENPA-containing nucleosomes at the centromere	201254	11339	8467	85236	3012	4869	8970	3015	474382	3014	3013	8348	3018	1058	102724334	3017	121504	3017	1060	5928	23421	5931	8338	8349	387103	723790	401541	55320	79682	94239	55166	91687	128312	100526739	55355	57082	2491	8334	8345	255626	80152	55839	51773	8341	8331	8342	8340	64105	55766	79172	64946	79019	54069	8607
PC_1553	Respiratory electron transport	4728	4697	6392	9167	4706	27089	10975	4694	4724	4711	4709	4717	4695	9997	4725	374291	4720	4726	4707	4722	6341	4712	4696	4710	4714	4708	4701	4718	4705	4716	4519	4512	4513	4514	4535	4536	4537	4538	4540	4541	7388	1537	1345	1351	1329	1337	1327	2108	1340	7381	1350	4713	4729	9377	6390	7385	1349	4719	6389	7384	2109	10128	7386	4723	4702	4731	4700	54205	10131	6834	2110	4698	4704	116228	126328	285521	84987	93058	6391	51204	80219	54539	51079	51241	29796	55967	4715	1353
PC_1554	Highly sodium permeable acetylcholine nicotinic receptors	1146	1141	1143	1136	1137	1145	1144
PC_1555	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1134	1141	1138	1143	1136	1139	1137	1142	1135	8973	55584
PC_1556	Highly calcium permeable nicotinic acetylcholine receptors	1134	1141	1138	1143	1136	1137	1142	1135	8973
PC_1557	RNA Polymerase II Pre-transcription Events	6829	6874	5433	904	905	8812	2963	2068	7936	5432	5434	2071	6908	6872	6917	5430	2960	2961	5431	2965	2962	5438	4300	6878	1022	1025	902	4331	22916	5437	5439	2957	2958	5440	8178	5435	5436	5441	6827	2959	4298	6749	4686	6881	2966	2967	6924	6921	6923	6877	6884	6882	6879	6883	6880	54457	83860	79577	6873	9646	404672	6830	51497	51224	138474	54623	123169	25920	23168	6875	2968	8148	55840	85403	55677	80349	7469	51616	27125	9150	11198
PC_1558	Formation of TC-NER Pre-Incision Complex	5433	9716	3150	7314	7316	2068	5432	5434	2071	7507	6917	5430	5431	2965	5438	1022	902	4331	5437	5439	5440	9318	5435	5436	5441	9978	6233	7311	2074	2033	2873	1161	8451	8450	2966	2967	1642	57654	404672	10980	2968	10987	7874	91603	10920	51138	64708	56949	50813	100534599	27339	10450	8533
PC_1559	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	5433	9716	3150	7314	7316	2068	5432	5434	2071	6917	5430	5431	2965	5438	1022	902	4331	5437	5439	5440	8178	5435	5436	5441	9978	6233	7311	2074	2033	1161	8451	8450	2966	2967	1642	57654	404672	2968	7874	91603	56949	100534599	27339	10450
PC_1560	Dual incision in TC-NER	5433	9716	3150	2067	7314	7316	5111	6118	2068	5432	5434	2071	7507	6917	5430	6117	5424	2073	5431	2965	6119	5984	5982	5981	5438	5985	5983	5425	1022	902	4331	5437	5439	5440	5427	5435	5436	5441	9978	6233	7311	2074	5426	2033	1161	8451	8450	2966	2967	10714	1642	57654	404672	2968	2072	7874	91603	56949	57804	56655	54107	51426	100534599	27339	10450
PC_1561	Gap-filling DNA repair synthesis and ligation in TC-NER	5433	9716	3150	7314	7316	5111	6118	2068	3978	7515	5432	5434	2071	6917	5430	6117	5424	5431	2965	6119	5984	5982	5981	5438	5985	5983	5425	3980	1022	902	4331	5437	5439	5440	5427	5435	5436	5441	9978	6233	7311	2074	5426	2033	1161	8451	8450	2966	2967	10714	1642	57654	404672	2968	7874	91603	56949	57804	56655	54107	51426	100534599	27339	10450
PC_1562	tRNA modification in the nucleus and cytosol	1787	2058	10785	54888	8270	348180	54901	63892	60487	134637	90353	152992	93587	221078	91801	113179	115708	54517	112858	81605	23536	81890	83480	54802	79691	55644	54482	54974	54920	55621	57604	4234	24140	51504	51605	51002	80324
PC_1563	Synthesis of wybutosine at G37 of tRNA(Phe)	129450	9836	57570	55039	127253	55253
PC_1564	Fanconi Anemia Pathway	197342	201254	2189	2175	7398	2067	7314	7316	6118	6117	6119	6233	7311	2176	80233	545	199990	9937	353497	84464	57697	100526739	2187	57599	84126	2072	146956	80198	548593	91442	2177	64858	2178	29089	2188	55215	55120	22909
PC_1565	Interleukin-10 signaling	6367	7076	7124	3552	3553	3627	1437	3569	3383	2208	2919	1435	1440	3576	6348	388372	6347	6352	3554	3976	414062	3557	7132	2920	7133	2357	3586	3716	5724	7850	3592	3593	7297	1230	941	5743	6774	729230	942	1234	6364	3588	3587	3606	6363
PC_1566	Glycine degradation	1738	2731	2653	275
PC_1567	tRNA processing in the nucleus	11097	11260	9631	10248	10799	11102	10898	10775	7175	1478	8021	23636	9972	5903	4928	6396	57122	5901	10557	10556	8480	29894	23279	283742	23511	53371	283989	339487	9688	80746	348995	79023	129401	23225	55746	116461	1653	23165	10978	51367	81929	9883	51095	4927	10940	60528	79042	55706	54913	79074	9818	79902	79897	8086	10762	51637	51493
PC_1568	tRNA processing in the mitochondrion	9692	4519	4512	4513	4514	4508	4535	4536	4537	4539	4538	4540	4541	4509	54931	51095	3028	60528
PC_1569	ERBB2 Regulates Cell Motility	9542	2069	1729	1956	1950	2064	2065	685	10718	387	3084	2066	145957	1839	51072
PC_1570	Interleukin-4 and Interleukin-13 signaling	6367	9021	3911	332	8651	2309	3717	9655	2162	7076	2353	4609	7040	5443	7124	3552	3553	2335	4312	301	7157	3689	3565	3569	3383	3688	2208	3320	1278	4313	4314	7431	3570	2247	3162	240	6288	3576	596	3312	3684	5292	6347	5008	3082	7184	4318	5451	3976	7422	4582	246	948	3726	3929	7412	7133	3687	4128	1901	3586	3716	2625	595	3566	5295	3592	3593	7297	207	3561	3596	4843	5743	4988	6095	6935	1026	6774	4985	604	6772	6778	356	6657	1052	6097	6356	3718	3597	3934	598	4170	2308	3606	3598	3662	7291	10538	3605	6624	3091	149233	58480	112744	4692	79923	51561
PC_1571	tRNA modification in the mitochondrion	9692	55687	54931	84705	3028	55006	54802	25821	80324
PC_1572	GDP-fucose biosynthesis	282969	8790	2762	7264	197258	55343
PC_1573	IL-6-type cytokine receptor ligand interactions	3717	9244	5008	3976	3589	3716	1270	1271	7297	3572	3977	3590	1489	386653	133396	9180	23529
PC_1574	rRNA modification in the nucleus and cytosol	10199	10528	9277	114049	9136	1736	27340	6187	2091	4839	6203	4809	6201	6208	6194	8602	10607	11103	22984	9790	23160	5822	9724	27042	84128	57647	134430	84135	10436	84916	88745	92856	79050	10813	55226	51202	55127	65083	25926	55505	57050	56902	25879	55272	55651	55623	54433	55813	51504	115939	27292	10885	10171	11056	51602	51077	51118	27341	51096	54555
PC_1575	TALDO1 deficiency	6888
PC_1576	Major pathway of rRNA processing in the nucleolus and cytosol	23481	10199	10528	8780	9277	114049	9136	27340	10799	11102	6176	6181	6175	6218	3921	6187	6165	6129	6139	4691	2091	6192	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	23517	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	1453	6164	102800317	9045	4809	8568	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	8602	10557	10556	6152	6173	6143	5394	6142	6128	5393	6141	10607	11103	23404	705	10438	23246	22984	9790	23016	23160	5822	55720	118460	79707	9724	27042	200916	51065	90459	84128	57647	117246	27043	134430	140032	84135	6123	10436	6166	84916	11340	116832	88745	92856	84946	140801	10200	10969	83732	54913	57418	79050	10813	26354	55781	55759	22803	51202	26168	55127	79897	65083	25926	81875	54512	56915	51010	57050	9188	56902	25879	55272	55131	54881	55813	79159	28987	51121	10885	51388	22894	10171	11056	51602	51077	51118	27341	51013	25873	81887	51096	54555
PC_1577	RPIA deficiency	22934
PC_1578	TALDO1 deficiency	6888
PC_1579	rRNA modification in the mitochondrion	79922	130916	51106	387338	55178	29960
PC_1580	Neurexins and neuroligins	9229	8825	8573	2906	26037	26045	2037	9066	58512	9546	2035	6857	2915	9378	9379	6812	1742	320	2902	2903	2904	2911	2905	1740	6804	341359	143425	347730	80059	347731	9456	91683	57502	22871	127833	22829	57555	1741	10611	321	57596	81858	2036	64130	57669	9369	9455	9454	55327	54413	9379	28988	9378	22941	22839	23136	9369	50944
PC_1581	TP53 Regulates Transcription of DNA Repair Genes	6829	1111	5433	904	905	5892	8812	2353	7157	3725	2963	1386	2068	7936	5432	5434	2071	6917	5430	5431	2965	2962	5438	672	4292	4436	1022	1025	902	4331	5437	5439	5440	5395	8178	5435	5436	5441	6827	2176	6749	472	545	2966	2967	8621	6924	9656	6921	6923	404672	51497	51224	25920	1643	2968	2177	7469	55215	51755	9150	11198
PC_1582	Choline catabolism	501	55349	23446	635	29958	1757
PC_1583	Neutrophil degranulation	441864	8773	5717	5718	10326	10857	5768	4126	10213	6386	1654	8635	2219	4125	8566	102	317	11001	80184	10555	8560	9522	6836	8778	10092	5709	8972	9145	7305	9535	7097	1729	10043	2215	102725035	8895	23317	8993	8804	10159	3417	8694	7226	6793	23114	9725	161	8987	4718	10533	25798	8876	9545	9342	1727	4860	3240	1675	5328	5265	12	718	1471	4893	5284	3106	116844	5004	197	7276	5473	4057	2512	2495	6590	847	2517	226	1476	1	3848	1536	383	3689	6279	4353	2717	2934	6280	5836	2821	3685	1509	302	823	203068	5645	5660	3074	353	1508	3320	1604	2990	3326	1991	1511	4311	929	5788	967	30	2950	2919	3146	1512	2268	240	4048	230	3303	3303	6036	2548	3107	5476	4257	3312	6515	3684	5834	3916	8288	3482	3615	2212	6037	1669	2547	7520	3920	1535	1938	634	210	5553	327	966	6402	4282	5315	4318	3728	290	410	2683	55	2799	411	1832	7077	960	2720	5175	948	3310	671	5211	2760	1378	3958	5702	7414	5223	965	963	5005	26	4790	6947	945	566	7133	5864	5870	5689	3683	3687	3614	175	2357	728	4831	6518	4317	5787	2204	5657	3577	3579	2358	5724	1520	5683	6286	5806	2040	527	5199	5686	5594	25801	2896	5777	6317	9588	2207	3105	3105	3163	1992	1143	6278	6282	1088	978	2588	968	5646	5269	178	5701	1116	5236	6727	1650	1084	4680	4332	2352	10120	2444	5547	221	8826	2992	11010	5273	976	1774	6556	5663	820	2665	10694	5878	7879	5873	5023	5713	3101	47	1315	1075	9798	10321	7415	3071	79792	1667	6616	53916	5869	10890	51552	10097	5908	5912	387	4069	567	10577	51646	5906	5478	5879	8655	6993	1460	1915	10383	5049	3043	140885	101	10576	4973	3934	6283	391	7130	23250	272	2171	10487	1828	5329	5580	10970	1823	961	100049587	683	684	3608	4033	5795	10549	5708	5611	1118	8514	5337	11333	6093	10312	427	10788	11031	6709	5317	8621	23406	9761	1778	10875	9961	3837	9861	1432	719	25797	196527	388698	387921	84443	160364	23352	83858	138050	3903	55004	10562	93100	23218	353189	201294	23191	79930	57020	11322	387263	51125	401258	10075	374395	154664	55832	340061	100302736	222487	388697	25852	374403	57153	199675	126014	94103	114790	84514	10288	121260	11026	57126	81567	150372	79888	81619	258010	158747	80301	79895	170482	124583	338339	23385	1794	23526	8836	26578	5799	535	53917	64114	326624	127829	23197	84329	55276	932	89777	5695	1265	5707	4758	10493	8904	55313	64333	23071	84766	2519	79169	8673	8907	84658	83716	54472	84061	84418	80331	79980	80142	25840	54509	56729	22931	51209	64386	22918	56954	53831	55754	54918	23601	55860	51316	51816	51806	29099	56888	9218	23412	1522	51411	11314	8649	29952	28988	29108	5719	10450	5036	10855	23200	11240	10396	28956	10394	51071	27180	51719	57826	51382	58485	23593	51143	22875
PC_1584	Complex I biogenesis	4728	4706	4694	4724	4711	4709	4717	4695	4725	374291	4720	4726	4707	4722	4712	4696	4710	4714	4708	4701	4718	4705	4716	4535	4536	4537	4538	4540	4541	4713	4729	4719	4723	4702	4731	4700	4698	4704	137682	79133	55471	126328	55863	91942	80224	51295	25915	28976	51300	54539	29078	51079	55967	51103	4715
PC_1585	Metal sequestration by antimicrobial proteins	4057	6279	6280	6278	3934	338324
PC_1586	Signaling by moderate kinase activity BRAF mutants	3717	4893	3265	3845	2243	2244	2266	2335	5894	7450	3690	3674	801	369	6714	673	7414	5595	4140	5594	5037	7529	409	5245	5605	1445	8826	408	5908	5906	5604	816	818	817	4296	283455	8315	54518	8844	22866	10256	815	7094
PC_1587	Signaling by high-kinase activity BRAF mutants	4893	3265	3845	2243	2244	2266	2335	5894	7450	3690	3674	369	6714	673	7414	5595	4140	5594	5037	7529	409	5605	1445	8826	408	5908	5906	5604	283455	54518	8844	22866	10256	7094
PC_1588	Signaling by RAS mutants	10156	3717	8437	4893	3265	3845	2243	2244	2266	2335	5894	7450	3690	3674	801	369	6714	673	7414	5921	4763	5595	4140	5594	5037	7529	409	5245	5605	1445	8826	408	5908	5906	5604	816	818	817	22821	5922	4296	399473	153090	283455	8315	54518	200734	161742	64926	8844	22866	10256	8831	9462	815	7094
PC_1589	Signaling by BRAF and RAF fusions	8546	8805	9061	10018	3717	10533	4893	3265	3845	4000	2243	2244	2266	2335	5894	7450	3690	3674	801	369	6714	673	7414	5595	4140	5594	5037	7529	409	5605	1445	8826	408	8087	1185	5908	5906	5604	816	818	817	55750	11044	54845	57085	283455	23164	80853	27044	56829	54518	9715	8844	55109	22866	10256	9444	10142	57670	10827	22906	815	7094
PC_1590	RAS signaling downstream of NF1 loss-of-function variants	4893	3265	3845	4763
PC_1591	Paradoxical activation of RAF signaling by kinase inactive BRAF	3717	4893	3265	3845	2243	2244	2266	2335	5894	7450	3690	3674	801	369	6714	673	7414	5595	4140	5594	5037	7529	409	5245	5605	1445	8826	408	5908	5906	5604	816	818	817	4296	283455	8315	54518	8844	22866	10256	815	7094
PC_1592	Antimicrobial peptides	8993	100526773	4057	6406	5645	1991	1511	1113	1191	6037	5320	3346	3347	671	5266	10578	5657	5646	820	149954	4069	117159	5068	130120	80341	128859	122665	92747	55600	6039	116842	140683	57115	114771	114770	84659	51297
PC_1593	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	7161	51499	665	7157	637	581	472	7159	5366	55240	147923	1387	94241	23368	10650	27113	84883	27113	8626	63970	27166
PC_1594	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	7161	332	7157	1121	604	5876	7159	9540	10397	5875	64065	23368	79370	8626
PC_1595	TP53 Regulates Transcription of Caspase Activators and Caspases	317	7161	7157	834	835	839	8738	472	843	8626	55367	58484
PC_1596	TP53 Regulates Transcription of Death Receptors and Ligands	8797	8795	8794	7161	7157	3486	355	7159	124446	23368	8626	8793
PC_1597	FGFR2 alternative splicing	5433	23543	3178	2963	5432	5434	2263	5430	5725	5431	7072	3187	2962	5438	4670	22916	5437	5439	3185	5440	5435	5436	5441	7073	4686	54845	80004
PC_1598	Ion influx/efflux at host-pathogen interface	475	6556	538	51248
PC_1599	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	6790	7157	983	5111	891	1647	5933	995	2810	581	5934	2033	7027	7029	1874	10498	25946	3276
PC_1600	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	23019	4849	4850	7157	4869	995	7832	9125	246175	85456	1263	28984	25904	55835	10769	4848	9337	29883	55571	5325
PC_1601	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	79733	9134	7157	890	898	1017	1026	1027	57060	8900	1869	144455	25946	1820
PC_1602	Regulation of TP53 Expression	639	7157
PC_1603	Regulation of TP53 Activity through Phosphorylation	6874	1111	6790	4194	5565	9891	5810	3364	4683	5884	11200	7157	7314	7316	6118	1459	6908	890	6872	1017	6117	6119	5984	5982	672	5985	5983	6878	4361	1763	641	5571	5563	6233	7311	1460	1457	8900	1020	4193	6749	6881	5562	472	7156	5300	545	7486	8851	6877	6884	6882	6879	5600	6794	6883	1432	6880	54457	83860	6873	144715	204851	8550	138474	84126	11073	8445	6875	8148	10111	10524	94241	116028	9212	112858	5883	5932	580	83695	83990	28996	1263	80010	51616	53632	51422	22974	9156	26155	5564	11198
PC_1604	Regulation of TP53 Degradation	6446	4194	5170	9099	11200	7157	983	7314	7316	890	1017	5518	5519	207	208	2475	900	5516	6233	7311	5515	8900	55615	4193	472	5527	253260	1029	117584	7874	80196	79109	64223	51230	1616	10000
PC_1605	Regulation of TP53 Activity through Acetylation	9219	23774	53615	7157	5371	207	208	7862	5928	2033	1107	3065	1108	5931	54815	57459	84289	3066	7994	64769	29117	27154	10000
PC_1606	Regulation of TP53 Activity through Association with Co-factors	7161	7157	207	208	5457	5458	7159	54971	10848	23368	25946	51230	8626	10000
PC_1607	Regulation of TP53 Activity through Methylation	10419	4194	11200	7157	7314	7316	6233	7311	4193	2033	472	91875	133746	133383	10919	79813	387893	56950	26013
PC_1608	Keratinization	337963	100505724	100505753	100507608	100533177	728318	3892	57830	3883	100653049	8689	8688	8687	9119	3861	3853	3854	3848	3875	3856	3880	3855	3868	728255	730755	3850	3858	3860	3852	3728	1832	3866	3851	3846	1830	3857	54474	3849	286887	353332	353323	353333	386683	386684	386677	386679	386682	386680	386674	386675	386681	386676	386678	386685	3889	3891	51350	1828	1824	3872	81851	1823	5317	1829	3884	3882	3887	1825	140807	3881	192666	100131902	100288323	337969	728299	337977	337978	337976	337975	337966	337967	337973	337972	337971	254950	284827	643812	643803	337979	337960	112802	337974	337959	338785	125115	390792	144501	440051	387273	440050	440023	387267	387266	387264	388818	439915	440021	121391	162605	342574	353288	147183	337970	374454	147409	319101	337882	140258	337880	337879	81850	196374	3886	3859	8502	5318	83902	81870	83901	85280	83900	83899	81871	653240	85285	100132386	728224	85289	84616	85290	85291	85293	83897	83896	730755	83895	728279	728279	25984	3890	3888	11187
PC_1609	Metabolism of vitamin K	154807	79001	29914
PC_1610	MET Receptor Activation	6692	10653	3249	4233	3082	3083
PC_1611	Negative regulation of MET activity	9146	10254	4233	7314	7316	3082	5771	5770	867	9101	2060	6233	7311	2885	5795	8027	30011	26018	6455	6456	6457
PC_1612	Bloch pathway	6309	10682	1718	1717
PC_1613	Kandutsch-Russell pathway	6309	10682	1718	1717
PC_1614	RNA polymerase II transcribes snRNA genes	6829	22936	5433	904	905	8812	10302	51585	6667	5452	2963	5451	5432	5434	6908	5430	2960	2961	5431	2962	5438	6878	1022	1025	22916	5437	5439	2957	2958	7702	5440	8178	5435	5436	5441	6827	2959	4686	6618	6877	6884	6882	6617	6880	6621	54973	23248	79664	65123	80789	55656	129685	79871	26173	84524	6619	64859	57117	92105	55197	81556	79035	51593	57508	51808	80237	29101	58490	55756	25896	55726	55174	26512	23379
PC_1615	COPI-mediated anterograde transport	10671	1780	11316	9570	6712	10282	10652	1783	11015	8615	11258	9527	3630	6708	1604	6710	966	2348	286	378	10945	11014	9276	4905	830	832	372	10972	829	1315	1314	8775	10121	377	22818	5861	8655	91949	375	381	6711	287	2801	11070	288	6811	1781	10540	6709	1639	1778	22796	2804	10959	84364	55738	9382	8729	140735	83548	93661	84342	8774	64689	84516	54732	81876	63908	57731	25839	26286	51332	51272	55860	51226	26958	51164	10466	57511	100302736	23423	22820	51143
PC_1616	Formation of the cornified envelope	448835	26239	9333	11202	5493	1475	826	823	3713	63036	5045	3728	1832	5266	2312	6699	6704	6703	7051	4014	5046	23581	1830	6698	6701	6700	1828	1824	7062	1823	5317	1829	1825	1041	5652	643394	353144	353145	353133	353134	353135	353137	353131	353132	149018	353142	353143	199834	353139	353140	353141	254910	643418	643414	340654	142910	23254	404203	126638	147409	2125	64065	6705	8502	5318	84648	6706	11005	43847	6707	43849	26085	25818	11187	6768
PC_1617	Retinoid metabolism disease events	5950
PC_1618	COPI-dependent Golgi-to-ER retrograde traffic	51594	3796	11316	3797	9371	6836	9183	11015	10749	23095	23046	9554	10112	24137	378	10945	3799	11014	9276	4905	372	10972	3832	1315	1314	8775	377	22818	5861	375	381	1062	9493	3831	547	3798	662	3835	10959	55083	124602	285643	60561	147700	221458	55605	55582	146909	84643	84364	55738	81930	8729	22920	90990	113220	55614	9585	11004	8774	54732	3833	64837	29127	81876	63908	64147	26286	23303	56992	89953	55850	51226	53407	26958	3834	26153	100302736	23423	11127	22820
PC_1619	COPI-independent Golgi-to-ER retrograde traffic	10671	1780	1783	8398	11258	5870	5048	5321	830	832	829	10121	8655	5049	2590	2589	1781	10540	1639	1778	22930	5050	23299	140735	636	93661	84516	25782	22931	51560	56894	55860	51164	51143
PC_1620	Intra-Golgi traffic	27333	9570	8675	10652	9265	10228	10905	9527	9342	9609	250	4121	4905	4122	8775	91949	375	6811	1523	22796	54734	9267	9321	27314	4124	57589	347517	9950	9382	9827	143187	83548	84342	9266	8774	83452	63908	25839	57134	11311	51272	27128	10466	57511
PC_1621	Retrograde transport at the Trans-Golgi-Network	8675	10618	10228	8677	10226	8674	22836	3482	5870	4074	400	4905	9367	23647	8775	7110	91949	2803	10139	22796	122830	9341	57589	55275	60560	10244	339122	9648	6293	90196	9382	9827	9712	2800	143187	79571	83548	84342	8774	84316	63908	25839	51209	51560	51542	738	60592	10466	57511
PC_1622	PI5P Regulates TP53 Acetylation	7157	5305	5608	8396	2033	5300	90809	79837	3622
PC_1623	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	5293	5296	9542	2069	8395	2255	8823	6801	8822	23396	8817	9965	90865	1956	5155	1950	7039	3630	2099	5154	2064	2246	3643	3932	2534	4233	2249	2247	5159	3815	940	2251	2260	2248	2250	6714	3082	5880	930	7409	374	5156	4254	2252	2263	2065	2264	2261	5595	5295	5594	5518	5519	2254	207	941	685	3667	942	5290	5291	8870	5305	3654	2253	10718	5516	2885	5879	5515	8396	391	9173	3084	5781	5527	2549	5528	5525	5526	2066	5529	50852	255324	118788	152831	79837	10818	145957	8503	2100	1839	8394	4615	8074	27006	26281	3556	51135	9365	8660	7189	29851
PC_1624	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	346562	2793	10681	2788	8787	8786	2771	2773	2775	2779	2784	6950	2781	2780	1459	908	22948	7203	9628	6000	2786	2790	10694	10575	54331	2791	2782	2783	2770	2792	2785	2787	1460	1457	10576	5082	10693	10574	59345	51764	55970	94235
PC_1625	Glycerophospholipid catabolism	133121	375775	79153	10908	284161	81544	51573
PC_1626	Assembly of the ORC complex at the origin of replication	5001	5000	4998	4999	23595	23594
PC_1627	CDC6 association with the ORC	1871	5001	5000	1869	4998	4999	1870	990	23595	84515	23594
PC_1628	CDT1 association with the CDC6	122706	5717	5718	5715	10213	5688	5709	5001	5000	51053	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	4998	4999	23198	9861	5711	143471	9491	5695	5707	990	81620	23595	84515	5721	5719	23594
PC_1629	Assembly of the pre-replicative complex	5001	5000	4172	4173	4174	4176	4171	4998	4999	4175	990	81620	23595	84515	23594
PC_1630	Mitotic Prophase	983	891	4926
PC_1631	Mitotic Prometaphase	3796	1780	10403	7514	332	1783	9183	699	9184	701	23122	11130	5518	5519	6249	5501	6232	5048	5905	1058	1063	5903	9735	4928	5347	6396	57122	5516	8655	5515	1062	1060	23279	991	4085	23421	5527	1781	9793	1778	5528	5525	5526	22919	5529	54821	55143	151246	151648	401541	100527963	79682	55166	57551	23332	91687	100526739	84643	147841	348995	79023	57082	81930	55746	348235	25909	2491	220134	80152	54908	81929	140735	9212	55839	25936	11004	80776	64105	79172	79902	83540	81565	79003	64946	79980	55055	57405	3619	79019	54820	55920	10726	8379	51143
PC_1632	Mitotic Metaphase/Anaphase Transition	5347	26271
PC_1633	cell division	10112	5347	9493	10726
PC_1634	G2 Phase	1871	890	1017	8900	1869
PC_1635	Orc1 removal from chromatin	122706	5717	5718	5715	10213	5688	5709	5001	5000	5716	7314	7316	5702	890	5689	1017	4172	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	4173	4174	4176	5701	5699	5704	5714	5691	5690	4171	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	6500	8900	5720	5708	6502	4998	4999	8454	4175	23198	9861	5711	143471	9491	5695	5707	990	81620	23595	84515	5721	5719	23594
PC_1636	DNA replication initiation	5422	5557	5558	5427	5426	23649	56655	54107
PC_1637	Activation of the pre-replicative complex	8317	5001	5000	8318	51053	5422	6118	1017	4172	6117	4173	4174	4176	6119	5557	5558	4171	5427	5426	29935	4998	4999	23649	4175	55388	990	81620	56655	54107	23595	10926	84515	23594
PC_1638	CDK-mediated phosphorylation and removal of Cdc6	122706	5717	5718	5715	10213	11065	5688	5709	5716	9134	7314	7316	5702	890	5689	898	1017	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	996	5701	5699	5704	5714	5691	5690	5713	7321	7324	5710	25906	7979	5687	10197	5700	5705	5706	6233	7311	8900	5720	8881	5708	23198	9861	5711	246184	143471	9491	119504	5695	5707	990	64682	51529	8697	51434	51433	29945	29882	5721	51343	10393	5719
PC_1639	Switching of origins to a post-replicative state	4172	4173	4174	4176	4171	4175
PC_1640	Polymerase switching	5422	5111	5424	5984	5982	5981	5985	5983	5425	5557	5558	23649	10714	57804
PC_1641	Removal of the Flap Intermediate	5422	5111	6118	6117	5424	6119	2237	5425	5557	5558	1763	23649	10714	57804
PC_1642	Processive synthesis on the lagging strand	5422	5111	3978	5424	5425	5557	5558	23649	10714	57804
PC_1643	Phosphorylation of proteins involved in G1/S transition by active Cyclin E	9134	5925	898	1017
PC_1644	Cyclin E associated events during G1/S transition	9134	4609	5925	898	1017	7465	993	207	208	1026	1027	1022	902	4331	4149	1869	5934	5928	7027	7029	1875	1874	91750	286826	132660	91768	55957	10000
PC_1645	G1/S-Specific Transcription	8318	1876	1719	7083	7298	983	5422	5111	898	5933	993	6241	8900	1869	5934	5928	4998	3065	7027	7029	1875	1874	91750	286826	132660	55957	990	81620	26271
PC_1646	Cyclin D associated events in G1	1871	3717	25	5925	4067	7314	7316	1019	6714	595	5933	5518	5519	894	896	1026	1029	1030	1031	1027	1028	1022	902	4331	1032	1163	5516	6233	7311	5520	6500	5515	1021	1869	5934	6502	8454	5753	7027	7029	1870	1875	1874	28227
PC_1647	Cyclin A/B1/B2 associated events during G2/M transition	7514	9133	983	891	890	1017	5518	5519	7465	993	994	995	1022	902	4331	5347	5516	5520	5515	8900	2305	9088	51451	51400	28227
PC_1648	Dimerization of procaspase-8	8797	8795	8837	355	356	8743	7186	8772	8737	841	8717
PC_1649	G2/M DNA damage checkpoint	1111	5810	85236	3364	4683	5884	9025	8924	11200	7468	7157	8970	6118	3014	8348	6117	3018	6119	5984	5982	672	5985	5983	79184	4361	1763	641	102724334	3017	7334	121504	3017	7341	7158	472	7156	545	7486	9656	7336	8290	8349	84142	144715	165918	128312	51588	84126	11073	10111	10524	8345	255626	116028	51720	5883	5932	580	8341	8342	8340	83695	83990	80010	29086	9577	9156
PC_1650	G2/M DNA replication checkpoint	9133	983	891	7465	9088
PC_1651	G2/M Checkpoints	122706	5717	5718	5715	10213	5688	5709	5716	7157	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	23198	9861	5711	143471	9491	5695	5707	51512	5721	5719
PC_1652	Stabilization of p53	4194	11200	7157	7314	7316	6233	7311	4193	472	1029	51230
PC_1653	p53-Dependent G1 DNA Damage Response	9134	890	898	1017	1026	1027	8900
PC_1654	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	122706	5717	5718	5715	10213	1111	5688	5709	5716	11200	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	993	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	23198	9861	5711	143471	9491	5695	5707	5721	5719
PC_1655	Cyclin A	4609	5925	890	1017	7465	993	994	207	208	1026	1027	1022	902	4331	4149	8900	1869	5934	5928	7027	7029	1875	1874	91750	286826	132660	91768	55957	51343	10000
PC_1656	Transcriptional activation of cell cycle inhibitor p21	7157	1026	57060	25946
PC_1657	Glycolysis	283871	26330	5230	226	2597	229	2023	2821	5232	669	5213	2026	230	2027	5315	5224	5211	5223	3098	5313	2645	10007	3099	3101	7167	5214	283209	132789	83440
PC_1658	Glycogen breakdown (glycogenolysis)	8908	5836	801	2548	5834	5837	5261	178	5256	5255	2992	5260	283209	5257	55276
PC_1659	Gluconeogenesis	8789	26330	2542	8604	2806	5230	226	2597	229	2023	2821	5232	2026	2203	230	5091	2027	5224	2805	5223	5105	2538	4190	4191	6576	54020	7167	8402	5106	219855	92579	57818	1468	10165
PC_1660	Pyruvate metabolism	8050	9123	25874	23539	3939	3945	3948	5160	1738	1737	5162	7416	5161	682	4199	6566	2739	3029	160287	92483	51660
PC_1661	Fructose catabolism	216	229	3795	26007	132158
PC_1662	Galactose catabolism	2592	2584	2582	283209	55276
PC_1663	Urea cycle	5009	445	435	383	1373	384	162417	83884	57407	10166
PC_1664	Proline catabolism	5625	8659	58510
PC_1665	Branched-chain amino acid catabolism	10295	587	1738	1629	593	594	38	3712	11112	36	586	4329	549	26275	152926	56922	3028	64087	27034
PC_1666	Histidine catabolism	57571	10841	3067	3034	3176	138199	131669	144193
PC_1667	Propionyl-CoA catabolism	5095	5096	4594	166785	84693
PC_1668	Lysine catabolism	123688	1738	1743	501	4967	1428	85007	51166	2639	89874	51268	10157
PC_1669	Tryptophan catabolism	8564	6520	3620	23498	6999	8140	8942	883	125061	120103	56267	169355	51166	130013
PC_1670	Carnitine synthesis	8424	6470	223	55217
PC_1671	Creatine metabolism	1158	1152	1159	1160	6535	6539	6538	2628	2593	6534
PC_1672	Pentose phosphate pathway	25796	2539	7086	6888	22934	5226	729020	6120	55276	64080	23729	51071
PC_1673	Ethanol oxidation	125	126	216	217	124	127	128	130	219	131	55902	84532
PC_1674	Citric acid cycle (TCA cycle)	6392	3420	1431	2271	1738	6390	4200	6389	1743	4191	3418	3419	3421	8802	4967	23530	10873	81889	8801	6391	50	8803
PC_1675	Pyrophosphate hydrolysis	5464	27068
PC_1676	mRNA Capping	6829	5433	8731	8732	2963	2068	5432	5434	2071	5430	5431	2965	2962	5438	1022	902	4331	22916	5437	5439	5440	5435	5436	5441	4686	2966	2967	404672	2968
PC_1677	pre-mRNA splicing	23350	22794	5433	1665	9128	9092	10236	9129	10465	5356	11051	8449	9716	51362	10084	55660	10772	23451	11193	23020	10286	22826	10285	24148	51585	10569	10421	10898	51691	25949	3183	6629	6625	6626	6631	3178	6627	3312	2963	6628	3191	6936	1655	5432	5434	3181	5430	11338	5725	5431	3187	1478	2962	2521	5438	27316	9775	8896	23517	10914	220988	4670	22916	5437	5439	3185	10181	5440	4809	3188	5435	4116	3190	6635	6636	6637	27258	11157	6632	6633	6634	5436	5441	6434	6638	4904	10907	6428	3192	102724594	6427	1477	9295	6426	6429	1660	4686	29894	10946	1993	1479	10949	8683	6430	6431	10992	22938	3184	9343	10921	5093	5094	23450	10262	8175	10291	7536	1994	6432	10713	10594	81608	10283	9879	84844	8106	10189	11325	10523	57794	55749	285755	10250	79869	84950	199746	85313	11017	26121	56259	9785	5546	8189	27238	10978	55110	23398	9410	84991	988	11100	9416	83443	51593	65109	51340	55339	23283	53938	57703	56949	55696	54883	51503	53981	24144	22827	51690	51692	100534599	27339	10450	23524	51729	57819	51639	51645	23658	25804	9939
PC_1678	U12 Dependent Splicing	5433	23451	23020	24148	2963	6628	5432	5434	5430	5431	2962	5438	22916	5437	5439	5440	4809	5435	6635	6636	6637	6632	6633	6634	5436	5441	4904	10907	6427	6426	4686	6431	10992	9343	23450	10262	8233	11066	6432	154007	10594	11325	10081	85437	9410	55599	9416	79622	83443	55954	57819	51639
PC_1679	mRNA 3'-end processing	10212	22794	11051	51362	9877	51585	10569	10898	11338	1478	9775	10914	22916	4116	84324	6428	102724594	6427	1477	9295	6426	6429	4686	29894	1479	8683	6430	6431	8563	7919	10921	6432	80145	81608	8106	10189	79228	10250	79869	57187	199746	9785	8189	10978	55110	9984	84321	84248	84271	65109	55339	23283	51213	53981	51692	26097	9939
PC_1680	mRNA Editing	100913187	339	164668	403314	29974	27350	9582	10930
PC_1681	Processing of Capped Intron-Containing Pre-mRNA	5433	10236	3183	3178	2963	3191	5432	5434	3181	5430	5725	5431	3187	2962	5438	27316	220988	4670	22916	5437	5439	3185	5440	3188	5435	3190	5436	5441	3192	4686	10949	3184	9589	5093	5094	56339	57721
PC_1682	Translation initiation complex formation	8665	8664	8667	8666	8669	1356	1965	1977	6218	3921	26986	6187	8894	6192	6188	1975	6206	6223	1968	6232	6203	6193	6204	1964	8662	3646	1973	6224	6189	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6191	6194	6209	6229	6230	6231	6234	2197	6233	6227	1981	8668	8661	1974	7458	51065	10480	140032	8663	27335	51386
PC_1683	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1977	1975	1973	1981	1978	1974	7458
PC_1684	Formation of a pool of free 40S subunits	8665	8664	8667	8666	8669	6176	6181	6175	6218	3921	6187	6165	6129	6139	6192	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	1964	6159	6164	9045	8662	3646	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	6152	6173	6143	6142	6128	6141	8668	8661	200916	51065	10480	140032	6123	6166	116832	140801	8663	27335	51121	51386	25873
PC_1685	Formation of the ternary complex, and subsequently, the 43S complex	8665	8664	8667	8666	8669	1965	6218	3921	6187	8894	6192	6188	6206	6223	1968	6232	6203	6193	6204	1964	8662	3646	6224	6189	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6191	6194	6209	6229	6230	6231	6234	2197	6233	6227	8668	8661	51065	10480	140032	8663	27335	51386
PC_1686	Ribosomal scanning and start codon recognition	8665	8664	8667	8666	8669	1965	1977	6218	3921	6187	8894	6192	6188	1975	6206	6223	1968	6232	6203	6193	6204	1964	1983	8662	3646	1973	6224	6189	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6191	6194	6209	6229	6230	6231	6234	2197	6233	6227	1981	8668	8661	1974	7458	51065	10480	140032	8663	27335	51386
PC_1687	GTP hydrolysis and joining of the 60S ribosomal subunit	8665	8664	8667	9669	8666	8669	1965	6176	6181	6175	1977	6218	3921	6187	6165	6129	6139	8894	6192	6188	1975	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	1968	6232	11224	6157	6125	6144	6158	6203	6193	6204	1964	6159	6164	9045	1983	8662	3646	1973	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	6152	6173	6143	6142	6128	1981	6141	8668	8661	1974	7458	200916	51065	10480	140032	6123	6166	116832	140801	8663	27335	51121	51386	25873
PC_1688	Recycling of eIF2	1965	8894	1968	8892	8893	1967	8891	8890
PC_1689	Eukaryotic Translation Termination	6176	6181	6175	6218	3921	327	2935	6187	6165	6129	6139	6192	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	2107	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	6152	6173	6143	6142	6128	6141	200916	51065	23708	140032	6123	6166	116832	140801	51504	51121	25873	29104
PC_1690	Transport of nucleotide sugars	7355	10559	11046	347734	84912	55343	51000	23169	23443
PC_1691	Pyrimidine salvage	7084	151531	7083	1890	1633	978	8226	7378	7371	83549	54963
PC_1692	Pyrimidine catabolism	151531	1890	4907	1806	1807	7378	30833	84618	64902	51251	56953	51733
PC_1693	RNA Polymerase I Promoter Opening	85236	3012	8970	3015	474382	3014	7343	3013	8348	5595	3018	102724334	3017	121504	3017	8350	3020	8338	8349	723790	126961	94239	128312	8334	8345	255626	8341	8331	8342	8340	55766	8932
PC_1694	RNA Polymerase I Transcription Initiation	9533	10849	9219	25885	53615	51082	7343	2068	5434	2071	6908	2965	1022	902	4331	5437	5440	5435	5441	2074	5928	1107	9112	3065	2966	2967	1108	7270	9013	9015	5931	221830	9014	404672	54815	57459	2968	3066	2648	8850	10919	57504	64425	79101	84172	54700	30834
PC_1695	RNA Polymerase I Promoter Escape	9533	10849	85236	25885	3012	8970	3015	474382	51082	3014	7343	2068	5434	2071	6908	3013	8348	2965	3018	1022	902	4331	5437	5440	102724334	3017	5435	121504	3017	5441	8350	3020	11335	2966	2967	9013	9015	8338	8349	221830	9014	723790	404672	126961	94239	128312	2968	8334	8345	255626	8341	8331	8342	8340	55766	64425	79101	84172	54700	30834
PC_1696	RNA Polymerase II Promoter Escape	6874	5433	2963	2068	5432	5434	2071	6908	6872	5430	2960	2961	5431	2965	2962	5438	6878	1022	902	4331	5437	5439	2957	2958	5440	5435	5436	5441	2959	6881	2966	2967	6877	6884	6882	6879	6883	6880	54457	83860	6873	404672	138474	6875	2968	8148	51616
PC_1697	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	6874	5433	2963	2068	5432	5434	2071	6908	6872	5430	2960	2961	5431	2965	2962	5438	6878	1022	902	4331	5437	5439	2957	2958	5440	5435	5436	5441	2959	6881	2966	2967	6877	6884	6882	6879	6883	6880	54457	83860	6873	404672	138474	6875	2968	8148	51616
PC_1698	RNA Polymerase III Chain Elongation	11128	9533	10622	27297	661	51082	5434	5437	5440	5435	5441	84265	10623	10621	55718	55703	51728	171568
PC_1699	Purine ribonucleoside monophosphate biosynthesis	5198	3615	3614	2618	10606	159	158	471	8833	5471	122622	64077
PC_1700	PRPP biosynthesis	5634	221823	5631
PC_1701	RNA Polymerase II Transcription Termination	10212	22794	11051	51362	9877	51585	10569	10898	6628	11338	1478	9775	10914	22916	4116	6635	6636	6637	6634	84324	134353	6428	102724594	6427	1477	9295	6426	6429	4686	29894	1479	8683	6430	6431	8563	7919	7884	10921	6432	80145	81608	8106	10189	79228	10250	79869	57187	25888	199746	9785	8189	10978	84967	55110	9984	84321	84248	84271	65109	55339	23283	51213	53981	51692	26097	9939
PC_1702	RNA Polymerase I Transcription Termination	9533	10849	25885	51082	7343	2068	5434	2071	6908	2965	1022	902	4331	5437	5440	5435	5441	2966	2967	7270	9013	9015	221830	9014	284119	404672	2968	64425	79101	84172	30834
PC_1703	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	5423	328
PC_1704	Resolution of Abasic Sites (AP sites)	328
PC_1705	Reversal of alkylation damage by DNA dioxygenases	54890	79068
PC_1706	RNA Polymerase III Transcription Termination	4781	11128	9533	10622	27297	661	6741	4782	51082	5434	5437	5440	5435	5441	4774	4784	84265	10623	10621	55718	55703	51728	171568
PC_1707	Purine salvage	4860	3251	100	353	270	1633	2766	132	272	271	1716	161823	51292
PC_1708	Purine catabolism	10591	4860	2876	4907	7498	22978	30833	100526794	84618	3704	9615
PC_1709	IRS activation	3630	3643	3667	2887	8660
PC_1710	Signal attenuation	3630	3643	5595	5594	6464	3667	2885	6654	2887	8660
PC_1711	Insulin receptor signalling cascade	4893	3265	3845	3630	3643	6464	2885	6654	2887
PC_1712	Signaling by Insulin receptor	3630	3643
PC_1713	RNA Polymerase III Abortive And Retractive Initiation	55814	4781	11128	9533	10622	27297	10302	661	6741	4782	51082	5451	5434	6908	5437	7702	5440	5435	5441	2975	4774	6618	4784	6617	6621	2976	2971	6619	2972	112495	84265	10623	10621	55290	55718	55703	9329	51728	171568	9328	9330
PC_1714	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B	1111	11200	983	891	10971	7465	995	7529	2810	7532	7531	7534	7533
PC_1715	Formation of the Editosome	100913187	339	164668	403314	29974	27350	9582	10930
PC_1716	C6 deamination of adenosine	103	104
PC_1717	Fatty acyl-CoA biosynthesis	6319	2194	5538	6576	47	109703458	31	79966	84869	7923	55301	9374	22880
PC_1718	Activation of BID and translocation to mitochondria	3002	4836	637	841
PC_1719	Triglyceride biosynthesis	8694	2710	2712	23175	80168	150763	392636	346606	9663	116255	84649	64900	57678
PC_1720	Apoptotic execution phase	10059	10134	841	8428
PC_1721	FasL/ CD95L signaling	355	356	8772	841	843
PC_1722	TRAIL signaling	8797	8795	8837	8743	8772	841	843	8793
PC_1723	Dissolution of Fibrin Clot	5340	5328	5327	3273	5055	5054	5270	302	5345	5269	5271	6281	5329
PC_1724	Ubiquitin-dependent degradation of Cyclin D	122706	5717	5718	5715	10213	5688	5709	5716	7314	7316	1019	5702	5689	595	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	2932	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	23198	9861	5711	143471	9491	5695	5707	5721	5719
PC_1725	Synthesis of very long-chain fatty acyl-CoAs	79993	9200	2182	2181	2180	3293	197322	51144	81616	253017	11000	401494	201562	23205	64834	6785	79071	83401	54898	60481	9524	51495	23305	51703
PC_1726	Platelet Adhesion to exposed collagen	8515	7450	3688	2534	2811	4067	2812	2815	3673	2207	2814	3672	51206
PC_1727	TNF signaling	9530	7124	7132	6868	7186	8737	8717
PC_1728	Plasmalogen biosynthesis	8540	8443	25979
PC_1729	RNA Polymerase II Transcription Initiation	6874	5433	2963	2068	5432	5434	2071	6908	6872	5430	2960	2961	5431	2965	2962	5438	6878	1022	902	4331	5437	5439	2957	2958	5440	5435	5436	5441	2959	6881	2966	2967	6877	6884	6882	6879	6883	6880	54457	83860	6873	404672	138474	6875	2968	8148	51616
PC_1730	RNA Polymerase II Transcription Elongation	6829	5433	904	905	8812	2963	2068	7936	5432	5434	2071	6917	5430	5431	2965	2962	5438	4300	1022	1025	902	4331	5437	5439	5440	8178	5435	5436	5441	6827	4298	6749	2966	2967	6924	6921	6923	79577	9646	404672	6830	51497	51224	54623	123169	25920	23168	2968	55840	85403	55677	80349	7469	27125	9150	11198
PC_1731	Response to elevated platelet cytosolic Ca2+	5582	5579	5578
PC_1732	Platelet Aggregation (Plug Formation)	2147	7450	2811	2812	2815	2814	7066	4352
PC_1733	RNA Polymerase II Transcription Initiation And Promoter Clearance	6874	5433	2963	2068	5432	5434	2071	6908	6872	5430	2960	2961	5431	2965	2962	5438	6878	1022	902	4331	5437	5439	2957	2958	5440	5435	5436	5441	2959	6881	2966	2967	6877	6884	6882	6879	6883	6880	54457	83860	6873	404672	138474	6875	2968	8148	51616
PC_1734	RNA Polymerase III Transcription Initiation From Type 1 Promoter	55814	11128	9533	10622	27297	661	51082	5434	6908	5437	5440	5435	5441	2975	2976	2971	2972	112495	84265	10623	10621	55718	55703	9329	51728	171568	9328	9330
PC_1735	RNA Polymerase III Transcription Initiation From Type 2 Promoter	55814	11128	9533	10622	27297	661	51082	5434	6908	5437	5440	5435	5441	2975	2976	2972	112495	84265	10623	10621	55718	55703	9329	51728	171568	9328	9330
PC_1736	RNA Polymerase III Transcription Initiation From Type 3 Promoter	55814	11128	9533	10622	27297	10302	661	51082	5451	5434	6908	5437	7702	5440	5435	5441	6618	6617	6621	6619	84265	10623	10621	55290	55718	55703	51728	171568
PC_1737	Formation of editosomes by ADAR proteins	103	104
PC_1738	RNA Pol II CTD phosphorylation and interaction with CE	6829	5433	8731	8732	2963	2068	5432	5434	2071	5430	5431	2965	2962	5438	1022	902	4331	5437	5439	5440	5435	5436	5441	2966	2967	404672	2968
PC_1739	Ketone body catabolism	38	5019	622	64064
PC_1740	Synthesis of Ketone Bodies	38	3155	3158	622	65985	54511	56898	79611
PC_1741	Beta oxidation of myristoyl-CoA to lauroyl-CoA	33	3030	3032
PC_1742	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	34	33	3030	1632	3032	1666
PC_1743	Mitochondrial Fatty Acid Beta-Oxidation	11332	4706	1622	10449	10965	117145	80724	84129	641371	27349	284486	414149	26027	134526	80221	84320	55856	58488	23597
PC_1744	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	3030	37	3032
PC_1745	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	33	1892	3030	3032	3033
PC_1746	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	34	1892	3030	3032	3033	51102
PC_1747	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	34	1892	3030	3032	3033
PC_1748	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	35	1892	3030	3032	3033
PC_1749	Beta oxidation of butanoyl-CoA to acetyl-CoA	35	1892	3033	6296	142827
PC_1750	Insulin receptor recycling	8992	9550	534	3630	3643	525	526	528	527	529	523	9114	10312	537	9296	245972	245973	155066	535	90423	127124	533	50617	51606	23545	51382
PC_1751	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	6628	22916	6635	6636	6637	6634	134353	4686	7884	25888	84967
PC_1752	Processing of Intronless Pre-mRNAs	11051	51585	10898	1478	10914	22916	1477	4686	29894	1479	81608	8106	79869	8189	10978	55339	23283	53981	51692
PC_1753	Transport of fatty acids	347	3933	286256	10999	376497	389812	392399	28965
PC_1754	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	9154	9153	292	291	293	402	3177	222962	2030	55315	64078	23568
PC_1755	The NLRP1 inflammasome	596	598	22861
PC_1756	The NLRP3 inflammasome	4210	9051	351	3326	7295	4790	834	4791	5970	114548	24145	5027	10628	29108	10910
PC_1757	The AIM2 inflammasome	9447	834	29108
PC_1758	The IPAF inflammasome	834	58484
PC_1759	Interferon gamma signaling	10475	9021	3664	4281	8651	3717	10612	4938	3458	3106	3105	3105	3122	3118	3117	3123	3123	3119	4502	3106	3107	3123	3105	3115	3383	3105	3120	3105	3105	3106	3107	3659	2209	10437	4684	3105	3133	3123	3123	3126	3660	3459	960	3105	3105	3105	3135	3105	3106	3106	3106	7412	6737	3113	3123	3716	6672	5724	5777	5371	4939	3105	3105	3105	3105	3105	3105	3105	3105	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3107	3107	3107	3107	3107	3107	3134	3105	3106	2633	2634	4261	3460	6772	567	3125	10379	3394	3106	5580	3107	3105	7726	816	818	817	3663	23650	9830	7706	3661	3662	8638	3106	3106	3107	3106	3107	3107	3123	3123	3127	3123	3106	3106	3123	55128	163351	80128	79097	10346	388646	3665	3106	3107	3123	115362	115361	55223	53840	81603	11074	117854	85363	23321	3123	2635	80263	3107	3123	10107	23087	815	51127	4940
PC_1760	Regulation of IFNG signaling	9021	8651	3717	8554	3458	3459	5771	5770	3716	5777	3460	6772	7341	5781
PC_1761	Advanced glycosylation endproduct receptor signaling	6285	351	3146	6288	5589	3958	5595	5594	1650	830	829	6283	177
PC_1762	Transport of organic anions	11309	551	213	6567	6579	353189	6578	28231	28234	53919	28232	10599
PC_1763	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	137872	728294	79944
PC_1764	Gastrin-CREB signalling pathway via PKC and MAPK	2520	1385	5595	5594	887	6197	5598	6196	6195
PC_1765	Synthesis of PIPs in the nucleus	5305	8396	90809	79837
PC_1766	ERBB2 Activates PTK6 Signaling	9542	2069	1956	1950	2064	2065	685	10718	3084	5753	2066	145957	1839
PC_1767	Threonine catabolism	23464	10993	10247	113675
PC_1768	PTK6 Regulates Proteins Involved in RNA Processing	10656	6421	10657	5753	202559
PC_1769	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	7314	7316	867	207	6233	7311	5753	116985	1796
PC_1770	PTK6 Regulates Cell Cycle	1019	595	898	1017	1027	5753
PC_1771	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	4893	3265	3845	5921	1398	5829	9564	387	5879	5753	1793	9844	63916	2909
PC_1772	PTK6 Down-Regulation	5770	5753	6725
PC_1773	PTK6 Expression	2908	5753	3091	27043	2034
PC_1774	PTK6 Activates STAT3	9021	6774	5753	55620
PC_1775	Synaptic adhesion-like molecules	2906	10211	10313	5792	5789	2890	2892	2893	1742	2902	2903	1739	2904	5802	2319	2905	78999	1741	79414	57622	57497
PC_1776	Phosphate bond hydrolysis by NTPDase proteins	955	956	957	953	377841	57089	9583	954
PC_1777	Butyrophilin (BTN) family interactions	10384	11119	5493	7498	11118	696	79908	153579	11120	10385	30835	56244
PC_1778	Signaling by FGFR2 IIIa TM	5433	2246	2247	2963	5432	5434	2263	5430	5431	2962	5438	22916	5437	5439	5440	5435	5436	5441	4686
PC_1779	MET activates RAS signaling	4893	3265	3845	4233	3082	6464	2885	6654	57610	200958	10048
PC_1780	MET activates PI3K/AKT signaling	4233	3082	5295	5290	2885	2549
PC_1781	The role of GTSE1 in G2/M progression after G2 checkpoint	122706	5717	5718	5715	10213	5688	5709	5716	9133	7157	983	3320	3326	7314	7316	891	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	1026	5699	5704	5714	5691	5690	5713	5347	5710	7979	5687	10197	5700	5705	5706	6233	7311	5720	5708	23198	9861	22919	5711	143471	9491	5695	5707	51512	63943	5721	5719
PC_1782	Signaling by MST1	6692	10653	3249	4485	4486
PC_1783	Signaling by FGFR2 fusions	2263
PC_1784	Signaling by FGFR3 fusions in cancer	4893	3265	3845	2261	5295	5290	2885	6654	2549	10818
PC_1785	Signaling by plasma membrane FGFR1 fusions	11160	9530	2260
PC_1786	Signaling by FGFR3 point mutants in cancer	8823	8822	8817	4893	3265	3845	2246	2249	2247	2250	5335	2261	5295	2254	5290	2253	2885	6654	2549	10818	8074	26281
PC_1787	Lysosomal oligosaccharide catabolism	4126	4125	4123	23324
PC_1788	RET signaling	5293	2675	5296	9046	5623	2676	5979	6714	5578	5566	5335	5568	5567	5295	6464	2668	5290	5291	5909	2674	2885	5781	6654	5598	2887	2549	2886	9048	220164	55715	10818	53358	8503	1796	4902	64096	9260	55816	9846	8660
PC_1789	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	122706	5717	5718	5715	10213	5688	6790	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	6500	5720	5708	8454	23198	9861	5711	143471	9491	5695	5707	23194	5721	5719
PC_1790	TBC/RABGAPs	8408	11337	5867	5868	5870	7249	5878	7879	11345	4218	5869	382	8766	9363	9135	11021	9230	4943	26000	374403	84958	414060	125058	64786	7248	51762	338382	128637	10133	83874	55357	81631	83452	79735	51560	54662	23163	107080638	57533	27342	23062	26088	57465	23637
PC_1791	AURKA Activation by TPX2	9814	10733	6790	80184	9738	8636	3161	8481	11258	23354	22995	5116	11116	10382	983	203068	3320	5566	7283	5518	5577	1069	5048	1453	102800317	4751	5347	10121	7532	7531	8655	7277	10383	1781	10540	9793	1639	1778	5108	22919	4957	84131	9662	79441	7846	23332	54801	11064	10806	9702	80321	121441	79959	7840	55125	115106	80254	55755	55559	10142	93323	11190	95681	54930	55835	55142	54820	55722	22974	22994	22897	22981
PC_1792	Interaction between PHLDA1 and AURKA	6790	22822
PC_1793	Interleukin-20 family signaling	9021	3717	3716	7297	6774	6772	6776	6777	3718	6773	5781	3588	11009	6775	53833	282618	163702	282617	282616	58985	116379	50616	55801	50604	29949	53832
PC_1794	Cargo recognition for clathrin-mediated endocytosis	23149	1856	1861	27348	2069	9146	10618	9892	8674	10254	161	22905	160	1956	3949	1950	7039	551	920	7037	7018	338	915	154	1129	1211	1212	917	7314	7316	3482	1080	374	3575	4074	6857	867	156	6869	554	185	409	685	157	7474	2060	408	6845	3267	8218	1175	9318	6233	7311	2885	163	6844	1601	4036	1213	115548	2873	8301	950	6453	9341	4738	6572	22848	26119	9856	255324	10980	143425	127833	90019	25977	9185	85439	8027	10987	30011	1173	85021	1839	10920	6455	6456	6457	84251	51138	23208	8673	64708	55707	29988	50618	58513	50813	29978	8322	29979	8533	29924	11037
PC_1795	Clathrin-mediated endocytosis	3092	8976	5286	274	23149	1856	2069	9146	2580	8871	10109	10094	10092	8867	10618	23396	9892	9829	9026	8674	10254	161	22905	160	1956	3949	1950	7039	551	920	7037	7018	338	915	154	1129	1211	1212	917	7314	7316	3312	3482	1080	374	3575	5868	4074	6857	867	6869	554	185	409	685	7474	2060	408	273	1785	5878	6845	3267	8218	1175	10093	5869	10096	10097	382	6233	7311	2885	163	6844	1601	4036	1213	4952	1759	115548	8301	950	2017	26130	9322	6453	9341	6572	22848	26119	54874	9856	255324	143425	55738	127833	90019	25977	9185	85439	10552	8027	30011	1173	85021	112574	23048	1839	6455	6456	6457	84251	23208	8673	29993	55707	29988	50618	58513	29763	8322	11252	26052	51429	29924	11037
PC_1796	PTK6 promotes HIF1A stabilization	1956	5753	10457	3091	120892	1839
PC_1797	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	10018	2309	4000	6648	826	351	3725	823	824	4001	831	993	994	995	7001	356	7531	1020	5052	2801	8851	84290
PC_1798	Downregulation of ERBB2 signaling	9542	2069	1956	1950	2064	3320	7314	7316	2065	685	4145	10718	6233	7311	3084	5782	2066	11140	145957	8065	55914	1839	26469	10273
PC_1799	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	348	7020	7913
PC_1800	MET activates PTPN11	4233	3082	2885	5781	2549
PC_1801	Reelin signalling pathway	1600	2534	5649	7436	30011
PC_1802	VLDL assembly	341	338	5034	346	4547
PC_1803	VLDLR internalisation and degradation	161	160	1211	1175	7376	163	7436	1213	10062	255738	29116	1173
PC_1804	Synthesis of active ubiquitin	55236	11065	7314	7316	7347	7317	8078	997	7319	7321	7324	7327	3093	7326	7328	7322	6233	7311	7320	7332	27338	54926	92912	8239	7874	10477	55284	90268	65264	29089
PC_1805	E3 ubiquitin ligases ubiquitinate target proteins	92305	5193	5192	85236	9810	5195	8915	3105	3105	8970	7314	7316	5111	8348	5828	3018	7319	5830	9781	7321	7324	7415	3017	7323	7334	3017	7322	6233	7311	7320	7332	5591	6596	257218	7336	56254	79577	9646	10670	118424	54623	220441	123169	23168	5194	8345	255626	8341	8342	8340	55829	51322	79139	80349	56852	51255
PC_1806	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	7020	7341	7329	339488	284252	83741	7021	7022	79047	51741
PC_1807	TFAP2 (AP-2) family regulates transcription of other transcription factors	7020	7022	5308	10370
PC_1808	Activation of the TFAP2 (AP-2) family of transcription factors	8089	7020	2033	339488	83741	7021	7022	1387	163732	4435	10370	51741
PC_1809	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	1956	7039	1081	2099	2064	7020	1082	3815	7422	7528	29028	7021	7022
PC_1810	TFAP2 (AP-2) family regulates transcription of cell cycle factors	4609	7020	1026	7022	10765
PC_1811	rRNA processing in the mitochondrion	9692	4519	4512	4513	4514	4508	4535	4536	4537	4539	4538	4540	4509	54931	3028	60528
PC_1812	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	7020	4869	4605	3329	4839
PC_1813	RAB geranylgeranylation	401409	5874	8934	9545	9609	5864	5865	5867	5868	5870	1121	1122	5878	7879	9367	5872	5873	5876	23682	57111	376267	4218	53916	5862	5869	10890	51552	8766	5861	10966	8073	11031	10981	9363	54734	11021	27314	9230	347517	201475	401258	339122	115273	84932	142684	5875	51762	53917	338382	326624	116442	115827	57799	83871	83452	64284	81876	22931	51209	51560	55647	23011	57403	51715	25837
PC_1814	MET activates PTK2 signaling	3911	3688	3912	4233	3915	6714	3082	3673	3908	284217	3675	3913	5747	3914	3918	3910	3909	10319
PC_1815	CREB3 factors activate genes	51360	10488	8720	84699	64764	153222	148327	90993	81501
PC_1816	InlB-mediated entry of Listeria monocytogenes into host cell	9146	10254	4233	7314	7316	867	2060	6233	7311	2885	8027	30011	6455	6456	6457
PC_1817	MET interacts with TNS proteins	3688	4233	3082	64759	84951
PC_1818	MET activates RAP1 and RAC1	4233	3082	1398	1399	5908	5906	2885	5879	2549	2889	85440
PC_1819	MET receptor recycling	4233	3082	5867	1398	1399	53916	382	2885	2549	23163
PC_1820	MET activates STAT3	4233	3082	6774
PC_1821	RAB GEFs exchange GTP for GDP on RABs	22898	80006	5874	27095	9909	8408	79090	6305	6399	5864	5868	5870	1121	1122	2664	207	208	7109	2665	5878	7879	9367	5872	5873	23682	4218	5869	10890	51552	7531	5861	6764	221960	221960	11031	10981	9610	54734	26130	22930	11021	57589	55667	259173	163259	201475	23258	163486	126432	160518	22879	60684	10260	122553	84315	81846	126003	79958	201627	414918	79890	5866	57706	51112	8567	54453	9827	3257	51762	338382	116442	84079	83696	57679	117177	81876	25782	79961	22931	51209	89781	51560	27342	23011	51693	27147	10000	51399	22878	58485
PC_1822	InlA-mediated entry of Listeria monocytogenes into host cells	1500	7314	7316	999	6714	1499	6233	7311	79872
PC_1823	Protein methylation	10196	22944	801	3312	1938	6187	2109	7415	1915	399818	79823	254013	221143	151194	196483	79091	79609
PC_1824	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	3458	3559	1493	1378	3558	861	4773	865	50943	8784
PC_1825	Vitamin E	7274
PC_1826	Transcriptional regulation by RUNX2	8493	983	1019	650	891	595	1026	6662	9464	581	860	865	7291	117581	10013
PC_1827	GABA synthesis	2572	2571
PC_1828	GABA synthesis, release, reuptake and degradation	10815	3312	5864	6857	6616	6812	6844	2572	6804	22999	2571	80331	140679
PC_1829	Reuptake of GABA	6529	6539	6538	6540
PC_1830	RUNX1 regulates estrogen receptor mediated transcription	8312	2099	861	865	200845	57678
PC_1831	Regulation of RUNX1 Expression and Activity	6714	595	5371	894	896	1021	861	5781	865	27327	192669	4343	57690	192670	27161	26523	23112
PC_1832	Receptor Mediated Mitophagy	8408	9140	6714	1459	1460	1457	139341	192111	81631	9474	84557
PC_1833	Digestion	8544	248	2984	2980	2981
PC_1834	RUNX1 regulates expression of components of tight junctions	7122	861	7082	865	100506658
PC_1835	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	8085	9739	85236	23309	5196	3012	8970	2811	7057	3674	3015	474382	2623	3014	3013	8348	10398	3018	102724334	3017	11091	121504	3017	8350	3020	861	4297	5588	2033	3065	865	5929	4778	8338	8349	723790	126961	94239	161882	55904	128312	27327	58508	8013	8850	8334	8345	255626	55170	25942	3276	8341	8331	8342	8340	55766	84661	192669	4343	57690	192670	9070	26523	9757	23112	23067
PC_1836	Aryl hydrocarbon receptor signalling	57491	9049	3326	405	196	10728	9915
PC_1837	ESR-mediated signaling	2099	3320	3326	5595	5594	5536	2288	5481	2289	10728	2100
PC_1838	RUNX1 regulates transcription of genes involved in differentiation of HSCs	122706	5717	5718	5715	10213	5688	7161	5709	85236	5716	25	3012	8970	3015	474382	7314	7316	4602	6929	2623	3014	6886	6688	5702	5689	3013	8348	2624	2625	5682	5683	5684	5685	4005	4004	5696	5698	5686	5692	5694	5693	3018	5701	5699	5704	10413	5714	5691	5690	1022	5713	902	4331	5710	102724334	3017	7979	5687	10197	5700	5705	5706	121504	3017	6233	7311	8350	3020	861	4297	5720	5708	865	23198	9861	5711	8338	8349	723790	126961	94239	8861	128312	143471	9491	8334	8345	255626	83737	6938	5695	5707	8341	8331	8342	8340	55766	5721	5719
PC_1839	RUNX1 regulates transcription of genes involved in differentiation of keratinocytes	9021	1515	1514	1513	861	865	122809	5275
PC_1840	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	8535	8289	51412	23466	86	1459	100532731	6595	6597	1460	1457	1911	861	6015	2033	6598	865	84733	196528	6604	84333	55193	1912	10138	23429	80012	57492	6601	26053	6599	6603	6605	22955	6602	6045	28996	57332
PC_1841	RUNX1 regulates transcription of genes involved in BCR signaling	1997	640	861	5079	865	1998
PC_1842	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	1437	5579	3958	861	860	865	1387
PC_1843	RUNX1 regulates transcription of genes involved in interleukin signaling	3562	1997	3977	861	865
PC_1844	RUNX1 regulates transcription of genes involved in WNT signaling	8312	2099	861	865	84870	50943
PC_1845	Regulation of RUNX2 expression and activity	122706	5717	5718	5715	10213	5688	5709	5716	2099	2908	7314	7316	2101	650	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	4488	5701	5699	6772	5704	5714	5691	5690	2932	5713	5710	1749	1750	7979	5687	10197	5700	5705	5706	9978	6233	7311	6500	579	5720	5708	6502	8454	860	865	23198	9861	7291	5711	59269	133522	143471	9491	55294	5695	5707	11059	57154	10891	5721	10273	5719
PC_1846	RUNX2 regulates osteoblast differentiation	8841	4094	25	1277	632	5925	7525	2737	367	6714	5595	5594	10413	860	865	3280	121340	221044	25925	25937	10013	23493	23314	23462
PC_1847	Invadopodia formation	8038	8751	9644	8728
PC_1848	RUNX2 regulates chondrocyte maturation	2736	9759	860	865	3549
PC_1849	RUNX2 regulates bone development	4091	4089	860	865	4086	100526737
PC_1850	RUNX2 regulates genes involved in cell migration	9358	3678	207	208	4322	860	865	10000
PC_1851	RUNX2 regulates genes involved in differentiation of myeloid cells	3958	861	860	865
PC_1852	Events associated with phagocytolytic activity of PMN cells	4353	4025
PC_1853	RUNX3 regulates CDKN1A transcription	7040	7157	1026	4088	4089	864	463
PC_1854	RUNX3 regulates NOTCH signaling	4851	182	3516	2033	10046	22938	864	3280	84441	9794	1387	2648	8850	55534
PC_1855	Regulation of RUNX3 expression and activity	5717	5718	5715	10213	5688	5709	5716	7040	7314	7316	6714	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	6233	7311	4193	5720	2033	5708	864	865	9861	5711	1029	9491	5695	5707	64750	57154	5721	5719
PC_1856	Intestinal infectious diseases	2984	79849
PC_1857	Regulation of PTEN mRNA translation	5728	27327	192669	4343	57690	192670	9218	27161	26523	23112
PC_1858	Regulation of PTEN gene transcription	8535	8841	10542	6591	23028	8726	9219	23466	6615	53615	7157	3725	1386	1958	5595	5594	100532731	5468	2475	1822	5728	1911	2122	6015	5928	389541	1107	5978	9112	3065	84733	1108	23512	6009	2146	5931	10325	55004	10670	54815	1912	57521	153129	80012	51564	57459	3066	22955	6045	57504	64223	84232	57332	58528	8649	57167	23186	10014	28956	7101
PC_1859	Collagen chain trimerization	131873	256076	1277	1280	1281	1282	1290	1278	1284	1301	1291	1292	1293	1302	1297	1289	1296	50509	1295	1287	1306	80781	1286	1285	1294	1300	7373	1307	1288	1299	1298	1310	255631	340267	1305	91522	85301	169044	136227	81578	1303	84570	57642	1308
PC_1860	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	27327	192669	4343	57690	192670	9218	27161	26523	23112
PC_1861	Regulation of PTEN localization	7314	7316	5371	4734	5728	6233	7311	331	7874
PC_1862	Regulation of PTEN stability and activity	122706	5717	5718	5715	11060	10213	5688	5709	5716	8658	7314	7316	5987	5702	1459	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	207	208	5701	5699	2444	5704	4734	5714	5691	5690	5713	5710	5728	7979	5687	10197	5700	5705	5706	6233	7311	1460	1457	331	5720	5708	23198	9861	5711	23252	80243	143471	9491	8975	5695	5707	80351	81847	23608	5721	10273	5719	10000
PC_1863	Mitochondrial calcium ion transport	3954	7416	7417	6547	80024	286097	221154	90550	8165	10367	91689	55013	7419
PC_1864	RUNX3 Regulates Immune Response and Cell Migration	6696	3676	3683	6097	864	865
PC_1865	Cristae formation	10651	10476	10632	4508	4509	516	506	8834	522	515	498	513	509	3313	539	518	9551	514	521	517	4580	10989	440574	125988	139322	27109	84303	79135	55735	54927	25813
PC_1866	Processing of SMDT1	9512	5245	23203	286097	221154	90550	79568	10730	11331	10367	55486	91689	55013	30968	6687	10939
PC_1867	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	9049	9987	6647	759	3458	6648	5055	6175	302	2939	6627	5898	3936	4282	6950	4001	3586	3181	1072	4478	6888	3313	3185	829	998	5908	5478	9446	375	5306	4507	5062	6775	27250	1265	552900	5721
PC_1868	RUNX3 regulates WNT signaling	4609	595	1499	6932	864	83439	6934	51176
PC_1869	Neddylation	122706	142686	390594	5717	5718	5715	10213	8835	9021	9306	5688	10537	332	5709	10324	28952	23363	9655	5716	26043	23014	11275	7314	7316	7347	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	7428	899	5704	5714	5691	5690	5713	7321	5710	6468	7979	5687	7323	9040	9318	10197	10238	11091	5700	5705	5706	7322	9978	6233	7311	6500	7704	5720	2873	5708	1161	6502	8883	8454	8453	8452	8451	8450	9817	23198	9820	9861	5929	10489	6921	6923	4738	5711	1642	5931	3091	84861	55827	80067	79269	50717	79791	84261	10517	283807	54620	55208	90864	285231	401036	10980	170622	89890	55832	149951	51122	80204	123879	23113	144699	26259	146330	23038	150684	200845	201456	222235	26263	84541	64326	126433	143471	84085	23369	9039	80344	150726	26094	84078	4008	140458	140456	136371	127247	142685	79754	142689	1643	9491	23142	10987	8065	55294	140739	114907	54461	92369	80176	122416	55336	140462	115290	54165	84961	8816	56929	90135	122769	123228	154881	92591	51088	51676	5695	5707	84727	10920	2034	140825	55527	51138	84259	79016	28991	54939	53339	64410	83987	8139	79176	93611	140460	140461	64708	26270	56995	1154	25879	55175	140459	54951	54876	54850	55884	51514	29099	55958	57542	90293	9616	23412	50813	26249	51725	9903	23194	26232	10116	26267	26268	26234	26235	23291	26272	26224	26190	5721	5719	8533	8945	27252	64344	25793	51666	100302652	51665	51667	51397	26118
PC_1870	RUNX3 regulates YAP1-mediated transcription	7003	1490	10413	864	7004	8463	7005	25937
PC_1871	RUNX3 regulates RUNX1-mediated transcription	861	864	865
PC_1872	RUNX3 regulates p14-ARF	3845	7040	595	6046	1029	9759	861	2033	864	865	1029
PC_1873	RUNX3 regulates BCL2L11 (BIM) transcription	10018	2309	4088	4089	864
PC_1874	Transcriptional Regulation by E2F6	8317	317	1111	1876	8726	6241	100532731	7703	672	23468	4149	1911	1869	6015	5888	5928	11335	7027	7029	23512	2146	5931	23269	10138	23429	80012	83746	10919	6045	5932	84108	80314	79813	8409
PC_1875	Carboxyterminal post-translational modifications of tubulin	25809	10382	7278	113457	10376	10383	10381	7280	23170	9654	164395	347688	79841	84871	25941	23093	112714	79739	91978	254173	7846	54839	284076	60509	340351	150465	158135	123624	84790	84276	84617	347733	83887	81027	23287	26140
PC_1876	Nucleobase catabolism	25939
PC_1877	Post-translational protein phosphorylation	4221	5768	3491	102	8542	4148	7425	10618	813	7466	8614	11098	10272	9210	1356	462	5265	718	7076	1471	3827	5179	335	348	336	2243	2266	2335	197	213	174	7018	5624	338	1114	351	3569	3053	5034	3912	4241	3484	3956	1435	720	6696	3915	2153	652	7857	1462	5589	7184	3486	1000	3698	3487	3270	3488	3371	6383	2200	2719	3913	4924	334	10970	4240	11167	6694	5611	1758	10232	2621	8404	8720	4052	10130	5954	3490	54972	375056	147111	64856	116519	401138	3895	56975	51246	80341	51280	255738	29106	57104	54757	265	54587	2519	91851	8074	84141	57719	258	56955	10117	51156	11320
PC_1878	Intestinal lipid absorption	29881
PC_1879	Tyrosine catabolism	2954	2184	6898	3242	3081
PC_1880	Aspartate and asparagine metabolism	8604	2806	440	2805	443	2346	339896	374569	339983	219595	10165	10003
PC_1881	Chylomicron assembly	335	348	336	344	345	338	337	5034	4547	51128
PC_1882	Assembly of active LPL and LIPC lipase complexes	51360	344	337	4023	5045	3990	5046	8720	84699	116519	55908	338328	5125	63924	64788	91289	51129	26291	27329
PC_1883	HDL assembly	19	2	335	649	5566	5568	5567	29801
PC_1884	Chylomicron remodeling	335	348	336	344	345	338	337	4023	116519	338328
PC_1885	HDL clearance	8029	335	3069	949	81693
PC_1886	Chylomicron clearance	3949	348	338	3990	26119
PC_1887	LDL clearance	4864	8435	161	160	3949	338	1211	6646	3988	1175	10577	163	1213	26119	57552	23491	51599	255738	1173
PC_1888	LDL remodeling	338	4018	1071	319
PC_1889	VLDL clearance	341	338	346	7436	55911	51599
PC_1890	HDL remodeling	335	348	344	345	213	3931	1071	9619	5360	9388
PC_1891	Phenylalanine metabolism	5053	5860	5092	883	80150	259307
PC_1892	G beta	2793	10681	2788	2784	2786	2790	54331	2791	2782	2783	2792	2785	2787	695	59345	51764	55970	94235
PC_1893	Glutamate and glutamine metabolism	2744	2746	2806	4942	2752	5831	2747	5832	883	65263	284716	29920	27165	57494
PC_1894	Alanine metabolism	2875	84706
PC_1895	Lipid particle organization	161247	1149	345275	128486	63924	29923
PC_1896	G beta	2793	10681	2788	2784	2786	2790	54331	998	2791	2782	2783	2792	2785	2787	5058	9459	59345	51764	55970	94235
PC_1897	Intestinal hexose absorption	6514	6523	6518	6248
PC_1898	Intracellular oxygen transport	4151	114757	58157
PC_1899	Interleukin-15 signaling	3560	3716	6464	3561	6774	3600	6776	6777	3718	2885	6654	6655	3601	9846
PC_1900	OAS antiviral response	23586	4938	2316	4939	6059	6041	8638	201626	4940
PC_1901	Interleukin-35 Signalling	3717	3716	821	3592	7297	3572	6774	6772	10148	6775	9466	3595
PC_1902	SLIT2	9353	387	4650	6091
PC_1903	Regulation of cortical dendrite branching	8440	6585	6092	6091
PC_1904	Interleukin-9 signaling	3578	3716	3561	6774	6772	6776	6777	3718	3581
PC_1905	Transcriptional Regulation by MECP2	6446	5816	6657	4204	3654	5728	4336	2593	27327	54487	192669	4343	57690	192670	27161	26523	23112
PC_1906	Signaling by Erythropoietin	3717	2056	4067	2057	8660
PC_1907	Interleukin-38 signaling	5599	84639	8808	11141
PC_1908	Interleukin-37 signaling	10068	5771	5775	5777	834	5778	6774	5780	84867	4088	5782	5781	5783	8809	5784	26095	59307	26469	25930	27178	29110
PC_1909	Extra-nuclear estrogen signaling	346562	5296	2793	10681	2069	6801	2788	1956	1950	7039	2099	2771	3320	3480	4313	4314	2773	4316	801	6714	4318	374	2784	5295	6464	4846	207	685	5290	2786	2790	858	54331	2791	2782	2783	2770	2792	2785	2787	857	5747	255324	340481	8503	2100	1839	1903	3276	59345	55625	8877	51764	55970	94235
PC_1910	ER Quality Control Compartment (ERQC)	7844	10299	10206	7314	7316	6233	7311	10956	84447	11236	9695	91445	6048	55741	80267	51009	55757	56886	6400	11253	267
PC_1911	Calnexin/calreticulin cycle	5589	811	821	2923	23193
PC_1912	Regulation of expression of SLITs and ROBOs	122706	23053	5717	5718	5715	10213	5688	22794	5709	4440	3199	6585	5716	9353	6176	6181	6175	6218	3921	7314	7316	26986	2935	6187	5702	6165	6129	6139	5689	6192	6188	6206	5682	5683	5684	5685	6137	6134	5696	5698	5686	5692	5694	5693	1287	6136	6133	6146	5701	6124	9775	6223	6122	5699	23521	6232	11224	5704	6157	6125	6144	6158	6203	6193	6204	6159	5714	6164	5691	5690	9355	9045	5713	22916	5710	6224	7979	5687	6189	6154	10197	6138	4116	6155	3670	6168	6167	6201	5700	5705	6202	6210	6217	6208	6228	6222	6235	6207	6205	5706	6130	2107	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	9978	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	6152	6173	6143	6142	6128	1981	5720	6141	4686	5708	8453	1605	23198	9861	10921	6921	6923	5711	200916	51065	8861	23708	143471	140032	23032	9491	6123	89884	6166	55110	116832	140801	64221	5695	5707	65109	65110	26019	6092	56956	8022	5721	5719	51121	25873	9939	6091
PC_1913	ROBO receptors bind AKAP5	5576	5532	5578	5566	5568	5567	9495	64221	6092
PC_1914	Interleukin-18 signaling	8807	10068	3565	240	3596	8809	3606	27178
PC_1915	NOTCH3 Activation and Transmission of Signal to the Nucleus	54492	11060	28514	102	9148	1956	1950	7314	7316	5663	5664	6233	7311	182	57534	83464	23385	142678	51107	54567	55851	4854	3714	10460
PC_1916	NOTCH3 Intracellular Domain Regulates Transcription	2173	5087	6772	4851	3516	2033	10320	10046	22938	3280	9787	388585	171558	23286	84441	9794	1387	2648	8850	55534	26508	23493	4854	23129	23462
PC_1917	NOTCH4 Intracellular Domain Regulates Transcription	2324	4851	59	4088	4853	3516	2033	10046	22938	3280	388585	84441	9794	1387	2648	8850	55534	4855	23493	23462
PC_1918	NOTCH4 Activation and Transmission of Signal to the Nucleus	102	5663	5664	7534	182	83464	23385	51107	4855	54567	55851
PC_1919	TLR3-mediated TICAM1-dependent programmed cell death	7098	8772	8737	841	148022	11035
PC_1920	TICAM1-dependent activation of IRF3/IRF7	7098	7314	7316	6233	7311	7187	9641	3661	148022	10010	3665	29110
PC_1921	TICAM1,TRAF6-dependent induction of TAK1 complex	7098	6885	7314	7316	6233	7311	10454	148022	257397	23118	7189
PC_1922	Interleukin-36 pathway	84639	8808	3556	27177	56300	26525	27179
PC_1923	Interleukin-33 signaling	90865	9173	3556
PC_1924	Noncanonical activation of NOTCH3	5663	5664	4904	83464	23385	51107	55851	4854
PC_1925	Estrogen-dependent gene expression	2494	9166	1105	8312	5433	5885	23028	904	85236	7764	23030	2353	4609	7039	2099	7031	3012	3725	5241	8970	1509	3320	6667	3326	3015	474382	4602	596	2963	5451	1386	3014	3727	1655	5432	5434	6908	3013	7391	8348	2625	595	5430	7528	5431	3018	2962	5438	6387	8204	1025	3838	5437	5439	2957	2958	2354	5440	3169	102724334	3017	5435	5436	121504	3017	5441	8350	3020	861	2288	7090	7033	2033	3065	865	23189	8243	10728	2066	10499	5469	8648	7392	8338	8349	9687	723790	126961	94239	51523	10498	128312	10735	200845	27327	10274	1387	8850	10524	8334	8345	255626	3276	8341	8331	8342	8340	4435	55766	192669	4343	57690	192670	57678	27161	26523	23112	9126	8202
PC_1926	Biosynthesis of D-series resolvins	240	4048	3248	2879
PC_1927	Biosynthesis of DHA-derived SPMs	246	239	5743
PC_1928	Biosynthesis of EPA-derived SPMs	5743
PC_1929	Biosynthesis of protectins	1543	1544	4048	246
PC_1930	Biosynthesis of maresins	240	2053
PC_1931	Biosynthesis of E-series 18(S)-resolvins	240	4048	3248	246	2879
PC_1932	Biosynthesis of aspirin-triggered D-series resolvins	240	4048	2879
PC_1933	Interleukin-2 signaling	3559	3932	3560	3716	6464	3561	6776	6850	6777	3718	3558	2185
PC_1934	Interleukin-12 signaling	3717	5034	3716	3592	3593	7297	3594	6845	6775	3595
PC_1935	Interleukin-1 signaling	122706	5717	5718	5715	10213	5688	3551	1147	3656	5709	6885	8767	5716	3552	3553	7314	7316	3554	5702	3557	4790	5689	5682	5683	5684	5685	4792	7850	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	3654	5713	5608	5710	7979	5687	7334	10197	5700	5705	5706	9978	6233	7311	6500	5970	5720	5708	387522	8878	8454	23198	9861	10454	5711	246330	257397	143471	9491	57162	5695	5707	4215	4615	54472	57161	64127	3556	51135	23118	5721	5719	10392	8945	7189	11213	8517
PC_1936	Interleukin-23 signaling	3717	5034	3593	7297	6774	3594	6775	149233	51561
PC_1937	Interleukin-27 signaling	3717	9244	3716	821	7297	3572	6774	6772	10148	9466	246778
PC_1938	Interleukin-21 signaling	3716	3561	6774	6772	6776	6777	3718	6775	59067	50615
PC_1939	Loss of MECP2 binding ability to 5hmC-DNA	4204
PC_1940	Loss of phosphorylation of MECP2 at T308	801	5566	4204	814
PC_1941	Loss of MECP2 binding ability to the NCoR/SMRT complex	8841	6907	9611	4204	2874	79718	9612
PC_1942	Loss of MECP2 binding ability to 5mC-DNA	627	4204	3065	25942
PC_1943	Regulation of MECP2 expression and activity	8841	6907	9611	801	1385	5566	3064	4204	2290	2874	3065	816	818	817	3930	814	27327	3066	9212	25942	79718	28996	192669	4343	57690	192670	27161	26523	23112	815	9612
PC_1944	MECP2 regulates neuronal receptors and channels	4233	6515	1385	5770	5775	4988	4986	2891	4851	4204	2903	2904	2289	7222	3065	114787	3066	25942
PC_1945	MECP2 regulates transcription of neuronal ligands	28514	1392	1385	627	4204	6750	3065	25942
PC_1946	MECP2 regulates transcription factors	1385	5468	4204	4208	54715
PC_1947	MECP2 regulates transcription of genes involved in GABA signaling	4204	2572	2571
PC_1948	Biosynthesis of E-series 18(R)-resolvins	240	4048	246	2879
PC_1949	BDNF activates NTRK2 (TRKB) signaling	627	4915
PC_1950	NTF3 activates NTRK2 (TRKB) signaling	4908	4915
PC_1951	Biosynthesis of DPAn-3 SPMs	5743
PC_1952	Biosynthesis of DPAn-6 SPMs	246	239
PC_1953	Biosynthesis of DPAn-3-derived protectins and resolvins	240	246
PC_1954	Biosynthesis of DPAn-3-derived maresins	240	239
PC_1955	NTF4 activates NTRK2 (TRKB) signaling	4909	4915
PC_1956	Biosynthesis of DPAn-3-derived 13-series resolvins	240
PC_1957	Activated NTRK2 signals through RAS	4893	3265	3845	627	6464	4909	2885	6654	4915
PC_1958	Activated NTRK2 signals through PLCG1	5335	627	4909	4915
PC_1959	Biosynthesis of maresin conjugates in tissue regeneration (MCTR)	2948	4056
PC_1960	Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)	4056
PC_1961	Erythropoietin activates Phosphoinositide-3-kinase (PI3K)	5293	3717	2056	4067	2057	5295	5290	5291	5294	2549	23533	8660
PC_1962	Erythropoietin activates Phospholipase C gamma (PLCG)	3717	2056	4067	5336	5335	2057	8660
PC_1963	Erythropoietin activates STAT5	3717	2056	4067	2057	6776	6777	8660
PC_1964	Erythropoietin activates RAS	3717	4893	3265	3845	2056	4067	7409	2057	6464	1399	2885	6654	2889	8660
PC_1965	Biosynthesis of maresin-like SPMs	1544	1571	1576	1558	1565	1559
PC_1966	Biosynthesis of electrophilic -3 PUFA oxo-derivatives	240	5743
PC_1967	Activated NTRK2 signals through PI3K	627	5295	4909	5290	2885	2549	4915
PC_1968	Activated NTRK2 signals through FRS2 and FRS3	10817	4893	3265	3845	627	4909	2885	5781	6654	4915	10818
PC_1969	Activated NTRK2 signals through FYN	2534	6714	627	2904	4915
PC_1970	NTRK2 activates RAC1	2534	627	5879	4915	1795
PC_1971	Activated NTRK2 signals through CDK5	627	5879	1020	7074	8851	4915
PC_1972	Peroxisomal protein import	390916	8540	5193	5191	10005	5264	11001	8443	8310	5189	5192	5195	10455	3417	23417	847	30	283927	7314	7316	3416	1610	189	6342	5828	2053	4843	3155	4358	1384	10965	5830	3295	7321	7323	7322	6233	7311	1962	1891	5190	570	51	219743	54469	196743	55670	83752	122970	5194	8239	8309	8528	10901	55825	26063	51179	51268	23600	26061	54363	54677	373156
PC_1973	TYSND1 cleaves peroxisomal proteins	8540	5264	30	6342	3295	51	219743
PC_1974	ABO blood group biosynthesis	28	2523	2524
PC_1975	NTF3 activates NTRK3 signaling	4908	4916
PC_1976	Signaling by NTRK3 (TRKC)	4908	5802	4916	5800
PC_1977	Activated NTRK3 signals through PLCG1	5335	4908	4916
PC_1978	Activated NTRK3 signals through RAS	4893	3265	3845	4908	6464	2885	6654	4916
PC_1979	Defective GGT1 causes Glutathionuria (GLUTH)	2678
PC_1980	Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI)	551	554
PC_1981	Rhesus blood group biosynthesis	6006	6007
PC_1982	Lewis blood group biosynthesis	8707	8705	2525	2526	2528	2524	2527	2529	6487	6484	170384	84750	124872	30815	10690	10402	10317	8708
PC_1983	Interferon alpha/beta signaling	9021	3437	3664	8651	4938	3439	3440	3446	3444	3452	3442	3448	3451	3456	3106	3105	3105	3106	3107	3105	3443	3441	3449	9636	3105	2537	3433	3434	3105	3105	3106	3107	3659	8519	3105	3133	3660	3105	3105	3105	3454	3135	1958	3105	3106	3106	3106	4599	4600	3716	5696	5777	7297	4939	3105	3105	3105	3105	3105	3105	3105	3105	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3107	3107	3107	3107	3107	3107	3134	3105	3106	2634	3445	3429	6772	3455	6773	103	6059	3430	10379	10410	10581	3394	3106	6041	5781	3107	3105	684	3663	3661	3662	8638	3106	3106	3107	3106	3107	3107	3106	3106	54739	91543	3665	3106	3107	3669	3107	51447	25939	4940
PC_1984	Meiotic recombination	4438	4439	5889	85236	4683	3012	8970	3015	474382	1019	6118	3014	3013	8348	1017	6117	3018	6119	672	4292	4361	675	641	102724334	3017	121504	3017	8350	3020	5888	472	7156	11144	8290	8338	8349	723790	126961	94239	128312	10111	8334	8345	255626	5932	8341	8331	8342	8340	55766	84057	56979	29893	27030	23626
PC_1985	Interleukin receptor SHC signaling	5293	5296	3636	3717	3559	1437	3567	3562	3560	1438	3716	3563	5295	5777	6464	3561	1439	5290	5291	3718	3558	2885	3568	6654	8503	3635	9846
PC_1986	Regulation of signaling by CBL	5293	5296	2534	7525	4067	3055	7409	867	5295	5290	5291	6850	1398	1399	2885	2889	29760	8503
PC_1987	Regulation of IFNA signaling	9021	8651	3439	3440	3446	3444	3452	3442	3448	3451	3456	3443	3441	3449	3454	5770	3716	5777	7297	3445	6772	3455	6773	5781	11274
PC_1988	O-linked glycosylation of mucins	9334	9245	4582	4586	4584	2650	2590	2589	2591	442117	394263	146712	140453	64409	374378	84752	4588	192134	140687	168391	283463	374907	11227	51809	55568	114805	79695	200958	143662	117248	57452	100528030	10164	11226	63917	93010	4589	94025	118430	29071	79623	4585	84002	79369	56667	727897	50614	56913	26290	10678	9331	10071	51146	10331
PC_1989	Degradation of GABA	7915	18
PC_1990	Endosomal Sorting Complex Required For Transport (ESCRT)	55048	9146	27243	9525	10254	7314	7316	6233	7311	51028	155382	137492	91782	8027	92421	93343	79643	11267	7251	84313	29082	128866	89853	79720	51534	51271	51510	51160	27183	25978	100526767
PC_1991	Iron uptake and transport	10539	1356	7037	7018	2512	2495	3162	7314	7316	210	48	3163	3658	4891	6233	7311	6500	3934	8454	4738	79901	55832	94033	51310	113235	9843	30061	26234	9429	28982
PC_1992	Transferrin endocytosis and recycling	8992	9550	534	7037	7018	525	526	528	527	529	523	9114	10312	537	9296	3077	55240	245972	245973	261729	155066	535	90423	127124	533	57192	50617	51606	7036	23545	51382
PC_1993	TRAF3-dependent IRF activation pathway	23586	3456	2033	7187	9641	7706	3661	57506	84282	1387	3665	80143	64135	29110
PC_1994	TRAF6 mediated IRF7 activation	23586	3439	3440	3446	3444	3452	3442	3448	3451	3456	3443	3441	3449	3445	2033	7186	9641	7706	3661	57506	84282	1387	10010	3665	80143	64135	29110	7189
PC_1995	TRAF6 mediated NF-kB activation	3551	1147	23586	6285	351	3146	6288	4790	4792	6283	4791	5970	7186	4214	7706	177	4793	57506	84282	64135	28511	28512	7189	8517
PC_1996	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	3551	1147	23586	8772	8737	7706	841	57506	84282	843	64135	8517
PC_1997	Negative regulators of RIG-I/MDA5 signaling	9246	9140	23586	9636	7314	7316	7128	7318	7321	7323	3093	7322	6233	7311	7187	5300	9641	7706	3661	5094	57506	79671	8887	84166	84282	54941	55593	83737	64135	9474	1540	54476	29110	51191
PC_1998	Ion transport by P-type ATPases	5348	6588	487	5205	374868	57194	148229	10079	9914	23120	476	481	801	478	482	488	490	495	493	5350	6717	540	477	496	479	483	486	53822	53828	27032	23250	57198	491	538	816	818	817	480	5349	492	344905	84239	51248	286410	79895	489	53826	57130	23400	51761	51076	57205	815	23200	10396
PC_1999	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	7099	929	7314	7316	6233	7311	5781	7187	9641	3661	23098	100302736	148022	10010	3665	29110	23643
PC_2000	IRAK1 recruits IKK complex	3551	1147	3654	7334	387522	246330	57162	57161	7189	8517
PC_2001	IKK complex recruitment mediated by RIP1	7099	3551	1147	929	7314	7316	7321	7323	7334	7322	6233	7311	387522	330	329	8737	23098	100302736	148022	7189	11035	8517	23643
PC_2002	IRAK2 mediated activation of TAK1 complex	3656	6885	7314	7316	6233	7311	10454	257397	23118	7189
PC_2003	TRAF6-mediated induction of TAK1 complex within TLR4 complex	7099	3656	6885	929	7314	7316	6233	7311	10454	23098	100302736	148022	257397	23118	7189	23643
PC_2004	Molybdenum cofactor biosynthesis	27304	4338	4338	55034	10243	4337	9054
PC_2005	Transport to the Golgi and subsequent modification	3998	90411
PC_2006	Activated NTRK3 signals through PI3K	6714	4908	5295	3667	5290	4916
PC_2007	NTRK3 as a dependence receptor	581	4916	25920
PC_2008	Class I peroxisomal membrane protein import	5193	10478	5195	8799	5825	5828	215	5824	224	8504	91452	55670	84896	54332	5194	5827	225	51024	9409	11264
PC_2009	Negative regulation of NOTCH4 signaling	5717	5718	5715	10213	5688	5709	5716	7314	7316	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	207	5701	5699	5704	5714	5691	5690	5713	5710	7979	5687	10197	5700	5705	5706	9978	6233	7311	7534	6500	5720	5708	8454	9861	5711	9491	55294	5695	5707	4855	5721	5719	10460
PC_2010	FLT3 Signaling	4893	3265	3845	2534	3055	5295	2322	2323	2885	5781	6654	9846
PC_2011	Defective MUTYH substrate binding	4595
PC_2012	Defective MUTYH substrate processing	4595
PC_2013	Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	7485	439	6449	1528	5621	351	3162	8266	7917	819	2010	224	23480	10952	6844	6811	6804	51608	118424	9381	9218	27230
PC_2014	Assembly and cell surface presentation of NMDA receptors	8825	8573	2906	116444	4747	88	1742	320	2902	2903	1739	2904	816	818	817	2905	1740	116443	1741	64130	55327	57576	815
PC_2015	Lipophagy	5565	10226	3312	5571	5563	123	53632	51422	5564
PC_2016	Chaperone Mediated Autophagy	10226	3320	6035	3326	3312	3920	2670	1915	3043	123
PC_2017	Regulation of localization of FOXO transcription factors	2309	10971	207	208	7529	2810	7532	7534	4303	2308	10000
PC_2018	FOXO-mediated transcription of cell death genes	10018	2309	4800	4801	1649	604	356	4303	2033	2308	4802	6794	1387	27113	10370	27113	65018
PC_2019	FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	181	2309	5443	4852	3630	847	2908	6648	3484	2645	5105	2538	6720	4287	4088	4303	2308	4089	3065	4087	23460	3066	114907	84676	25942	91584	56729	23410	10891
PC_2020	Microautophagy	55048	27243	10226	6035	3312	3043	155382	137492	91782	92421	93343	79643	123	7251	29082	128866	89853	79720	51271	51160	25978	100526767
PC_2021	Transcriptional regulation of granulopoiesis	85236	4609	3012	8970	3570	3015	474382	4602	5914	1019	3014	1385	6886	1051	6688	6256	3013	8348	2624	1017	5371	3018	7913	1026	6774	1050	102724334	3017	121504	3017	8350	3020	1869	861	2313	4297	2033	688	865	7027	7029	1053	8338	8349	723790	126961	94239	128312	8334	8345	255626	1441	2672	8341	8331	8342	8340	55766	51176
PC_2022	Defective Base Excision Repair Associated with NEIL1	79661
PC_2023	Negative regulation of NMDA receptor-mediated neuronal transmission	2906	4747	801	88	9647	1742	2902	2903	1739	2904	816	818	817	8536	2905	1740	814	22843	1741	815
PC_2024	Regulation of FOXO transcriptional activity by acetylation	2309	7295	4303	2033	2308	1387	8850	23411	10628	23410
PC_2025	FOXO-mediated transcription of cell cycle genes	2660	9314	2309	1647	1026	1027	2290	57060	694	4088	4303	857	5934	2308	4089	4087	901
PC_2026	Activation of RAC1 downstream of NMDARs	801	5879	8536	8874	84254	10645	28964
PC_2027	Activation of AMPK downstream of NMDARs	5565	801	4137	5571	5563	5562	10645	53632	51422	5564
PC_2028	Long-term potentiation	2906	4747	801	6714	88	2890	2891	1742	3084	2902	2903	1739	2904	816	818	817	2905	2066	1740	4900	1741	815
PC_2029	Regulation of the apoptosome activity	317	5595	5594	842	331	54205	51074	55075	57099	56616	22900
PC_2030	Defective Base Excision Repair Associated with NEIL3	55247
PC_2031	Defective NTHL1 substrate processing	4913
PC_2032	Defective NTHL1 substrate binding	4913
PC_2033	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4	1019	1029
PC_2034	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6	1019	1029	1021
PC_2035	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4	1019	1029
PC_2036	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6	1019	1029	1021
PC_2037	Regulation of glycolysis by fructose 2,6-bisphosphate metabolism	5208	5207	5566	5568	5567	5518	5519	5516	5515	5528	5209	5210
PC_2038	Estrogen-stimulated signaling through PRKCZ	5170	4893	3265	3845	5594	5590
PC_2039	Estrogen-dependent nuclear events downstream of ESR-membrane signaling	2069	7514	2309	1956	2353	1950	7039	596	6722	374	1385	2002	595	5595	5594	207	208	685	1027	5747	255324	127933	1839	10000
PC_2040	NEIL3-mediated resolution of ICLs	55247
PC_2041	Wax biosynthesis	158833	158835	84188	55711
PC_2042	STAT5 Activation	2322	6776	2323	6777	2885	5781	9846
PC_2043	N-glycan trimming and elongation in the cis-Golgi	4245	79694
PC_2044	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	10905	4121	57134
PC_2045	Vitamins B6 activation to pyridoxal phosphate	8566	316	55163
PC_2046	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	3654	7334	387522	3665	4615	54106	51311	51135	51284	7189
PC_2047	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	3656	3654	4214	4615	51295	54106	51311	51135	51284	7189
PC_2048	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	3551	1147	3654	7334	387522	246330	57162	57161	7189	8517
PC_2049	MyD88 dependent cascade initiated on endosome	3656	3654	4615	54106	51311	51135	51284	7189
PC_2050	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	7099	3656	6885	929	7314	7316	6233	7311	10454	100302736	148022	257397	23118	7189	23643
PC_2051	Reactions specific to the hybrid N-glycan synthesis pathway	4248
PC_2052	N-Glycan antennae elongation	51046	9334	8703	8702	8704	2683	6480	338596	4249	6484	8128	25834	9331	11320	11282
PC_2053	Reactions specific to the complex N-glycan synthesis pathway	9486	1081	3972	2517	2525	4122	4247	4124	2530	64377
PC_2054	Retinoid metabolism and transport	375790	57016	9672	2239	9227	55937	3949	335	348	336	344	345	5950	7276	338	1208	337	4023	5947	5406	1109	6382	6385	6383	2817	8644	5948	2719	2262	3339	4036	1645	4035	7804	54884	151056	26020	338328	221914	51109	83875	53630	29967	10082
PC_2055	MyD88 cascade initiated on plasma membrane	3656	7100	3654	4214	4615	51295	81793	51135	7189
PC_2056	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	6176	6181	6175	6218	3921	26986	2935	6187	6165	6129	6139	6192	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	22916	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	2107	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	6169	6227	6152	6173	6143	6142	6128	1981	6141	4686	200916	51065	23708	140032	5976	6123	6166	116832	140801	51121	25873
PC_2057	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	22794	6176	6181	6175	6218	3921	26986	2935	6187	6165	6129	6139	6192	6188	6206	6137	6134	6136	5518	6133	6146	6124	9775	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	22916	6224	6189	6154	6138	4116	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	2107	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	6233	7311	5520	6169	6227	5515	6152	6173	6143	6142	6128	1981	6141	4686	10921	200916	51065	23293	23708	55181	140032	9887	5976	6123	6166	55110	116832	140801	23049	65109	56006	65110	26019	55802	55629	51121	23381	25873	9939
PC_2058	Termination of O-glycan biosynthesis	6480	4582	4586	4584	6482	6487	6484	6483	394263	140453	4588	283463	200958	143662	256435	4589	94025	118430	4585	56667	27090	727897	10610	10071
PC_2059	Amyloid fiber formation	54959	102	9246	6478	5071	85236	23555	1471	4878	5617	796	3630	335	2243	325	7276	4057	6406	3012	351	793	2934	337	8970	5045	3015	474382	7314	7316	6288	3375	3014	3013	8348	3018	6622	23621	102724334	3017	4069	567	10098	121504	3017	6233	7311	8350	3020	3339	4240	7045	8338	8349	723790	126961	340348	6477	128312	81619	83464	23385	6653	8239	8334	8345	255626	51107	8341	8331	8342	8340	55851	23163	9027	51471	23062	26088	9445	9627
PC_2060	Serine biosynthesis	619189	26227	5723	10955	256987	347735	63826	57515	29968
PC_2061	GABA receptor activation	200959	23229	2554	2560	2566	2569	2562	2570	2558	2556	2555	2561	2557	2559	2567	55879	27020
PC_2062	GABA B receptor activation	9568	2550
PC_2063	Regulation of Complement cascade	2147	715	629	718	727	712	713	714	735	722	7448	710	3426	717	5627	731	732	733	1604	1991	3075	716	720	100293534	730	1191	729	966	1369	930	4179	1378	1380	725	728	1370	3080	975	10878	3078	719	10877	1361	81494	27202
PC_2064	Growth hormone receptor signaling	8835	9021	8651	3717	5617	2688	2689	4067	1442	2690	5618	5770	5595	5594	5777	3667	6774	6772	6776	6777	6868	25970	1154	8660
PC_2065	Antigen processing	55236	122706	142686	390594	5717	5718	5715	10213	11065	9021	5688	9246	9870	8651	9867	5709	6478	5071	23295	10324	5716	26046	23376	22888	23014	4591	11275	10533	10425	8924	7314	7316	5702	6737	5689	7317	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	7174	996	5701	5699	7428	899	7318	5704	4734	5714	997	7319	5691	5690	5713	7321	7324	7064	5710	9520	6468	7327	7979	5687	7323	9040	3093	7334	10197	5700	5705	7326	7328	5706	7322	9978	6233	7311	7320	6500	7332	6047	7337	7704	5720	991	8881	22954	868	5708	6502	387522	8454	8453	8452	642	9354	9817	9320	23198	9820	9861	8916	10489	6921	6923	9690	8925	7336	5711	27338	91694	131405	84861	26091	79654	23352	51320	143279	55182	148581	63891	79791	84261	10517	57674	283807	54620	84231	90678	285231	127544	54778	401036	54926	55070	89910	255488	5930	57630	90025	10075	55585	89890	140691	80204	55819	135892	9666	6477	55008	197131	23304	57531	144699	118424	26259	146330	221687	158506	200845	201456	84937	222235	26263	84541	64219	223082	246184	126433	143471	84085	84708	9039	154214	151636	150726	90933	51444	92912	84078	4008	140458	140456	136371	127247	142685	79754	142689	29116	9491	11146	8065	55294	80196	140739	114907	84676	10477	54461	92369	142678	55284	80176	64320	55336	140462	115290	81559	84961	83737	90135	122769	7325	154881	92591	25898	51088	23327	51676	5695	5707	84727	25847	10422	55658	10293	10616	114088	89122	63893	79876	53339	64410	11059	64682	8139	79176	93611	10193	140460	140461	65264	64718	64750	57154	56658	55521	26270	25897	55175	51132	140459	54850	51529	55958	57542	90293	57520	9616	9604	26249	51725	23608	51191	4012	9903	23194	8697	51434	51433	29945	29882	26232	26267	26268	26234	26235	23291	26272	26224	26190	5721	25831	51343	10393	10273	5719	6049	8945	27252	51619	51465	25793	9730	27246	55905	51666	100302652	51665	26118
PC_2066	Antigen Presentation	6892	9871	22872	10802	10427	3106	3105	3105	3106	3107	3105	3105	3105	3105	3106	3107	3309	3105	3133	3105	3105	3105	3135	3105	3106	3106	3106	811	821	2923	3105	3105	3105	3105	3105	3105	3105	3105	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3106	3107	3107	3107	3107	3107	3107	3134	3105	3106	9632	6396	567	6890	6891	3106	3107	3105	10484	3106	3106	3107	3106	3107	3107	3106	3106	64167	3106	3107	51752	3107	51128
PC_2067	Kinesins	3796	3797	9371	10749	23095	23046	10112	24137	3799	3832	1062	9493	3831	547	3798	3835	55083	124602	285643	147700	221458	55605	55582	146909	84643	81930	22920	90990	113220	55614	9585	11004	3833	64837	29127	64147	23303	56992	89953	3834	26153	11127
PC_2068	Factors involved in megakaryocyte development and platelet production	10603	5890	4097	5889	11216	23028	3717	7975	9927	25	3439	3440	3446	3444	3452	3442	3448	3451	3456	3045	3046	7157	3443	3441	3449	4602	5573	3659	5576	3660	2623	5566	5868	5568	5567	2624	2625	1017	7465	5575	5577	3445	2626	23468	830	832	829	998	5879	8350	3043	3047	3048	3020	1020	3065	3705	1793	221037	4778	139818	55604	126961	55669	161882	1795	9732	81704	91768	64780	23414	1794	8165	3066	2627	51317	55619	57572	85440	25942	81928	140628	23348	64145	10938	80005	25970	11311	30845	30846	10362	50808	23186	23764	10019
PC_2069	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	5293	10768	2534	4067	801	973	930	7409	4690	5336	933	5295	5777	974	6850	7220	640	2885	695	6654	6786	3709	3710	3708	118788	29760	30011	84876	80228	27071
PC_2070	Ion channel transport	8992	9550	534	525	526	528	527	529	523	9114	10312	537	9296	245972	245973	155066	535	90423	127124	533	50617	51606	23545	51382
PC_2071	Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits	2793	2788	9568	2784	3761	3763	3762	3760	2786	2790	54331	2782	2783	2792	2785	2787	3759	3766	3768	3765	3772	3773	55970	2550	94235
PC_2072	Citrullinemia Type I	8604	2746	5009	2806	445	435	383	2875	1373	6509	6510	27165	10166
PC_2073	Carbamoyl Phosphate Synthetase Deficiency	8604	2746	5009	2806	445	435	383	2875	1373	6509	6510	27165	10166
PC_2074	Argininosuccinic Aciduria	8604	2746	5009	2806	445	435	383	2875	1373	6509	6510	27165	10166
PC_2075	Glycine and Serine Metabolism	26227	23464	217	1738	211	10993	4128	189	2731	1491	6470	6472	2617	275	6301	2628	5723	2593	27232	132158	63826	29958	1757	29968
PC_2076	Pterine Biosynthesis	1719	5860	231	873	2644	2643	6697	5805
PC_2077	Tyrosine Metabolism	2954	124	1621	5409	4282	7299	2184	2805	26	1644	4128	1312	218	1638	23498	3081
PC_2078	beta-Alanine Metabolism	217	18	4329	1806	1807	8639	84735	2571	51733
PC_2079	Phenylalanine and Tyrosine Metabolism	2954	5053	2184	2805	6898	3242	8565	3081	259307	10056	2193
PC_2080	Ammonia Recycling	2752	343	2746	440	1738	10993	2731	1373	3034	275	80150	27165
PC_2081	Nucleotide Sugars Metabolism	7358	2592	2645	5236	2584	2582	7360	80146
PC_2082	Inositol Metabolism	3706	3612	5290	5297	3628	55697	3705	8678	27124	113026	5289	253430	114971	9896	3631	30849	55626	64768	51477	55586	9562	200576
PC_2083	Catecholamine Biosynthesis	7054	5409	1644
PC_2084	Cysteine Metabolism	1497	3939	2805	4357	1491	2729	2730	833	1036
PC_2085	Glutathione Metabolism	26873	79017	2936	2876	290	2729	2730	2937	840	124975	119391
PC_2086	Propanoate Metabolism	23417	5095	5096	1738	1629	34	593	594	38	1892	18	4329	31	26275	84693	92483	79611	84532
PC_2087	Vitamin B6 Metabolism	8566	249	316	57026	55163
PC_2088	Alpha Linolenic Acid and Linoleic Acid Metabolism	3992	9415	100137049	6785	60481
PC_2089	Arginine and Proline Metabolism	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2090	Taurine and Hypotaurine Metabolism	1036	124975	84890	2571	51380
PC_2091	Steroid Biosynthesis	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2092	Porphyrin Metabolism	10720	7389	2990	3145	3162	7390	211	210	2235	1371	5498	644	1352	1355	94033	55640
PC_2093	Phospholipid Biosynthesis	8611	10423	5338	10434	100137049	2819	1606	1103	1119	2820	9791	5130	9489	23659	162466	114971	1040	10554	81490	57678	51573	10400	23761	54675	26279
PC_2094	Pantothenate and CoA Biosynthesis	8876	5167	80347	53354	60490	79717
PC_2095	Caffeine Metabolism	1544	1571	1576	1558	10	1548	1559	7498
PC_2096	Selenoamino Acid Metabolism	9061	2678	191	4144	1491	102724560	4141	131965	51540	22928	64116	27430
PC_2097	Oxidation of Branched-Chain Fatty Acids	5264	788	5195	217	1376	2180	215	1384	5194	225	26061
PC_2098	Pentose Phosphate Pathway	25796	226	2821	2203	2539	5211	221823	7086	5236	6888	22934	5226	6120	64080	51071
PC_2099	Valine, Leucine, and Isoleucine Degradation	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2100	Methionine Metabolism	262	6723	1786	4144	1491	6470	102724560	4524	4141	4507	253827	55349	635	259307	27430	22921
PC_2101	Sphingolipid Metabolism	8611	10558	9517	8879	2629	2717	410	2720	2581	2531	7357	7368	123099	339221	259230	130367	64781	125981	9514	56848	55331	9331	10825
PC_2102	Bile Acid Biosynthesis	9420	9023	1109	6342	1581	3988	3295	6718	1593	570	8309	80270	51302	23600	1582	10998	10858
PC_2103	D-Arginine and D-Ornithine Metabolism	1610
PC_2104	Lysine Degradation	1738	38	1892	1743	501	6542	3033	51166	2639	55526	83884	51268	10157
PC_2105	Glycerolipid Metabolism	8611	8612	4023	3990	231	2819	218	2820	132158	10554	57678
PC_2106	Glycolysis	5230	226	2597	2023	2821	669	5213	6514	5224	5223	5313	2538	3099	130589
PC_2107	Sulfate/Sulfite Metabolism	6820	9060	10380	6817	6821	50515
PC_2108	Galactose Metabolism	2717	2592	3938	2548	231	2683	2720	3098	2538	5236	2582	7360
PC_2109	Histidine Metabolism	57571	10196	10841	217	3035	3067	26	4128	218	3034	23438	3176	138199	84735	55748	131669	144193
PC_2110	Amino Sugar Metabolism	5238	3073	3098	10007	5973	2673	1118	6675	55907	140838	64841	80896	54187	26503	55577	10020	51005
PC_2111	Pyrimidine Metabolism	10201	151531	7083	7298	1503	1890	790	6241	978	1635	1854	22978	1723	1806	1807	129607	50484	124583	3704	54963	51733	50808	9615
PC_2112	Nicotinate and Nicotinamide Metabolism	65220	4860	5167	4837	10135	22978	316	683	23530	23475	55191	83594	23057	54981
PC_2113	Purine Metabolism	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2114	Fatty Acid Metabolism	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2115	Beta Oxidation of Very Long Chain Fatty Acids	788	5195	1376	2180	215	1384	5194	92960	225	54677
PC_2116	Folate Metabolism	10840	10841	1719	4522	10797	4524	10588	2356	25902	8836	123263	113235
PC_2117	Fatty Acid Elongation in Mitochondria	1892	3030	10449	5538	3032	3028	51102
PC_2118	Alanine Metabolism	5091	189	2875	57505	51660
PC_2119	Citric Acid Cycle	6392	3420	1431	2271	5160	1738	1737	5162	5091	6390	6389	1743	4190	3419	3421	8802	55526	8801	6391	50	51660
PC_2120	Starch and Sucrose Metabolism	8972	7358	10720	276	5836	2821	2990	6476	2645	178	5236	3099	2998	2632	7360	283209
PC_2121	Urea Cycle	8604	2746	5009	2806	445	435	383	2875	1373	6509	6510	27165	10166
PC_2122	Pyruvate Metabolism	3939	217	97	5160	1738	1737	5162	5091	231	38	5313	5105	4190	4199	2739	31	3029	197257	134526	55902	9380
PC_2123	Tryptophan Metabolism	8564	11185	847	1543	217	3620	7166	1644	7453	438	23498	6999	15	8942	125061	51166	130013	10352
PC_2124	Fructose and Mannose Degradation	8790	2762	226	229	2203	231	5207	5211	3098	4351	3795	7167	6652	7264	197258	5372	29085	29925
PC_2125	Ubiquinone Biosynthesis	84274	27235	10229	51805	51004
PC_2126	Biotin Metabolism	32	686	3141	28972
PC_2127	Aspartate Metabolism	4677	445	435	440	1615	790	158	443	18	80150	122622	259307	2571	8528
PC_2128	Androgen and Estrogen Metabolism	6820	10720	7367	1586	412	1588	3283	3292	6715	3293	6783	6718
PC_2129	Riboflavin Metabolism	7299	5167	52	80308	55312
PC_2130	Ketone Body Metabolism	38	3155	5019	622
PC_2131	Glutamate Metabolism	2752	2746	2936	2806	2875	790	8659	1373	5859	2729	2730	2937	8833	7915	18	5471	2673	124454	64841	2571	27165	55577
PC_2132	Butyrate Metabolism	35	38	1892	3155	5019	116285	3033
PC_2133	Retinol Metabolism	1592	8608	8694	9249	8854	9227	216	124	1576	3309	1548	9601	1555	1577	1549	54658	5479	100861540	10961	8228	64714	10130	6121	1553	158833	10525	54884	51109	145226	10170	10901	53630	64816	23753	50700	51726
PC_2134	Arachidonic Acid Metabolism	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2135	Thiamine Metabolism	10560	84284	79178	27010
PC_2136	Piroxicam Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2137	Chlorothiazide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2138	Ibandronate Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2139	Polythiazide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2140	Methyclothiazide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2141	Simvastatin Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2142	Acetylsalicylic Acid Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2143	Etodolac Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2144	Ketoprofen Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2145	Ibuprofen Action Pathway	9536	247	54600	242	1571	7363	2876	1576	240	4048	100137049	1558	3309	1559	9601	246	873	7364	239	2678	1555	54658	5742	5479	6916	10961	1557	2053	5743	54659	5730	8644	1573	8529	11283	1579	4051	64714	10130	5740	4056	9356	10525	113612	127281	9376	54575	23753	51726
PC_2146	Rofecoxib Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2147	Bumetanide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2148	Pravastatin Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2149	Bendroflumethiazide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2150	Quinethazone Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2151	Rosuvastatin Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2152	Diclofenac Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2153	Sulindac Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2154	Alendronate Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2155	Celecoxib Action Pathway	9536	247	242	125	1571	2876	124	1576	240	4048	100137049	1558	1565	1559	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281	54575
PC_2156	Ethacrynic Acid Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2157	Ketorolac Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2158	Lovastatin Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2159	Hydrochlorothiazide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2160	Suprofen Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2161	Bromfenac Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2162	Cyclothiazide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2163	Indomethacin Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2164	Metolazone Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2165	Meloxicam Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2166	Zoledronate Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2167	Hydroflumethiazide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2168	Mefenamic Acid Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2169	Indapamide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2170	Cerivastatin Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2171	Risedronate Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2172	Oxaprozin Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2173	Nabumetone Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2174	Furosemide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2175	Valdecoxib Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2176	Pamidronate Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2177	Torsemide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2178	Fluvastatin Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2179	Naproxen Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2180	Trichlormethiazide Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2181	Chlorthalidone Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2182	Betaine Metabolism	191	4144	501	55349	635	4548	27430	10400
PC_2183	Glycerol Phosphate Shuttle	2597	2819	2820
PC_2184	Phenylacetate Metabolism	116285	348158	10249
PC_2185	Glucose-Alanine Cycle	2746	6514	6517	2875	6509	84706	55089	79751
PC_2186	Gluconeogenesis	2542	3939	226	2597	2023	2821	669	2203	6514	5091	5224	5223	5105	2538	5236	4191	3099	7167	8402	53354	130589	51660
PC_2187	Malate-Aspartate Shuttle	8604	2806	4191	8402
PC_2188	Steroidogenesis	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2189	Atorvastatin Action Pathway	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2190	Triamterene Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2191	Amiloride Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2192	Spironolactone Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2193	Eplerenone Action Pathway	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2194	2-Hydroxyglutric Aciduria (D and L Form)	2752	2746	2936	2806	2875	790	8659	1373	5859	2729	2730	2937	8833	7915	18	5471	2673	124454	64841	2571	27165	55577
PC_2195	2-Methyl-3-hydroxybutyryl-CoA Dehydrogenase Deficiency	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2196	3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2197	3-Methylglutaconic Aciduria Type I	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2198	3-Methylglutaconic Aciduria Type III	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2199	3-Methylglutaconic Aciduria Type IV	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2200	5-Oxoprolinuria	26873	79017	2936	2876	290	2729	2730	2937	840	124975	119391
PC_2201	Adenosine Deaminase Deficiency	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2202	Benazepril Action Pathway	5972	183	1636
PC_2203	Captopril Action Pathway	5972	183	1636
PC_2204	Cilazapril Action Pathway	5972	183	1636
PC_2205	Enalapril Action Pathway	5972	183	1636
PC_2206	Fosinopril Action Pathway	5972	183	1636
PC_2207	Lisinopril Action Pathway	5972	183	1636
PC_2208	Moexipril Action Pathway	5972	183	1636
PC_2209	Perindopril Action Pathway	5972	183	1636
PC_2210	Quinapril Action Pathway	5972	183	1636
PC_2211	Ramipril Action Pathway	5972	183	1636
PC_2212	Rescinnamine Action Pathway	5972	183	1636
PC_2213	Spirapril Action Pathway	5972	183	1636
PC_2214	Trandolapril Action Pathway	5972	183	1636
PC_2215	Candesartan Action Pathway	5972	183	1636	185	2776	54331	2782
PC_2216	Eprosartan Action Pathway	5972	183	1636	185	2776	54331	2782
PC_2217	Forasartan Action Pathway	5972	183	1636
PC_2218	Irbesartan Action Pathway	5972	183	1636	185	2776	54331	2782
PC_2219	Losartan Action Pathway	5972	183	1636	185	2776	54331	2782
PC_2220	Olmesartan Action Pathway	5972	183	1636	185	2776	54331	2782
PC_2221	Telmisartan Action Pathway	5972	183	1636	185	2776	54331	2782
PC_2222	Valsartan Action Pathway	5972	183	1636	185	2776	54331	2782
PC_2223	Adenylosuccinate Lyase Deficiency	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2224	AICA-Ribosiduria	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2225	Alkaptonuria	2954	124	1621	5409	4282	7299	2184	2805	26	1644	4128	1312	218	1638	23498	3081
PC_2226	Aromatic L-Aminoacid Decarboxylase Deficiency	7054	5409	1644
PC_2227	beta-Ureidopropionase Deficiency	10201	151531	7083	7298	1503	1890	790	6241	978	1635	1854	22978	1723	1806	1807	129607	50484	124583	3704	54963	51733	50808	9615
PC_2228	beta-Ketothiolase Deficiency	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2229	Biotinidase Deficiency	32	686	3141	28972
PC_2230	Canavan Disease	4677	445	435	440	1615	790	158	443	18	80150	122622	259307	2571	8528
PC_2231	Cystathionine beta-Synthase Deficiency	262	6723	1786	4144	1491	6470	102724560	4524	4141	4507	253827	55349	635	259307	27430	22921
PC_2232	Dihydropyrimidinase Deficiency	10201	151531	7083	7298	1503	1890	790	6241	978	1635	1854	22978	1723	1806	1807	129607	50484	124583	3704	54963	51733	50808	9615
PC_2233	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	26227	23464	217	1738	211	10993	4128	189	2731	1491	6470	6472	2617	275	6301	2628	5723	2593	27232	132158	63826	29958	1757	29968
PC_2234	Ethylmalonic Encephalopathy	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2235	Galactosemia	2717	2592	3938	2548	231	2683	2720	3098	2538	5236	2582	7360
PC_2236	gamma-Glutamyltransferase Deficiency	26873	79017	2936	2876	290	2729	2730	2937	840	124975	119391
PC_2237	Glucose Transporter Defect (SGLT2)	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2238	Glutaric Aciduria Type I	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2239	Glutaric Aciduria Type I	1738	38	1892	1743	501	6542	3033	51166	2639	55526	83884	51268	10157
PC_2240	Glycerol Kinase Deficiency	8611	8612	4023	3990	231	2819	218	2820	132158	10554	57678
PC_2241	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2242	Hartnup Disorder	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2243	Hawkinsinuria	2954	124	1621	5409	4282	7299	2184	2805	26	1644	4128	1312	218	1638	23498	3081
PC_2244	Histidinemia	57571	10196	10841	217	3035	3067	26	4128	218	3034	23438	3176	138199	84735	55748	131669	144193
PC_2245	Hypoacetylaspartia	4677	445	435	440	1615	790	158	443	18	80150	122622	259307	2571	8528
PC_2246	Iminoglycinuria	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2247	Leigh Syndrome	3939	217	97	5160	1738	1737	5162	5091	231	38	5313	5105	4190	4199	2739	31	3029	197257	134526	55902	9380
PC_2248	Lysinuric Protein Intolerance	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2249	Malonic Aciduria	23417	5095	5096	1738	1629	34	593	594	38	1892	18	4329	31	26275	84693	92483	79611	84532
PC_2250	Maple Syrup Urine Disease	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2251	Methylmalonic Aciduria	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2252	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	23417	5095	5096	1738	1629	34	593	594	38	1892	18	4329	31	26275	84693	92483	79611	84532
PC_2253	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	10201	151531	7083	7298	1503	1890	790	6241	978	1635	1854	22978	1723	1806	1807	129607	50484	124583	3704	54963	51733	50808	9615
PC_2254	Molybdenum Cofactor Deficiency	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2255	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	8604	2746	5009	2806	445	435	383	2875	1373	6509	6510	27165	10166
PC_2256	Phenylketonuria	2954	5053	2184	2805	6898	3242	8565	3081	259307	10056	2193
PC_2257	Prolidase Deficiency (PD)	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2258	Prolinemia Type II	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2259	Hypercholesterolemia	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2260	Purine Nucleoside Phosphorylase Deficiency	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2261	Pyruvate Dehydrogenase Complex Deficiency	3939	217	97	5160	1738	1737	5162	5091	231	38	5313	5105	4190	4199	2739	31	3029	197257	134526	55902	9380
PC_2262	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	262	6723	1786	4144	1491	6470	102724560	4524	4141	4507	253827	55349	635	259307	27430	22921
PC_2263	Sialuria or French Type Sialuria	5238	3073	3098	10007	5973	2673	1118	6675	55907	140838	64841	80896	54187	26503	55577	10020	51005
PC_2264	Tyrosinemia Type I	2954	124	1621	5409	4282	7299	2184	2805	26	1644	4128	1312	218	1638	23498	3081
PC_2265	UMP Synthase Deficiency (Orotic Aciduria)	10201	151531	7083	7298	1503	1890	790	6241	978	1635	1854	22978	1723	1806	1807	129607	50484	124583	3704	54963	51733	50808	9615
PC_2266	Xanthine Dehydrogenase Deficiency (Xanthinuria)	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2267	Methionine Adenosyltransferase Deficiency	262	6723	1786	4144	1491	6470	102724560	4524	4141	4507	253827	55349	635	259307	27430	22921
PC_2268	Glycine N-Methyltransferase Deficiency	262	6723	1786	4144	1491	6470	102724560	4524	4141	4507	253827	55349	635	259307	27430	22921
PC_2269	Non-Ketotic Hyperglycinemia	26227	23464	217	1738	211	10993	4128	189	2731	1491	6470	6472	2617	275	6301	2628	5723	2593	27232	132158	63826	29958	1757	29968
PC_2270	Neuron Function	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2271	Esomeprazole Action Pathway	1193	759	495	496
PC_2272	Omeprazole Action Pathway	1193	759	495	496
PC_2273	Lansoprazole Action Pathway	1193	759	495	496
PC_2274	Pantoprazole Action Pathway	1193	759	495	496
PC_2275	Rabeprazole Action Pathway	1193	759	495	496
PC_2276	Ranitidine Action Pathway	1193	759	495	496
PC_2277	Famotidine Action Pathway	1193	759	495	496
PC_2278	Cimetidine Action Pathway	1193	759	495	3274	496
PC_2279	Nizatidine Action Pathway	1193	759	495	496
PC_2280	Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency)	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2281	Propionic Acidemia	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2282	3-Methylcrotonyl-CoA Carboxylase Deficiency Type I	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2283	Isovaleric Aciduria	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2284	Saccharopinuria/Hyperlysinemia II	1738	38	1892	1743	501	6542	3033	51166	2639	55526	83884	51268	10157
PC_2285	Salla Disease/Infantile Sialic Acid Storage Disease	5238	3073	3098	10007	5973	2673	1118	6675	55907	140838	64841	80896	54187	26503	55577	10020	51005
PC_2286	Dimethylglycine Dehydrogenase Deficiency	26227	23464	217	1738	211	10993	4128	189	2731	1491	6470	6472	2617	275	6301	2628	5723	2593	27232	132158	63826	29958	1757	29968
PC_2287	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2752	2746	2936	2806	2875	790	8659	1373	5859	2729	2730	2937	8833	7915	18	5471	2673	124454	64841	2571	27165	55577
PC_2288	Sarcosinemia	26227	23464	217	1738	211	10993	4128	189	2731	1491	6470	6472	2617	275	6301	2628	5723	2593	27232	132158	63826	29958	1757	29968
PC_2289	Pirenzepine Action Pathway	1193	759	495	496
PC_2290	Clopidogrel Action Pathway	1544	5243	1576	1559	1555	1577	5444	1557
PC_2291	Ticlopidine Action Pathway	64805
PC_2292	Cilostazol Action Pathway	1576	1577	1557	5144
PC_2293	Warfarin Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2294	Acenocoumarol Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2295	Dicumarol Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2296	Phenprocoumon Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2297	Enoxaparin Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2298	Fondaparinux Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2299	Heparin Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2300	Ardeparin Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2301	Argatroban Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2302	Bivalirudin Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2303	Lepirudin Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2304	Ximelagatran Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2305	Alteplase Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2306	Anistreplase Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2307	Streptokinase Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2308	Tenecteplase Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2309	Urokinase Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2310	Reteplase Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2311	Aminocaproic Acid Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2312	Tranexamic Acid Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2313	Aprotinin Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2314	Diflunisal Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2315	Acebutolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2316	Alprenolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2317	Atenolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2318	Betaxolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2319	Bisoprolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2320	Esmolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2321	Metoprolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2322	Nadolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2323	Oxprenolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2324	Penbutolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2325	Pindolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2326	Propranolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2327	Dopamine Activation of Neurological Reward System	1812	5567	2778	108
PC_2328	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	1385	5567	5499	2782	2778	2792	3360	837856
PC_2329	Corticotropin Activation of Cortisol Production	5443	5567	2782	2778	2792	4158
PC_2330	Excitatory Neural Signalling Through 5-HTR 7 and Serotonin	1385	5567	3363	5499	2782	2778	2792	837856
PC_2331	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin	1385	5567	3362	5499	2782	2778	2792	837856
PC_2332	Lactic Acidemia	5091	189	2875	57505	51660
PC_2333	Congenital Bile Acid Synthesis Defect Type II	9420	9023	1109	6342	1581	3988	3295	6718	1593	570	8309	80270	51302	23600	1582	10998	10858
PC_2334	Cerebrotendinous Xanthomatosis (CTX)	9420	9023	1109	6342	1581	3988	3295	6718	1593	570	8309	80270	51302	23600	1582	10998	10858
PC_2335	Zellweger Syndrome	9420	9023	1109	6342	1581	3988	3295	6718	1593	570	8309	80270	51302	23600	1582	10998	10858
PC_2336	Familial Hypercholanemia (FHCA)	9420	9023	1109	6342	1581	3988	3295	6718	1593	570	8309	80270	51302	23600	1582	10998	10858
PC_2337	Congenital Bile Acid Synthesis Defect Type III	9420	9023	1109	6342	1581	3988	3295	6718	1593	570	8309	80270	51302	23600	1582	10998	10858
PC_2338	Lysosomal Acid Lipase Deficiency (Wolman Disease)	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2339	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	5609	3551	1147	5170	10411	3265	3725	673	1386	1385	2002	4790	5567	4792	5594	135	207	5605	5290	5599	5608	998	5906	2782	2778	2792	4791	5590	5058	4214	8874	6195	5600	572	50855	9693	4216
PC_2340	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	5609	3551	1147	5170	10411	3265	3725	673	1386	1385	2002	4790	5567	4792	5594	136	207	5605	5290	5599	5608	998	5906	2782	2778	2792	4791	5590	108	5058	4214	8874	6195	5600	572	50855	9693	4216
PC_2341	Vasopressin Regulation of Water Homeostasis	5567	2492	554	2782	2778	2792	108	55970
PC_2342	Quinidine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2343	Procainamide (Antiarrhythmic) Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2344	Disopyramide Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2345	Fosphenytoin (Antiarrhythmic) Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2346	Phenytoin (Antiarrhythmic) Action Pathway	3775	8913	54600	10060	8912	476	481	1544	1571	2052	7169	1576	7168	3309	1559	478	9601	482	3753	1728	488	54578	1312	54658	54657	3741	5479	10961	6546	1557	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	64714	6640	6645	480	6641	775	6331	3767	10130	3764	144245	10525	6262	23753	30819	9254	51726	3752	10021	9992
PC_2347	Lidocaine (Antiarrhythmic) Action Pathway	3775	8913	10060	8912	476	481	1544	7169	1576	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2348	Mexiletine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2349	Tocainide Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2350	Flecainide Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2351	Ibutilide Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2352	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	1385	5567	2492	5499	2782	2778	2792	108	837856	55970
PC_2353	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	3939	217	97	5160	1738	1737	5162	5091	231	38	5313	5105	4190	4199	2739	31	3029	197257	134526	55902	9380
PC_2354	Intracellular Signalling Through Histamine H2 Receptor and Histamine	1385	5567	3274	5499	2782	2778	2792	108	837856
PC_2355	Vitamin A Deficiency	1592	8608	8694	9249	8854	9227	216	124	1576	3309	1548	9601	1555	1577	1549	54658	5479	100861540	10961	8228	64714	10130	6121	1553	158833	10525	54884	51109	145226	10170	10901	53630	64816	23753	50700	51726
PC_2356	Glutathione Synthetase Deficiency	26873	79017	2936	2876	290	2729	2730	2937	840	124975	119391
PC_2357	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	1081	3972	1385	5567	3973	5499	2782	2778	2792	108	837856
PC_2358	Hyperinsulinism-Hyperammonemia Syndrome	2752	2746	2936	2806	2875	790	8659	1373	5859	2729	2730	2937	8833	7915	18	5471	2673	124454	64841	2571	27165	55577
PC_2359	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	262	6723	1786	4144	1491	6470	102724560	4524	4141	4507	253827	55349	635	259307	27430	22921
PC_2360	Hypermethioninemia	262	6723	1786	4144	1491	6470	102724560	4524	4141	4507	253827	55349	635	259307	27430	22921
PC_2361	Hereditary Coproporphyria (HCP)	10720	7389	2990	3145	3162	7390	211	210	2235	1371	5498	644	1352	1355	94033	55640
PC_2362	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	5567	2782	2778	2792	108	5729
PC_2363	Acute Intermittent Porphyria	10720	7389	2990	3145	3162	7390	211	210	2235	1371	5498	644	1352	1355	94033	55640
PC_2364	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	10720	7389	2990	3145	3162	7390	211	210	2235	1371	5498	644	1352	1355	94033	55640
PC_2365	Porphyria Variegata (PV)	10720	7389	2990	3145	3162	7390	211	210	2235	1371	5498	644	1352	1355	94033	55640
PC_2366	Metachromatic Leukodystrophy (MLD)	8611	10558	9517	8879	2629	2717	410	2720	2581	2531	7357	7368	123099	339221	259230	130367	64781	125981	9514	56848	55331	9331	10825
PC_2367	Globoid Cell Leukodystrophy	8611	10558	9517	8879	2629	2717	410	2720	2581	2531	7357	7368	123099	339221	259230	130367	64781	125981	9514	56848	55331	9331	10825
PC_2368	Gaucher Disease	8611	10558	9517	8879	2629	2717	410	2720	2581	2531	7357	7368	123099	339221	259230	130367	64781	125981	9514	56848	55331	9331	10825
PC_2369	Pyruvate Carboxylase Deficiency	5091	189	2875	57505	51660
PC_2370	GABA-Transaminase Deficiency	217	18	4329	1806	1807	8639	84735	2571	51733
PC_2371	Primary Hyperoxaluria Type I	5091	189	2875	57505	51660
PC_2372	Leukotriene C4 Synthesis Deficiency	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2373	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	4634	5567	5739	2782	2778	2792	108	4638
PC_2374	Mitochondrial Electron Transport Chain	6392	4694	2542	4512	4508	2597	506	291	6390	515	498	513	6389	7384	509	2820	514	54205	517	6391
PC_2375	17-beta Hydroxysteroid Dehydrogenase III Deficiency	6820	10720	7367	1586	412	1588	3283	3292	6715	3293	6783	6718
PC_2376	Argininemia	8604	2746	5009	2806	445	435	383	2875	1373	6509	6510	27165	10166
PC_2377	Fc Epsilon Receptor I Signaling in Mast Cells	5609	27040	4893	3265	3845	5894	2534	4067	2205	5578	5335	5295	5594	2207	207	5605	5290	6850	5599	6416	5606	5321	5608	2885	5879	2206	5604	695	6654	3937	5163	1432	10451	9846
PC_2378	Diltiazem Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2379	Hyperprolinemia Type II	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2380	Hyperprolinemia Type I	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2381	Arginine	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2382	Ornithine Aminotransferase Deficiency (OAT Deficiency)	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2383	Lesch-Nyhan Syndrome (LNS)	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2384	Gout or Kelley-Seegmiller Syndrome	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2385	Nebivolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2386	Carvedilol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2387	Labetalol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2388	Tyrosinemia Type 2 (or Richner-Hanhart Syndrome)	2954	5053	2184	2805	6898	3242	8565	3081	259307	10056	2193
PC_2389	Tyrosinemia Type 3 (TYRO3)	2954	5053	2184	2805	6898	3242	8565	3081	259307	10056	2193
PC_2390	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2391	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2392	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2393	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2542	3939	226	2597	2023	2821	669	2203	6514	5091	5224	5223	5105	2538	5236	4191	3099	7167	8402	53354	130589	51660
PC_2394	Verapamil Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2395	Amlodipine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2396	Felodipine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2397	Isradipine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2398	Nifedipine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2399	Nimodipine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2400	Nisoldipine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2401	Nitrendipine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2402	Methylmalonate Semialdehyde Dehydrogenase Deficiency	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2403	Homocarnosinosis	2752	2746	2936	2806	2875	790	8659	1373	5859	2729	2730	2937	8833	7915	18	5471	2673	124454	64841	2571	27165	55577
PC_2404	Desmosterolosis	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2405	CHILD Syndrome	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2406	Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2407	Smith-Lemli-Opitz Syndrome (SLOS)	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2408	Tay-Sachs Disease	5238	3073	3098	10007	5973	2673	1118	6675	55907	140838	64841	80896	54187	26503	55577	10020	51005
PC_2409	Insulin Signalling	5170	3265	5894	3643	6517	5594	6464	207	3667	5605	5599	5294	2885	5604	6654	2308	146850	8660
PC_2410	Benzocaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2411	Bupivacaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2412	Chloroprocaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2413	Cocaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2414	Dibucaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2415	Levobupivacaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2416	Lidocaine (Local Anaesthetic) Action Pathway	773	5443	476	481	1544	1576	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2417	Mepivacaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2418	Oxybuprocaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2419	Prilocaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2420	Procaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2421	Proparacaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2422	Ropivacaine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2423	Codeine Action Pathway	773	5443	476	481	1576	1565	478	482	5126	7364	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2424	Morphine Action Pathway	773	5443	476	481	7363	3309	478	9601	482	5126	7364	1141	54658	5479	6530	10961	6532	54659	1137	477	483	486	7366	6531	782	2902	6324	2903	64714	480	10130	10525	116443	54576	23753	30819	9254	3751	51726	6336
PC_2425	Methadone Action Pathway	773	5443	476	481	1576	1558	1565	478	482	5126	1141	1555	6530	100861540	6532	1557	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2426	Oxycodone Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2427	Hydromorphone Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2428	Hydrocodone Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2429	Oxymorphone Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2430	Alfentanil Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2431	Carfentanil Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2432	Fentanyl Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2433	Remifentanil Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2434	Sufentanil Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2435	Imipramine Action Pathway	773	5443	476	481	1544	1576	1565	478	482	5126	1141	6530	6532	1557	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2436	Desipramine Action Pathway	773	5443	476	481	1565	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2437	Citalopram Action Pathway	773	5443	476	481	1565	478	482	5126	1141	4128	6530	100861540	4129	6532	1557	1137	477	483	486	6531	782	2902	316	6324	2903	480	116443	30819	9254	3751	6336
PC_2438	Escitalopram Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2439	Fluoxetine Action Pathway	773	5443	476	481	1576	1565	1559	478	482	5126	1141	1577	6530	6532	1557	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2440	Azathioprine Action Pathway	5198	10257	10057	9153	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	7172	132	2983	5471	316	108	5144	3177	2987	1716	377841	84896	2030	3704	64078	11164	10846	9615
PC_2441	Mercaptopurine Action Pathway	5198	10257	10057	9153	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	7172	132	2983	5471	316	108	5144	3177	2987	1716	377841	84896	2030	3704	64078	11164	10846	9615
PC_2442	Disulfiram Action Pathway	2954	125	847	217	1571	124	1621	5409	4282	7299	2184	2805	26	1644	4128	1312	219	218	1638	23498	3081	55902	84532
PC_2443	Thioguanine Action Pathway	5198	10257	10057	9153	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	7172	132	2983	5471	316	108	5144	3177	2987	1716	377841	84896	2030	3704	64078	11164	10846	9615
PC_2444	Nicotine Action Pathway	773	54600	5443	476	481	1548	478	482	5126	1141	1555	54657	6530	2328	6532	1137	477	483	486	6531	782	2902	316	6324	2903	480	116443	30819	9254	3751	6336
PC_2445	Methotrexate Action Pathway	10840	10841	1719	4522	10797	4524	10588	2356	25902	8836	123263	113235
PC_2446	Irinotecan Action Pathway	8824	54600	590	5243	1576	3309	9601	1577	54658	1066	5479	10961	4363	64714	10130	10525	1244	54575	23753	51726	9429	10599
PC_2447	Paclitaxel Action Pathway	5243	4363	1244	28234	9429
PC_2448	Docetaxel Action Pathway	5243	4363	1244	28234	9429
PC_2449	Vinblastine Action Pathway	8714	5243	1576	4363	10928	89845	1244
PC_2450	Vincristine Action Pathway	8714	5243	4363	10928	89845	1244
PC_2451	Vindesine Action Pathway	8714	5243	4363	10928	89845	1244
PC_2452	Vinorelbine Action Pathway	8714	5243	1576	4363	10928	89845	1244
PC_2453	Prednisone Action Pathway	1576
PC_2454	Prednisolone Action Pathway	2908
PC_2455	Etoposide Action Pathway	8714	4353	5243	1576	3309	9601	1577	54658	5742	5479	10961	5743	64714	10130	10525	23753	51726
PC_2456	Teniposide Action Pathway	4353	1576	1577
PC_2457	Lactose Synthesis	3906	2592	6513	2683	4831	51727	2538	7355	7360	124583
PC_2458	Spermidine and Spermine Biosynthesis	4953	262	6723	4144	6611	27430
PC_2459	Gemcitabine Action Pathway	9154	4830	1633	51727	1635	30833	2030	64078
PC_2460	Cyclophosphamide Action Pathway	216	1576	2944	1558	1548	1559	1555	218	1557
PC_2461	Ifosfamide Action Pathway	216	1576	1558	1548	1559	1555	1577	218
PC_2462	Ethanol Degradation	125	847	217	1571	219	55902	84532
PC_2463	Phytanic Acid Peroxisomal Oxidation	5264	11001	215	224	225	26061
PC_2464	Refsum Disease	5264	11001	215	224	225	26061
PC_2465	Threonine and 2-Oxobutanoate Degradation	5095	5096	1738	1629	593	10993	594	4594
PC_2466	Nateglinide Action Pathway	773	3630	6514	782	6833	9254
PC_2467	Repaglinide Action Pathway	773	3630	6514	782	6833	9254
PC_2468	Homocysteine Degradation	1491	102724560
PC_2469	Fatty Acid Biosynthesis	2194	31
PC_2470	Lactose Degradation	476	481	3938	6514	478	6523	482	477	483	486	480
PC_2471	Lactose Intolerance	476	481	3938	6514	478	6523	482	477	483	486	480
PC_2472	Pyruvaldehyde Degradation	2739	3029	197257
PC_2473	Glibenclamide Action Pathway	773	3630	6514	782	6833	9254
PC_2474	Gliclazide Action Pathway	773	3630	6514	782	6833	9254
PC_2475	Inositol Phosphate Metabolism	8821	11165	3706	3612	3628	3705	27124	9677	253430	9807	3631	64768	51477	9562
PC_2476	Phosphatidylinositol Phosphate Metabolism	5293	5286	10423	8821	8867	2064	5295	5297	5305	5728	55697	8678	1956	5289	9896	3635	30849	8394	55626	23236	56623	200576
PC_2477	Vitamin K Metabolism	1728	2677	79001
PC_2478	Carnitine Synthesis	8424	6470	223	80854	55217
PC_2479	Transfer of Acetyl Groups into Mitochondria	5160	5162	5091	4190	4199	47	8402	51660
PC_2480	Trehalose Degradation	11181	476	481	6514	478	6523	482	2645	477	483	486	480
PC_2481	Degradation of Superoxides	6647	847	6648	6649	7306
PC_2482	Capecitabine Action Pathway	9154	1890	1066	978
PC_2483	Fluorouracil Action Pathway	7298
PC_2484	Tamoxifen Action Pathway	2099	1576	1565	1555	1577	54657	2328	6817	2326	54575
PC_2485	Erlotinib Action Pathway	5243	9429
PC_2486	Plasmalogen Synthesis	8540	8611	8443	10554	10390
PC_2487	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	35	38	33	1892	10449	3033	3028	79611
PC_2488	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	788	34	1892	3030	10449	3032	116285	3033
PC_2489	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	788	1376	33	1892	2180	3030	10449	1374	3032	3033
PC_2490	Dimethylglycine Dehydrogenase Deficiency	26227	23464	217	1738	211	10993	4128	189	2731	1491	6470	6472	2617	275	6301	2628	5723	2593	27232	132158	63826	29958	1757	29968
PC_2491	Hyperglycinemia, Non-Ketotic	26227	23464	217	1738	211	10993	4128	189	2731	1491	6470	6472	2617	275	6301	2628	5723	2593	27232	132158	63826	29958	1757	29968
PC_2492	DOPA-Responsive Dystonia	1719	5860	231	873	2644	2643	6697	5805
PC_2493	Hyperphenylalaninemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency	1719	5860	231	873	2644	2643	6697	5805
PC_2494	Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps)	1719	5860	231	873	2644	2643	6697	5805
PC_2495	Hyperphenylalaninemia Due to DHPR-Deficiency	1719	5860	231	873	2644	2643	6697	5805
PC_2496	Segawa Syndrome	1719	5860	231	873	2644	2643	6697	5805
PC_2497	Sepiapterin Reductase Deficiency	1719	5860	231	873	2644	2643	6697	5805
PC_2498	Carnosinuria, Carnosinemia	217	18	4329	1806	1807	8639	84735	2571	51733
PC_2499	Tyrosinemia, Transient, of the Newborn	2954	124	1621	5409	4282	7299	2184	2805	26	1644	4128	1312	218	1638	23498	3081
PC_2500	Galactosemia II (GALK)	7358	2592	2645	5236	2584	2582	7360	80146
PC_2501	Galactosemia III	7358	2592	2645	5236	2584	2582	7360	80146
PC_2502	Tyrosine Hydroxylase Deficiency	7054	5409	1644
PC_2503	Dopamine beta-Hydroxylase Deficiency	2954	124	1621	5409	4282	7299	2184	2805	26	1644	4128	1312	218	1638	23498	3081
PC_2504	beta-Mercaptolactate-Cysteine Disulfiduria	1497	3939	2805	4357	1491	2729	2730	833	1036
PC_2505	5-Oxoprolinase Deficiency	26873	79017	2936	2876	290	2729	2730	2937	840	124975	119391
PC_2506	gamma-Glutamyltranspeptidase Deficiency	26873	79017	2936	2876	290	2729	2730	2937	840	124975	119391
PC_2507	Malonyl-CoA Decarboxylase Deficiency	23417	5095	5096	1738	1629	34	593	594	38	1892	18	4329	31	26275	84693	92483	79611	84532
PC_2508	Hypophosphatasia	8566	249	316	57026	55163
PC_2509	Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2510	Hyperornithinemia with Gyrate Atrophy (HOGA)	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2511	Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2512	L-Arginine	5625	2746	5009	445	4942	435	383	2058	1152	1610	2805	4842	8659	1373	2628	2593	57038	283208	29920	10166
PC_2513	Cholesteryl Ester Storage Disease	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2514	Hyper-IgD Syndrome	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2515	Mevalonic Aciduria	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2516	Wolman Disease	6309	7108	9453	3156	2224	6646	2222	3988	4047	4597	51478	4598	3422	6713	10682	10654	1718	50814	6307	1595	39
PC_2517	Xanthinuria Type I	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2518	Xanthinuria Type II	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2519	gamma-Cystathionase Deficiency (CTH)	1491	102724560
PC_2520	Homocystinuria, Cystathionine beta-Synthase Deficiency	1491	102724560
PC_2521	Adrenoleukodystrophy, X-Linked	788	5195	1376	2180	215	1384	5194	92960	225	54677
PC_2522	Carnitine-Acylcarnitine Translocase Deficiency	788	5195	1376	2180	215	1384	5194	92960	225	54677
PC_2523	Glucose-6-phosphate Dehydrogenase Deficiency	25796	226	2821	2203	2539	5211	221823	7086	5236	6888	22934	5226	6120	64080	51071
PC_2524	Ribose-5-phosphate Isomerase Deficiency	25796	226	2821	2203	2539	5211	221823	7086	5236	6888	22934	5226	6120	64080	51071
PC_2525	Transaldolase Deficiency	25796	226	2821	2203	2539	5211	221823	7086	5236	6888	22934	5226	6120	64080	51071
PC_2526	3-Hydroxyisobutyric Acid Dehydrogenase Deficiency	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2527	3-Hydroxyisobutyric Aciduria	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2528	Isobutyryl-CoA Dehydrogenase Deficiency	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2529	Isovaleric Acidemia	217	5095	5096	1738	1629	34	593	35	594	38	3712	1892	11112	3155	10449	36	586	3158	5019	18	4329	316	549	26275	56922	3028	64087	27034
PC_2530	Fabry Disease	8611	10558	9517	8879	2629	2717	410	2720	2581	2531	7357	7368	123099	339221	259230	130367	64781	125981	9514	56848	55331	9331	10825
PC_2531	Krabbe Disease	8611	10558	9517	8879	2629	2717	410	2720	2581	2531	7357	7368	123099	339221	259230	130367	64781	125981	9514	56848	55331	9331	10825
PC_2532	Hyperlysinemia I, Familial	1738	38	1892	1743	501	6542	3033	51166	2639	55526	83884	51268	10157
PC_2533	Hyperlysinemia II or Saccharopinuria	1738	38	1892	1743	501	6542	3033	51166	2639	55526	83884	51268	10157
PC_2534	D-Glyceric Acidura	8611	8612	4023	3990	231	2819	218	2820	132158	10554	57678
PC_2535	Familial Lipoprotein Lipase Deficiency	8611	8612	4023	3990	231	2819	218	2820	132158	10554	57678
PC_2536	Glycogenosis, Type VII. Tarui Disease	5230	226	2597	2023	2821	669	5213	6514	5224	5223	5313	2538	3099	130589
PC_2537	Sulfite Oxidase Deficiency	6820	9060	10380	6817	6821	50515
PC_2538	Monoamine Oxidase-A Deficiency (MAO-A)	2954	124	1621	5409	4282	7299	2184	2805	26	1644	4128	1312	218	1638	23498	3081
PC_2539	G(M2)-Gangliosidosis	5238	3073	3098	10007	5973	2673	1118	6675	55907	140838	64841	80896	54187	26503	55577	10020	51005
PC_2540	Adenine Phosphoribosyltransferase Deficiency (APRT)	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2541	Mitochondrial DNA Depletion Syndrome-3	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2542	Myoadenylate Deaminase Deficiency	5198	957	10201	4860	3251	203	100	353	7295	3614	221823	2618	10606	270	6240	159	158	6241	471	2977	2766	7498	22978	8833	318	2983	5471	108	5144	2987	1716	377841	84896	3704	11164	10846	9615
PC_2543	Carnitine Palmitoyl Transferase Deficiency I	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2544	Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2545	Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2546	Carnitine Palmitoyl Transferase Deficiency II	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2547	Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2548	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	10840	10841	1719	4522	10797	4524	10588	2356	25902	8836	123263	113235
PC_2549	Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD)	1892	3030	10449	5538	3032	3028	51102
PC_2550	Trifunctional Protein Deficiency	34	35	1376	38	33	1892	2180	3030	10449	36	37	1374	3032	2639
PC_2551	Congenital Lactic Acidosis	6392	3420	1431	2271	5160	1738	1737	5162	5091	6390	6389	1743	4190	3419	3421	8802	55526	8801	6391	50	51660
PC_2552	Fumarase Deficiency	6392	3420	1431	2271	5160	1738	1737	5162	5091	6390	6389	1743	4190	3419	3421	8802	55526	8801	6391	50	51660
PC_2553	Mitochondrial Complex II Deficiency	6392	3420	1431	2271	5160	1738	1737	5162	5091	6390	6389	1743	4190	3419	3421	8802	55526	8801	6391	50	51660
PC_2554	2-Ketoglutarate Dehydrogenase Complex Deficiency	6392	3420	1431	2271	5160	1738	1737	5162	5091	6390	6389	1743	4190	3419	3421	8802	55526	8801	6391	50	51660
PC_2555	Pyruvate Dehydrogenase Deficiency (E3)	6392	3420	1431	2271	5160	1738	1737	5162	5091	6390	6389	1743	4190	3419	3421	8802	55526	8801	6391	50	51660
PC_2556	Pyruvate Dehydrogenase Deficiency (E2)	6392	3420	1431	2271	5160	1738	1737	5162	5091	6390	6389	1743	4190	3419	3421	8802	55526	8801	6391	50	51660
PC_2557	Glycogen Synthetase Deficiency	8972	7358	10720	276	5836	2821	2990	6476	2645	178	5236	3099	2998	2632	7360	283209
PC_2558	Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis	8972	7358	10720	276	5836	2821	2990	6476	2645	178	5236	3099	2998	2632	7360	283209
PC_2559	Glycogenosis, Type IV. Amylopectinosis, Anderson Disease	8972	7358	10720	276	5836	2821	2990	6476	2645	178	5236	3099	2998	2632	7360	283209
PC_2560	Glycogenosis, Type VI. Hers Disease	8972	7358	10720	276	5836	2821	2990	6476	2645	178	5236	3099	2998	2632	7360	283209
PC_2561	Mucopolysaccharidosis VII. Sly Syndrome	8972	7358	10720	276	5836	2821	2990	6476	2645	178	5236	3099	2998	2632	7360	283209
PC_2562	Sucrase-Isomaltase Deficiency	8972	7358	10720	276	5836	2821	2990	6476	2645	178	5236	3099	2998	2632	7360	283209
PC_2563	Primary Hyperoxaluria II, PH2	3939	217	97	5160	1738	1737	5162	5091	231	38	5313	5105	4190	4199	2739	31	3029	197257	134526	55902	9380
PC_2564	Pyruvate Kinase Deficiency	3939	217	97	5160	1738	1737	5162	5091	231	38	5313	5105	4190	4199	2739	31	3029	197257	134526	55902	9380
PC_2565	Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1)	2542	3939	226	2597	2023	2821	669	2203	6514	5091	5224	5223	5105	2538	5236	4191	3099	7167	8402	53354	130589	51660
PC_2566	Fructosuria	8790	2762	226	229	2203	231	5207	5211	3098	4351	3795	7167	6652	7264	197258	5372	29085	29925
PC_2567	Fructose-1,6-diphosphatase Deficiency	2542	3939	226	2597	2023	2821	669	2203	6514	5091	5224	5223	5105	2538	5236	4191	3099	7167	8402	53354	130589	51660
PC_2568	Triosephosphate Isomerase Deficiency	2542	3939	226	2597	2023	2821	669	2203	6514	5091	5224	5223	5105	2538	5236	4191	3099	7167	8402	53354	130589	51660
PC_2569	Multiple Carboxylase Deficiency, Neonatal or Early Onset Form	32	686	3141	28972
PC_2570	Aromatase Deficiency	6820	10720	7367	1586	412	1588	3283	3292	6715	3293	6783	6718
PC_2571	17-alpha-Hydroxylase Deficiency (CYP17)	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2572	Succinic Semialdehyde Dehydrogenase Deficiency	2752	2746	2936	2806	2875	790	8659	1373	5859	2729	2730	2937	8833	7915	18	5471	2673	124454	64841	2571	27165	55577
PC_2573	Short-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (SCHAD)	35	38	33	1892	10449	3033	3028	79611
PC_2574	Succinyl CoA	38	3155	5019	622
PC_2575	Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type	262	6723	1786	4144	1491	6470	102724560	4524	4141	4507	253827	55349	635	259307	27430	22921
PC_2576	Pyridoxine Dependency with Seizures	1738	38	1892	1743	501	6542	3033	51166	2639	55526	83884	51268	10157
PC_2577	Fanconi-Bickel Syndrome	5230	226	2597	2023	2821	669	5213	6514	5224	5223	5313	2538	3099	130589
PC_2578	Glycogenosis, Type IB	2542	3939	226	2597	2023	2821	669	2203	6514	5091	5224	5223	5105	2538	5236	4191	3099	7167	8402	53354	130589	51660
PC_2579	Glycogenosis, Type IC	2542	3939	226	2597	2023	2821	669	2203	6514	5091	5224	5223	5105	2538	5236	4191	3099	7167	8402	53354	130589	51660
PC_2580	11-beta-Hydroxylase Deficiency (CYP11B1)	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2581	21-Hydroxylase Deficiency (CYP21)	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2582	Corticosterone Methyl Oxidase I Deficiency (CMO I)	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2583	Corticosterone Methyl Oxidase II Deficiency (CMO II)	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2584	Congenital Disorder of Glycosylation CDG-IId	3906	2592	6513	2683	4831	51727	2538	7355	7360	124583
PC_2585	GLUT-1 Deficiency Syndrome	3906	2592	6513	2683	4831	51727	2538	7355	7360	124583
PC_2586	Glycogenosis, Type IA. Von Gierke Disease	2542	3939	226	2597	2023	2821	669	2203	6514	5091	5224	5223	5105	2538	5236	4191	3099	7167	8402	53354	130589	51660
PC_2587	Joubert Syndrome	5293	5286	10423	8821	8867	2064	5295	5297	5305	5728	55697	8678	1956	5289	9896	3635	30849	8394	55626	23236	56623	200576
PC_2588	Blue Diaper Syndrome	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2589	Lysinuric Protein Intolerance (LPI)	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2590	Coagulation	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2591	Angiotensin Metabolism	5972	183	1636
PC_2592	Striated Muscle Contraction	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2593	Gastric Acid Production	1193	759	495	496
PC_2594	Ibuprofen Metabolism Pathway	54600	7363	1576	1558	3309	1559	9601	7364	54658	5479	10961	1557	54659	64714	10130	9356	10525	9376	54575	23753	51726
PC_2595	Irinotecan Metabolism Pathway	8824	54600	590	5243	1576	3309	9601	1577	54658	1066	5479	10961	4363	64714	10130	10525	1244	54575	23753	51726	9429	10599
PC_2596	Etoposide Metabolism Pathway	8714	4353	5243	1576	3309	9601	1577	54658	5742	5479	10961	5743	64714	10130	10525	23753	51726
PC_2597	Teniposide Metabolism Pathway	4353	1576	1577
PC_2598	Gemcitabine Metabolism Pathway	9154	4830	1633	51727	1635	30833	2030	64078
PC_2599	Cyclophosphamide Metabolism Pathway	216	1576	2944	1558	1548	1559	1555	218	1557
PC_2600	Ifosfamide Metabolism Pathway	216	1576	1558	1548	1559	1555	1577	218
PC_2601	Tamoxifen Metabolism Pathway	2099	1576	1565	1555	1577	54657	2328	6817	2326	54575
PC_2602	Capecitabine Metabolism Pathway	9154	1890	1066	978
PC_2603	Fluorouracil Metabolism Pathway	7298
PC_2604	Mercaptopurine Metabolism Pathway	10257	10057	9153	3251	3614	7498	8833	7172	132	316	3177	2030	64078
PC_2605	Clopidogrel Metabolism Pathway	1544	5243	1576	1559	1555	1577	5444	1557
PC_2606	Ticlopidine Metabolism Pathway	64805
PC_2607	Cimetidine Metabolism Pathway	3274
PC_2608	Felodipine Metabolism Pathway	782	775	9254
PC_2609	Lidocaine (Local Anaesthetic) Metabolism Pathway	1544	1576
PC_2610	Codeine Metabolism Pathway	1576	1565	7364
PC_2611	Morphine Metabolism Pathway	7363	3309	9601	7364	54658	5479	10961	54659	7366	64714	10130	10525	54576	23753	51726
PC_2612	Heroin Metabolism Pathway	8824	590	1066
PC_2613	Methadone Metabolism Pathway	1576	1558	1565	1555	100861540	1557
PC_2614	Imipramine Metabolism Pathway	1544	1576	1565	1557
PC_2615	Desipramine Metabolism Pathway	1565
PC_2616	Citalopram Metabolism Pathway	1565	4128	100861540	4129	1557	316
PC_2617	Nicotine Metabolism Pathway	54600	1548	1555	54657	2328	316
PC_2618	Adefovir Dipivoxil Metabolism Pathway	203	4830	4831	204
PC_2619	Tenofovir Metabolism Pathway	203	4830	4831	204
PC_2620	Prednisone Metabolism Pathway	1576
PC_2621	Prednisolone Metabolism Pathway	2908
PC_2622	Felbamate Metabolism Pathway	1571	124	1576	218
PC_2623	Carbamazepine Metabolism Pathway	2052	1576	1558	1555	1577	100861540	1557
PC_2624	Valproic Acid Metabolism Pathway	1548	1559	1555	3712	54659	3030	36	3032	1962	116285	3028
PC_2625	Venlafaxine Metabolism Pathway	5243	1576	1565	1557
PC_2626	Tramadol Metabolism Pathway	6580	1576	1565	7364	1555	1244	54576
PC_2627	Levomethadyl Acetate Metabolism Pathway	100861540
PC_2628	Clomipramine Metabolism Pathway	1544	1576	1565	1557
PC_2629	Acetaminophen Metabolism Pathway	10257	10057	54600	1544	1571	5243	1576	2950	1565	3309	1548	9601	54578	54658	5479	10961	2952	4363	6783	445329	6817	7366	6822	64714	10130	10525	23753	51726	9429
PC_2630	Doxepin Metabolism Pathway	1544	1576	1565	1559	1557
PC_2631	Nevirapine Metabolism Pathway	216	1576	1565	1559	1555	1577	89845	54575
PC_2632	Celecoxib Metabolism Pathway	125	124	1576	1565	1559	5742	5743	54575
PC_2633	Fluoxetine Metabolism Pathway	1576	1565	1559	1577	1557
PC_2634	Thioguanine Metabolism Pathway	3251
PC_2635	Sorafenib Metabolism Pathway	54600	1576
PC_2636	Lamivudine Metabolism Pathway	6582	6580	8714	10257	6581	5230	5243	4830	1633	51727	4363	5130	6817	30833	56994	1244	5833	9429
PC_2637	Doxorubicin Metabolism Pathway	374291	4720	4722	874	5243	10327	1728	873	5447	4846	4363	8644	7498	10928	85413	1244	9429
PC_2638	Artemether Metabolism Pathway	54600	1576	7364	1577
PC_2639	Mycophenolic Acid Metabolism Pathway	8824	54600	5243	1576	1558	7364	1577	1066	1244	54577	54576	28234	9429	10599
PC_2640	Rosiglitazone Metabolism Pathway	1558	1559	10599
PC_2641	Warburg Effect	6392	3420	1431	3417	25796	3939	2746	5230	2597	229	2023	2821	2271	5160	1738	1737	6514	5162	2539	5091	5224	5211	48	6390	7086	5313	6389	1743	6888	4190	22934	3419	3421	5226	3099	8802	6566	6510	55526	8801	6391	50	27165	51660
PC_2642	Phenindione Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2643	Dicoumarol Action Pathway	2157	2162	2147	2158	2159	5340	2161	5327	2243	2244	2266	2160	2165	2155	2153	2152	2677	79001
PC_2644	Bopindolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2645	Carteolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2646	Timolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2647	Sotalol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2648	Epinephrine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2649	Dobutamine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2650	Isoprenaline Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2651	Arbutamine Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2652	Amiodarone Action Pathway	3775	10975	8913	10060	8912	476	481	7169	153	7168	5573	478	5576	482	3753	488	5566	6548	3741	5568	5567	5575	5577	6546	3761	3762	3760	477	3784	483	486	2778	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	90550	6262	30819	9254	3752	23439	10021	9992
PC_2653	Levobunolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2654	Metipranolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2655	Bevantolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2656	Practolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2657	Bupranolol Action Pathway	3775	8913	10060	8912	476	481	7169	7168	478	482	3753	488	3741	6546	3761	3762	3760	477	3784	483	486	3759	782	6833	3757	1739	6640	6645	480	6641	775	6331	3767	3764	144245	6262	30819	9254	3752	10021	9992
PC_2658	Tramadol Action Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2659	Propoxyphene Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2660	Levorphanol Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2661	Anileridine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2662	Diphenoxylate Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2663	Dezocine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2664	Levomethadyl Acetate Action Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2665	Methadyl Acetate Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2666	3-Methylthiofentanyl Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2667	Dimethylthiambutene Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2668	Ethylmorphine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2669	Leucine Stimulation on Insulin Signaling	3643	3667	2475	5294	8140	1978	146850	8660
PC_2670	Levallorphan Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2671	Buprenorphine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2672	Alvimopan Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2673	Pentazocine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2674	Naltrexone Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2675	Naloxone Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2676	Dihydromorphine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2677	Ketobemidone Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2678	Nalbuphine Action Pathway	773	5443	476	481	478	482	5126	1141	6530	6532	1137	477	483	486	6531	782	2902	6324	2903	480	116443	30819	9254	3751	6336
PC_2679	Antipyrine Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2680	Antrafenine Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2681	Carprofen Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2682	Etoricoxib Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2683	Fenoprofen Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2684	Flurbiprofen Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2685	Magnesium Salicylate Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2686	Lumiracoxib Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2687	Lornoxicam Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2688	Phenylbutazone Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2689	Nepafenac Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2690	Trisalicylate-Choline Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2691	Tolmetin Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2692	Tiaprofenic Acid Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2693	Tenoxicam Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2694	Salsalate Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2695	Salicylate-Sodium Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2696	Salicylic Acid Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2697	Acetaminophen Action Pathway	9536	247	242	1571	2876	240	4048	100137049	1558	246	873	239	2678	1555	5742	6916	2053	5743	5730	8644	1573	8529	11283	1579	4051	5740	4056	113612	127281
PC_2698	Thyroid Hormone Synthesis	7038	1536	7173	1535	6528	50508	50507	50506	53905
PC_2699	Apparent Mineralocorticoid Excess Syndrome	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2700	3-beta-Hydroxysteroid Dehydrogenase Deficiency	1586	1583	1589	3283	1584	1109	1585	3284	3290	6718	3291
PC_2701	2-Aminoadipic 2-Oxoadipic Aciduria	1738	38	1892	1743	501	6542	3033	51166	2639	55526	83884	51268	10157
PC_2702	27-Hydroxylase Deficiency	9420	9023	1109	6342	1581	3988	3295	6718	1593	570	8309	80270	51302	23600	1582	10998	10858
PC_2703	3-Phosphoglycerate Dehydrogenase Deficiency	26227	23464	217	1738	211	10993	4128	189	2731	1491	6470	6472	2617	275	6301	2628	5723	2593	27232	132158	63826	29958	1757	29968
PC_2704	Cystinosis, Ocular Nonnephropathic	1497	3939	2805	4357	1491	2729	2730	833	1036
PC_2705	Cystinuria	6582	476	481	6520	478	482	6337	6505	477	6338	6340	6339	1187	483	486	6559	11136	8140	6519	6557	480	8170	9356	9057	55089	54716	23428	9990	9056
PC_2706	Folate Malabsorption, Hereditary	10840	10841	1719	4522	10797	4524	10588	2356	25902	8836	123263	113235
PC_2707	Fructose Intolerance, Hereditary	8790	2762	226	229	2203	231	5207	5211	3098	4351	3795	7167	6652	7264	197258	5372	29085	29925
PC_2708	Temocapril Action Pathway	5972	183	1636
PC_2709	Roxatidine Acetate Action Pathway	1193	759	495	3274	496
PC_2710	Metiamide Action Pathway	1193	759	495	3274	496
PC_2711	Betazole Action Pathway	1193	759	495	3274	496
PC_2712	Activation of PKC Through G Protein-Coupled Receptor	5578	2776	3708	23236
PC_2713	The Oncogenic Action of 2-Hydroxyglutarate	6392	3420	1431	3417	2271	5160	1738	1737	5162	5091	48	6390	6389	1743	3418	3419	3421	8802	55526	8801	6391	50	27165	51660
PC_2714	The Oncogenic Action of Succinate	6392	3420	1431	3417	2271	5160	1738	1737	5162	5091	48	6390	6389	1743	3418	3419	3421	8802	55526	8801	112398	6391	50	54583	112399	1468	51660
PC_2715	The Oncogenic Action of Fumarate	6392	3420	1431	3417	2271	5160	1738	1737	5162	5091	48	6390	6389	1743	3418	3419	3421	8802	55526	8801	112398	6391	50	54583	112399	1468	51660
PC_2716	Glutaminolysis and Cancer	6392	3420	1431	3939	2746	2806	2271	5160	1738	1737	5162	5091	6390	6389	1743	6509	4199	3418	3419	3421	47	8802	6566	6510	92745	55526	8801	26292	6391	50	27165	9056	51660
PC_2717	Sarcosine Oncometabolite Pathway	4144	6470	6472	501	27232	57153	55349	23446	635	4548	27430	29958	1757
PC_2718	The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxyglutaric aciduria	6392	3420	1431	3417	2746	2271	5160	1738	1737	5162	5091	48	6390	6389	1743	3418	3419	3421	8802	55526	8801	6391	50	79944	27165	51660
PC_2719	The Oncogenic Action of D-2-Hydroxyglutarate in Hydroxyglutaric aciduria	6392	3420	1431	3417	2746	2271	5160	1738	1737	5162	5091	48	6390	6389	1743	3418	3419	3421	8802	728294	55526	8801	6391	50	79944	27165	51660
PC_2720	Phosphatidylcholine Biosynthesis	1119	5130	5833	10400	23761	10390
PC_2721	De Novo Triacylglycerol Biosynthesis	8694	2819	23175	10554	57678
PC_2722	Cardiolipin Biosynthesis	8760	2819	9489	114971	57678	55326	54675
PC_2723	Phosphatidylethanolamine Biosynthesis	1119	9791	5833	23761	10390
PC_2724	Androstenedione Metabolism	3309	1588	9601	1584	1109	6715	54658	5479	3290	10961	3293	6718	64714	10130	10525	23753	51726
PC_2725	Estrone Metabolism	1543	3309	9601	3292	1577	1312	54658	5479	10961	6783	64714	10130	10525	23753	51726
PC_2726	BCR-ABL Action in CML Pathogenesis	3717	4609	7157	867	6198	5295	6776	2475	1398	1399	1027	2885	4193	598	6654	6502	572	9846
PC_2727	Imatinib Inhibition of BCR-ABL	6580	3717	4609	7157	5243	867	6198	5295	6776	2475	1398	1399	1027	2885	4193	598	6654	6502	572	9846
PC_2728	Dasatinib Inhibition of BCR-ABL	3717	4609	7157	867	6198	5295	6776	2475	1398	1399	1027	2885	4193	598	6654	6502	572	9846
PC_2729	Nilotinib Inhibition of BCR-ABL	3717	4609	7157	867	6198	5295	6776	2475	1398	1399	1027	2885	4193	598	6654	6502	572	9846
PC_2730	Bosutinib Inhibition of BCR-ABL	3717	4609	7157	867	6198	5295	6776	2475	1398	1399	1027	2885	4193	598	6654	6502	572	9846
PC_2731	Bafetinib Inhibition of BCR-ABL	3717	4609	7157	867	6198	5295	6776	2475	1398	1399	1027	2885	4193	598	6654	6502	572	9846
PC_2732	Ponatinib Inhibition of BCR-ABL	3717	4609	7157	867	6198	5295	6776	2475	1398	1399	1027	2885	4193	598	6654	6502	572	9846
PC_2733	Lafutidine H2-Antihistamine Action	1193	759	495	3274	496
PC_2734	Chlorphenamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2735	Pheniramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2736	Dexchlorpheniramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2737	Brompheniramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2738	Dexbrompheniramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2739	Triprolidine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2740	Dimetindene H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2741	Mepyramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2742	Antazoline H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2743	Chloropyramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2744	Talastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2745	Tripelennamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2746	Histapyrrodine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2747	Methapyrilene H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2748	Thonzylamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2749	Diphenhydramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2750	Carbinoxamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2751	Doxylamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2752	Orphenadrine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2753	Bromodiphenhydramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2754	Clemastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2755	Chlorphenoxamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2756	Diphenylpyraline H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2757	Phenyltoloxamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2758	Cyclizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2759	Chlorcyclizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2760	Hydroxyzine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2761	Meclizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2762	Buclizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2763	Oxatomide H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2764	Cetirizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2765	Cinnarizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2766	Levocetirizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2767	Promethazine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2768	Alimemazine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2769	Cyproheptadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2770	Phenbenzamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2771	Fenethazine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2772	Hydroxyethylpromethazine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2773	Isothipendyl H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2774	Mequitazine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2775	Methdilazine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2776	Oxomemazine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2777	Azatadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2778	Ketotifen H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2779	Doxepin H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2780	Acrivastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2781	Astemizole H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2782	Bepotastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2783	Bilastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2784	Loratadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2785	Desloratadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2786	Ebastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2787	Terfenadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2788	Fexofenadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2789	Levocabastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2790	Mizolastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2791	Rupatadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2792	Olopatadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2793	Azelastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2794	Thiazinamium H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2795	Quifenadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2796	Betahistine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2797	Emedastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2798	Flunarizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2799	Mebhydrolin H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2800	Phenindamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2801	Epinastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2802	Tolpropamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2803	Embramine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2804	Latrepirdine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2805	Thenyldiamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2806	Propiomazine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2807	Clocinizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2808	Homochlorcyclizine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2809	Temelastine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2810	Alcaftadine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2811	Bamipine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2812	Deptropine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2813	Quetiapine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2814	Mirtazapine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2815	Pimethixene H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2816	Pyrrobutamine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2817	Thenalidine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2818	Tritoqualine H1-Antihistamine Action	5579	4790	3269	2776	54331	2782	3708	23236
PC_2819	Histamine H1 Receptor Activation	5579	4790	3269	2776	54331	2782	3708	23236
PC_2820	Lysophosphatidic Acid LPA1 Signalling	6722	207	54331	2782	107	6093	3708	1902	23236
PC_2821	Lysophosphatidic Acid LPA2 Signalling	6722	207	54331	2782	107	6093	3708	9170	23236
PC_2822	Lysophosphatidic Acid LPA3 Signalling	207	54331	2782	107	3708	2778	23236	23566
PC_2823	Lysophosphatidic Acid LPA4 Signalling	6722	207	54331	2782	107	6093	3708	2778	2846	23236
PC_2824	Lysophosphatidic Acid LPA5 Signalling	6722	207	54331	2782	107	6093	3708	2778	57121	23236
PC_2825	Lysophosphatidic Acid LPA6 Signalling	6722	207	10161	54331	2782	107	6093	2778
PC_2826	Activation of cAMP-dependent protein kinase, PKA	5573	5576	5566	5568	5567	5575	5577	2782	2778	2792	2778	55811
PC_2827	Ahr Signal Transduction Pathway	3320	405	196
PC_2828	Apoptotic DNA Fragmentation and Tissue Homeostasis	1676	3146	3002	7153	3148	790	836	840	2021
PC_2829	BTG Family Proteins and Cell Cycle Regulation	4803	7157	2246	5925	3219	595	694	7832	10036	3276
PC_2830	Nitric Oxide Signaling Pathway	217	801	5578	5567	4842	7498	1742	2902	5530	2903	3708	116443
PC_2831	Ion Channels and Their Functional Role in Vascular Endothelium	3786	3785	4846	2977	9132	2982	2983	5593	7222	5592	55811	59341	57113	56479	7223
PC_2832	P53 Signaling Pathway	317	4616	5925	983	596	1019	5111	891	595	898	1017	1026	1869	581
PC_2833	Phospholipase C Signaling Pathway	7409	5578	5335	207	5294	146850	23236
PC_2834	Ras Signaling Pathway	317	1147	3265	5894	5898	2002	5595	207	5290	842	998	387	5879	4088	4303	54205	5604	598	5900	5337	4089	10928	572	10451
PC_2835	TNF/Stress Related Signaling	5609	3551	1147	7124	3725	466	4790	4792	835	5599	6416	5606	5608	8738	5871	7186	4214	8737	8717	1432	10010	8517
PC_2836	Rac 1 Cell Motility Signaling Pathway	4660	4633	5111	5156	6198	1072	595	896	1026	23647	3984	60	5879	1020	10487	5058	4214	5337	10928	4638	8936	10451
PC_2837	Cadmium Induces DNA Synthesis and Proliferation in Macrophages	778	3265	5894	5579	5578	4790	4792	5595	5594	776	5604	5970	779	775	3708	23236
PC_2838	Growth Hormone Signaling Pathway	8651	3717	3265	2688	3630	5894	3643	2690	6517	5578	5335	5595	5594	5777	6464	3667	6776	6777	2885	5604	6654	6195
PC_2839	EGF Signalling Pathway	1956	2353	3265	1950	5894	3725	5579	6722	5578	5335	2002	5921	3716	5595	6464	6774	6772	6778	5599	6416	6773	2885	1457	5604	6654	4214
PC_2840	GnRH Signaling Pathway	5609	81	778	1956	3265	2796	1081	2488	3972	5894	3725	5579	4313	100137049	6714	5578	5566	1958	468	2002	5594	2767	2798	5599	5606	4323	998	2885	2778	776	782	5604	6654	107	4214	5337	779	775	3708	1432	163688	1839	23236	9254	815	10746
PC_2841	NF-kB Signaling Pathway	7099	3551	1147	6885	7124	3552	7316	3554	7132	4790	7133	4792	3654	5970	8772	4214	8737	8717	10454	84254	10645	9020	4615	7189	8517	8202
PC_2842	Complement Pathway	10747	715	1675	629	718	727	712	713	714	735	710	717	731	716	720	100293534	730	4153	729	5648
PC_2843	Alternative Complement Pathway	1675	629	718	727	735	731	730	729	5199
PC_2844	UbiquitinProteasome Pathway	5688	10537	7314	7316	5702	5689	7317	5682	5683	5684	5685	5686	5692	5694	5693	5701	5704	5691	5690	7324	5710	5687	5700	5705	5706	5695	10273	5719
PC_2845	Lectin-Induced Complement Pathway	10747	718	727	735	717	731	720	100293534	730	4153	729	5648
PC_2846	Toll-Like Receptor Pathway 1	7099	3551	1147	7098	6885	7097	2353	3725	929	2002	5610	4790	4792	5599	6416	5606	3654	5608	114609	5970	5465	4214	10454	1432	4615	51295	54472	54106	23118	51284	7189	8517	23643
PC_2847	Classical Complement Pathway	715	718	727	712	713	714	735	717	731	716	720	100293534	730	729
PC_2848	CXCR4 Signaling Pathway	5288	3265	5894	5335	4790	4792	5595	5594	1398	6387	5829	2776	9564	7852	2782	2770	2792	5604	5747	2185
PC_2849	D4-GDI Signaling Pathway	9743	317	3725	142	3002	5551	834	836	397	842	54205	394	841	843
PC_2850	T Cell Receptor Signaling Pathway	27040	10125	4772	2353	3265	5894	915	3725	5579	3932	2534	916	917	7316	801	801	801	7409	5532	5578	5335	2002	4790	919	4792	5595	5295	6464	5778	5290	7535	5599	6416	5533	5294	2885	5879	5604	5970	6654	5530	4775	4214	4773	4776
PC_2851	Stat3 Signaling Pathway	3716	5594	7297	6774	2475
PC_2852	Toll-Like Receptor Pathway 2	7099	3551	1147	7098	6885	7100	7097	929	4790	4792	5599	6416	3654	114609	5970	4214	7096	10454	1432	257397	4615	51295	54472	54106	51311	23118	51284	10333	7189	8517	23643
PC_2853	EPO Signaling Pathway	3717	2353	3265	2056	5894	3725	5335	2057	2002	5595	5777	6464	6776	5599	2885	5604	6654
PC_2854	FAS signaling pathway ( CD95 )	1676	8837	6885	8767	1677	4000	3725	5925	142	4001	355	836	5599	6416	356	397	840	839	5591	84823	5783	5058	8772	5062	4214	6709	841	843	1616	11124
PC_2855	BCR Signaling Pathway	4772	2353	3265	5894	3725	5579	4067	801	801	801	973	7409	5532	5578	5335	2002	5595	6464	974	6850	5599	5533	2885	5879	5604	695	6654	5530	4775	4214	4773	4776	29760	84876
PC_2856	Cardiolipin Biosynthesis (Barth Syndrome)	8760	2819	9489	114971	57678	55326	54675
PC_2857	Succinate Signalling	7099	3553	3091	283208	114548	23410
PC_2858	NAD+ Signalling Pathway (Cancer)	65220	7157	1728	952	10135	23411	349565	84883	23057	64802
PC_2859	NAD+ Signalling and Aging	9575	65220	1728	4881	6095	10135	23411	349565	23057	64802	10891
PC_2860	Succinate Signalling During Inflammation	3551	1147	1385	5578	4790	5742	5595	5594	4846	5600	56670	23236	8517
PC_2861	Bile Acid Direct Signalling Pathway (1)	10257	6579	6555	151306	9971
PC_2862	Bile Acid Indirect Signalling Pathway	9965	2260	2263	2264	2261	6555	152831	9971
PC_2863	Bile Acid Direct Signalling Pathway (2)	2740	6555	151306
PC_2864	CD40L Signalling Pathway	3551	1147	8518	4790	7128	958	4792	1843	959	7187	4214	1432	7189	8517
PC_2865	G-Protein Signaling Through Tubby Proteins	1128	3358	2776	7275	2782	2792	23236
PC_2866	g-Secretase Mediated ErbB4 Signalling Pathway	9542	5578	2065	5663	6868	2066	1956
PC_2867	Ion Channel and Phorbal Esters Signaling Pathway	5579	5578	5335	5029	2185
PC_2868	Circadian Rhythms	9575	5187	4881	102800317	1407
PC_2869	Hop Pathway in Cardiac Development	6722	2626	1482	84525
PC_2870	LPS and Citrate Signaling and Inflammation	7099	6392	3551	1147	1431	929	853155	4790	6390	4792	6389	4190	4199	6576	47	114609	5970	31	6391	4615	7189	8517	23643
PC_2871	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	16	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2872	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	5917	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2873	Protein Synthesis	4677	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2874	Protein Synthesis	6176	6181	6175	6218	3921	1615	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2875	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	833	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2876	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	5859	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2877	Protein Synthesis	6176	6181	6175	2058	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2878	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	2617	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2879	Protein Synthesis	6176	6181	6175	6218	3921	3035	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2880	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	3376	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2881	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	51520	25873
PC_2882	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	3735	25873
PC_2883	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	4141	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2884	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	10056	2193	25873
PC_2885	Protein Synthesis	6176	6181	6175	2058	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2886	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	6301	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2887	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6897	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2888	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	7453	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2889	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	8565	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2890	Protein Synthesis	6176	6181	6175	6218	3921	6187	6165	6129	6139	6188	6206	6137	7407	6134	6136	6133	6146	6124	6223	6122	23521	6232	11224	6157	6125	6144	6158	6203	6193	6204	6159	6164	9045	6224	6189	6154	6138	6155	6168	6167	6201	6202	6210	6217	6208	6228	6222	6235	6207	6205	6130	6191	6147	6194	9349	6209	6229	6230	6231	6234	2197	6156	6170	6160	4736	6161	6135	6132	6171	7311	6169	6227	10399	6152	6173	6143	6142	6128	6141	25873
PC_2891	Protein Synthesis	234734
PC_2892	Kidney Function- Proximal Convoluted Tubule	6582	759	6520	6548	358	6505	11136	8140	6519	9356	9057	55089	54716	23428	9056	8671
PC_2893	Kidney Function - Descending Limb of the Loop of Henle	358
PC_2894	Kidney Function - Ascending Limb of The Loop of Henle	5972	476	481	478	482	477	1187	483	486	6557	480	9990
PC_2895	Kidney Function - Collecting Duct	5972	759	6521	476	481	478	482	525	6337	359	477	6338	6340	6339	483	486	480	8170	360
PC_2896	Kidney Function - Distal Convoluted Tubule	5972	476	481	478	482	495	6546	359	477	496	1187	483	486	6559	480	360	56302
PC_2897	Pancreas Function - Beta Cell	773	6514	5578	1131	5864	2740	2776	54331	2782	6844	782	6833	3710	84254	11069	55811	23236	9254	9699
PC_2898	Pancreas Function - Alpha Cell	773	2641	6514	782	6833	6640	6645	6641	6331	9254
PC_2899	Mevalonate Pathway	3156	2224	38	2222	4047	4597	3157	4598	3422	6713	10654
PC_2900	Bloch Pathway (Cholesterol Biosynthesis)	6309	51478	3930	10682	1718	50814	6307	1595	1717
PC_2901	Kandutsch-Russell Pathway (Cholesterol Biosynthesis)	6309	51478	3930	10682	1718	50814	6307	1595	1717
PC_2902	Arsenate Detoxification	364	366	4860	6513	6517	9446	57412
PC_2903	Eumelanin Biosynthesis	7299	1638
PC_2904	Aldosterone from Steroidogenesis	1583	1589	3283	1585	185	2776	54331	2782
PC_2905	Pancreas Function - Delta Cell	773	6514	6750	782	6833	9254
PC_2906	2-Amino-3-Carboxymuconate Semialdehyde Degradation	1738	1743	130013	55526	64577
PC_2907	Arginine and Proline metabolism ( Arginine and Proline metabolism )	8974	314	216	5009	445	383	217	2058	4953	5033	262	6723	26	4128	6303	4129	4846	4842	8659	219	4843	223	501	224	6611	5917	384	2593	8639
PC_2908	Reelin signaling pathway	5609	8440	1600	3688	2534	4137	867	3675	5295	4043	207	5290	5048	5599	1399	4131	2932	5906	5649	7436	1020	2903	2904	2889	7804	8851	4296	9479	9181
PC_2909	Wnt secretory pathway (Canonical) ( Canonical Wnt signaling pathway Diagram )	7480	7476	7483	7484	7481	7471	7472	7474	7473	89780	54361	7477	7482	7479	80326	7478	81029	51384	7475
PC_2910	TGF-beta_super_family_signaling_pathway(canonical) ( TGF-beta_super_family_signaling_pathway(canonical) )	658	2660	4093	2661	10220	27302	9210	7040	3623	3624	3625	7043	650	652	651	655	7490	653	654	92	656	657	91	7046	94	7048	8200	6597	3626	2662	83729	7042	4088	90	2033	4089	93	659	4087	4086	269	392255	151449	84441	9794	1387	55534	4838	4090	9573	2658
PC_2911	ERK cascade ( CD4 T cell receptor signaling )	5894	369	673	5595	5594	5605	5604
PC_2912	Drosophila Notch signaling pathway ( Notch signaling pathway Diagram )	5663	5664	2033	1387
PC_2913	Ras signaling in the CD4+ TCR pathway	2353	4893	3265	3845	5894	5579	673	5578	2002	5595	5594	5778	1326	5604
PC_2914	Signaling events mediated by PTP1B	9021	27040	10253	3717	25	1956	5155	1950	5617	3630	3690	1447	3643	3932	2534	1436	823	7525	4067	3674	3055	1435	5159	2268	7295	2212	6714	5618	2241	5770	1000	5295	6464	7297	207	3667	6774	3952	1445	6776	5290	1398	3953	640	6777	9564	387	2885	4904	857	1796	55503	50507
PC_2915	cysteine biosynthesis/homocysteine degradation	1491	102724560
PC_2916	Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling )	2353	3725	8061	2355	2354
PC_2917	IKK-NF-kappaB cascade ( CD4 T cell receptor signaling )	4794	3551	1147	4790	4792	5970	4793	8517
PC_2918	NADH + (S)-1-Pyrroline-5-carboxylic acid = NAD+ + L-Proline ( Arginine and Proline metabolism )	5831	65263
PC_2919	D-Ribose 5-phosphate = D-Ribulose 5-phosphate ( Pentose phosphate cycle )	22934
PC_2920	ketogenesis	30	38	3155	3158	3032	622
PC_2921	acyl carrier protein metabolism	60496
PC_2922	ID	5894	5925	4617	2114	4654	4656	6925	6929	467	2002	4618	1017	5595	2005	5594	5933	5605	6720	3397	2004	3400	5710	4088	3398	3399	5079	5604	5076	7849	5934	10215	2274	3280	3428	116448	6938	64750	6934
PC_2923	DNA-PK pathway in nonhomologous end joining	1791	2547	7520	3981	5591	7518	54840	200558	64421	11284	79840	27434	27343
PC_2924	NAD+ + (S)-Lactic acid = NADH + Pyruvic acid ( Pyruvate metabolism )	3939	3945	3948	92483
PC_2925	Beta catenin degradation signaling (Canonical) ( Canonical Wnt signaling pathway Diagram )	8312	324	1499	2932	6500	8454	8945	8313
PC_2926	Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) )	7099	3552	3553	929	3554	3929	3654	4214	4615	51295	54472	3556	51135	7189	23643
PC_2927	G alpha s GDP-GTP exchange signaling ( GPCR signaling (G alpha q) )	8326	2918	2793	10681	2916	8323	8324	1813	2784	1812	1815	1816	3577	3579	135	136	134	185	1814	2915	186	2776	2911	7855	2535	2912	2917	2913	2914	6608	8325	7976	8322	11211	8321
PC_2928	JNK cascade ( PDGF signaling pathway )	3725	5599	6416	4214
PC_2929	purine ribonucleosides degradation to ribose-1-phosphate	4860	100	113179
PC_2930	4-hydroxyproline degradation I	8659
PC_2931	Cytosolic calcium ion concentration elevation (through IP3 receptor) ( VEGF signaling pathway )	3710	3708
PC_2932	2-Oxo-glutaric acid + L-erythro-4-Hydroxy-glutamic acid = L-Glutamic acid + D-4-Hydroxy-2-oxo-glutaric acid ( Arginine and Proline metabolism )	2806	2805
PC_2933	catecholamine biosynthesis	1621	5409	1644
PC_2934	Validated nuclear estrogen receptor alpha network	9814	322	9166	1147	1826	9611	6647	718	4609	5617	2099	7031	3725	5241	1509	5111	1051	7494	522	595	3732	4350	672	80781	8125	6776	8204	190	4731	9759	63977	9040	8543	6418	5457	3298	3823	2033	162	5458	64714	9112	4089	3065	6294	8431	10499	5469	8648	4738	9687	286827	135112	9039	79039	2100	10521	84458	11331	21	10011	57658	8313	9612	8202
PC_2935	Alpha4 beta1 integrin signaling events	2335	3688	7057	929	6696	5573	6714	3676	5566	5786	7412	4192	5567	5575	7058	1398	5829	9564	58494	975	998	382	5879	7534	5747	1793	2185	120425	10006	93185	10863	4620	28964	7094
PC_2936	Signaling events mediated by TCPTP	8554	1956	5155	1950	3630	3688	3643	1436	4233	1435	5159	6714	3082	7422	5771	5770	5610	5867	3716	5295	6464	3791	6774	6772	6778	6776	5290	5291	3998	6777	3838	3718	3672	2885	6654	2549	545	3837	1387	83939
PC_2937	FOXA1 transcription factor network	4781	1826	6647	5265	2353	2641	3630	2099	7448	338	7031	3725	354	6667	4782	367	7356	5451	1051	7494	522	725	595	7026	1562	6441	672	80781	1027	8204	3169	3171	4731	63977	2033	162	4774	6469	729238	653509	1387	4824	23761	3170	8202
PC_2938	Deoxy-uridine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Uracil ( Pyrimidine Nucleotides and Nucleosides metabolism )	1890
PC_2939	N-cadherin signaling events	8312	23396	1500	4041	2934	4633	2260	3728	2241	2697	2596	5770	1000	5335	1268	5295	3799	1495	1499	2891	5290	5599	998	387	801	5879	5781	6093	818	1639	2017	22919	221955	747
PC_2940	arginine biosynthesis IV	2746	5009	445	4942	435	2747
PC_2941	Notch secretory pathway (Drosophila) ( Notch signaling pathway Diagram )	5045
PC_2942	EGFR-dependent Endothelin signaling events	1956	3265	1950	1906	1909	6464	2475	2885	6654
PC_2943	glycogen degradation II	5836	5834	5837	178	5236	5239	55276
PC_2944	Negative regulation of (G alpha i GDP-GTP exchange signaling) ( GPCR signaling (G alpha i) )	6003	6002	6004	8490	10636	6001	8787	8601	8786	2771	5997	9628	10287	5998	5999	6000	85397	2770	5996	64407	26575
PC_2945	ATP + IDP = ADP + ITP ( Purine nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_2946	ATP + UDP = ADP + UTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_2947	formaldehyde oxidation II (glutathione-dependent)	2098	128
PC_2948	dermatan sulfate degradation (metazoa)	3073	3425	6677	3373
PC_2949	ethanol degradation II	125	217	224	79611	55902	84532
PC_2950	EGFR1	143872	9743	375791	9124	3092	5293	8976	5296	6386	1654	5287	9021	8625	5609	10067	8462	8520	5338	103910	9146	4659	9987	5359	3636	6004	8651	5170	6478	10236	10817	10253	10252	10251	8440	81	2029	8444	10768	23239	9046	3717	1500	10043	9672	8882	6451	2317	9252	10040	8412	10254	10211	9219	22905	9019	10617	160	8436	3939	4513	25	1956	2353	4609	3265	3845	3949	1950	3853	213	7037	5894	226	1476	301	2064	7157	476	351	5582	6175	3725	3688	5579	3875	3856	3643	3932	2534	2934	983	2023	302	5216	4067	6667	4233	7431	3855	1211	307	5159	3178	7314	369	596	5792	5573	3815	4168	5834	5898	5899	293	87	999	6714	3852	634	966	5315	3728	673	7409	6187	1832	3691	1385	4690	5336	5578	2697	3727	1051	5770	378	7414	5786	5223	6382	466	1000	5335	2002	4790	5868	5921	2041	2065	1001	867	6421	6198	3716	5791	1072	52	1017	156	3675	1656	5595	5295	2005	5594	1843	1969	2048	5777	6464	7086	4846	6317	7297	5037	558	6717	6385	207	7529	10963	6282	3308	4627	5605	509	8407	6622	6774	1445	5584	6772	6776	5290	5291	2475	2060	27	2444	3064	5599	5601	1398	1399	5606	6204	4734	8826	5294	5829	1050	2931	2932	8572	7408	858	6777	6197	5613	6773	7410	1948	1175	754	5563	2049	2050	2047	2043	84867	842	9564	83481	5728	60	6281	998	10096	10097	387	3336	6812	801	6633	59	5906	6156	2885	5879	163	7534	8655	1915	140885	6868	1999	4088	1601	4303	5935	5306	1020	1213	5604	857	5970	1981	3872	1759	5782	5747	5590	1917	5580	800	5781	5523	334	10657	6654	6655	10188	79026	7984	2308	6810	2059	5900	394	5562	10241	5058	5607	5598	868	4214	2887	1487	5337	8754	2549	8899	1978	8737	3065	1859	9610	5753	1829	23650	8874	23513	9815	1793	2017	2319	2185	2888	2886	4739	9961	9741	10318	5587	5339	5818	5801	5796	10928	6196	6195	6461	7050	7205	4087	6794	5586	1432	5931	1033	8290	55234	84069	51248	56243	23371	64759	284119	54862	253260	23164	146691	57478	51065	9765	10075	90102	51599	6477	152137	8844	10006	84951	23111	9732	50488	153562	84632	10044	51633	55198	9185	9052	54756	55616	56288	84959	10818	10015	257364	142683	57513	8503	23294	10342	9712	8027	1741	6528	11184	572	4026	23558	91894	30011	26472	85021	83737	55243	63916	116985	131566	54407	9223	55914	9020	8502	6311	1796	4215	26469	5318	6456	6457	23344	10616	81848	25921	54472	29127	55040	28996	25930	10114	65125	84189	84168	64762	54477	7145	57402	9047	1540	8798	50649	25970	29085	2909	50618	51232	51079	51196	58513	8727	9414	8994	55971	54206	26060	10451	55573	50807	23624	4646	1308	27071	10458	9846	815	22874	10746	28964	11187	9149	7094	8660	11183	27131	10723	29924	8202	4216	10401
PC_2951	BCR signaling pathway	3551	1147	5170	6885	9467	4772	8915	2353	3265	5894	3725	4067	5788	5452	613	973	2113	930	5532	5336	2002	4790	933	5921	971	4792	5595	5295	5594	5777	6464	207	2213	974	604	1445	5290	6850	5599	5533	7410	5728	801	2885	5879	1457	5604	5970	695	6654	5530	4214	818	4793	1432	597	112476	29760	3635	11184	1796	84433	55824	25998	10892	27071	7189	8517
PC_2952	CD28 signaling ( CD4 T cell receptor signaling )	5293	5296	5170	3932	2534	940	5295	207	208	941	942	5290	5291	10000
PC_2953	5-Formimino-tetrahydro-folic acid = 5,10-Methenyl-tetrahydro-folic acid + NH3 ( Folate metabolism )	10841
PC_2954	L-Arginine + Glycine = L-Ornithine + Guanidino-acetic acid ( Glycine and Serine metabolism )	2628
PC_2955	L-glutamine biosynthesis II (tRNA-dependent)	5188	55278
PC_2956	pentose phosphate pathway (non-oxidative branch)	7086	6888	22934	8277	6120	84076
PC_2957	Signaling events mediated by HDAC Class II	8625	7514	8841	2099	2908	3320	6722	2623	2624	156	7529	8021	23636	604	5905	9972	5903	9759	54331	7531	121504	5901	2782	7341	7329	10376	4208	7280	814	8338	8349	54880	126961	23225	51564	83933	79885	57763	10013	9734	10014	815	9612
PC_2958	PKA activation signaling ( GPCR signaling (G alpha s, PKA and ERK) )	112	109	115	111	5573	5576	5566	5568	5567	5575	5577	114	113	2778	108	107	196883	55811
PC_2959	Negative regulation of (Phosphorylation of cytokine receptor) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram )	3559	3570	2690	3554	3560	3459	1438	5618	3575	3454	2057	3566	3577	3579	3563	1271	7850	5777	3561	1439	3460	3572	4352	3594	3977	3953	3455	3597	3581	3568	3588	3601	8809	3587	3598	23765	1441	9180	3595	3556
PC_2960	Angiopoietin receptor Tie2-mediated signaling	5338	285	9046	2147	5340	7124	2335	3688	2534	2242	4313	3678	2247	2113	4690	2002	4790	5921	6198	5595	5295	5594	6464	4846	185	207	1997	1026	6776	5290	5599	1398	5829	6777	660	2885	5879	7010	5970	5747	5781	2308	5058	2888	2886	284	1998	1432	79155	51378
PC_2961	5'-Phospho-ribosyl-4-(N-succino-carboxamide)-5-amino-imidazole = 5'-Phospho-ribosyl-4-carboxamido-5-amino-imidazole + Fumaric acid ( Purine nucleotides and Nucleosides metabolism )	158
PC_2962	Caspase9 activation signaling ( TNFR1 signaling pathway )	317	842	54205
PC_2963	EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) ( EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) )	5293	5296	3717	2056	2057	5295	6774	6772	6776	5290	5291	6777
PC_2964	ERK cascade ( EGF signaling pathway Diagram )	5894	2002	5595	5594	5605	5604
PC_2965	phosphatidylethanolamine biosynthesis III	81490
PC_2966	Negative regulation of (nuclear import of R-smad	5603	5595	5594	5599	5601	6300	5602	5598	5600	4086	1432
PC_2967	IL8- and CXCR1-mediated signaling events	5170	9630	2771	5582	5579	4067	3055	2268	3576	5578	5868	867	3577	156	2769	207	409	5294	408	54331	2782	5330	5331	5581	1759	5337	146850	92170	23236
PC_2968	AKT(PKB) activation signaling ( Insulin receptor signaling (Mammal) )	5293	5170	207	208	5290	5291	2475	7249	253260	7248	79109	64223	10000
PC_2969	serotonin and melatonin biosynthesis	7166	1644	438	15	121278
PC_2970	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	3705	253430
PC_2971	Citric acid = cis-Aconitic acid + H2O ( Citrate cycle )	48	50
PC_2972	Signaling without Wnt (Drosophila) ( Drosophila Wingless/Wnt signaling pathway Diagram )	7088	7089	7090	7091
PC_2973	T cell receptor signaling pathway ( CD4 T cell receptor signaling )	27040	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	917	3123	3123	3126	5880	7409	5336	5335	4790	3113	3123	919	7535	5881	2885	5879	3125	5970	5588	3123	3123	3123
PC_2974	Citrate cycle ( Citrate cycle )	1431
PC_2975	3-Hydroxy-propanoyl-CoA = Propenoyl-CoA + H2O ( Propanoate metabolism )	1892	3030	1962
PC_2976	myo-inositol biosynthesis	3613	3612	51477	54928
PC_2977	2-Oxo-glutaric acid + L-O-Phospho-serine = L-Glutamic acid + 3-Phospho-hydroxy-pyruvic acid ( Glycine and Serine metabolism )	29968
PC_2978	S-adenosyl-L-methionine biosynthesis	4144	4143	27430
PC_2979	Canonical Wnt signaling pathway ( Mammalian Wnt signaling pathway Diagram )	375790	7480	7476	7483	7484	6885	9672	4041	2239	4040	22943	7481	7471	7472	960	6382	10971	6385	7529	2810	6383	2817	1499	6932	7474	7473	89780	54361	7477	7532	7531	7534	3339	7533	6424	79412	2487	7482	7479	6423	83999	80326	7478	81029	83439	6934	56998	51701	27122	27121	27123	51384	51176	25776	11197	7475
PC_2980	trehalose degradation II (trehalase)	11181	2645	80201	130589
PC_2981	Signaling events mediated by the Hedgehog family	50846	2736	2737	5744	156	5295	4043	207	409	5290	2619	7042	4036	5727	3549	6469	6491	50937	55733	84976	64399	6608	91653	8643
PC_2982	HGF signaling pathway ( HGF signaling pathway )	5293	4893	3265	3845	5894	4233	6714	3082	5880	5336	5335	5295	6464	5290	5291	1398	1399	5881	5908	5906	2885	5879	25759	5781	6654	6655	2549	2889	1793	53358
PC_2983	Regulation of nuclear SMAD2/3 signaling	10284	4092	2309	23309	9611	8819	8928	2353	4609	3456	2099	2908	3567	5054	3725	6667	1278	367	3915	3312	7421	1019	6497	6498	4654	1386	6929	1385	1051	3693	467	7030	3586	2625	1017	5933	207	1026	3172	1030	1482	2290	1745	145258	4149	4088	4303	861	6670	4208	5928	2033	2308	7709	1487	4089	3065	864	860	865	7027	1875	7050	10499	8648	4087	1874	5931	51588	79753	3066	1387	2648	8850	3665	51586	25942	4435	60436	55802	10401
PC_2984	Beta catenin degradation signaling (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	8312	324	1499	2932	6500	8454	8945	8313
PC_2985	Aurora A signaling	6790	332	6867	7157	5566	5921	1647	4792	994	207	672	1058	2932	3836	4946	5901	4193	5058	9793	8874	5528	3837	9787	23424	9212	84962	64506	81565	54998	22974	51343	28964	10460
PC_2986	Nectin adhesion pathway	23396	9855	9076	5155	3690	3685	5159	999	6714	5817	5295	5797	1495	1499	5290	1398	8826	7410	4301	998	5908	5906	5879	5747	2889	5818	5819	25945	7094	50848
PC_2987	pyrimidine ribonucleotides de novo biosynthesis	4833	10201	7372	4830	1503	4831	790	51727	8382	4832	129607	124583	56474	29922
PC_2988	thiamin salvage III	27010
PC_2989	Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )	8326	2918	28514	7480	7476	9542	2793	10681	2660	7483	7484	2069	2916	2255	8823	50846	2277	8822	8323	2661	8324	8817	10220	27302	9965	9210	7481	183	3827	5155	1950	7039	7040	4803	2796	4878	5020	551	5443	1081	7252	2488	3972	5617	2688	796	2641	7432	2691	5539	4852	3630	3481	2520	4049	7124	3439	3440	3446	3444	3452	3442	3448	3451	3456	3458	3552	3553	2056	5154	1437	7471	2771	3467	3443	3441	3449	3479	3623	3565	3567	2246	3569	1906	885	1392	796	1622	2922	3624	2249	3562	2247	3625	7472	2695	6343	1440	5697	797	3576	7043	2251	2248	2250	650	652	651	4295	3574	1908	3082	1813	3976	3578	374	7422	2784	655	6863	7200	4908	1907	3589	4254	1812	2252	1815	1816	653	654	3586	51083	627	3577	3579	135	136	3592	3593	959	134	185	2254	3445	941	4909	656	685	3596	1814	2668	200081	7066	3600	3952	7474	2915	942	8200	356	7423	7424	186	8743	2253	3626	2662	7473	89780	54361	7477	10718	83729	6750	7042	2770	182	51052	4693	3084	2911	7855	3603	3606	2535	2912	3549	2917	2913	2914	6469	3605	392255	151449	145957	2258	2256	2259	7482	7479	4838	1839	6608	80326	8074	7478	81029	8325	27006	26281	7976	9573	54567	26291	10683	51384	6866	2658	8322	11211	8321	3714	7475
PC_2990	NAD+ + Isocitric acid = NADH + 2-Oxo-glutaric acid + CO2 ( Citrate cycle )	3420	3419	3421
PC_2991	flavin biosynthesis IV (mammalian)	80308	55312
PC_2992	glycolysis I	8789	26330	5230	226	2597	229	2023	2821	5232	669	5213	2026	2203	1462	2027	5315	5224	5211	5223	5313	7167	5214
PC_2993	ERK cascade ( Insulin receptor signaling (Mammal) )	5894	369	673	2002	5595	5594	5605	5604
PC_2994	Folate metabolism ( Folate metabolism )	10840	1719	7298	5860	4522	2618	2643	471	6697	4524	275	10588	5805	2356	25902	4548
PC_2995	Raf activation signaling (through Grb2 and Sos) ( CD4 T cell receptor signaling (ERK cascade) )	4893	3265	3845	5894	369	673	2885	6654	6655
PC_2996	D-Glucose 1-phosphate = D-Glucose 6-phosphate ( Glycolysis and Gluconeogenesis )	5236
PC_2997	Choloyl-CoA + Taurine = CoA + Taurocholic acid ( Methionine and Cysteine metabolism )	570
PC_2998	TGF-beta receptor signaling	4092	8312	5170	6885	23645	9372	7040	7043	6198	1490	6464	5371	409	1499	7046	7048	10413	5499	7531	5516	2280	2885	5520	5515	4088	1601	331	6711	857	7049	6654	25805	4089	10454	4087	100506658	168002	54778	9765	9392	7021	83737	23327	83939	11059	64750	57154	83658	50855	23118	1616	815	11171
PC_2999	Butanoate metabolism ( Butanoate metabolism )	3158	3157	116285	65985
PC_3000	IL1-mediated signaling events	3551	1147	6885	3552	3553	3725	3554	3557	4790	7850	5295	834	5584	5290	5599	3654	5608	7334	5970	5590	387522	8878	10454	57162	100302736	23085	4215	4615	54472	3556	51135	23118	7189	11213	8517
PC_3001	JNK cascade ( IL-1 signaling pathway (through JNK cascade) )	5609	5603	6885	3725	5605	5599	5601	6416	5606	5608	6300	5602	5604	5607	5600	1432
PC_3002	uracil degradation II (reductive)	10570	1806	1807	1400	1809	1808	56896	51733
PC_3003	Posttranslational regulation of adherens junction stability and dissassembly	102	9146	1500	6585	25	1956	3265	1950	3481	2534	5979	3480	4314	4233	4316	999	6714	3728	4830	1832	2241	5770	1000	5868	627	5777	1495	1499	2668	836	8826	1785	7879	2674	998	10204	382	5879	2768	7074	6642	10672	4915	4225	79872	10009	91768	54453	1387	6091
PC_3004	histamine biosynthesis	3067
PC_3005	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Pyruvate metabolism )	38	39
PC_3006	C. elegans Notch signaling pathway ( Notch signaling pathway Diagram )	4851	5663	5664	4853	2033	1387	4855	4854
PC_3007	spermine and spermidine degradation I	6303	8639	196743	112483	54498
PC_3008	threonine degradation II	23464
PC_3009	(S)-3-Hydroxy-3-methyl-glutaryl-CoA = Acetyl-CoA + Acetoacetic acid ( Butanoate metabolism )	3155
PC_3010	phosphatidylethanolamine biosynthesis II	5833	85465	55500	55224	1120	10390
PC_3011	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Butanoate metabolism )	38	39
PC_3012	ATP + Pyruvic acid + CO2 + H2O = ADP + Oxaloacetic acid + Orthophosphate ( Alanine,Aspartic acid and Asparagine metabolism )	5091
PC_3013	NAD+ + 4-Trimethyl-ammonio-butanal + H2O = NADH + 4-Trimethyl-ammonio-butanoic acid ( Lysine degradation )	8854	216	217	219	223	501	224
PC_3014	E-cadherin signaling in keratinocytes	1500	1956	2534	999	6714	3728	5335	5295	207	208	1495	1499	846	5290	7408	387	5879	7791	342184	84962	8394
PC_3015	2-Oxo-glutaric acid + 4-Amino-butanoic acid = L-Glutamic acid + Succinate semialdehyde ( Glutamic acid and Glutamine metabolism )	18
PC_3016	ERK cascade ( FGF signaling pathway )	5894	369	2078	2113	2114	673	6688	2002	5595	2005	5594	5605	2119	2120	2004	2313	5604
PC_3017	galactose degradation I (Leloir pathway)	2592	2584	2582	130589
PC_3018	ERK cascade ( NGF signaling pathway )	5894	369	673	2002	5595	5594	5605	5604
PC_3019	Ci/Gli processing signaling ( Hedgehog signaling pathway )	2735	2736	2737	5566	5568	5567	1026	1029	1030	1031	1027	2932	1028	1032	6500	8454	8945
PC_3020	guanosine nucleotides degradation III	4860	7498	22978	9615
PC_3021	Validated transcriptional targets of AP1 family members Fra1 and Fra2	4772	5328	632	4312	3569	3725	7056	3713	1634	6667	1278	4313	4256	3162	3576	6347	4318	3976	8061	2355	3691	3726	2697	3727	468	890	595	4846	5329	2033	4775	4773	7392	3909	1029	55787	9988
PC_3022	Regulation of CDC42 activity	79658	23263	23229	8412	9855	4168	4830	5335	324	396	7410	998	2245	392	8874	9459	10928	6453	139818	55114	23268	115557	25791	55619	57572	221178	23348	29127	50618	10451	28964
PC_3023	Gene expression of MuRF1 by FOXO ( Insulin receptor signaling (Mammal) )	2309	4303	2308
PC_3024	PDGFR-alpha signaling pathway	2353	3725	3685	6722	5156	5335	2002	3716	5295	6464	5290	1398	1399	859	2885	1457	857	6654	2889	6461	112476
PC_3025	NAD+ + (S)-Malic acid = NADH + Pyruvic acid + CO2 ( Glycolysis and Gluconeogenesis )	4200
PC_3026	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Tryptophan degradation )	38	39
PC_3027	ATP + CMP = ADP + CDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	51727
PC_3028	Negative regulation of heterotrimeric GPCR signaling pathway (through G alpha s) ( GPCR signaling (cholera toxin) )	112	109	115	111	2771	114	113	2770	108	107	196883	55811
PC_3029	arginine degradation VI (arginase 2 pathway)	4942	383	5831	384	65263	29920
PC_3030	glutamine degradation I	2744	440	27165
PC_3031	(S)-3-Hydroxy-2-methyl-butanoyl-CoA = 2-Methylbut-2-enoyl-CoA + H2O ( Valine,Leucine and Isoleucine degradation )	1892	3030	1962
PC_3032	Glutamic acid and Glutamine metabolism ( Glutamic acid and Glutamine metabolism )	2936	2058	790	1373	5859	2729	2730	2937	2572	2571
PC_3033	N-acetylglucosamine degradation II	10007	132789	55577	51005
PC_3034	Toll-like receptor signaling pathway (through LPS, TLR4, MyD88, IRAK, TAK1 and IKK-NF-kappaB cascade)(Canonical) ( Toll-like receptor signaling pathway (trough NF-kappaB) )	7099	6885	3552	3553	929	3554	3929	3654	7334	387522	10454	4615	51295	54472	3556	51135	23118	7189	23643
PC_3035	p75(NTR)-mediated signaling	317	3551	1147	8767	10018	6610	11319	5340	4803	4914	7157	351	389	4804	4314	4782	4316	5045	4908	4099	5567	4974	627	5295	6464	207	4909	5584	5290	836	5599	5601	5663	3654	396	5602	842	839	387	7531	388	5879	6868	331	54205	27018	1869	5590	330	329	8878	2532	79158	83464	23385	572	51107	84894	10782	56160	6272	4692	4615	92170	65078	28986	55859	57142	56616	55851	11108	7189	9500	8517
PC_3036	Signaling mediated by p38-alpha and p38-beta	26959	4286	9252	8986	2099	7157	3315	3725	3856	1977	3880	1386	1385	1051	466	22926	6548	5868	7391	2005	2664	4843	5743	1649	5321	9261	4205	4208	1978	5600	1432	7867	8550	8569	10891
PC_3037	noradrenaline and adrenaline degradation	125	217	127	5409	4128	1312	4129	130	224	220074
PC_3038	ERK cascade ( HGF signaling pathway )	5894	2002	5595	5594	5605	5604
PC_3039	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	3705	253430	64768
PC_3040	Tryptophan degradation ( Tryptophan degradation )	8564	314	8854	11185	216	847	1543	217	1544	1571	1576	1558	1565	1548	1588	1559	1580	3620	7166	26	1644	1555	1577	1549	4128	7453	100861540	1572	4129	1892	219	1562	1557	3030	438	23498	6999	223	501	1573	224	11283	4193	7337	316	1962	4799	15	1545	1553	8942	8639	125061	130013	2639	64320	64816	57834	66002	10352
PC_3041	(S)-Malic acid = Fumaric acid + H2O ( Arginine and Proline metabolism )	2271
PC_3042	NAD+ + (S)-3-Hydroxy-butanoyl-CoA = NADH + Acetoacetyl-CoA ( Tryptophan degradation )	3030	1962	3033	3028
PC_3043	IKK-NF-kappaB cascade ( CD4 T cell receptor signaling (NF-kB cascade) )	4794	3551	1147	4790	4792	5970	4793	8517
PC_3044	2-Oxo-glutaric acid + L-Cysteic acid = L-Glutamic acid + 3-Sulfo-pyruvic acid ( Methionine and Cysteine metabolism )	2806	2805
PC_3045	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	8326	1855	1856	8312	8323	8324	4041	23401	4040	324	1499	102800317	2932	7855	2535	10023	1857	8325	7976	8322	11211	8321	8313
PC_3046	tyrosine biosynthesis IV	5053
PC_3047	Lissencephaly gene (LIS1) in neuronal migration and development	1641	11104	1600	25	4043	6249	5048	4131	8826	998	387	801	7531	5879	6993	1457	5049	5649	7436	1020	7941	8941	7804	1778	5528	8851	5050	81565	10726
PC_3048	Vitamin B6 metabolism ( Vitamin B6 metabolism )	8566	316	55163	29968
PC_3049	Arf6 trafficking events	10640	274	5338	10066	8853	9043	23396	11336	1500	8515	3630	3688	3685	154	3678	5898	999	3676	6517	4830	7253	1363	3673	3655	3675	554	185	1495	1499	1785	8516	3672	382	1213	3831	5337	3679	3680	9744	9341	149371	54536	60412	55770	55763	22801	23265	23162
PC_3050	purine nucleotides degradation II (aerobic)	4860	100	3615	3614	4907	7498	22978	115024	113179	84618	51251	9615
PC_3051	Regulation of cytoplasmic and nuclear SMAD2/3 signaling	10106	10217	5595	5594	8021	5494	9972	3838	801	7329	4088	4214	4089	3837	4087	51588	9392	58190
PC_3052	heme biosynthesis II	7389	3145	7390	211	210	212	2235	1371	5498
PC_3053	ATP + dADP = ADP + dATP ( Purine nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3054	Cytosolic calcium ion concentration elevation (through IP3 receptor) ( GPCR signaling (G alpha q) )	3710	3708
PC_3055	Drosophila Toll-like receptor signaling ( Drosophila Toll-like receptor signaling )	5717	5718	5715	658	8317	102	5609	5688	3551	1147	5603	5170	3656	5709	9175	6885	8767	5565	7092	3717	9028	5716	10298	1956	4342	2147	5894	4914	5582	5579	3643	3932	2534	983	354	3480	4804	4233	5159	5045	3002	369	5573	3815	2260	1019	6714	649	5576	673	5156	5578	5566	2321	5702	5689	2263	2264	2261	5568	5567	6198	3716	5583	1017	156	5682	5683	5684	5685	92	5595	5696	5698	5686	5692	5694	5693	5594	4058	834	7297	7465	5575	5577	207	208	23581	2868	6259	2869	157	2324	3791	5701	5605	657	91	7046	94	7048	5699	1445	1326	5584	2475	836	835	7006	2870	7535	6850	5704	5599	5601	6416	5606	5714	1452	1453	9261	1024	837	102800317	5691	5690	5663	5664	2931	2932	1022	1025	3654	5713	6197	838	902	4331	3718	5608	5347	6300	5602	5571	5563	5710	840	842	839	2674	5687	5700	5705	1455	6868	4293	1018	1021	1020	5581	5604	4294	5588	90	5747	5590	5580	695	3702	5871	7786	5562	5058	5607	5598	5062	5708	4214	5593	8737	816	818	817	93	659	5592	9641	2185	9700	841	9861	6196	6195	5600	5711	1432	4296	7867	269	84451	8491	8550	131890	83464	23385	843	51107	84735	5695	5707	9020	4217	4215	8569	1263	53944	106821730	51135	54933	55851	57144	51701	6199	53632	51422	27330	238	5719	815	10000	10746	5564	11035	8517	7093	1456
PC_3056	Stabilization and accumulation of cytoplasmic beta-catenin (Mammal) ( Mammalian Wnt signaling pathway Diagram )	8326	1855	1856	8312	8323	8324	4041	23401	4040	324	1499	102800317	2932	7855	2535	10023	1857	8325	7976	8322	11211	8321	8313
PC_3057	FGF signaling pathway (D. melanogaster tracheal cells) ( FGF signaling pathway )	10971	7529	2810	7532	7531	7534	7533
PC_3058	IL12-mediated signaling events	8651	8767	3717	4616	8807	10912	8320	2353	3458	3553	3559	920	925	3122	3123	915	3105	3565	3932	916	917	3002	6348	926	3001	388372	3554	3560	1386	4790	919	3592	3593	7297	3561	4843	6774	6772	6778	6776	2475	3594	5606	356	7879	1234	5608	3558	567	4791	5971	5970	8809	3606	6775	3142	1432	3595	56848	30009
PC_3059	stearate biosynthesis I (animals)	11332	11001	2182	2181	2180	10965	81616	641371	122970	23205	64834	79071	51703
PC_3060	ATP + dCMP = ADP + dCDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	51727
PC_3061	UTP + N-Acetyl-D-glucosamine 1-phosphate = Pyrophosphate + UDP-N-acetyl-D-glucosamine ( Aminosugars metabolism )	6675
PC_3062	L-Alanine + 2-Oxo-glutaric acid = Pyruvic acid + L-Glutamic acid ( Alanine,Aspartic acid and Asparagine metabolism )	2875	84706
PC_3063	IL3	5293	5296	8835	9021	10018	2309	9046	3717	3265	5894	3315	5579	3932	2534	5925	2242	4067	5788	3055	3562	5914	596	6513	6714	1386	7409	2623	1385	5578	5566	7414	466	6256	4790	867	3716	2624	3563	10971	5595	5295	5594	5777	6464	7297	2207	207	7529	1439	6774	6776	7006	6850	5599	1398	1399	5829	2931	2932	6777	2885	7534	10399	5515	5604	1759	5747	5781	581	598	6654	5530	2308	5058	2549	2889	1432	3635	572	1796	1154	29990	9846	30818
PC_3064	4-hydroxybenzoate biosynthesis	6898
PC_3065	Mammalian Wnt signaling pathway ( Mammalian Wnt signaling pathway Diagram )	375790	7480	7476	7483	7484	6885	9672	4041	2239	4040	22943	7481	7471	7472	960	6382	6385	6383	2817	1499	6932	7474	7473	89780	54361	7477	3339	6424	79412	2487	7482	7479	6423	83999	80326	7478	81029	83439	6934	56998	51701	27122	27121	27123	51384	51176	25776	11197	7475
PC_3066	IFN-gamma pathway	4092	8651	3717	8554	3458	3553	3659	3459	1051	5771	867	3716	5595	5295	5594	834	207	6774	6772	5290	2475	1399	1612	5908	801	5906	10379	5604	5580	5781	2033	4214	816	818	817	2889	4296	51588	1387	80142	815
PC_3067	AMP + Pyrophosphate = Adenine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	3251
PC_3068	Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, p38 cascade) ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, p38 cascade) )	7099	6885	929	3929	3654	4214	10454	4615	51295	54472	51135	23118	7189	23643
PC_3069	Adenylate cyclase activation signaling ( GPCR signaling (G alpha i) )	112	109	115	111	114	113	2778	108	107	196883	55811
PC_3070	NAD biosynthesis III	10135	349565	23057	64802
PC_3071	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	6309	7108	2222	4047	51478	6713	3930	10682	1718	50814	6307	1595	1717
PC_3072	proline biosynthesis I	5831	5832	65263	29920
PC_3073	glutamate degradation X	2746	2747
PC_3074	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	3613	8871	3636	8867	3706	3707	3612	3633	3628	5728	4952	3632	27124	253430	3635	80271	51763	54928	9562	22876
PC_3075	Negative regulation of (Binding of GPCR ligand and GPCR) ( GPCR signaling (pertussis toxin) )	2771	2770
PC_3076	2-Oxo-glutaric acid + L-Cysteine = L-Glutamic acid + 3-Mercapto-pyruvic acid ( Methionine and Cysteine metabolism )	2806	2805
PC_3077	adenosine nucleotides degradation II	4860	100	4907	7498	22978	113179	84618	51251
PC_3078	CD40/CD40L signaling	51567	4609	722	3565	3725	4790	7128	958	4792	5295	959	207	6776	5290	5291	5599	5601	6416	5294	3718	5602	5970	598	7186	7185	7187	868	4214	330	329	5600	1432	146850	83953	9020	7189
PC_3079	tetrahydrobiopterin biosynthesis II	2643	6697	5805
PC_3080	dermatan sulfate biosynthesis (late stages)	51363	113189	29940	10090
PC_3081	NAD+ + L-Glutamic acid + H2O = NADH + 2-Oxo-glutaric acid + NH3 ( Arginine and Proline metabolism )	2746	2747
PC_3082	Notch degradation signaling ( Notch signaling pathway Diagram )	4851	4853	55294	4855	4854
PC_3083	ERK cascade ( FGF signaling pathway )	5894	369	673	2002	5595	5594	5605	5604
PC_3084	Fc-epsilon receptor I signaling in mast cells	8611	5609	3551	5338	1147	7456	27040	2353	3265	5894	5319	3725	5579	2534	4067	2205	3059	7409	2241	5335	4790	5921	1901	867	5595	5295	5594	1843	6464	2207	207	2213	5605	5290	6850	5599	6416	5321	5829	2885	2206	5604	5970	5747	5781	695	6654	3702	5783	3937	5062	868	4214	4773	112476	3635	10219	2571	1796	7462	8877	9846	8517
PC_3085	Rapoport-Luebering glycolytic shunt	669	5224	5223	9562
PC_3086	Nicotinate and Nicotinamide metabolism ( Nicotinate and Nicotinamide metabolism )	5169	65220	4907	5167	952	4837	22978	683	8776	8898	5168	23475	55191	30833	100526794	51251	56953	9107
PC_3087	Secretory pathway of Hh ( Hedgehog signaling pathway )	50846	3549	6469	55733
PC_3088	Signaling events mediated by VEGFR1 and VEGFR2	9146	5170	8440	7448	5894	3690	5579	2534	3685	2242	3320	3326	6714	673	7422	4690	5578	5566	5771	2321	7414	5335	867	5595	5295	5594	5777	4846	207	1003	1495	1499	3791	5605	5290	5606	4734	8826	5829	9261	1785	5608	998	387	801	2885	375	5604	857	5747	5580	5781	5795	5062	2887	6093	2549	1605	2185	6461	5600	1432	8165	10645	9047	26509	23291
PC_3089	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	8871	3636	8867	3706	3707	3633	4952	3705	3632	27124	253430	3635	80271	51763	64768
PC_3090	Activation of Smo ( Hedgehog signaling pathway )	156	409	6608	11127
PC_3091	3-Methyl-butanoyl-CoA + Acceptor = 3-Methylbut-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	34	84129
PC_3092	Deoxy-inosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Hypoxanthine ( Purine nucleotides and Nucleosides metabolism )	1890
PC_3093	GMP + Pyrophosphate = Guanine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	353
PC_3094	zymosterol biosynthesis	7108	51478	3930	50814	6307	1595
PC_3095	5-Formimino-tetrahydro-folic acid + L-Glutamic acid = L-Tetrahydro-folic acid + N-Formimino-L-glutamic acid ( Histidine degradation )	10841
PC_3096	Signaling with Wnt (Canonical) ( Mammalian Wnt signaling pathway Diagram )	8326	607	7480	7476	7483	7484	8323	8324	4041	4040	7481	7471	7472	1499	6932	7474	6597	7473	89780	54361	7477	7088	7089	7090	7091	2033	7855	4089	2535	1387	7482	7479	90780	80326	7478	81029	8325	83439	7976	6934	51384	51176	8322	11211	8321	26108	7475
PC_3097	putrescine biosynthesis III	4953	113451
PC_3098	Adenylo-succinic acid = AMP + Fumaric acid ( Purine nucleotides and Nucleosides metabolism )	158
PC_3099	Arf6 signaling events	5662	9265	11033	9630	1956	1950	3690	154	3674	4233	6714	3082	4690	7253	1942	3973	1969	2767	185	2769	409	9098	5829	408	2776	382	9744	23527	9922	26034	116984	9266	23303	26269	51454	28964
PC_3100	Dimethylallyl diphosphate = Isopentenyl diphosphate ( Steroids metabolism )	3422	91734
PC_3101	AndrogenReceptor	5296	1613	7041	10542	23028	1620	9404	9611	8554	9063	25803	11143	6840	7468	1956	7432	2099	2908	2597	3315	3725	2934	5925	983	3320	6667	3303	142	367	1329	3309	3312	1629	7150	291	6714	2547	7520	7181	2963	7184	5451	1386	6925	1385	1655	2068	2071	1644	984	2316	595	898	405	811	5295	834	896	993	994	207	2965	3308	1499	2962	196	672	3572	6774	2119	836	4110	8204	5829	7182	1050	2932	1022	1025	902	4331	840	3169	3275	5728	5881	5499	5901	10399	7329	6047	7110	4088	1020	4193	861	2288	857	6736	7337	5747	5052	166	2033	2308	10957	3065	8031	2966	2967	860	2274	23054	841	4841	8431	7050	10499	7536	8648	11140	64800	55128	51497	27043	51588	83637	51564	2968	1387	8850	6599	10524	6605	94274	23411	64324	25898	10048	25942	11315	3276	573	23081	10114	23598	106821730	57786	29843	29893	8409	9604	1616	26060	57178	5325	10273	5036	6049	23132	55818	9612	8926	8202	10401
PC_3102	oxidized GTP and dGTP detoxification	4521
PC_3103	Caspase3 activation signaling ( TNFR1 signaling pathway )	836	841
PC_3104	Aurora C signaling	3020	9212	3619	6795
PC_3105	glutamate degradation III (via 4-aminobutyrate)	7915	18	2572	2571
PC_3106	Signaling with Wnt (Drosophila) ( Drosophila Wingless/Wnt signaling pathway Diagram )	7088	7089	7090	7091
PC_3107	ERK cascade ( GPCR signaling (G alpha s, PKA and ERK) )	673	5595	5594	5605	5604
PC_3108	UTP + AMP = UDP + ADP ( Pyrimidine Nucleotides and Nucleosides metabolism )	50808
PC_3109	Notch degradation signaling (C. elegans) ( Notch signaling pathway Diagram )	4851	4853	4855	4854
PC_3110	coenzyme A biosynthesis	80347	60490	79717
PC_3111	salvage pathways of pyrimidine ribonucleotides	4833	10201	151531	4830	4831	978	8382	4832	7378	139596	7371	57379	83549	54963	29922
PC_3112	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	5634	221823
PC_3113	eumelanin biosynthesis	7299	7306	1638	7220
PC_3114	Caspase3 activation signaling ( Fas signaling pathway )	836	842
PC_3115	L-cysteine degradation III	4357
PC_3116	ERK cascade ( Integrin signaling pathway )	5894	5595	5594	5605	5604
PC_3117	ALK1 pathway	94	2280	90
PC_3118	superpathway of inositol phosphate compounds	5293	5286	5296	5287	10423	8395	8871	3636	23262	8867	23396	9651	5288	5336	5335	3706	5295	3707	3633	5290	5291	5297	5305	5294	5333	5728	8396	5330	4952	5331	3705	8897	3632	5332	27124	23007	138429	146850	9677	90809	89869	113026	55529	64419	5289	253430	79837	55300	23533	9807	9896	8503	3635	80271	117283	30849	8394	84812	51763	55361	64768	23236	22908	51196	5298	51447	9562	200576
PC_3119	Negative feedback regulation of FGF8 signaling by Sprouty1 (Xenopus) ( FGF signaling pathway )	10252	6654	6655
PC_3120	thiosulfate disproportionation III (rhodanese)	7263
PC_3121	D-Sedoheptulose 7-phosphate + D-Glyceraldehyde 3-phosphate = D-Erythrose 4-phosphate + D-Fructose 6-phosphate ( Pentose phosphate cycle )	6888
PC_3122	Signaling without Hh ( Hedgehog signaling pathway )	2735	2736	2737	5727	6608	51684
PC_3123	p38 cascade ( IL-1 signaling pathway (through p38 cascade) )	5603	6885	1386	5599	5601	5608	6300	5602	5600	1432
PC_3124	JNK cascade ( IL-1 signaling pathway (through JNK cascade) )	5603	6885	3725	5599	5601	5608	6300	5602	5600	1432
PC_3125	Gene expression of smad7 by R-smad	4092	4093	4088	4089	4087	4086	4090
PC_3126	Ephrin B reverse signaling	6885	8440	3690	3932	2534	7525	4067	3674	3055	2268	6714	5295	2048	5290	5599	6416	5998	640	1948	2050	2047	5879	1947	1759	5783	7074
PC_3127	CoA + GTP + Succinic acid = Succinyl-CoA + GDP + Orthophosphate ( Citrate cycle )	8802	8801
PC_3128	Signaling without Wnt (Canonical) ( Canonical Wnt signaling pathway Diagram )	6932	7088	7089	7090	7091	83439	6934	51176
PC_3129	Insulin-mediated glucose transport	10652	9882	3630	3643	2997	6517	23433	10971	207	208	7529	2810	5501	5584	434	2932	7532	801	7531	6844	7534	7533	5590	6810	9322	5506	252983	4012
PC_3130	IMP + Pyrophosphate = Hypoxanthine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	3251
PC_3131	colanic acid building blocks biosynthesis	5373	2762	7358	2821	2592	4351	2584	7264	2582	7360	5372	29926	29925
PC_3132	Notch-mediated HES/HEY network	23028	3717	9611	920	632	5925	142	4602	2548	367	2690	4654	6929	2623	7528	405	3791	6774	5730	2626	1027	4851	429	1827	1869	7088	3516	2033	1487	3065	817	860	3280	7291	8648	3091	256297	84441	9794	1387	2627	55502	23013	5932	23493	50674	23462	9612
PC_3133	N-Acetyl-D-glucosamine 1-phosphate = N-Acetyl-D-glucosamine 6-phosphate ( Aminosugars metabolism )	5238
PC_3134	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	23475	55191	349565	23057	64802
PC_3135	EphrinB-EPHB pathway	2048	1948	2049	2050	2047	1947
PC_3136	Regulation of retinoblastoma protein	8535	1871	8841	6839	4286	25	632	5894	1437	3725	4632	5925	1158	4233	1019	4654	1386	7343	11016	1051	6688	6908	890	6872	5077	595	898	1017	6046	1786	894	896	1997	6441	5468	1026	1029	5601	1027	1050	1052	5948	6597	145258	7042	5515	1021	4193	1869	3398	4208	5928	2033	6598	6502	1487	3065	860	7027	1870	5600	1874	1432	1387	23411	26574	28227
PC_3137	Negative regulation of heterotrimeric GPCR signaling pathway (through G alpha q and PLC beta) ( GPCR signaling (G alpha q) )	6003	6002	6004	8490	10636	6001	8787	8601	8786	5997	9628	10287	5998	5999	6000	2776	85397	5996	64407	26575
PC_3138	CXCR3-mediated signaling events	6373	5170	10563	4893	3265	3845	5196	3627	5894	2771	2773	2775	6714	2781	5595	5295	5594	207	5605	5290	5291	2475	5606	408	2833	6356	5608	54331	2782	2770	5604	1759	4283	5600	1432	253260	79109	64223
PC_3139	Noncanonical Wnt signaling pathway	1855	1856	6885	8323	8324	7525	2316	409	5468	7474	5599	5601	1452	5602	89780	998	387	5879	4920	5590	6093	7855	4773	2535	9869	10454	1857	115908	23118	55636	51701	815	23002
PC_3140	Gene expression of SOCS by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram )	8835	30837	9021	9306	8651	9655	6774	6772	6778	6776	6777	6773	6775	122809
PC_3141	Coregulation of Androgen receptor activity	3092	10106	7113	7041	23028	8554	6840	2934	354	3178	367	6722	2547	7520	6925	3817	4117	984	595	896	207	1499	672	1029	8204	6197	7329	5591	7110	1021	2288	7337	5052	8031	2274	2185	23054	841	7050	10499	5469	24149	10498	27043	51588	146225	9039	5074	10048	4824	58190	23081	23598	26524	26060	10451	57178	5036	55818	8926	10401
PC_3142	Glycine and Serine metabolism ( Glycine and Serine metabolism )	57016	314	211	1610	26	10993	4128	212	2731	6897	4129	1491	102724560	2617	6301	5723	2593	27232	22949	50814	8639	51144	635	51268	10400	23761	29958
PC_3143	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	55907	140838	54187	10020
PC_3144	regulation of target gene expression by AP-1 ( IL-1 signaling pathway (through p38 cascade) )	1386
PC_3145	IL2 signaling events mediated by PI3K	7015	2309	4609	3559	3932	3320	4602	596	3560	6609	4790	6198	3716	5295	6464	207	3561	5290	2475	3718	3558	801	6194	2885	5879	1869	5970	5590	5781	598	6654	4773	8661	7357	259230	9846
PC_3146	Presenilin action in Notch and Wnt signaling	28514	1855	102	8312	6885	4040	22943	2353	4609	7471	3725	6927	595	324	5595	5594	1499	4851	4734	1452	5663	2932	1457	5467	7088	3516	166	1487	3065	5528	10454	1840	79412	83464	23385	1387	10023	85407	51107	55851	51701	27123	23291	8321	8945	11197
PC_3147	Cytokine receptor degradation signaling ( JAK-STAT pathway and regulation pathway Diagram )	9021	3559	3570	2690	3554	3560	3459	1438	5618	3575	3454	2057	3566	3577	3579	3563	1271	7850	3561	1439	3460	3572	4352	3594	3977	3953	3455	3597	3581	3568	3588	3601	8809	3587	3598	23765	1441	9180	3595	3556
PC_3148	Signaling events regulated by Ret tyrosine kinase	3265	3725	5979	6714	1385	4690	5578	5566	5921	5595	5295	5594	6464	3667	2668	5290	5599	1398	5829	2674	9564	387	5906	2885	5879	5747	5781	6654	2887	2549	2886	220164	55715	10818	1796	9260	55816	8660
PC_3149	IL27-mediated signaling events	3717	7040	7124	3458	3553	3569	3716	2625	3592	3593	7297	3572	6774	6772	6776	3594	6773	3558	3606	10148	6775	3605	9466	246778	3595	30009
PC_3150	Validated nuclear estrogen receptor beta network	718	7561	6597	190	9040	6598	8431	10499	8648	4738	9039	79039	2100	6605	8202
PC_3151	TWEAK	7188	3551	1147	6885	407977	7124	142	4790	4792	5595	5594	207	208	1499	5599	5601	2932	5879	4791	5971	5970	7186	7185	7187	8772	329	8737	3065	841	4793	1432	9332	572	8718	51330
PC_3152	2-Oxo-glutaric acid + beta-Alanine = L-Glutamic acid + Malonate semialdehyde ( Alanine,Aspartic acid and Asparagine metabolism )	18
PC_3153	p38 MAPK signaling pathway	6885	4616	10912	9064	7295	1647	5606	5608	801	5879	4294	7186	4214	472	816	10454	5600	1432	57551	4217	4215	83605	51347	23118	9344	7189	4216
PC_3154	Canonical Notch signaling pathway ( Notch signaling pathway Diagram )	28514	102	4851	5663	5664	182	6868	4853	3516	2033	84441	9794	1387	55534	4855	54567	10683	4854	3714
PC_3155	5,6-Dihydro-uracil + H2O = Ureido-propanoic acid ( Pyrimidine Nucleotides and Nucleosides metabolism )	1807
PC_3156	Citric acid = Isocitric acid ( Citrate cycle )	48	50
PC_3157	Validated transcriptional targets of deltaNp63 isoforms	6862	26959	23541	9133	100	3552	3861	5452	7153	7421	3852	2355	3486	2877	1289	3675	624	558	2810	1029	4851	10413	2194	1052	2932	4361	675	6236	1749	1750	23682	10399	4193	861	3084	472	3280	5525	11047	252983	1029	55294	64065	83737	11059	8626	83439	3070
PC_3158	molybdenum cofactor biosynthesis	27304	4338	4338	10243	9054
PC_3159	ERK cascade ( FGF signaling pathway )	5894	369	2078	2113	2114	673	6688	2002	5595	2005	5594	5605	2119	2120	2004	2313	5604
PC_3160	G alpha s GDP-GTP exchange signaling ( GPCR Dopamine D1like receptor signaling pathway )	2793	10681	2784	1812	1816	2778
PC_3161	Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )	8326	2918	28514	7480	7476	9542	2793	10681	2660	7483	7484	2069	2916	2255	8823	50846	2277	8822	8323	2661	8324	8817	10220	27302	9965	9210	7481	183	3827	5155	1950	7039	7040	4803	2796	4878	5020	551	5443	1081	7252	2488	3972	5617	2688	796	2641	7432	2691	5539	4852	3630	3481	2520	4049	7124	3439	3440	3446	3444	3452	3442	3448	3451	3456	3458	3552	3553	2056	5154	1437	7471	3467	3443	3441	3449	3479	3623	3565	3567	2246	3569	1906	885	1392	796	1622	2922	3624	2249	3562	2247	3625	7472	2695	6343	1440	5697	797	3576	7043	2251	2248	2250	650	652	651	4295	3574	1908	3082	1813	3976	3578	374	7422	2784	655	6863	7200	4908	1907	3589	4254	1812	2252	1815	1816	653	654	3586	51083	627	3577	3579	135	136	3592	3593	959	134	185	2254	3445	941	4909	656	685	3596	1814	2668	200081	7066	3600	3952	7474	2915	942	8200	356	7423	7424	186	8743	2253	3626	2662	7473	89780	54361	7477	10718	83729	6750	7042	2778	182	51052	4693	3084	2911	7855	3603	3606	2535	2912	3549	2917	2913	2914	6469	3605	392255	151449	145957	2258	2256	2259	7482	7479	4838	1839	6608	80326	8074	7478	81029	8325	27006	26281	7976	9573	54567	26291	10683	51384	6866	2658	8322	11211	8321	3714	7475
PC_3162	GTP + Oxaloacetic acid = GDP + Phosphoenol-pyruvic acid + CO2 ( Citrate cycle )	5105	5106
PC_3163	Porphyrin_metabolism ( Porphyrin metabolism )	7389	3145	7390	210	2235	1371	5498
PC_3164	4-aminobutyrate degradation I	7915	18
PC_3165	L-Alanine + 2-Oxo-glutaric acid = Pyruvic acid + L-Glutamic acid ( Glutamic acid and Glutamine metabolism )	2875	84706
PC_3166	Validated targets of C-MYC transcriptional repression	8841	8837	2309	7812	22943	4609	2495	1791	2064	3688	6667	1278	3956	5159	596	1191	6352	3691	1385	6688	6908	3655	4800	595	1647	4801	5933	6278	1649	672	1026	7474	1030	1027	223	6556	1050	1052	7249	3158	4149	4088	3398	3394	677	2033	7709	4089	3065	2966	4802	10608	5524	4087	6422	10397	2672	81855	84233	9414	23671	57447	1788
PC_3167	Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	7157	3320	405	7428	8260	9978	10399	10956	8453	6921	6923	3091	1029	10987	112398	54583	112399	55662	64344
PC_3168	Purine nucleotides and Nucleosides metabolism ( Purine nucleotides and Nucleosides metabolism )	5138	5198	9061	112	5147	109	115	5151	955	956	957	8654	5152	8622	9060	111	100	3615	5315	4881	5145	5148	4882	3614	4907	2618	10606	270	6240	2984	5141	159	5313	6241	471	2977	5158	2766	114	7498	22978	8833	953	318	5146	113	2986	5136	132	5153	272	271	2982	2983	3000	5471	5142	108	5143	5144	107	5140	5150	5149	5137	5139	122622	55821	196883	30833	124583	100526794	55811	53343	3704	51251	27115	56953	51292	11164	9583	10846	9615	954
PC_3169	Ephrin A reverse signaling	2534	1946	2044
PC_3170	S1P5 pathway	2771	2773	2775	2781	387	2770	2768	53637
PC_3171	B-Raf activation signaling ( GPCR signaling (G alpha s, Epac and ERK) )	673	5908	5906
PC_3172	BMP signaling in Drosophila (dorsolateral) ( BMP signaling in Drosophila )	7490	6597	2033	84441	9794	1387	55534
PC_3173	Negative feedback regulation pathway of TGF beta superfamily signaling by (binding of smad6/7 and TGF beta receptor I) ( TGF-beta_super_family_signaling_pathway(canonical) )	658	4092	4091	657	91	7046	94	90
PC_3174	Rap1 activation signaling (through cAMP, PKA, Cbl and C3G) ( GPCR signaling (G alpha s, PKA and ERK) )	6714	5566	5568	867	5567	1399	5908	5906	868	2889	23624
PC_3175	Integrin family cell surface interactions	8515	3690	3689	3688	3685	3674	3678	3684	3676	3691	3673	3693	3694	3683	3687	3655	3675	3695	3696	3682	8516	3672	3681	3679	3680	22801
PC_3176	ERK cascade ( Insulin receptor signaling )	5894	369	673	2002	5595	5594	5605	5604
PC_3177	EPHA2 forward signaling	3636	6714	1942	867	52	5295	1969	6464	5290	7410	9564	387	2885	5879	5747	7074	5058	2909	10451
PC_3178	Xenopus axis formation Wnt signaling pathway ( Xenopus axis formation Wnt signaling pathway Diagram )	7480	7476	7483	7484	4041	4040	22943	7481	7471	7472	7474	7473	89780	54361	7477	79412	7482	7479	83999	80326	7478	81029	27122	27121	27123	51384	11197	7475
PC_3179	Negative feedback regulation of FGF8 signaling by Mkp3 (Xenopus) ( FGF signaling pathway )	5595	5594	1848
PC_3180	Signaling events mediated by HDAC Class I	10284	10419	7514	4092	8841	23309	9611	8819	9219	53615	7124	7181	2623	5566	7132	4790	2624	7528	4792	8021	23636	5468	6774	5905	9972	5903	9759	4149	121504	5901	7341	7329	2287	5970	4084	5928	2033	7024	1107	3065	1108	5931	8338	8349	126961	54815	161882	22933	51548	125997	23225	51564	57459	3066	1387	8850	83933	79885	23411	25942	79084	55869	57154	51547	23410	23408	8932	10013	9734	23381	10014	8945	9612	23409
PC_3181	Inactivation of Ptc by Hh ( Hedgehog signaling pathway )	50846	5727	3549	6469	8643
PC_3182	IL9	3578	3716	5595	5295	5594	6464	7297	207	3561	3667	5605	6774	6772	6778	6776	6777	3718	7415	2885	3581	5604	5781	10524	8660
PC_3183	Xanthosine + Orthophosphate = Xanthine + D-Ribose 1-phosphate ( Purine nucleotides and Nucleosides metabolism )	4860
PC_3184	JNK cascade ( TNFR1 signaling pathway )	5609	3725	5599	5601	6416	5602	4217
PC_3185	folate polyglutamylation	4522	6470	6472	2356	25902
PC_3186	NAD salvage pathway III	349565	23057	64802	27231	54981
PC_3187	oleate biosynthesis II (animals)	6319	3992	9415	10965	79966	641371	283985	122970
PC_3188	glutathione biosynthesis	2729	2730	2937
PC_3189	CD4 T cell receptor signaling (through Vav, Rac and JNK cascade ( CD4 T cell receptor signaling (JNK cascade) )	27040	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	917	3123	3123	3126	5880	7409	5336	5335	3113	3123	919	7535	5881	5879	3125	5588	3123	3123	3123
PC_3190	Alpha6Beta4Integrin	1179	5293	5296	3911	7161	9423	25	1956	2353	2064	3725	2534	1977	3912	7525	4233	7431	3921	367	3915	6714	1832	3691	5578	3655	3908	284217	10971	5595	5295	5594	2048	6464	207	7529	2810	3667	5290	5291	2475	836	977	5294	3913	3692	387	7531	2885	5879	7534	4088	667	4486	7533	5747	5580	5781	5058	2549	1978	3914	3918	5339	4087	1432	3909	91807	8503	572	55914	6242	1308	9635	8660
PC_3191	IL2	6446	5293	5296	9021	7015	8651	2309	3717	10254	3559	5894	2908	3725	3932	2534	1977	3320	4067	7429	596	3560	2113	2114	1386	7409	1385	2002	4790	867	6198	3716	898	1017	5595	5295	5594	5777	6464	207	3561	3667	5605	6774	3600	6772	6776	5290	5291	2475	6850	5599	1398	1399	5294	6777	3718	8662	3558	6194	2885	4904	5604	5970	5590	5781	6654	9111	1978	2185	6775	6461	1432	8503	8027	572	8569	23236	1154	9846	9445	8660
PC_3192	tryptophan degradation III (eukaryotic)	8564	30	38	23498	6999	3032	8942	125061	130013	2639	39
PC_3193	pentose phosphate pathway (oxidative branch)	25796	9563	2539	5226
PC_3194	fatty acid beta-oxidation I	11001	2182	10455	2181	30	1892	2180	3030	1632	10449	3032	1962	3033	81616	23205	3028	23305	51703
PC_3195	Integrins in angiogenesis	131873	256076	5286	10085	1277	1280	1281	1282	2335	7448	3479	3690	1290	3685	1436	3320	3480	1278	1284	2247	1435	6696	1301	1291	1292	1293	6714	1302	7422	7414	6382	1289	867	6198	5595	5295	5594	1287	207	3667	3791	7048	5290	5297	1027	5829	1286	9564	387	5879	1285	1294	5747	5781	4240	3611	6093	1288	2185	841	25960	5298	10451	7094	27329	50848
PC_3196	Wnt	8326	607	6656	7476	1855	1856	9368	7483	7484	8395	8312	6885	8323	8324	4041	23401	4040	22943	7481	5894	7471	5582	3725	5579	7525	7472	999	6714	3728	6925	6929	5578	5566	1000	595	5583	324	5595	5594	207	7529	409	6259	1499	1139	5468	7474	5599	6416	1452	1453	408	102800317	2931	2932	2719	1488	7473	89780	54361	7477	387	5499	5879	5515	1601	1021	4919	4920	5581	5076	5588	5580	4035	4214	1487	3611	7855	4773	5300	2535	2646	23184	9869	85458	4086	284654	6424	340419	2011	6422	2487	10023	1857	6423	83999	55361	84870	81029	8325	7976	6934	50649	55636	51701	6199	84152	9365	51176	8322	11211	8321	8945	8313	23002	11197	7475	4216
PC_3197	NAD+ + 3-Methoxy-4-hydroxy-phenyl-glycolaldehyde + H2O = NADH + 3-Methoxy-4-hydroxy-mandelic acid ( Tyrosine metabolism )	218	221	220
PC_3198	Raf activation signaling (through Grb2 and Sos) ( JAK-STAT pathway and regulation pathway Diagram )	4893	3265	3845	5894	369	673	2885	6654	6655
PC_3199	IFN alpha signaling pathway((JAK1 TYK2 STAT1 STAT2) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) )	3439	3440	3446	3444	3452	3442	3448	3451	3443	3441	3449	3454	3716	7297	3445	6772	3455	6773	10379
PC_3200	FSH	6446	2309	25	1956	1081	2488	5894	3315	2534	5914	5573	6714	1385	2697	5566	7052	2492	156	10971	5595	5594	207	208	409	2868	5605	407	2475	2870	408	7249	5333	6197	5563	6194	4193	5604	5970	2308	1978	5801	1432	8290	26060
PC_3201	sulfite oxidation IV	6821
PC_3202	NAD+ + (S)-3-Hydroxy-butanoyl-CoA = NADH + Acetoacetyl-CoA ( Butanoate metabolism )	3030	1962	3033	3028
PC_3203	Signaling events mediated by PRL	11156	183	3688	389	6714	1958	890	898	1017	5595	5594	1026	5876	3672	9564	387	5879	10376	8073	6093	5875	7803	22809
PC_3204	NAD+ + (S)-3-Hydroxy-2-methyl-butanoyl-CoA = NADH + 2-Methyl-3-acetoacetyl-CoA ( Valine,Leucine and Isoleucine degradation )	3030	1962	3033	3028
PC_3205	histamine degradation	314	26	3176
PC_3206	arginine degradation I (arginase pathway)	4942	383	8659	384
PC_3207	IL-5 signaling pathway(JAK1 JAK2 STAT1 STAT5) ( IL-5 signaling(JAK1 JAK2 STAT1 STAT5) )	3717	3567	3716	6464	1439	6772	6776	6777	25759	3568	53358
PC_3208	urate biosynthesis/inosine 5'-phosphate degradation	4860	3615	3614	4907	7498	22978	115024
PC_3209	Gene expression of SOCS1 by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram )	8651	6774	6772	6778	6776	6777	6773	6775
PC_3210	Gene expression of MAFbx by FOXO ( Insulin receptor signaling (Mammal) )	2309	4303	2308
PC_3211	D-Glucose 1-phosphate = D-Glucose 6-phosphate ( Galactose metabolism )	5236
PC_3212	NAD+ + Succinate semialdehyde + H2O = NADH + Succinic acid ( Glutamic acid and Glutamine metabolism )	7915
PC_3213	PLC beta signaling ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	2776	5330	5331	5332	23236
PC_3214	G alpha i GDP-GTP exchange signaling ( GPCR signaling (G alpha i) )	8326	2918	2793	10681	2916	8323	8324	2771	1813	2784	1812	1815	1816	3577	3579	135	136	134	185	1814	2915	186	2770	2911	7855	2535	2912	2917	2913	2914	6608	8325	7976	8322	11211	8321
PC_3215	diphthamide biosynthesis	51611
PC_3216	L-Glutamine + H2O = L-Glutamic acid + NH3 ( Glutamic acid and Glutamine metabolism )	2744	27165
PC_3217	Regulation of p38-alpha and p38-beta	5063	3932	2534	7525	4067	3055	2268	5898	5899	6714	1843	6416	5606	640	5608	998	5879	7786	5058	5062	1850	8737	5592	10454	5600	1432	4215	83605	80824	7189	11221
PC_3218	D-myo-inositol-5-phosphate metabolism	9651	5336	5335	5305	5333	5330	5331	8897	5332	23007	90809	89869	113026	55529	64419	79837	84812	23236	51196
PC_3219	citrulline degradation	5009
PC_3220	TRAIL signaling pathway	8797	8795	8794	3551	1147	8837	6609	5595	5295	5594	5290	5291	5599	6416	8743	7818	7186	8772	4214	8737	841	8717	843	8793	8517
PC_3221	Phospholipase C gamma signaling ( CD4 T cell receptor signaling (JNK cascade) )	5336	5335	3702	3710	3708
PC_3222	IL12 signaling mediated by STAT4	9063	8807	2353	7040	3458	3559	920	3122	3123	915	3725	916	917	940	3659	5551	919	941	3596	6774	2119	942	5599	5601	3558	4773	8809	3606	6775	1387	30009
PC_3223	Signaling without Wnt (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	6932	7088	7089	7090	7091	83439	6934	51176
PC_3224	Stabilization and expansion of the E-cadherin adherens junction	23396	1729	11336	1500	1956	1950	3479	3480	4233	4633	87	999	3082	4690	7414	1942	1969	1495	1499	7408	362	4301	387	382	4248	6810	6093	7791	144100	10006	55740	360	5819	4026	60412	26999	3801	55763	57662	51474	4646	10787	28964
PC_3225	Aminosugars metabolism ( Aminosugars metabolism )	3098	2645	3099	3101	55907	64841	54187	55577	10020
PC_3226	Pyrimidine Nucleotides and Nucleosides metabolism ( Pyrimidine Nucleotides and Nucleosides metabolism )	7084	955	956	957	7083	7298	7372	1503	4907	6240	1633	790	6241	978	1635	1854	22978	953	30833	124583	100526794	3704	7371	57379	51251	83549	56953	56474	51733	9583
PC_3227	ErbB1 downstream signaling	2151	8976	5338	10095	10109	10094	10092	5170	9252	8986	1956	2353	4893	3265	3845	1950	5894	3725	5898	6722	6714	673	1386	1385	5578	824	378	1958	466	2002	6548	5868	7538	10971	5595	5295	5594	1843	5037	5518	207	7529	2810	5605	6774	6772	5290	5291	2475	5599	5601	6416	8826	6197	7410	1124	5536	10093	998	10096	10097	7532	801	7531	6194	2885	5879	7534	5520	5515	5604	7533	5590	5580	4208	598	6654	2059	5900	5607	5598	4214	5337	2549	9610	4086	1848	253260	8844	10006	55845	9712	572	29895	26999	79109	64223	9047	81624	10458	10787	10746	10163
PC_3228	NAD+ + L-Saccharopine + H2O = NADH + L-2-Amino-adipate 6-semialdehyde + L-Glutamic acid ( Lysine degradation )	10157
PC_3229	Nongenotropic Androgen signaling	2353	3265	2796	5894	6462	2771	2773	2775	367	6714	1385	5336	2781	5335	5595	5295	5594	207	5605	5290	54331	998	2782	5879	2770	5330	5331	5604	5747	27043	23236
PC_3230	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Pentose phosphate cycle )	5634	221823
PC_3231	Syndecan-1-mediated signaling events	131873	256076	6386	8573	3911	9965	7040	1277	1280	1281	1282	4312	1290	1278	1284	4233	4316	1301	1291	1292	1293	6352	1302	3082	4318	5566	6382	1289	2263	2264	2261	5479	5595	5594	1287	682	1286	1285	1294	1288	8074	10855
PC_3232	5,10-Methenyl-tetrahydro-folic acid + H2O = 10-Formyl-tetrahydro-folic acid ( Folate metabolism )	4522	10797	25902
PC_3233	Beta5 beta6 beta7 and beta8 integrin cell surface interactions	3491	10085	5328	2335	7448	3685	3676	3693	3694	6382	7412	3695	3696	2200	7046	5329	8174
PC_3234	Integrin signaling pathway ( Integrin signaling pathway )	375790	1463	11081	9672	2239	8515	4893	3265	3845	1277	1280	1281	1282	2335	5894	3690	3689	3688	1290	3932	2534	3685	1634	1278	3674	1284	3678	4168	3684	1301	1291	1292	6714	1462	3676	1302	673	7409	2006	960	176	3691	3673	3693	7414	3694	6382	3683	3687	1297	1289	633	7148	3655	3371	1296	3675	3695	3696	1295	6464	1287	6385	6383	2817	3682	1306	80781	5599	5601	1398	5829	4060	1286	8516	5602	3672	9564	60	998	5908	387	5906	2885	5879	25759	3339	1285	1294	857	1300	5747	1307	6654	6655	3681	3679	3914	3918	3680	2889	1288	1299	1298	1793	1310	9459	1795	9732	81704	53358	1794	55619	63827	57572	85440	1303	23348	80005	22801	9126	7094	83660
PC_3235	NAD+ + (R)-Lactic acid = NADH + Pyruvic acid ( Pyruvate metabolism )	197257
PC_3236	Hh signaling pathway ( Hedgehog signaling pathway )	50846	3549	6469	50937	91653
PC_3237	IL6-mediated signaling events	9021	8600	3717	4286	8554	2	7076	2353	4609	2266	1401	1	3569	3725	3055	3570	3659	7184	7409	3726	1051	3929	3716	5791	5295	7297	207	3572	6774	6772	5290	6416	1052	5608	8543	2885	5879	5580	5781	598	4170	6654	2308	2549	5600	1432	9846	10401
PC_3238	Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )	8326	2918	28514	7480	7476	9542	2793	10681	2660	7483	7484	2069	2916	2255	8823	50846	2277	8822	8323	2661	8324	8817	10220	27302	9965	9210	7481	183	3827	5155	1950	7039	7040	4803	2796	4878	5020	551	5443	1081	7252	2488	3972	5617	2688	796	2641	7432	2691	5539	4852	3630	3481	2520	4049	7124	3439	3440	3446	3444	3452	3442	3448	3451	3456	3458	3552	3553	2056	5154	1437	7471	2771	3467	3443	3441	3449	3479	3623	3565	3567	2246	3569	1906	885	1392	796	1622	2922	3624	2249	3562	2247	3625	7472	2695	6343	1440	5697	797	3576	7043	2251	2248	2250	650	652	651	4295	3574	1908	3082	1813	3976	3578	374	7422	2784	655	6863	7200	4908	1907	3589	4254	1812	2252	1815	1816	653	654	3586	51083	627	3577	3579	135	136	3592	3593	959	134	185	2254	3445	941	4909	656	685	3596	1814	2668	200081	7066	3600	3952	7474	2915	942	8200	356	7423	7424	186	8743	2253	3626	2662	7473	89780	54361	7477	10718	83729	6750	7042	2770	182	51052	4693	3084	2911	7855	3603	3606	2535	2912	3549	2917	2913	2914	6469	3605	392255	151449	145957	2258	2256	2259	7482	7479	4838	1839	6608	80326	8074	7478	81029	8325	27006	26281	7976	9573	54567	26291	10683	51384	6866	2658	8322	11211	8321	3714	7475
PC_3239	trans, trans-farnesyl diphosphate biosynthesis	9453	2224	3422	91734
PC_3240	TSLP	3717	3575	4790	3716	4792	5595	5594	207	6774	6772	6778	6776	5599	5601	6777	6194	4791	5971	5970	1978	6775	1432	85480	64109
PC_3241	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Citrate cycle )	38	39
PC_3242	Osteopontin-mediated events	1147	9475	5328	2353	3690	3725	2934	3685	4313	6696	4318	960	4790	4792	5595	5295	5594	5290	6850	5599	9564	998	387	5879	58	5970	4214	3611	2185	9020	8394	10451
PC_3243	TSH	5296	9021	3551	8651	5170	3717	2778	3265	1081	7252	7038	5894	301	2771	476	3150	3151	5925	1508	3480	2773	2775	3309	3312	6513	1019	6714	1386	1385	7253	5578	5566	3716	898	1017	4792	5595	328	811	821	5295	5594	6464	2767	896	207	682	6774	3952	6772	5290	2475	1027	5606	5909	2776	7408	5608	6566	387	6194	2770	375	5604	1390	2768	5970	5747	5590	5144	5900	1978	23513	10672	6195	4793	1432	84335	84152	30818	8660
PC_3244	Gene expression of SOCS3 by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram )	9021	6774	6772	6778	6776	6777	6773	6775
PC_3245	Plexin-D1 Signaling	8829	8395	9723	8515	3688	3685	3678	6237	3676	7422	3673	3655	3675	8153	8516	3672	382	3679	3680	9922	10512	64218	22801	23129
PC_3246	p73 transcription factor network	274	8611	1111	7161	10018	2309	699	9184	4720	9191	10277	9134	25	100	5265	4609	174	4914	5054	5925	983	6667	200933	891	2623	7490	890	5567	3716	3566	898	1017	355	6273	5371	2810	1026	835	27065	10413	2194	675	5347	10399	1021	3297	4193	5970	5888	581	2033	5300	2319	8682	5600	1432	578	3029	9540	54894	23151	7846	196513	64782	10524	23411	83737	25898	23327	5204	9518	27113	8626	1263	63970	3556	51741	23493	9635	3714
PC_3247	S1P1 pathway	5155	2771	2773	2775	5159	7422	2781	5335	1901	5595	5594	4363	5743	3791	387	5879	2770	5330	112476	8877
PC_3248	Succinic acid + Ubiquinone = Fumaric acid + Ubiquinol ( Arginine and Proline metabolism )	6390	6389
PC_3249	Negative regulation of (Phosphorylation of JAK) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram )	3717	3716	5777	7297	3718
PC_3250	methylglyoxal degradation I	2739	3029	197257
PC_3251	Role of Calcineurin-dependent NFAT signaling in lymphocytes	7514	4772	5582	5579	596	5292	5578	5566	3164	9495	5583	10971	5595	7529	2810	8021	1326	836	5599	5601	1452	2932	3838	1827	7532	801	7531	5901	2280	7534	1457	5581	5588	7533	5590	5580	581	598	2033	4775	4214	4773	10231	23770	4209	3837	1432	814	1387	572	11261	23523
PC_3252	Caspase3 activation signaling ( TNFR1 signaling pathway )	836	842
PC_3253	Caspase Cascade in Apoptosis	8797	1676	317	8795	2620	1677	7124	4000	351	7020	3875	2934	7431	142	3002	596	7150	5551	7132	4001	355	207	6720	836	835	356	8743	397	3984	840	842	839	637	58	8738	331	54205	6304	84823	5747	581	598	7186	8772	4214	330	8737	6709	841	4926	8717	8567	843	9748	55367	56616	1073
PC_3254	methylthiopropionate biosynthesis	55256
PC_3255	Syndecan-2-mediated signaling events	6386	23495	8573	9965	3827	3265	7040	2335	1437	3688	4313	3576	2035	6714	7430	3673	5566	5921	4763	2263	2264	2261	284217	5595	5594	2048	6383	836	5599	858	387	10399	5580	581	3909	112476	8074	51399
PC_3256	L-Arginino-succinic acid = L-Arginine + Fumaric acid ( Alanine,Aspartic acid and Asparagine metabolism )	435
PC_3257	Deoxy-guanosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Guanine ( Purine nucleotides and Nucleosides metabolism )	1890
PC_3258	Thymidine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Thymine ( Pyrimidine Nucleotides and Nucleosides metabolism )	1890
PC_3259	NAD+ + 2-Propyn-1-al + H2O = NADH + Propiolic acid ( Propanoate metabolism )	8854	216	217	219	223	501	224
PC_3260	2-Oxo-glutaric acid + 4-Amino-butanoic acid = L-Glutamic acid + Succinate semialdehyde ( Arginine and Proline metabolism )	18
PC_3261	Glucocorticoid receptor regulatory network	6446	4772	2353	5443	1081	5617	3458	3861	2266	174	632	4312	1437	2908	7157	3565	3567	3569	3383	3725	1447	3320	3576	3659	2212	3852	5451	1385	6401	5566	6898	6688	1958	4790	6908	5568	5567	3164	2625	5595	5449	5594	207	2810	7433	3596	1026	5087	6772	6776	5599	5601	2932	6597	6777	5536	5602	3558	6613	1020	4193	2288	5970	3872	7533	581	2033	2289	4773	3065	9970	8851	10499	5600	8648	1432	5106	51111	6601	3066	1387	6599	6602	7251	30009
PC_3262	4-hydroxy-2-nonenal detoxification	2941	2938	2950	2940	221357
PC_3263	Rapid glucocorticoid signaling	1392	2774	5599	5601	54331	2782	2778	5600	1432	92170
PC_3264	Notch	5296	28514	4242	102	3717	9611	8819	351	3932	5045	6714	6929	4790	7528	5595	5295	5594	207	6774	4100	4851	4856	8650	5663	5664	2932	429	9978	6500	182	6868	2647	4088	5970	4853	3516	4208	6015	2033	1272	6502	3065	22938	8454	2273	3280	4086	388585	9541	1840	84441	3955	83464	23385	9794	3066	8850	55294	51107	55502	83737	55534	25942	23013	4855	55759	23509	54567	10683	55851	23493	51176	4854	3714	9612	9253
PC_3265	Succinyl-CoA + Acetoacetic acid = Succinic acid + Acetoacetyl-CoA ( Butanoate metabolism )	5019
PC_3266	Visual signal transduction	2793	10681	8787	9227	9626	101060233	2784	2780	407	118142757	5146	2986	3000	5149	6011	1261	6121	388531	131890	5959	145226	54714	25769	2979
PC_3267	Notch secretory pathway (C. elegans) ( Notch signaling pathway Diagram )	5045	4851	4853	4855	4854
PC_3268	pyrimidine ribonucleotides interconversion	4833	10201	4830	1503	4831	51727	8382	4832	129607	124583	56474	29922
PC_3269	Stabilization and accumulation of cytoplasmic beta-catenin (Xenopus) ( Xenopus axis formation Wnt signaling pathway Diagram )	8326	8323	8324	4041	4040	7855	2535	8325	7976	8322	11211	8321
PC_3270	citrulline-nitric oxide cycle	445	435	4846	4842	4843
PC_3271	D-glucuronate degradation I	51181	51084
PC_3272	phenylethylamine degradation I	314	217	224	8639
PC_3273	N-acetylglucosamine degradation I	10007	132789	51005
PC_3274	aspartate biosynthesis	2806	2805	137362
PC_3275	acyl-CoA hydrolysis	11332	10005	23597
PC_3276	PLC gamma signaling ( PDGF signaling pathway )	5156	5335
PC_3277	KitReceptor	8797	5296	10603	9306	2533	8651	7456	2309	27040	9046	3717	4286	9655	8935	8777	25	3265	5894	3725	5579	2534	2242	7525	4067	3055	2268	3815	6714	2997	7430	1386	7409	2241	3575	5336	5578	5335	2057	2002	5921	4254	867	6198	1017	4478	5595	5295	5594	5777	6464	207	1439	5962	5605	6774	6772	6776	5290	2475	4145	7006	7454	5599	1398	1399	2931	2932	7879	6777	3718	6300	10097	6194	2885	1213	5604	5970	5781	695	6654	2033	5058	868	4085	10146	2887	4773	1978	10750	2886	6195	1432	79930	200734	161742	122809	10076	3635	572	30011	1796	26228	9846	10019
PC_3278	ERK cascade ( Integrin signaling pathway )	673	5595	5594	5605	5604
PC_3279	ERK cascade ( JAK-STAT pathway and regulation pathway Diagram )	5894	369	673	5595	5594	5605	5604
PC_3280	ATR signaling pathway	1111	5810	3364	4683	5884	6118	890	1017	6117	5518	993	995	7529	4176	5984	5982	5985	5983	4171	675	5347	7534	5515	5521	4193	5888	545	84126	11073	5883	990	54962	2177	63967	50485	23291	8914	22897	8945
PC_3281	Gene expression of Sprouty1 ( FGF signaling pathway )	10252
PC_3282	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	51074	84245	55256	58478
PC_3283	Negative feedback regulation of FGF8 signaling by Mkp3 (Mouse) ( FGF signaling pathway )	5595	5594
PC_3284	a4b7 Integrin signaling	3688	3676	7412	3695	5829	387	5747	8174
PC_3285	Signaling with high concentrations of Hh ( Hedgehog signaling pathway )	2033	1387
PC_3286	L-cysteine degradation I	2805	1036
PC_3287	ATP + dUMP = ADP + dUDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	1841
PC_3288	Fanconi anemia pathway	8553	1111	2189	2175	7517	5810	3364	4683	5884	7398	6118	3014	6117	5984	5982	672	5985	5983	4361	675	641	2176	80233	472	7156	545	3280	79728	57697	100526739	2187	57599	84126	11073	10111	5883	91442	83990	2177	80010	2178	29089	2188	55215	55120	23291	8945	22909
PC_3289	ErbB2/ErbB3 signaling events	9542	3717	2353	4893	3265	3845	1134	5894	2064	3725	6714	5532	5566	2065	5595	5295	5594	6464	207	4771	5605	6774	9101	5290	5291	2475	5599	5601	5602	998	2885	5879	3084	5604	1145	5781	6654	4776	572	85440	10193
PC_3290	2-Methyl-butanoyl-CoA + Acceptor = 2-Methylbut-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	34	84129
PC_3291	tyrosine degradation I	2954	2184	6898	3242	3081
PC_3292	2-Oxo acid + L-Ornithine = L-Amino acid + L-Glutamate 5-semialdehyde ( Arginine and Proline metabolism )	4942
PC_3293	C-MYB transcription factor network	8535	22797	3950	6885	10043	9611	4094	8089	100	759	4609	4893	3265	3845	920	7471	4353	1436	6667	1278	1991	2944	1211	3015	4602	596	3815	3309	3312	5292	6497	891	2113	2114	290	4654	2623	1051	6688	490	4254	4618	2625	5657	595	947	136	4144	4173	5743	1026	1029	1027	8826	1050	1052	6595	1314	839	5897	4069	7329	8900	5250	1021	5079	5530	5481	2033	10155	330	3280	10454	6510	463	171558	27044	161882	1387	25942	28996	23118	51701	51176	8379	10401
PC_3294	Signaling by Aurora kinases	6790	9212	6795
PC_3295	5,6-Dihydro-thymine + H2O = 3-Ureido-2-methyl-propanoic acid ( Pyrimidine Nucleotides and Nucleosides metabolism )	1807
PC_3296	Negative regulation of (G alpha GDP-GTP exchange signaling) ( GPCR signaling (G alpha s, PKA and ERK) )	6003	6002	6004	8490	10636	6001	8787	8601	8786	5997	9628	10287	5998	5999	6000	85397	2778	5996	64407	26575
PC_3297	proline biosynthesis II (from arginine)	5009	4942	5831	65263	29920
PC_3298	D-Glucose 6-phosphate = D-Fructose 6-phosphate ( Pentose phosphate cycle )	2821
PC_3299	Effects of Botulinum toxin	10497	1134	5185061	6857	6616	6812	6844	6804	22999	25782
PC_3300	Inactivation of Ptc by Hh ( Hedgehog signaling pathway )	50846	5727	3549	6469
PC_3301	androgen biosynthesis	1586	3283	6715	3284	6716	3293	8644
PC_3302	Class IB PI3K non-lipid kinase events	5594	5294	5604	5140	146850
PC_3303	lanosterol biosynthesis	4047
PC_3304	5-Formimino-tetrahydro-folic acid + L-Glutamic acid = L-Tetrahydro-folic acid + N-Formimino-L-glutamic acid ( Folate metabolism )	10841
PC_3305	FGF signaling pathway	5170	10253	1500	9965	10298	5328	2353	632	2246	3725	4233	3002	6696	2260	999	6714	4684	3082	4318	1000	5335	2263	2264	2261	867	5595	5295	5594	6464	6385	207	6383	6774	6772	5290	5663	6777	2885	5329	5781	6654	2549	860	2017	2185	6195	1432	1848	152831	54756	10818	54434	8074	9365	815
PC_3306	IKK activation signaling (through PKC beta and CARMA1	3551	6885	8915	5579	7334	387522	84433	10892	7189	8517
PC_3307	Beta catenin degradation signaling (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	8312	324	1499	2932	6500	8454	8945	8313
PC_3308	Syndecan-3-mediated signaling events	181	1463	8573	9672	9965	1956	5443	2534	3576	6714	5764	2263	2264	2261	4160	5663	2017	112476	83464	23385	51107	8074	55851
PC_3309	Proteoglycan syndecan-mediated signaling events	9672	6382	6385	6383
PC_3310	Gene expression of smad7 by R-smad	4092	4093	4088	4089	4087	4086	4090
PC_3311	Wnt secretory pathway (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	7480	7476	7483	7484	7481	7471	7472	7474	7473	89780	54361	7477	7482	7479	80326	7478	81029	51384	7475
PC_3312	lysine degradation II	501	51097	10157
PC_3313	5'-Phospho-ribosyl-5-amino-imidazole-4-carboxylic acid = 5'-Phospho-ribosyl-5-amino-imidazole + CO2 ( Purine nucleotides and Nucleosides metabolism )	10606
PC_3314	ERK cascade ( GPCR signaling (G alpha q) )	5894	369	673	5595	5594	5605	5604
PC_3315	NAD+ + (S)-Malic acid = NADH + Pyruvic acid + CO2 ( Pyruvate metabolism )	4199	10873
PC_3316	NAD+ + 3,4-Dihydroxy-phenyl-acetaldehyde + H2O = NADH + 3,4-Dihydroxy-phenyl-acetic acid ( Tyrosine metabolism )	218	221	220
PC_3317	tetrapyrrole biosynthesis II	3145	7390	211	210	212
PC_3318	Phenylalanine degradation ( Phenylalanine degradation )	314	26	1644	4128	4129	8639
PC_3319	VEGF and VEGFR signaling network	8829	2277	8828	7422	2321	2324	3791	5228	7423	7424
PC_3320	IL5	5296	6386	10603	8651	2309	3717	3265	5894	3567	3725	5579	4067	3055	240	3059	3560	1386	7409	2002	4790	867	3716	4792	5595	5295	5594	5777	6464	207	1439	1499	5605	6774	6772	6776	6850	1399	5321	5294	2931	2932	1785	6777	2885	7534	10399	25759	3568	5580	5781	695	6659	581	6654	9094	2889	2185	6195	1432
PC_3321	Canonical NF-kappaB pathway	3551	7514	1147	8767	8915	7124	5578	7132	4790	7128	4792	7323	5901	5970	472	329	23085	4215	64127	1540	10892	8945	7189	8517
PC_3322	urea cycle	5009	445	435	383	1373	384
PC_3323	alanine biosynthesis III	9054
PC_3324	2-Oxo-glutaric acid + beta-Alanine = L-Glutamic acid + Malonate semialdehyde ( Pyrimidine Nucleotides and Nucleosides metabolism )	18
PC_3325	Glypican 2 network	4192	221914
PC_3326	TGF beta receptor I degradation signaling ( TGF-beta_super_family_signaling_pathway(canonical) )	5717	5718	5715	658	5688	4092	5709	5716	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	657	91	7046	94	5699	5704	5714	5691	5690	5713	5710	5687	5700	5705	90	5708	9861	5711	5695	5707	64750	5719
PC_3327	Nicotinamide D-ribonucleotide + Pyrophosphate = Nicotinamide + D-5-Phospho-ribosyl 1-diphosphate ( Nicotinate and Nicotinamide metabolism )	10135
PC_3328	oxidative ethanol degradation III	217	1571	224	79611	55902	84532
PC_3329	(R)-Methyl-malonyl-CoA = Succinyl-CoA ( Propanoate metabolism )	4594
PC_3330	superpathway of cholesterol biosynthesis	6309	7108	9453	3156	30	2224	38	2222	4047	4597	3158	3032	51478	3157	4598	3422	6713	3930	10682	10654	1718	50814	6307	1595	39	91734	1717
PC_3331	PDGF receptor signaling network	5155	5154	5159	5156	80310	56034
PC_3332	phosphatidylglycerol biosynthesis II (non-plastidic)	10555	8760	2820	9489	84803	254531	150763	10162	253558	154141	129642	137964	51099	1040	79143	10554	57678	56895	56894	55326
PC_3333	Beta catenin degradation signaling (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	8312	324	1499	2932	6500	8454	8945	8313
PC_3334	PLK1 signaling events	3796	10403	6790	4659	9055	699	701	8555	9475	10112	983	7178	891	7283	5518	7465	994	995	5347	387	5500	5861	5515	1062	2801	991	5058	9587	5524	55857	54821	4957	151648	79866	79682	10735	147841	64689	1894	63967	3619	23291	26271	22974	51343	10726	8945	22981
PC_3335	leukotriene biosynthesis	240	4048	1800	4056	64174
PC_3336	Acetyl-CoA + Dihydro-lipoamide = CoA + 6-S-Acetyl-dihydro-lipoamide ( Pyruvate metabolism )	8050	1737
PC_3337	AKT(PKB)-Bad signaling ( Insulin receptor signaling )	10971	207	208	7529	2810	7532	7531	7534	7533	572	10000
PC_3338	NADP+ + Cholesterol = NADPH + 7-Dehydro-cholesterol ( Steroids metabolism )	1717
PC_3339	salvage pathways of pyrimidine deoxyribonucleotides	7084	7083	1890	978	57379
PC_3340	5'-Orotidylic acid + Pyrophosphate = Orotic acid + D-5-Phospho-ribosyl 1-diphosphate ( Pentose phosphate cycle )	7372
PC_3341	Deoxy-adenosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Adenine ( Purine nucleotides and Nucleosides metabolism )	1890
PC_3342	2-Oxo-glutaric acid + L-Cysteine = L-Glutamic acid + 3-Mercapto-pyruvic acid ( Glycine and Serine metabolism )	2806	2805
PC_3343	TCR	5296	6386	1654	5287	3551	9146	1147	2533	8767	7456	27040	9051	9046	1729	9404	9948	23308	2317	8935	9252	9402	10254	10125	9019	4772	8915	3939	25	100	2353	920	925	7037	5894	915	476	3725	921	3932	2534	983	914	3945	302	203068	916	2058	4067	3326	5788	6625	2026	924	917	940	2539	6714	478	5315	1386	7409	4582	1385	5175	5532	4690	1493	2241	5336	1051	1958	5786	5223	5335	4691	4790	4969	5921	919	867	3164	6198	191	1606	52	3337	4792	5774	10971	5595	3732	5295	5594	2042	5777	6464	207	3189	941	1499	5605	5236	1326	942	6772	6776	5297	7006	7294	7454	7535	6850	5599	5601	1398	1399	5829	2932	2665	7408	1785	10694	311	1845	6777	3718	397	7410	47	754	998	801	5901	5906	2885	7534	58	7277	6452	1213	622	5604	5970	5588	5966	5782	5747	5580	5781	10657	6654	6655	3702	1739	6789	3937	5058	5598	868	4214	6503	9094	8754	4773	8899	10750	1859	2889	8874	9815	7706	2185	4739	3708	6775	9459	5587	6461	4793	5600	1432	1808	7296	342908	653583	50852	118788	7846	10480	23191	10235	27291	8631	1840	23390	54900	10006	10044	55740	150372	9950	56288	84959	51564	57513	9844	1794	1387	3635	11184	9181	114836	83737	55243	90427	115352	55914	9020	8502	1796	7251	84320	84433	25865	54923	50619	84174	55140	4063	55167	5794	9047	2909	9454	1154	55824	54893	55860	51759	50618	57530	10892	27347	51466	8832	4012	28988	10451	9846	10019	26191	27240	9149	7189	23607	23523	54555	10163	29851
PC_3344	S1P2 pathway	9294	9630	2353	2771	3725	2773	2775	2781	2002	5595	5295	5594	2767	2769	1003	3667	5290	5599	2776	387	5879	2770	2768	5058	10672	1432
PC_3345	Raf activation signaling (through RasGRP) ( CD4 T cell receptor signaling (ERK cascade) )	10125	4893	3265	3845	5894	369	673	5588
PC_3346	asparagine biosynthesis I	440
PC_3347	regulation of target gene expression by NF-kB ( IL-1 signaling pathway (through NF-kappaB) )	3725	4790	5970
PC_3348	AP-1 transcription factor network	3491	4097	10018	4094	4772	5328	183	7076	2353	4609	7040	4878	5179	3458	4502	2099	4312	1437	2908	3105	7157	3565	3567	3569	1906	3725	983	7054	6667	1278	3576	4602	6347	4318	2113	2167	1386	8061	2355	1385	3726	2697	3727	1958	467	3586	2624	595	1843	4922	1997	1499	1029	1027	2354	5728	3558	58	2033	4775	1758	4773	865	7205	3091	149603	23373	10987	573	6934	9988
PC_3349	JNK cascade ( Toll-like receptor signaling pathway (through JNK cascade) )	6885	3725	5599	5601	5608	5602
PC_3350	NAD+ + 5,10-Methylene-tetrahydro-folic acid = NADH + 5,10-Methenyl-tetrahydro-folic acid ( Folate metabolism )	10797
PC_3351	Negative regulation of (G alpha i GDP-GTP exchange signaling) ( GPCR signaling (pertussis toxin) )	6003	6002	6004	8490	10636	6001	8787	8601	8786	2771	5997	9628	10287	5998	5999	6000	85397	2770	5996	64407	26575
PC_3352	Adenylate cyclase activation signaling ( GPCR signaling (pertussis toxin) )	112	109	115	111	114	113	2778	108	107	196883	55811
PC_3353	D-Mannose 6-phosphate = D-Fructose 6-phosphate ( Fructose and Mannose metabolism )	4351
PC_3354	Class I PI3K signaling events	6446	3636	5170	2309	27040	9265	11033	4893	3265	3845	3932	2534	3320	7525	4067	3055	2268	6714	5336	5335	5295	207	5290	5291	7535	6850	5294	640	5728	387	382	5906	5879	375	381	695	3702	9267	146850	29760	64411	3635	9266	59339	59338	27071
PC_3355	cholesterol biosynthesis III (via desmosterol)	6309	7108	2222	4047	51478	6713	3930	10682	1718	50814	6307	1595	1717
PC_3356	L-Glutamine + D-Fructose 6-phosphate = L-Glutamic acid + D-Glucosamine 6-phosphate ( Aminosugars metabolism )	9945	2673
PC_3357	fatty acid alpha-oxidation III	224	79152	26061
PC_3358	Prolactin	5296	8835	30837	9021	8651	2309	3717	1956	5328	2353	4609	5617	2099	5894	2064	5054	3151	3725	3688	5579	2534	5925	1509	916	4067	4602	7068	6714	673	7409	4690	5618	5770	2002	4790	2316	867	5479	3716	595	4792	5595	5295	5594	5777	6464	7297	5596	207	3667	5605	6774	6772	6776	5290	5291	2475	7006	7535	5599	5601	5294	5829	819	2932	1785	6777	4752	7410	6558	7532	6194	5478	2885	7534	5515	3476	140885	5604	5970	5747	5580	5781	10657	6654	2033	5058	5598	1978	6596	2066	6196	4793	1432	1387	116986	55835	25970	1154	23291	9846	8945	8660	10401
PC_3359	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	130013
PC_3360	IL-12 signaling pathway(JAK2 TYK2 STAT4) ( IL-12 signaling(JAK2 TYK2 STAT4) )	3717	3592	3593	7297	3594	6775	3595
PC_3361	ERK cascade ( PDGF signaling pathway )	5894	2002	5595	5594	5605	5604
PC_3362	Glycolysis and Gluconeogenesis ( Glycolysis and Gluconeogenesis )	8789	5213	2203	5315	5211	3098	5313	2645	2538	3099	3101	5214
PC_3363	Signaling with Wnt (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	8326	607	7480	7476	7483	7484	8323	8324	4041	4040	7481	7471	7472	1499	6932	7474	6597	7473	89780	54361	7477	7088	7089	7090	7091	2033	7855	4089	2535	1387	7482	7479	90780	80326	7478	81029	8325	83439	7976	6934	51384	51176	8322	11211	8321	26108	7475
PC_3364	S1P4 pathway	8698	2771	2773	2775	2781	5335	5595	5594	998	387	2770	2768	10672	53637
PC_3365	phenylalanine degradation I (aerobic)	5053	5860	5092	84105
PC_3366	2-Oxo-glutaric acid + L-Phenylalanine = L-Glutamic acid + Phenyl-pyruvic acid ( Phenylalanine degradation )	6898
PC_3367	Signaling events mediated by focal adhesion kinase	8976	9826	8440	81	9475	11279	5894	3725	3688	3932	2534	3685	7525	3678	6237	87	6714	2113	673	4690	824	3693	7414	5335	5921	595	5295	5594	88	5290	5599	5601	6416	1398	5829	660	9564	5908	387	5906	2885	5879	58	5604	5747	6654	89	5058	2889	8874	9815	1793	2886	4638	11099	64283	9844	6455	2909	50807	23092	23162	7094
PC_3368	AKT(PKB) activation signaling ( Insulin receptor signaling )	5293	5170	207	208	5290	5291	10000
PC_3369	Calcium signaling in the CD4+ TCR pathway	4772	2353	3458	3559	1437	3565	3725	3562	5451	8061	3726	5566	9495	959	5743	356	1827	3558	801	2280	1390	4775	4773	10231	11261	55509	23523
PC_3370	glutamate biosynthesis II	2746	2747
PC_3371	IFN gamma signaling pathway(JAK1 JAK2 STAT1) ( IFN gamma signaling(JAK1 JAK2 STAT1) )	3717	3458	3459	3716	3460	6772
PC_3372	ATP + Pyruvic acid + CO2 + H2O = ADP + Oxaloacetic acid + Orthophosphate ( Glycolysis and Gluconeogenesis )	5091
PC_3373	AlphaE beta7 integrin cell surface interactions	999	3695	3682
PC_3374	Gene expression of smad6/7 by R-smad	4092	4093	4091	4088	4089	4087	4086	4090
PC_3375	Galactose metabolism ( Galactose metabolism )	8704	3906	2683	2720	2584	2585
PC_3376	EphrinA-EPHA pathway	1969	2042	2046	1946	2044	2043	2045	285220
PC_3377	FOXA2 and FOXA3 transcription factor networks	2147	3630	335	7276	213	174	7037	2908	229	4023	6667	3484	6514	34	211	1385	1051	6898	6927	4763	5313	207	2645	5105	2538	3172	7080	1050	1052	37	1374	3651	3169	3171	7351	8788	3157	622	6833	2294	3767	3033	126129	1375	3170
PC_3378	ERK cascade ( PDGF signaling pathway )	5894	2002	5595	2005	5594	5605	5604
PC_3379	B cell receptor signaling pathway ( B cell receptor signaling )	5293	5296	5579	3932	2534	973	6714	930	7409	5336	5295	974	5290	5291	6850	2885	29760	27071
PC_3380	ATP + L-Glutamic acid + NH3 = ADP + L-Glutamine + Orthophosphate ( Arginine and Proline metabolism )	2752
PC_3381	CD28 signaling ( CD4 T cell receptor signaling (NF-kB cascade) )	5293	5296	5170	3932	2534	940	5295	207	208	941	942	5290	5291	10000
PC_3382	NADP+ + GDP-L-fucose = NADPH + GDP-4-dehydro-6-deoxy-D-mannose ( Fructose and Mannose metabolism )	7264
PC_3383	IFN alpha signaling pathway(JAK1 TYK2 STAT1 STAT3) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) )	3439	3440	3446	3444	3452	3442	3448	3451	3443	3441	3449	3454	3716	7297	3445	6774	6772	3455
PC_3384	TGF_beta_Receptor	5296	1780	1855	10755	3551	9146	7514	4092	1147	8312	7161	5170	6885	2309	4091	9839	6643	9252	8928	23645	8554	9063	9133	8723	9372	2353	4609	7040	2099	5894	7157	3690	3725	3688	5925	983	6667	6678	367	7043	3312	7421	1019	6497	6498	6714	5576	2113	1386	4830	6925	960	3726	3727	2022	1655	467	4790	6198	4800	595	898	1017	4801	4792	1496	5595	5295	5594	5933	6464	5371	5518	996	993	3205	5575	207	409	6383	1495	1499	8021	5494	5605	5501	7046	94	7048	6935	672	1026	3172	5290	2475	5599	1398	5606	10413	6662	5829	2339	10664	9972	2932	7321	5608	2354	2290	9564	102724428	7323	387	7042	7322	9978	2280	2885	163	5520	7341	6500	7329	5515	1455	4088	1601	4303	1021	6711	861	2130	4205	5604	857	7049	5747	4208	6654	5934	2033	2308	10131	8881	7071	8668	6093	4089	1978	3065	816	818	817	22938	6642	8454	864	860	4802	7027	7029	3837	5163	1875	7050	10454	8648	4087	6794	1874	1432	54778	9765	26145	114790	163126	154075	64219	79753	116448	56288	83657	1387	8850	10987	11184	57559	83737	23339	23327	51586	55914	4435	64328	25937	11059	3622	64682	64750	57154	83658	50855	55802	1616	51176	8697	51434	51433	29945	29882	51343	10393	58533	51592	815	8945	8313	11171	7189	51377
PC_3385	Gene expression of Mkp3 ( FGF signaling pathway )	1848
PC_3386	dolichol and dolichyl phosphate biosynthesis	79947	79644	22845
PC_3387	phosphatidylcholine biosynthesis I	1119	5130	56994	1120	9468	10390
PC_3388	regulation of target gene expression by AP-1 ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) )	3725
PC_3389	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	2762	7264
PC_3390	D-Fructose 1-phosphate = Dihydroxy-acetone phosphate + D-Glyceraldehyde ( Fructose and Mannose metabolism )	226	229	230
PC_3391	IKK activation signaling (through PKC theta and CARMA1	3551	6885	8915	7334	5588	387522	84433	10892	7189	8517
PC_3392	Degradation of beta catenin	1855	1856	8312	4040	324	1499	1452	1453	102800317	2931	2932	89780	6500	7855	8454	1857	8945	8313
PC_3393	D-Glycerate 2-phosphate = Phosphoenol-pyruvic acid + H2O ( Glycolysis and Gluconeogenesis )	2023	2026	2027
PC_3394	dolichyl-diphosphooligosaccharide biosynthesis	8813	10195	56052	79053	1798	79868	54344	29929	29880
PC_3395	mTOR signaling pathway	6446	29904	3551	5338	5170	9776	8408	4893	3265	3845	5894	1977	1938	673	5578	6198	1975	898	1017	7528	10971	5595	5594	5371	6249	207	7529	2810	3667	5605	6720	2475	7249	1973	7532	7531	7534	55615	54205	5604	7533	664	5337	1978	6009	6195	27250	10325	253260	10670	9706	57521	64798	9821	7248	84335	79109	64223	84271	64121	58528	54541	54700	10891	23291	8945
PC_3396	chondroitin sulfate degradation (metazoa)	3073	411	2588	6677	3373	23553
PC_3397	Wnt secretory pathway (Mammal) ( Mammalian Wnt signaling pathway Diagram )	7480	7476	7483	7484	7481	7471	7472	7474	7473	89780	54361	7477	7482	7479	80326	7478	81029	51384	7475
PC_3398	Signaling without Wnt (Canonical) ( Mammalian Wnt signaling pathway Diagram )	6932	7088	7089	7090	7091	83439	6934	51176
PC_3399	ATP + GDP = ADP + GTP ( Folate metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3400	FGF8 signaling pathway(Xenopus) ( FGF signaling pathway )	4893	3265	3845	5894	369	2078	2113	2114	673	6688	2002	2005	2119	2120	2004	2313	6654	6655
PC_3401	L-Arginine + Glycine = L-Ornithine + Guanidino-acetic acid ( Arginine and Proline metabolism )	2628
PC_3402	tetrahydrobiopterin biosynthesis I	2643	6697	5805
PC_3403	cholesterol biosynthesis I	6309	7108	2222	4047	51478	6713	3930	10682	1718	50814	6307	1595	1717
PC_3404	Integrin-linked kinase signaling	6790	4659	7514	8440	1729	6615	3725	3320	142	87	1385	595	10398	207	1499	6935	8826	3987	5829	2932	998	5879	391	3611	4666	9793	8874	9815	9459	7791	11140	253260	55679	81706	94274	26472	63916	80895	64098	29780	7145	55742	51176	10856	8607	10460
PC_3405	5'-Phospho-ribosyl-4-carboxamido-5-amino-imidazole + Pyrophosphate = 5-Amino-4-imidazole-carboxyamide + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	353
PC_3406	purine nucleotides de novo biosynthesis II	5198	3615	3614	2618	10606	159	158	471	8833	5471	122622
PC_3407	adenine and adenosine salvage VI	132
PC_3408	Thromboxane A2 receptor signaling	9368	10681	9630	1956	1950	2771	5582	3383	5579	3932	2534	7525	4067	3055	2268	6714	6401	5578	5566	7412	6915	7052	5583	156	4846	2767	2769	207	409	157	407	5739	6850	5294	2776	640	54331	387	8766	2782	5879	5330	5581	2768	5588	1759	5590	5580	5729	6093	5592	10672	5600	1432	146850	9138
PC_3409	glutamate degradation II	2806	2805	137362
PC_3410	Direct p53 effectors	8797	1871	317	8795	8794	7161	6591	51499	665	4068	639	8812	22943	9448	1956	7039	174	7157	5054	3725	5925	2876	1509	6667	3303	4313	4233	596	6696	7421	5111	1462	3082	891	3976	7306	1655	3486	467	1907	2232	4800	1647	324	4801	355	3732	1843	6273	1969	834	5371	624	2810	5268	1026	80781	4292	604	3064	4436	7249	6597	900	5395	1434	839	3169	637	57060	5728	6376	7832	4193	1869	5457	857	6890	10153	581	598	4170	2033	5458	3663	7159	5366	4802	7027	1870	3090	597	6880	578	1847	9540	333926	55240	51065	50484	255488	93624	10498	133746	64326	54487	1643	10397	3066	1387	2648	599	843	94241	64065	23368	25898	25946	1820	3276	9518	84883	27113	79370	8626	1263	28984	55367	58484	57103	29102	54541	55800	8793	29108	5564	8295	27244
PC_3411	ATP + Creatine = ADP + N-Phospho-creatine ( Arginine and Proline metabolism )	1158	1152	1159	1160
PC_3412	Signaling with Wnt (Xenopus) ( Xenopus axis formation Wnt signaling pathway Diagram )	8326	8323	8324	4041	4040	6932	2033	7855	4089	2535	1387	8325	83439	7976	6934	51176	8322	11211	8321
PC_3413	NAD+ + 3-Methoxy-4-hydroxy-phenyl-acetaldehyde + H2O = NADH + Homovanillic acid ( Tyrosine metabolism )	218	221	220
PC_3414	L-dopa degradation	1312
PC_3415	Alpha-synuclein signaling	1861	5338	5071	3932	2534	7054	823	7525	4067	3055	2268	7345	6714	4129	3308	2869	6622	6850	640	2280	7332	1457	5330	6531	5580	5337	2185	5528	112476	5653	572	11315	10273	9627
PC_3416	Hedgehog signaling events mediated by Gli proteins	10284	7514	9788	8405	23309	8819	8554	2771	2735	2773	2775	2736	2737	5566	3958	2781	4254	207	409	1452	1453	102800317	2932	54331	2782	2770	1455	5604	5580	5928	8100	3065	5727	6469	5931	3066	1387	25942	6608	53944	27148	26160	23291	51715	51684	3170	8945	11127	1456
PC_3417	creatine-phosphate biosynthesis	1158	1152	1159	1160
PC_3418	IL1	5296	5537	5609	3551	1147	3656	6885	8518	6647	3552	3553	6285	1965	3725	5925	3554	1386	176	3557	5335	4790	4792	5595	7850	5295	5594	207	3667	5605	6774	5599	5601	6416	5606	5321	2932	3654	5608	7334	140885	5604	5970	5966	5590	5781	387522	8878	4793	10454	3316	1432	257397	54461	57162	9020	1796	4215	4615	51295	54472	57161	3556	51135	23118	9451	10746	7189	11213	8517
PC_3419	JNK cascade ( PDGF signaling pathway )	3725	5599	6416	4214
PC_3420	NADH + L-1-Pyrroline-3-hydroxy-5-carboxylic acid = NAD+ + trans-4-Hydroxy-L-proline ( Arginine and Proline metabolism )	5831	65263
PC_3421	UTP + D-Glucose 1-phosphate = Pyrophosphate + UDP-D-glucose ( Galactose metabolism )	7360
PC_3422	uridine-5'-phosphate biosynthesis	7372	790
PC_3423	FOXM1 transcription factor network	332	9133	11200	2353	4609	7039	2099	5925	983	1059	6667	3303	4313	1019	891	7515	890	595	898	1017	994	2119	1058	1063	2931	675	4751	5347	2619	1163	5604	2305	2033	4775	6502	3910	1029	1387	255626	9212	3175
PC_3424	PKA activation signaling ( GPCR Dopamine D1like receptor signaling pathway )	111	5573	5576	5566	5568	5567	5575	5577	2778
PC_3425	Alternative NF-kappaB pathway	1147	4790	4791	5971	9020	8945
PC_3426	inosine-5'-phosphate biosynthesis II	10606	158	471
PC_3427	RANKL	4982	5296	7188	10213	5609	8600	3551	1147	6885	7305	2215	4286	4772	25	1956	3725	2534	823	3320	4067	2214	3309	3312	6714	1386	1385	5336	1051	6688	5335	4790	867	6198	3716	2204	4792	5595	5295	5594	5777	207	208	529	2119	1326	6772	2475	6850	5599	5601	6597	5608	5563	4303	4791	861	5971	5604	5970	5966	5747	7186	7185	7187	5562	868	8878	1978	2274	10454	1432	10326	126014	572	1540	23118	54209	6199	29992	10451	9846	7189	8517	8792
PC_3428	D-Glycerate 2-phosphate = Phosphoenol-pyruvic acid + H2O ( Citrate cycle )	2023	2026	2027
PC_3429	Insulin Pathway	6446	2151	10640	10603	5170	2309	8440	11336	3265	3630	3643	4690	23433	5770	5786	5921	867	6198	5295	6464	207	208	3667	6337	5584	5290	1398	2885	857	5590	5781	6654	2887	1978	2889	2888	9322	149371	54536	3635	60412	55770	1796	10580	50855	55763	23265
PC_3430	superoxide radicals degradation	6647	847	6648	6649	7306
PC_3431	T cell receptor signaling (PLC gamma, PKC, Ras and ERK cascade) ( CD4 T cell receptor signaling (ERK cascade) )	27040	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	917	3123	3123	3126	7409	5336	5335	3113	3123	919	7535	2885	3125	3123	3123	3123
PC_3432	AKT(PKB)-Bad signaling ( EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) )	658	8317	5609	3551	1147	5603	5170	3656	9175	6885	8767	5565	3717	10298	1956	4342	5894	4914	5582	5579	3643	3932	2534	983	3480	4804	4233	5159	369	5573	3815	2260	1019	6714	5576	673	5156	5578	5566	2321	2263	2264	2261	5568	5567	6198	3716	5583	1017	156	92	10971	5595	5594	4058	7297	7465	5575	5577	207	208	2868	6259	2869	157	2324	3791	5605	657	91	7046	94	7048	1445	1326	5584	2475	7006	2870	7535	6850	5599	5601	6416	5606	1452	1453	9261	1024	102800317	2931	2932	1022	1025	3654	6197	902	4331	3718	5608	5347	6300	5602	5571	5563	2674	1455	4293	1018	1021	1020	5581	5604	4294	5588	90	5747	5590	5580	695	3702	5871	7786	5562	5058	5607	5598	5062	4214	5593	8737	816	818	817	93	659	5592	9641	2185	6196	6195	5600	1432	4296	7867	269	84451	8491	8550	131890	572	9020	4217	4215	8569	1263	53944	106821730	51135	57144	51701	6199	53632	51422	27330	238	815	10000	10746	5564	11035	8517	1456
PC_3433	Wnt secretory pathway (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	7480	7476	7483	7484	7481	7471	7472	7474	7473	89780	54361	7477	7482	7479	80326	7478	81029	51384	7475
PC_3434	IL2 signaling events mediated by STAT5	4609	4049	3559	3565	3932	6667	596	5551	3560	890	3716	5295	6464	894	896	3561	1997	6776	5290	356	6777	3718	3558	2885	1021	5781	598	6654	50943	9846
PC_3435	mitochondrial L-carnitine shuttle pathway	1376	1374	126129
PC_3436	thyroid hormone biosynthesis	7173	1509
PC_3437	IL-6 signaling pathway(JAK1 JAK2 STAT3) ( IL-6 signaling(JAK1 JAK2 STAT3) )	3717	3569	3570	3716	3572	6774
PC_3438	ATP + GMP = ADP + GDP ( Purine nucleotides and Nucleosides metabolism )	2987
PC_3439	Leptin	5296	32	8835	30837	9021	8471	3551	1147	5565	3717	1956	1401	2099	5894	2064	3315	3932	2534	1977	6667	3480	4137	6714	6517	1386	960	1385	5336	2596	3693	466	5335	2002	4790	6198	3716	4792	5595	5295	5594	6464	4846	2923	207	3667	5605	6774	3952	6772	6776	2475	5599	5606	3953	9261	2931	2932	2776	4323	6777	3718	5608	3984	5563	5728	6194	2885	1457	1020	5581	6670	5604	5970	5966	5747	5590	5580	5781	10657	2033	2308	31	5562	1978	860	5139	6196	6195	8648	3316	1432	572	25970	1154	1073	5564	8660	8517
PC_3440	(S)-3-Hydroxy-butanoyl-CoA = Crotonoyl-CoA + H2O ( Lysine degradation )	1892	3030	1962
PC_3441	IL4	5293	5296	9021	3551	1147	8651	9046	3717	9655	3565	3932	2534	2242	2113	1386	5336	1051	6688	5335	2002	4790	5921	867	6198	3716	3566	958	4792	5595	5295	5594	5777	6464	7297	207	3561	3596	3667	157	6774	6772	6778	6776	5290	6850	5599	1050	6777	3718	7852	2885	3597	5970	5747	5590	5580	5781	695	598	6654	2033	5600	1432	8290	126961	27044	8027	1387	3635	572	9846	8660	8202
PC_3442	D-Mannose 1-phosphate = D-Mannose 6-phosphate ( Fructose and Mannose metabolism )	5373	5372	55276
PC_3443	L-2-Amino-adipic acid + 2-Oxo-glutaric acid = 2-Oxo-adipic acid + L-Glutamic acid ( Lysine degradation )	51166
PC_3444	p38 signaling mediated by MAPKAP kinases	5894	3315	7054	6722	6929	1385	10971	994	7529	2810	4046	9261	7249	2115	7532	7531	7534	7533	5600	1432	7867
PC_3445	Secretory pathway of Hh ( Hedgehog signaling pathway )	50846	3549	6469	55733
PC_3446	Endothelins	112	109	115	3717	111	9630	2353	3265	1281	4312	5894	2771	5582	1906	3725	5579	1278	2773	2775	6714	1908	5578	2781	6548	1907	1910	5583	1909	5595	5594	2767	2769	207	5605	2774	114	5599	1398	5321	6550	2776	113	9564	998	387	5879	2770	2778	5330	5331	5581	5604	2768	5588	5580	108	107	2185	1432	196883	23236	57105	7225	10800
PC_3447	IKK activation signaling (through PKC theta and CARMA1	3551	6885	8915	7334	5588	387522	84433	10892	7189	8517
PC_3448	adenine and adenosine salvage I	353
PC_3449	PDGF signaling pathway ( PDGF signaling pathway )	4893	3265	3845	5155	5894	5154	5159	5156	6464	2885	25759	6654	6655	4214	53358
PC_3450	glycerol degradation I	2710	2712	256356
PC_3451	ErbB4 signaling events	9542	2069	3717	863	9611	5617	2064	2534	5618	5595	5295	5594	6464	685	6776	5290	5291	4734	10413	6777	10718	2885	1742	6868	4193	3084	2904	2066	145957	83737	26018	1839	11059	23118	51741
PC_3452	D-mannose degradation	4351
PC_3453	D-myo-inositol (1,4,5)-trisphosphate degradation	3613	8871	3636	8867	3612	3633	3628	4952	3632	27124	51763	54928	22876
PC_3454	regulation of target gene expression by AP-1 ( Toll-like receptor signaling pathway (p38 cascade) )	1386
PC_3455	ALK1 signaling events	4092	4093	3196	7040	3624	7043	2022	92	5595	5594	409	7046	94	7048	3397	5499	2280	1460	857	90	4089	93	659	4086	4090	2658
PC_3456	Caspase8 activation signaling ( Fas signaling pathway )	8772	841
PC_3457	IFN alpha signaling pathway(JAK1 TYK2 STAT3) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) )	3439	3440	3446	3444	3452	3442	3448	3451	3443	3441	3449	3454	3716	7297	3445	6774	3455
PC_3458	acetyl-CoA biosynthesis III (from citrate)	47
PC_3459	all-trans-decaprenyl diphosphate biosynthesis	23590	57107
PC_3460	IKK-NFkB cascade ( TNFR1 signaling pathway )	4794	3551	1147	8767	4790	4792	5970	8737	4793	11035	8517
PC_3461	Signaling events mediated by HDAC Class III	2309	7157	3008	2547	4654	3206	1026	9759	121504	10376	3020	4303	581	2033	2308	7280	2274	4209	22933	1387	8850	23411	55902	51547	23410	84532	10891
PC_3462	Adenosine + Orthophosphate = Adenine + D-Ribose 1-phosphate ( Purine nucleotides and Nucleosides metabolism )	4860
PC_3463	Beta catenin degradation signaling (Xenopus) ( Xenopus axis formation Wnt signaling pathway Diagram )	6500	8454	8945
PC_3464	NAD+ + Dihydro-lipoamide = NADH + Lipoamide ( Citrate cycle )	1738
PC_3465	ERK cascade ( IGF1 signaling pathway )	5894	369	673	2002	5595	5594	5605	5604
PC_3466	Mammalian Hh signaling pathway ( Hedgehog signaling pathway )	50846	3549	6469	50937	64399	91653
PC_3467	Pentose phosphate cycle ( Pentose phosphate cycle )	8789	25796	9563	5213	2203	2539	5211	5226	5214	64080
PC_3468	Nicotinate D-ribonucleoside + Orthophosphate = Nicotinic acid + D-Ribose 1-phosphate ( Nicotinate and Nicotinamide metabolism )	4860
PC_3469	glutathione redox reactions I	2880	2936	2876	2877	2878	2879	257202	493869	2882
PC_3470	cardiolipin biosynthesis II	9489	54675
PC_3471	a6b1 and a6b4 Integrin signaling	3911	1956	3265	1950	3552	2064	3688	3912	4233	3915	999	3691	5578	6256	2065	928	3655	6198	3908	284217	4485	10971	5295	6257	6464	207	7529	2810	5290	836	6258	840	3913	7532	7531	2885	5879	7534	5376	4486	7533	3914	3918	3910	3909	1308
PC_3472	Fructose and Mannose metabolism ( Fructose and Mannose metabolism )	2762	5208	5207	3098	2645	3795	3099	3101	5209	5210	197258	29926	29925
PC_3473	NAD+ + Acetaldehyde + H2O = NADH + Acetic acid ( Pyruvate metabolism )	8854	216	217	219	223	501	224
PC_3474	2-oxoglutarate + [dihydrolipoyllysine-residue succinyltransferase] lipoyllysine = [dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine + CO2 ( Citrate cycle )	4967
PC_3475	Arf6 downstream pathway	5338	8997	9727	4830	5595	5594	387	382	8766	5879	375	5329	7074	5337	8394
PC_3476	EGF signaling pathway ( EGF signaling pathway Diagram )	1956	4893	3265	3845	1950	5894	6464	2885	25759	6654	6655	4214	53358
PC_3477	(R)-S-Lactoyl-glutathione = Glutathione + Methyl-glyoxal ( Pyruvate metabolism )	2739
PC_3478	TGF beta receptor complex degradation signaling ( TGF-beta_super_family_signaling_pathway(canonical) )	5717	5718	5715	658	5688	4092	5709	5716	5702	5689	5682	5683	5684	5685	92	5696	5698	5686	5692	5694	5693	5701	657	91	7046	94	7048	5699	5704	5714	5691	5690	5713	5710	5687	5700	5705	90	5708	93	659	9861	5711	269	5695	5707	57154	5719
PC_3479	ATP + CoA + Citric acid = ADP + Acetyl-CoA + Oxaloacetic acid + Orthophosphate ( Lysine degradation )	47
PC_3480	ATP + AMP = 2 ADP ( Purine nucleotides and Nucleosides metabolism )	203	205	204	26289
PC_3481	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	4522	10797	2618	441024
PC_3482	IFN alpha signaling pathway(JAK1 TYK2 STAT1) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) )	3439	3440	3446	3444	3452	3442	3448	3451	3443	3441	3449	3454	3716	7297	3445	6772	3455
PC_3483	Glypican pathway	2817	2719	221914
PC_3484	JNK signaling in the CD4+ TCR pathway	6885	27040	9402	3725	5579	1326	5599	6416	1398	1399	3937	4214	11184	28988
PC_3485	Succinyl-CoA + Acetoacetic acid = Succinic acid + Acetoacetyl-CoA ( Valine,Leucine and Isoleucine degradation )	5019
PC_3486	Regulation of Telomerase	10284	7015	5810	1736	3364	4683	23309	8819	8658	25	1956	2353	4609	1950	7040	3458	1489078	2099	3725	3320	3183	6667	3659	2547	7520	5578	4691	7490	4790	6198	595	7026	5595	5594	207	2475	1027	3455	4361	641	7013	3558	4149	7531	4088	1869	6670	7337	4084	5928	472	3065	7486	10728	7014	5931	23293	3066	10111	65057	54984	25942	5883	26277	80119	64858	25913	54386	57169	10038	23381
PC_3487	G alpha s GDP-GTP exchange signaling ( GPCR signaling (G alpha s, PKA and ERK) )	8326	2918	2793	10681	2916	8323	8324	1813	2784	1812	1815	1816	3577	3579	135	136	134	185	1814	2915	186	2778	2911	7855	2535	2912	2917	2913	2914	6608	8325	7976	8322	11211	8321
PC_3488	2-Methyl-butanoyl-CoA + Acceptor = 2-Methylbut-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	35
PC_3489	Alanine,Aspartic acid and Asparagine metabolism ( Alanine,Aspartic acid and Asparagine metabolism )	4677	445	440	1615	790	159	443	16	2572	122622	2571	8528
PC_3490	amb2 Integrin signaling	5340	5328	5327	7124	338	7070	3689	3569	3383	4313	4018	3055	3146	3684	4318	6403	4790	4485	1490	58494	5908	387	5906	5329	4486	4035	6093	6404	177	83700	4620	7094
PC_3491	Signaling mediated by p38-gamma and p38-delta	29904	5603	4137	3925	595	5606	5608	6300	6640	5585	51776
PC_3492	fatty acid activation	11001	2182	2181	2180	81616	23205	23305	51703
PC_3493	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)	2151	8976	9146	3636	5170	8440	6615	10298	3265	5894	3725	1977	4233	999	6714	3082	2113	4690	5771	5770	1958	5335	5868	867	324	5595	5295	5594	6464	207	208	1495	1499	5605	5584	5290	2475	2060	5599	6416	1398	1399	5829	8650	9564	998	5908	387	382	5906	2885	5879	5604	5747	5590	5781	6654	5795	5058	5062	4214	2549	1978	2889	3837	57610	57521	200958	64798	54453	3635	572	84335	30011	10048	6456	64223	50855	50649	9846
PC_3494	Notch signaling pathway	28514	102	8038	23028	9611	9148	4609	3565	2023	5045	867	2625	595	7528	1026	2060	4851	8650	4237	8766	6500	182	8788	4853	1759	3516	2033	1272	6502	8076	1487	3065	8454	171558	2011	1840	57534	84441	92737	84708	83464	23385	9794	55294	51107	83737	23013	26292	4855	5932	54567	10683	55851	4854	27255	3714	8945	9612
PC_3495	(S)-3-Hydroxy-3-methyl-glutaryl-CoA = Acetyl-CoA + Acetoacetic acid ( Pyruvate metabolism )	3155
PC_3496	Methionine and Cysteine metabolism ( Methionine and Cysteine metabolism )	10768	191	4357	4144	1491	102724560	833	4141	4143	2572	1036	635	23382	2571	4548	51380
PC_3497	IMP + H2O = 5'-Phospho-ribosyl-4-carboxamido-5-formamido-imidazole ( Purine nucleotides and Nucleosides metabolism )	471
PC_3498	histidine degradation III	10841	4522	10797	3034	131669	144193	441024
PC_3499	JAK degradation signaling ( JAK-STAT pathway and regulation pathway Diagram )	8651	3717	3716	7297	3718
PC_3500	Atypical NF-kappaB pathway	3551	3932	6714	4790	602	4792	5295	409	5290	6850	5970	5966	1432	8945
PC_3501	Thrombin/protease-activated receptor (PAR) pathway	2147
PC_3502	Drosophila Wingless/Wnt signaling pathway ( Drosophila Wingless/Wnt signaling pathway Diagram )	375790	9672	2239	960	6382	6385	6383	2817	3339
PC_3503	Adenylate cyclase inactivation signaling ( GPCR signaling (pertussis toxin) )	112	109	115	111	2771	114	113	2770	108	107	196883	55811
PC_3504	ketolysis	30	38	3032	5019	622	56898
PC_3505	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Lysine degradation )	38	39
PC_3506	glycine biosynthesis III	189	64902
PC_3507	Gene expression of c-FLIP ( TNFR1 signaling pathway )	8837	4790	5970
PC_3508	AKT(PKB)-mTOR signaling ( Insulin receptor signaling (Mammal) )	8672	1977	6198	207	208	2475	7249	5728	1973	6194	1981	1978	1974	6009	10000
PC_3509	UDP-N-acetyl-D-glucosamine biosynthesis II	9945	5238	2673	6675	64841
PC_3510	sphingosine and sphingosine-1-phosphate metabolism	427	22949	340485	130367	125981	81537	56624	56848	8877
PC_3511	HIF-2-alpha transcription factor network	8553	5230	2056	5054	6667	6513	2113	7422	2321	2002	1942	405	328	135	3791	7428	4891	4323	3646	5460	2033	6921	6923	7291	2395	1387	23411	112398	2034	10370	54583	112399	55662	9429
PC_3512	Raf activation signaling (through Grb2 and Sos) ( CD4 T cell receptor signaling )	4893	3265	3845	5894	369	673	2885	6654	6655
PC_3513	NAD+ + 4-Trimethyl-ammonio-butanal + H2O = NADH + 4-Trimethyl-ammonio-butanoic acid ( Lysine degradation )	223
PC_3514	NAD+ + D-Glycerate 3-phosphate = NADH + 3-Phospho-hydroxy-pyruvic acid ( Glycine and Serine metabolism )	26227
PC_3515	Adenylo-succinic acid = AMP + Fumaric acid ( Alanine,Aspartic acid and Asparagine metabolism )	158
PC_3516	mevalonate pathway I	3156	30	38	4597	3158	3032	3157	4598	3422	10654	39	91734
PC_3517	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	8871	3636	8867	3706	3707	3633	5728	4952	3632	27124	253430	3635	80271	51763	9562
PC_3518	JAK-STAT pathway and regulation pathway ( JAK-STAT pathway and regulation pathway Diagram )	3717	4049	7124	3439	3440	3446	3444	3452	3442	3448	3451	3456	3458	3552	3553	2056	3559	1437	3467	3443	3441	3449	3565	3567	3569	3562	3570	1440	3576	2690	3574	3554	3560	3976	3578	3459	1438	5618	3575	3454	2057	3589	4254	3586	3716	3566	3577	3579	3563	1271	7850	3592	3593	7297	959	3561	3445	1439	3596	3460	3572	200081	7066	4352	6774	3600	6772	6778	6776	3594	3977	356	3953	3455	8743	6777	3718	6773	2885	3597	3581	3568	3588	3601	8809	3587	3603	3606	3598	6775	3605	23765	1441	9180	3595	3556
PC_3519	NAD+ + (R)-3-Hydroxy-butanoic acid = NADH + Acetoacetic acid ( Butanoate metabolism )	622
PC_3520	PLC gamma signaling ( PDGF signaling pathway )	5159	5335
PC_3521	Rap1 activation signaling (through cAMP and Epac) ( GPCR signaling (G alpha s, Epac and ERK) )	10411	5908	5906	11069
PC_3522	p38 cascade ( IL-1 signaling pathway (through p38 cascade) )	5609	5603	6885	1386	5605	5599	5601	6416	5606	5608	6300	5602	5604	5607	5600	1432
PC_3523	IL-3 signaling pathway(JAK1 JAK2 STAT5) ( IL-3 signaling(JAK1 JAK2 STAT5) )	3717	3562	3716	3563	1439	6776	6777
PC_3524	JNK cascade ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) )	5609	3725	5605	5599	5601	6416	5606	5608	5602	5604	5607	4214
PC_3525	Signaling with Wnt (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	8326	607	7480	7476	7483	7484	8323	8324	4041	4040	7481	7471	7472	1499	6932	7474	6597	7473	89780	54361	7477	7088	7089	7090	7091	2033	7855	4089	2535	1387	7482	7479	90780	80326	7478	81029	8325	83439	7976	6934	51384	51176	8322	11211	8321	26108	7475
PC_3526	2-Oxo-glutaric acid + L-Cysteine-sulfinic acid = L-Glutamic acid + 3-Sulfinyl-pyruvic acid ( Methionine and Cysteine metabolism )	2806	2805
PC_3527	JNK cascade ( EGF signaling pathway Diagram )	3725	5599	6416	4214
PC_3528	Signaling without Wnt (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	6932	7088	7089	7090	7091	83439	6934	51176
PC_3529	TNFR1 signaling pathway ( TNFR1 signaling pathway )	8837	8767	7124	7132	637	54205	581	7186	8772	8737	841	8717	83737	4217	11035
PC_3530	IL6	6446	5296	9021	3636	6885	2309	3717	2353	3265	2064	3315	3569	3725	2534	5925	1977	2242	3320	4067	3055	3570	3178	2268	367	4137	7409	1051	5335	4790	6927	2065	867	6198	3716	958	4792	5595	5295	5594	6464	7297	207	5605	3572	6774	6772	6776	7006	5599	6416	5829	2932	1025	6777	660	5608	2885	5879	140885	4303	1020	5604	5747	5580	5781	695	6654	2033	2308	2549	1978	3065	2185	6196	8648	1432	1387	3635	572	83939	51701	1616	9846	4216	10401
PC_3531	choline biosynthesis III	5338	5130	5337	23646	201164	56994	122618	9468	10390
PC_3532	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	8564	23498	6999	8942	125061
PC_3533	methylglyoxal degradation VI	197257
PC_3534	Plasma membrane estrogen receptor signaling	6801	9475	9630	4893	3265	3845	2099	2771	3479	3480	4313	2773	2775	6714	4318	2781	4478	5295	6464	4846	2767	2769	207	2774	5290	2776	9564	54331	387	2782	2885	2770	2778	5330	5331	6654	10672	5600	27043	2100	1839	23236
PC_3535	BMP2 signaling pathway(through TAK1) ( BMP2 signaling(through TAK1) )	658	6885	4091	650	657	331	659	10454
PC_3536	ATP + Pyruvic acid + CO2 + H2O = ADP + Oxaloacetic acid + Orthophosphate ( Citrate cycle )	5091
PC_3537	Calcineurin-regulated NFAT-dependent transcription in lymphocytes	4094	4772	2353	7124	3458	3559	1437	3565	3567	3725	6520	3562	3576	1959	1019	5451	8061	1493	3726	5770	1958	1606	2625	959	5743	5468	836	356	3558	801	1869	1390	5588	1961	1960	4775	868	10320	4773	5796	3662	79589	83737	50943	2635	55509	30009
PC_3538	ATF-2 transcription factor network	8739	9021	9555	5328	2353	3630	3458	2099	383	3569	3725	5925	7054	4313	3576	596	1019	5451	1386	1385	5156	6401	5578	3726	3727	467	890	4763	43	595	1647	5595	5594	1843	4843	1649	5268	672	5599	5601	7042	3048	598	2033	1850	8452	865	3280	5600	1466	1432	1847	255631	122953	10524	51561	10891	10856	11221
PC_3539	LIF signaling pathway ( LIF signaling(JAK1 JAK2 STAT3) )	3717	3976	3716	3572	6774	3977	2033	4089	4086	1387
PC_3540	2-Methyl-propanoyl-CoA + Acceptor = 2-Methylprop-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	34	84129
PC_3541	Steroids metabolism ( Steroids metabolism )	6309	8435	9453	3156	2224	6646	4597	4598	6713	10654
PC_3542	Trk receptor signaling mediated by PI3K and PLC-gamma	5170	2309	4893	3265	3845	4803	4914	6714	1385	1958	5335	595	10971	5295	6464	207	7529	2810	6776	5290	2932	7532	7531	2885	7534	7533	5580	6654	2549	7222	814	7442	572	116986	2036	815
PC_3543	Signaling with Hh ( Hedgehog signaling pathway )	2735	2736	2737
PC_3544	Raf activation signaling (through RasGRP) ( CD4 T cell receptor signaling )	10125	4893	3265	3845	5894	369	673
PC_3545	(S)-Malic acid = Fumaric acid + H2O ( Citrate cycle )	2271
PC_3546	ATP + dGMP = ADP + dGDP ( Purine nucleotides and Nucleosides metabolism )	2987
PC_3547	S-methyl-5'-thioadenosine degradation II	4507
PC_3548	EPHB forward signaling	8976	8867	8997	9448	4893	3265	3845	7018	6237	6714	4690	5921	5595	5295	5594	2048	6464	5290	1398	5829	1948	1946	2049	2050	2047	998	5908	5906	2885	5879	1947	5604	1759	5747	5058	6093	2886	1949	6453	6456
PC_3549	aspartate degradation II	2806	2805	4190	4191	137362
PC_3550	Valine,Leucine and Isoleucine degradation ( Valine,Leucine and Isoleucine degradation )	8854	216	217	30	3712	219	11112	10449	223	501	224	3158	3032	3157	56922	64087
PC_3551	ALK2 signaling events	4093	3196	268	655	2280	90	4089	659	4086	269	4090
PC_3552	JNK cascade ( CD4 T cell receptor signaling (JNK cascade) )	2353	3725	8061	2355	5595	5594	5605	5599	5601	2354	5602	5604
PC_3553	Guanosine + Orthophosphate = Guanine + D-Ribose 1-phosphate ( Purine nucleotides and Nucleosides metabolism )	4860
PC_3554	IKK-NF-kappaB cascade ( B cell receptor signaling )	4794	3551	1147	4790	4792	5970	4793	8517
PC_3555	Tyrosine metabolism ( Tyrosine metabolism )	2954	314	7054	1621	5409	7299	2184	26	1644	4128	1312	4129	3242	8639	3081
PC_3556	glutathione-mediated detoxification I	4259	2941	2954	2938	2939	2950	2944	2953	653689	4257	290	2678	2947	2946	2952	2949	2948	2940	124975	221357	8836	4258	119391	2686	373156
PC_3557	thymine degradation	10570	1806	1807	1400	1809	1808	56896	51733
PC_3558	Internalization of ErbB1	9146	8867	10253	10617	1956	4893	3265	3845	1950	5894	6714	5868	867	5295	6464	9101	5290	5291	2060	273	7321	998	7323	7322	2885	1759	5747	6654	868	8874	6453	30011	26018	7251	6456	57732	100526767	29924
PC_3559	IL-2 signaling pathway(JAK1 JAK3 STAT5) ( IL-2 signaling(JAK1 JAK3 STAT5) )	3559	3560	3716	3561	6776	6777	3718
PC_3560	N6-Acetyl-L-lysine + 2-Oxo-glutaric acid = 6-Acetamido-2-oxo-hexanoic acid + L-Glutamic acid ( Lysine degradation )	51166
PC_3561	ATP + D-Glycerate 3-phosphate = ADP + 1,3-Bisphospho-D-glyceric acid ( Glycolysis and Gluconeogenesis )	5230	5232
PC_3562	Sphingosine 1-phosphate (S1P) pathway	9294	8879	9630	8698	2771	2773	2775	2781	1901	2767	2769	4363	2776	2770	2768	10672	1903	81537	53637	56848	8877
PC_3563	2 Farnesyl diphosphate + NADPH => NADP+ + Squalene + 2 Pyrophosphate ( Steroids metabolism )	2222
PC_3564	D-Mannose 6-phosphate = D-Fructose 6-phosphate ( Aminosugars metabolism )	4351
PC_3565	NAD+ + 3-Mercapto-lactic acid = NADH + 3-Mercapto-pyruvic acid ( Methionine and Cysteine metabolism )	3939	3945	3948	92483
PC_3566	Alpha9 beta1 integrin signaling events	8038	2277	2162	2335	1437	3688	6696	6714	1438	7422	7412	6303	7052	3371	4843	5829	7424	9564	5879	101	8751	3680	196743	3772	2515
PC_3567	Cytosolic calcium ion concentration elevation (through IP3 receptor) ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	3710	3708
PC_3568	IL3-mediated signaling events	3717	3562	5292	5008	5566	1051	5568	5567	3563	5295	6464	1439	3397	6776	5290	6726	6777	7532	2885	7534	5781	598	3065	3635	10256	1154	9846
PC_3569	Signaling with Hh ( Hedgehog signaling pathway )	2736
PC_3570	ATP + CoA + Citric acid = ADP + Acetyl-CoA + Oxaloacetic acid + Orthophosphate ( Citrate cycle )	47
PC_3571	Arf1 pathway	79658	9570	5338	2069	10652	8615	160	920	1211	1212	10945	10914	23647	1314	10096	10097	5879	375	9267	55738	8729	1173	9266	8394	23163	50807	28964	10565
PC_3572	selenocysteine biosynthesis II (archaea and eukaryotes)	6301	22929	118672	22928	51091	54938
PC_3573	Canonical Wnt signaling pathway ( C. elegans endoderm induction Wnt signaling pathway Diagram )	375790	7480	7476	7483	7484	6885	9672	4041	2239	4040	22943	7481	7471	7472	960	6382	10971	6385	7529	2810	6383	2817	1499	6932	7474	7473	89780	54361	7477	7532	7531	7534	3339	7533	6424	79412	2487	7482	7479	6423	83999	80326	7478	81029	83439	6934	56998	51701	27122	27121	27123	51384	51176	25776	11197	7475
PC_3574	ERK cascade ( VEGF signaling pathway )	5894	2002	5595	5594	5605	5604
PC_3575	N-Ribosyl-nicotinamide + Orthophosphate = Nicotinamide + D-Ribose 1-phosphate ( Nicotinate and Nicotinamide metabolism )	4860
PC_3576	xanthine and xanthosine salvage	4860
PC_3577	D-Fructose 1,6-bisphosphate = Dihydroxy-acetone phosphate + D-Glyceraldehyde 3-phosphate ( Fructose and Mannose metabolism )	226	229	230
PC_3578	gamma-glutamyl cycle	26873	79017	290	2678	2729	2730	2937	124975	54878	55748	2686
PC_3579	Trk receptor signaling mediated by the MAPK pathway	9252	2353	4893	3265	3845	5894	6722	673	1385	1958	2002	4908	5595	5594	5606	9261	5608	5908	5906	1020	5604	5580	4208	5607	5598	8851	6195	1432	7442	6016	6014	23623	30844	10746
PC_3580	(S)-3-Hydroxy-2-methyl-propanoyl-CoA = 2-Methylprop-2-enoyl-CoA + H2O ( Valine,Leucine and Isoleucine degradation )	1892	3030	1962
PC_3581	EPHA forward signaling	1943	22899	3932	2534	7525	4067	3055	2268	6714	5335	1942	2041	867	1969	2042	2046	1398	1399	5294	640	7410	1944	1946	2044	2043	387	1020	6093	2045	146850	25791	285220	10451
PC_3582	S1P3 pathway	3717	9630	5155	2771	2773	2775	5159	6714	7422	2321	2781	5595	5594	2767	2769	207	2776	7852	387	5879	2770	2768	10672	1903	10000
PC_3583	2-Oxo-glutaric acid + L-Tyrosine = L-Glutamic acid + 4-Hydroxy-phenyl-pyruvic acid ( Tyrosine metabolism )	6898
PC_3584	NADP+ + D-Glucose = NADPH + D-Glucono-1,5-lactone ( Pentose phosphate cycle )	9563
PC_3585	Acetyl-CoA + Glycine = CoA + L-2-Amino-3-oxo-butanoic acid ( Glycine and Serine metabolism )	23464
PC_3586	Lysine degradation ( Lysine degradation )	8424	6470	6472	2639	55217	10157
PC_3587	IL8- and CXCR2-mediated signaling events	5338	5170	9630	2771	5582	5579	4067	3055	2268	3576	5880	5578	5868	867	3579	5518	2769	207	409	5294	408	7408	7879	54331	8766	2782	5515	5330	5331	1759	146850	9844	1794	92170	23236
PC_3588	IL-1_signaling(through_JNK_cascade)(canonical) ( IL-1 signaling pathway (through JNK cascade) )	6885	3552	3553	3554	3654	7334	387522	10454	4615	54472	3556	51135	23118	7189
PC_3589	AKT(PKB) activation signaling ( IGF1 signaling pathway )	5293	5170	207	208	5290	5291	10000
PC_3590	2-Oxo-glutaric acid + L-Valine = L-Glutamic acid + 3-Methyl-2-oxo-butanoic acid ( Valine,Leucine and Isoleucine degradation )	587	586
PC_3591	5'-Orotidylic acid + Pyrophosphate = Orotic acid + D-5-Phospho-ribosyl 1-diphosphate ( Pyrimidine Nucleotides and Nucleosides metabolism )	7372
PC_3592	Calcineurin activation signaling ( CD4 T cell receptor signaling (JNK cascade) )	5532	5533	5534	5530
PC_3593	glycerol-3-phosphate shuttle	2819	2820
PC_3594	D-Fructose 1,6-bisphosphate = Dihydroxy-acetone phosphate + D-Glyceraldehyde 3-phosphate ( Glycolysis and Gluconeogenesis )	226	229	230
PC_3595	NAD+ + (S)-Malic acid = NADH + Pyruvic acid + CO2 ( Pyruvate metabolism )	4200
PC_3596	Regulation of RAC1 activity	9743	5924	8997	7204	4168	613	7409	1123	5910	396	7410	1124	5879	6654	392	2059	29	7074	5923	8874	1793	9459	10928	55114	80243	115557	26230	10006	25791	57580	9844	1794	9181	57572	221178	64333	29127	50619	10451
PC_3597	FGF signaling pathway ( FGF signaling pathway )	5293	2255	8823	10817	8822	8817	9965	4893	3265	3845	5894	2246	2249	2247	369	2251	2260	2248	2250	673	5336	5335	2252	2263	2264	2261	5295	2254	5290	5291	2253	2885	5580	6654	6655	2549	10818	2258	2256	2259	8074	27006	26281	26291
PC_3598	BARD1 signaling events	571	2189	2175	4683	7157	5111	2547	7520	898	1017	672	4361	7323	7332	5591	2176	2130	1477	5888	472	545	11073	10111	5932	580	2177	2178	2188	55120
PC_3599	Validated targets of C-MYC transcriptional activation	1871	7015	332	1736	4683	8464	9913	6615	86	3939	4609	7037	7083	2597	7157	1965	661	5757	1977	2023	4869	3320	5213	3329	6513	5292	1019	4953	891	4318	8061	4830	3159	7343	1104	4691	4831	790	10935	894	993	6470	3308	100532731	3811	3658	586	1973	4149	6135	4088	3398	1981	581	2033	6881	9112	4089	5366	6883	6880	389421	10075	23089	92140	84864	91942	80177	6875	1387	2648	10524	5274	11235	83879	57678	8886	10856	8607	8295
PC_3600	Regulation of nuclear beta catenin signaling and target gene transcription	607	3491	1046	7015	7514	6862	9314	8913	6591	26959	6907	4286	22943	4513	4609	3848	3725	4313	2249	3576	367	999	4617	1462	4318	4656	6925	595	324	10971	894	7529	2810	1499	6932	1029	1044	6597	113	7532	7531	7534	6500	3398	7088	7089	7091	7533	166	2033	1487	3065	8454	10499	814	389058	170261	80333	3066	4762	1857	9968	5308	79718	57680	83439	6934	3619	56998	10642	29969	27121	57167	51176	23043	10856	8945	8313	25776	8295
PC_3601	FoxO family signaling	6446	3551	7514	1147	10018	2309	7763	847	6648	5898	5899	891	1647	1017	4485	10971	207	7529	2810	1499	2538	604	5599	5601	1027	356	1452	1453	102800317	5347	5602	7532	7531	5901	7534	1455	4303	7533	5934	2033	2308	6502	1387	8850	7874	114907	23411	53944	1456
PC_3602	VEGFR1 specific signals	8829	5170	8828	5579	3320	7422	4690	5578	5566	2321	5335	5921	867	5595	5295	5594	4846	207	5290	5228	7423	801	25759	857	5781	3091	23607
PC_3603	L-cysteine degradation II	1491
PC_3604	glutamate removal from folates	8836
PC_3605	Canonical Wnt signaling pathway ( Drosophila Wingless/Wnt signaling pathway Diagram )	375790	7480	7476	7483	7484	6885	9672	4041	2239	4040	22943	7481	7471	7472	960	6382	10971	6385	7529	2810	6383	2817	1499	6932	7474	7473	89780	54361	7477	7532	7531	7534	3339	7533	6424	79412	2487	7482	7479	6423	83999	80326	7478	81029	83439	6934	56998	51701	27122	27121	27123	51384	51176	25776	11197	7475
PC_3606	JNK cascade ( Toll-like receptor signaling pathway (through JNK cascade) )	5609	6885	3725	5605	5599	5601	6416	5606	5608	5602	5604	5607
PC_3607	IL5-mediated signaling events	6386	3717	3567	4067	5292	5295	1439	6776	5290	6777	2885	3568	5781	1154
PC_3608	Endogenous TLR signaling	7099	3551	1147	7098	3656	7097	6289	6279	6280	929	3146	3329	1462	633	3654	114609	387	7096	148022	653509	4615	51135	10333	8517	23643
PC_3609	BMP signaling pathway ( BMP signaling in Drosophila )	658	2660	4093	2661	10220	27302	9210	650	652	651	655	7490	653	654	656	657	8200	6597	2662	4088	2033	4089	659	4087	4086	392255	151449	84441	9794	1387	55534	4090	9573	2658
PC_3610	IL-23 signaling pathway(JAK2 TYK2 STAT3 STAT4) ( IL-23 signaling(JAK2 TYK2 STAT3 STAT4) )	3717	3593	7297	6774	3594	6775
PC_3611	IGF1 pathway	5170	8440	3265	5894	3479	3480	5770	6198	5295	6464	207	3667	5290	1398	1399	5829	9564	7531	2885	7534	10399	5747	5590	5580	5781	6654	2887	5587	572	8660
PC_3612	RhoA signaling pathway	2151	3491	11113	5338	4659	8395	23396	1729	9475	2353	3725	3688	4633	6722	7430	1386	7414	6548	1072	4478	5962	2119	5599	6416	1027	5606	6550	5608	3984	3985	6300	5728	998	387	58	5590	5337	6093	5585	5586	286205	57591	8394	6456	50855	7094
PC_3613	TGF beta signaling pathway(through TAK1) ( TGF-beta signaling(through TAK1) )	6885	7040	7043	7046	7048	7042	331	10454
PC_3614	glucose and glucose-1-phosphate degradation	2645	5236	5239	80201	55276
PC_3615	AKT(PKB)-GSK3beta signaling ( Insulin receptor signaling (Mammal) )	2997	207	208	2932	2998	10000
PC_3616	EGF signaling pathway (D. melanogaster) ( EGF signaling pathway Diagram )	10971	7529	2810	7532	7531	7534	7533
PC_3617	Beta3 integrin cell surface interactions	3491	10085	5328	5155	1277	1282	2243	2244	2266	2335	7448	7070	3690	3685	3912	7057	1278	3674	1284	3146	5159	6696	3915	5817	7422	5175	6382	3381	3371	1287	6385	3897	2200	3791	7048	1286	1285	5329	961	1288	7045	3910	8877	50848
PC_3618	TNFalpha	9755	4794	5718	5296	7188	3839	1654	5537	317	5609	3551	4659	9919	1147	9533	8837	5709	6885	9055	10270	9043	26471	1620	904	23633	8726	9252	9099	7763	8518	9530	25885	86	1956	7124	1410	2064	7157	3315	249	3725	5925	5836	3320	3303	3326	3146	7295	4633	3309	3312	6714	1535	653361	2752	1385	2720	5578	3726	5702	7132	6256	4790	7133	602	2316	7128	2065	2091	6198	4163	1072	10398	4792	10971	5595	5295	5693	5594	943	5371	207	208	7529	4174	4176	3667	9276	5701	6124	200081	1326	6772	6776	2475	836	835	10128	6850	5599	5601	6416	4528	7182	9261	997	1025	10914	6597	5713	8237	3784	3838	5437	5608	840	842	637	140823	7323	10238	7532	5700	7531	6207	6205	7322	5441	6156	6132	2885	7534	7341	6500	10399	7329	1457	2969	8738	4088	331	1020	4791	5971	5581	5604	6128	857	5970	5588	5966	7533	5747	5590	5580	5781	581	598	6654	6655	2033	2308	6598	5871	10131	7186	22954	7185	7709	7187	5058	8772	5607	5708	4214	2289	2549	330	329	8737	3065	10788	8454	9641	22821	841	9861	5163	8717	4793	4638	10454	4087	5134	5585	1432	11140	4296	8290	605	134728	56957	84231	2011	3895	8887	222643	257397	150684	79155	6601	26133	10848	8567	117584	8439	3066	5977	1387	10010	843	9138	2734	10987	6599	9181	6605	55312	55294	64320	92610	83737	147945	83696	57761	5707	9020	4217	1796	4215	9618	10293	2177	64332	64425	5178	10628	84172	56616	55512	23118	28511	28512	10013	29110	5202	9462	23291	9908	5719	11124	8533	8945	51082	10746	26994	8660	7189	11035	8517	8792	10401
PC_3619	BCR	5293	5296	10603	3551	8395	1147	5170	6885	10018	2309	23396	8915	2353	5894	3725	5579	921	3932	2534	5925	4067	5788	3055	5911	6348	596	1019	973	8519	388372	3059	673	1386	930	7409	1385	4690	5336	3726	5335	2002	4790	1380	890	933	5921	971	867	6198	493	898	1017	4792	5595	5295	5594	5777	6464	894	896	5596	207	2213	1499	5605	974	6774	604	1445	6772	836	7006	7454	7535	6850	5599	5601	1398	1399	5305	5294	9261	2931	2932	7408	1785	1022	640	7410	2354	840	842	8115	9564	975	3190	22800	6194	2885	6452	2969	8396	54205	1021	5581	5604	5970	5588	5966	5747	5580	5781	695	581	6654	6655	3702	2308	4775	3937	868	4773	2549	1978	2889	2185	4739	3709	3708	5587	6195	1432	118788	79930	51363	151888	25780	55024	79837	51564	29760	3635	11184	123920	1796	8394	26469	84433	7462	54923	84174	59339	59338	10892	28988	26228	27071	9846	10014	8517
PC_3620	p38 cascade ( BMP2 signaling(through TAK1) )	5603	6885	1386	5606	5608	6300	5600	1432
PC_3621	L-Arginino-succinic acid = L-Arginine + Fumaric acid ( Citrate cycle )	435
PC_3622	D-Fructose 6-phosphate + D-Glyceraldehyde 3-phosphate = D-Erythrose 4-phosphate + D-Xylulose 5-phosphate ( Pentose phosphate cycle )	7086	8277	84076
PC_3623	VEGFR3 signaling in lymphatic endothelium	2277	1277	2335	3688	1278	3678	3676	1385	3673	5595	5295	5594	6464	207	2324	5290	6416	1398	7424	3672	2885	6654	6195	5600	1432	112476
PC_3624	fatty acid biosynthesis initiation II	2194	146861	54995
PC_3625	Uridine + Orthophosphate = Uracil + D-Ribose 1-phosphate ( Pyrimidine Nucleotides and Nucleosides metabolism )	7378
PC_3626	Succinic acid + Ubiquinone = Fumaric acid + Ubiquinol ( Citrate cycle )	6390	6389
PC_3627	Citric acid = cis-Aconitic acid + H2O ( Citrate cycle )	48	50
PC_3628	spermidine biosynthesis I	262	6723
PC_3629	LKB1 signaling events	4609	2099	7157	1509	3320	4137	4133	7430	1385	5566	10971	7529	2810	2475	2118	5664	7249	2932	102724428	7532	7531	7534	7533	4089	6794	11140	200186	6604	2011	92335	9024	57521	114790	84446	7248	84335	57787	64223	55437	23235	51765	23387	51719
PC_3630	NADP+ + 5,6-Dihydro-uracil = NADPH + Uracil ( Pyrimidine Nucleotides and Nucleosides metabolism )	1806
PC_3631	(S)-2,3-Epoxy-squalene = Lanosterol ( Steroids metabolism )	4047
PC_3632	IL-1 signaling pathway (through p38 cascade) ( IL-1 signaling pathway (through p38 cascade) )	6885	3552	3553	3554	3654	7334	387522	10454	4615	54472	3556	51135	23118	7189
PC_3633	Calcineurin activation signaling ( CD4 T cell receptor signaling )	5532	5533	5534	5530
PC_3634	Growth hormone signaling pathway(JAK2 STAT5) ( Growth hormone signaling(JAK2 STAT5) )	8835	9021	8651	3717	2688	2690	6776	6777	5781
PC_3635	BMP Signalling Pathway	650	6497	7321	7323	4089	9765
PC_3636	ATP + UMP = ADP + UDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	51727
PC_3637	fatty acid alpha-oxidation II	5264	11001	2182	2181	2180	81616	23205	26061	23305	51703
PC_3638	Signaling with Wnt (Canonical) ( Canonical Wnt signaling pathway Diagram )	8326	607	7480	7476	7483	7484	8323	8324	4041	4040	7481	7471	7472	1499	6932	7474	6597	7473	89780	54361	7477	7088	7089	7090	7091	2033	7855	4089	2535	1387	7482	7479	90780	80326	7478	81029	8325	83439	7976	6934	51384	51176	8322	11211	8321	26108	7475
PC_3639	IL-7 signaling pathway(JAK1 JAK3 STAT5) ( IL-7 signaling(JAK1 JAK3 STAT5) )	5293	5296	3574	3575	3716	5295	3561	6776	5290	5291	6777	3718	572
PC_3640	NGF signaling pathway ( NGF signaling pathway )	4893	3265	3845	4803	5894	4914	369	673	5335	6464	2885	25759	5580	6654	6655	53358
PC_3641	CD28 signaling ( CD4 T cell receptor signaling )	940	941	942
PC_3642	Malonyl-CoA = Acetyl-CoA + CO2 ( Pyruvate metabolism )	23417
PC_3643	Butanoyl-CoA + Acceptor = Crotonoyl-CoA + Reduced acceptor ( Butanoate metabolism )	35
PC_3644	(S)-Dihydro-orotic acid + O2 = Orotic acid + H2O2 ( Pyrimidine Nucleotides and Nucleosides metabolism )	1723
PC_3645	pyridoxal 5'-phosphate salvage pathway	8566	55163
PC_3646	alanine degradation III	2875	84706
PC_3647	Validated transcriptional targets of TAp63 isoforms	3551	1147	4968	26959	9249	25	100	6667	1959	7421	1728	3691	3486	2877	2232	1647	355	3675	10971	6273	5371	5268	1026	5347	182	4193	667	5580	581	4240	6749	2033	5366	2319	6469	9540	6604	1029	132671	91768	64782	7022	2125	64065	83737	9518	9618	27113	11059	8626	23405	9635	8945	26155
PC_3648	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	9453	3156	30	2224	38	4597	3158	3032	3157	4598	3422	10654	39	91734
PC_3649	2-Oxo-glutaric acid + N2-Succinyl-L-ornithine = L-Glutamic acid + N2-Succinyl-L-glutamate 5-semialdehyde ( Arginine and Proline metabolism )	4942
PC_3650	T cell receptor signaling (PLC gamma, PKC, Ras and IKK-NF-kappaB cascade) ( CD4 T cell receptor signaling (NF-kB cascade) )	27040	10125	920	3122	3118	3117	3123	3123	3119	3123	915	3115	3120	3932	916	917	3123	3123	3126	7409	5336	5335	4790	3113	3123	919	7535	3125	5970	5588	3123	3123	3123
PC_3651	UDP-D-xylose and UDP-D-glucuronate biosynthesis	7358	80146
PC_3652	L-Alanine + Glyoxylic acid = Pyruvic acid + Glycine ( Glycolysis and Gluconeogenesis )	189	64902
PC_3653	Syndecan-4-mediated signaling events	6386	23495	10755	8038	8324	2147	5340	2335	3688	7057	3678	2247	7035	2251	2260	87	6352	4318	5578	4192	3371	284217	6385	6387	1785	7852	387	5879	5747	5580	3909	84309
PC_3654	alpha-tocopherol degradation	8529
PC_3655	C-MYC pathway	8312	26959	8464	9913	86	4609	5371	2932	4149	5515	6881	7709	5062	6502	5300	5525	6883	6880	1029	2648	10524	55294	10856	8607	8295
PC_3656	ERK cascade ( CD4 T cell receptor signaling (ERK cascade) )	5894	369	673	5595	5594	5605	5599	5601	5602	5604
PC_3657	Glypican 1 network	9353	462	7040	5621	351	3932	2534	7525	4067	3055	2247	2268	7043	2260	6714	6997	5320	7422	2321	284217	2817	7046	7048	640	3084	4087
PC_3658	triacylglycerol degradation	8513	3990	5406	8228	5408	3991	119548	26090	57104	11343	57406	80339	9388
PC_3659	N-Acetyl-D-glucosamine = N-Acetyl-D-mannosamine ( Aminosugars metabolism )	5973
PC_3660	BMP2 signaling pathway(through Smad) ( TGF-beta_BMP Diagram(MolecularVariation) )	658	4092	4091	650	657	6774	2033	25805	4089	659	4086	23090	1387
PC_3661	G alpha s GDP-GTP exchange signaling ( GPCR Adenosine A2A receptor signaling pathway )	2793	10681	2784	135	2778
PC_3662	heme biosynthesis from uroporphyrinogen-III I	7389	2235	1371	5498
PC_3663	Caspase9 activation signaling ( Fas signaling pathway )	317	842	54205
PC_3664	Wnt signaling network	8326	7476	8323	8324	4041	4040	10159	22943	7471	7472	3487	6259	7474	7473	89780	7477	4920	7855	2535	284654	79412	115908	83999	50964	8325	8322	11211	8321	11197
PC_3665	p63 transcription factor network	8626
PC_3666	Mammalian Notch signaling pathway ( Notch signaling pathway Diagram )	28514	4851	5663	5664	182	6868	4853	3516	2033	84441	9794	1387	55534	4855	4854
PC_3667	NAD+ + Phenyl-acetaldehyde + H2O = NADH + Phenyl-acetic acid ( Phenylalanine degradation )	218	221	220
PC_3668	JNK cascade ( TGF-beta signaling(through TAK1) )	6885	3725	5599	5601	6416	5602
PC_3669	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	8326	1855	1856	8312	8323	8324	4041	23401	4040	324	1499	102800317	2932	7855	2535	10023	1857	8325	7976	8322	11211	8321	8313
PC_3670	L-Tetrahydro-folic acid + L-Serine = 5,10-Methylene-tetrahydro-folic acid + Glycine + H2O ( Folate metabolism )	6470	6472
PC_3671	Rap1 activation signaling (through cAMP, PKA, Cbl and C3G) ( GPCR Adenosine A2A receptor signaling pathway )	6714	5566	5568	867	5567	1399	5908	5906	868	2889	23624
PC_3672	inositol pyrophosphates biosynthesis	23262	9677	253430	9807	117283	64768	51447
PC_3673	NAD phosphorylation and dephosphorylation	65220	23530	92370	51205
PC_3674	L-Alanine + Glyoxylic acid = Pyruvic acid + Glycine ( Glycine and Serine metabolism )	189	64902
PC_3675	p38 cascade ( Toll-like receptor signaling pathway (p38 cascade) )	5609	5603	6885	1386	5605	6416	5606	5608	6300	5604	5607	5600	1432
PC_3676	thio-molybdenum cofactor biosynthesis	55034
PC_3677	IGF1 signaling pathway ( IGF1 signaling pathway )	5293	5296	4893	3265	3845	5894	3479	354	3480	3484	369	673	3486	3485	3487	3489	3488	5295	6464	3667	5290	5291	2885	25759	6654	6655	53358
PC_3678	calcium transport I	487	9914	488	27032	489
PC_3679	Signaling without Wnt (Mammal) ( Mammalian Wnt signaling pathway Diagram )	6932	7088	7089	7090	7091	83439	6934	51176
PC_3680	Negative regulation of gene expression ( Insulin receptor signaling )	2309	207	208	4303	2308	10000
PC_3681	TPO signaling pathway(JAK2 STAT3) ( TPO signaling(JAK2 STAT3) )	3717	7066	4352	6774
PC_3682	PRPP biosynthesis I	5634	221823	5631
PC_3683	2-Oxo-glutaric acid + L-Leucine = L-Glutamic acid + 4-Methyl-2-oxo-pentanoic acid ( Valine,Leucine and Isoleucine degradation )	587	586
PC_3684	L-Serine + Pyruvic acid = Hydroxy-pyruvic acid + L-Alanine ( Glycine and Serine metabolism )	189
PC_3685	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( Mammalian Wnt signaling pathway Diagram )	8326	1855	1856	8312	8323	8324	4041	23401	4040	324	1499	102800317	2932	7855	2535	10023	1857	8325	7976	8322	11211	8321	8313
PC_3686	Visual signal transduction	10681	9187	8787	9227	9626	6010	6295	2779	5145	5148	1259	5158	118142757	2986	2782	2792	3000	1258	6011	6121	388531	5959	145226	2979
PC_3687	E-cadherin signaling events	999	3728	1499
PC_3688	protein citrullination	353238	29943	51702	23569	11240
PC_3689	NAD+ + 2-Hydroxy-butanoic acid = NADH + 2-Oxo-butanoic acid ( Propanoate metabolism )	3939	3945	3948	92483
PC_3690	NAD+ + (S)-3-Hydroxy-2-methyl-propanoic acid = NADH + (S)-Methyl-malonate semialdehyde ( Valine,Leucine and Isoleucine degradation )	3030	1962	3033	3028
PC_3691	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	5634	221823
PC_3692	NAD biosynthesis II (from tryptophan)	8564	23498	6999	23475	8942	125061	55191	349565	23057	64802
PC_3693	Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )	8326	2918	28514	7480	7476	9542	2793	10681	2660	7483	7484	2069	2916	2255	8823	50846	2277	8822	8323	2661	8324	8817	10220	27302	9965	9210	7481	183	3827	5155	1950	7039	7040	4803	2796	4878	5020	551	5443	1081	7252	2488	3972	5617	2688	796	2641	7432	2691	5539	4852	3630	3481	2520	4049	7124	3439	3440	3446	3444	3452	3442	3448	3451	3456	3458	3552	3553	2056	5154	1437	7471	3467	3443	3441	3449	3479	3623	3565	3567	2246	3569	1906	885	1392	796	1622	2922	3624	2249	3562	2247	3625	7472	2695	6343	1440	5697	797	3576	7043	2251	2248	2250	650	652	651	4295	3574	1908	3082	1813	3976	3578	374	7422	2784	655	6863	7200	4908	1907	3589	4254	1812	2252	1815	1816	653	654	3586	51083	627	3577	3579	135	136	3592	3593	959	134	185	2254	3445	941	4909	656	685	3596	1814	2668	200081	7066	3600	3952	7474	2915	942	8200	356	7423	7424	186	8743	2253	3626	2662	7473	89780	54361	7477	10718	83729	6750	7042	2778	182	51052	4693	3084	2911	7855	3603	3606	2535	2912	3549	2917	2913	2914	6469	3605	392255	151449	145957	2258	2256	2259	7482	7479	4838	1839	6608	80326	8074	7478	81029	8325	27006	26281	7976	9573	54567	26291	10683	51384	6866	2658	8322	11211	8321	3714	7475
PC_3694	4-hydroxyphenylpyruvate biosynthesis	6898
PC_3695	E-cadherin signaling in the nascent adherens junction	23396	1500	760	999	6714	3728	4830	595	3695	5295	207	1495	1499	3682	5290	1398	8826	7410	4301	998	5908	387	382	5906	5879	7082	1739	7074	2889	2017	10006	55740	26999	8907	10787	27252	10163
PC_3696	5-aminoimidazole ribonucleotide biosynthesis I	5198	2618	5471
PC_3697	NAD+ + (S)-Malic acid = NADH + Oxaloacetic acid ( Citrate cycle )	4190	4191
PC_3698	regulation of target gene expression by AP-1 ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, p38 cascade) )	1386
PC_3699	CDP-diacylglycerol biosynthesis I	10555	8760	2820	84803	254531	150763	10162	253558	154141	129642	137964	51099	1040	79143	10554	57678	56895	56894	55326
PC_3700	NAD salvage pathway II	5169	4907	5167	92370	115024	349565	83594	23057	64802	51205	27231	54981
PC_3701	IL-13 signaling pathway(JAK1 TYK2 STAT6) ( IL-13 signaling(JAK1 TYK2 STAT6) )	3565	3716	3566	7297	3596	3667	6778	3597	3598	8660
PC_3702	RAC1 signaling pathway	5609	8395	10095	10109	10094	10092	23396	1536	3725	999	1535	653361	1386	4688	1072	1495	1499	6774	6776	5599	5601	6416	1398	5606	8826	5608	396	3984	9564	10093	10096	10097	5879	5330	394	5058	5062	4214	1432	4296	10811	128239	10006	124056	55845	8936	26999	8394	29127	10152	10458	10787	27035	10163
PC_3703	AKT(PKB)-TOR signaling ( Insulin receptor signaling )	8672	1977	6198	207	208	2475	7249	5728	1973	6194	1981	1978	1974	6009	10000
PC_3704	superpathway of serine and glycine biosynthesis I	26227	6470	6472	5723	29968
PC_3705	ATP + dUDP = ADP + dUTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3706	Negative regulation of (G alpha s GDP-GTP exchange signaling) ( GPCR signaling (cholera toxin) )	6003	6002	6004	8490	10636	6001	8787	8601	8786	5997	9628	10287	5998	5999	6000	85397	2778	5996	64407	26575
PC_3707	Netrin-mediated signaling events	8976	7204	8633	9423	2534	7525	6714	4690	5335	5595	5295	5594	5605	5290	1630	4131	1612	9564	998	387	5879	5306	5604	5747	5058	1793	90249	219699	9844	116986	4651	815
PC_3708	Glypican 3 network	22943	5045	652	2252	5599	5601	2719	5727	6469
PC_3709	2-Oxo-glutaric acid + L-Phenylalanine = L-Glutamic acid + Phenyl-pyruvic acid ( Phenylalanine degradation )	2806	2805
PC_3710	triacylglycerol biosynthesis	8611	8613	10555	8612	8694	84803	196051	254531	150763	10162	79948	253558	154141	129642	9890	137964	346606	51099	64748	79143	116255	84649	10554	57678	56895	56894	55326
PC_3711	p38 cascade ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, p38 cascade) )	5609	5603	1386	5605	6416	5606	5608	6300	5604	5607	4214	5600	1432
PC_3712	GMCSF-mediated signaling events	3551	3717	2353	4893	3265	3845	5894	1437	4067	5292	6347	5008	1438	5566	5568	5567	5595	5295	5594	6464	1439	5605	6774	6772	6776	5290	6850	6777	6773	2885	7534	3394	5604	5781	6654	3635	1154	9846
PC_3713	2-Oxo-glutaric acid + L-Isoleucine = L-Glutamic acid + (R)-2-Oxo-3-methyl-pentanoic acid ( Valine,Leucine and Isoleucine degradation )	587	586
PC_3714	NAD+ + (S)-3-Hydroxy-butanoyl-CoA = NADH + Acetoacetyl-CoA ( Lysine degradation )	1892	3030	1962
PC_3715	Notch secretory pathway ( Notch signaling pathway Diagram )	5045	4851	4853	4855	4854
PC_3716	1,25-dihydroxyvitamin D3 biosynthesis	1594	5447	120227
PC_3717	serine biosynthesis	26227	5723	29968
PC_3718	phospholipases	5338	8399	8398	9651	5319	100137049	100137047	5320	5336	5335	5322	5321	5333	11145	5330	5331	729330	5337	5332	123745	23007	255189	151056	283748	89869	23646	201164	113026	122618	84812	81579	64600	50640	23236	50487	30814	51196	26279	8605
PC_3719	L-Alanine + 2-Oxo-glutaric acid = Pyruvic acid + L-Glutamic acid ( Glycolysis and Gluconeogenesis )	2875	84706
PC_3720	BMP receptor signaling	658	10106	4092	10217	4093	6885	4091	26585	23645	9350	197	650	652	6497	655	10468	654	5594	8021	5494	657	2932	5499	331	25805	9241	4089	659	10454	4086	285704	25928	148738	9765	56963	4090	91851	58190	8646	64750	57154	23118
PC_3721	taurine biosynthesis	1036	51380
PC_3722	SnoN degradation signaling ( TGF-beta_super_family_signaling_pathway(canonical) )	5717	5718	5715	5688	5709	5716	6498	5702	5689	5682	5683	5684	5685	5696	5698	5686	5692	5694	5693	5701	5699	5704	5714	5691	5690	5713	5710	5687	5700	5705	5708	9861	4087	5711	5695	5707	64750	5719
PC_3723	NAD+ + (S)-Lactic acid = NADH + Pyruvic acid ( Glycolysis and Gluconeogenesis )	3939	3945	3948	92483
PC_3724	Beta1 integrin cell surface interactions	131873	256076	3911	8515	2162	5328	1277	1280	1281	1282	2243	2244	2266	2335	7448	3688	1290	3685	3912	7057	1278	929	1284	3678	6696	3915	1301	1291	1292	1293	3676	1302	4811	7422	3673	7412	1289	4192	7052	3655	3908	3371	284217	3675	1287	7058	2200	80781	1286	8516	3913	3672	58494	975	1285	1294	5329	3679	3914	3918	3680	1288	7045	3910	3909	1464	255743	93185	22801
PC_3725	ATP + dAMP = ADP + dADP ( Purine nucleotides and Nucleosides metabolism )	203	205	204	26289
PC_3726	GDP-glucose biosynthesis	2645	5236	5239	80201	55276
PC_3727	E2F transcription factor network	79733	1871	8824	317	10419	7161	26959	1876	9134	1719	5328	4609	7083	7298	5054	5925	983	6667	5422	4605	7515	7030	890	1066	6240	898	1017	4172	7528	5933	896	993	6241	672	1026	1031	5902	23468	1027	1050	6595	840	1869	6822	4170	5934	5928	2033	5729	10155	472	4998	3065	7027	7029	1870	3090	9587	1875	1874	283848	221223	23491	23429	1029	11073	8936	1387	2648	8850	144455	23411	5932	990	8409	8295
PC_3728	Citric acid = Isocitric acid ( Citrate cycle )	48	50
PC_3729	Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )	8326	2918	28514	7480	7476	9542	2793	10681	2660	7483	7484	2069	2916	2255	8823	50846	2277	8822	8323	2661	8324	8817	10220	27302	9965	9210	7481	183	3827	5155	1950	7039	7040	4803	2796	4878	5020	551	5443	1081	7252	2488	3972	5617	2688	796	2641	7432	2691	5539	4852	3630	3481	2520	4049	7124	3439	3440	3446	3444	3452	3442	3448	3451	3456	3458	3552	3553	2056	5894	5154	1437	7471	3467	3443	3441	3449	3479	3623	3565	3567	5582	2246	3569	1906	5579	885	1392	796	1622	2922	3624	2249	3562	2247	3625	7472	2695	6343	1440	5697	797	3576	369	7043	2251	2248	2250	650	652	651	4295	3574	1908	3082	1813	3976	673	3578	374	7422	2784	5578	655	6863	7200	4908	1907	3589	4254	1812	2252	1815	1816	653	654	3586	51083	627	5583	3577	3579	135	136	3592	3593	959	134	185	2254	3445	941	4909	656	685	3596	1814	2668	200081	7066	3600	3952	7474	2915	5584	942	8200	356	7423	7424	186	2776	8743	2253	3626	2662	7473	89780	54361	7477	10718	83729	6750	7042	182	51052	4693	5581	3084	5588	5590	5580	2911	7855	3603	3606	2535	2912	3549	2917	2913	2914	6469	3605	392255	151449	145957	2258	2256	2259	7482	7479	4838	1839	6608	80326	8074	7478	81029	8325	27006	26281	7976	9573	54567	26291	10683	51384	6866	2658	8322	11211	8321	3714	7475
PC_3730	B-Raf activation signaling ( GPCR Adenosine A2A receptor signaling pathway )	673	5908	5906
PC_3731	Negative regulation of (transcription by R-smad	4093	8841	6497	6498	9759	4088	7088	7089	7090	7091	4089	3065	4087	4086	51564	3066	4090	55869	10013	9734	10014
PC_3732	PDGF signaling pathway (Mammal) ( PDGF signaling pathway )	5293	5296	4893	3265	3845	5155	5894	5154	5159	5156	4690	5921	5295	6464	6776	5290	5291	1398	6777	998	2885	25759	5781	6654	6655	5058	9459	53358	9020
PC_3733	IL-4 signaling pathway(JAK1 JAK3 STAT6) ( IL-4 signaling(JAK1 JAK3 STAT6) )	3565	3716	3566	5777	3561	6778	3718
PC_3734	p38 cascade ( Toll-like receptor signaling pathway (p38 cascade) )	5603	6885	1386	5608	6300	5600	1432
PC_3735	fatty acid beta-oxidation III (unsaturated, odd number)	10455	1632	1962
PC_3736	Pyruvate metabolism ( Pyruvate metabolism )	32	97	98	31	3029	84264	55902
PC_3737	FGF8 signaling pathway(Mouse) ( FGF signaling pathway )	10817	4893	3265	3845	5894	369	2078	2113	2114	673	6688	2002	2005	2119	2120	2004	2313	6654	6655	10818
PC_3738	IL-10 signaling pathway(JAK1 TYK2 STAT3) ( IL-10 signaling(JAK1 TYK2 STAT3) )	3586	3716	7297	6774	3588	3587
PC_3739	epoxysqualene biosynthesis	2222	6713
PC_3740	NAD+ + D-Sorbitol = NADH + D-Fructose ( Fructose and Mannose metabolism )	6652
PC_3741	AKT(PKB)-Bad signaling ( Insulin receptor signaling (Mammal) )	10971	207	208	7529	2810	7532	7531	7534	7533	572	10000
PC_3742	Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling (JNK cascade) )	2353	3725	8061	2355	2354
PC_3743	(S)-3-Hydroxy-3-methyl-glutaryl-CoA = Acetyl-CoA + Acetoacetic acid ( Valine,Leucine and Isoleucine degradation )	3155
PC_3744	Phospholipase C gamma signaling ( CD4 T cell receptor signaling )	5336	5335	3702	3710	3708
PC_3745	UDP-D-glucose + D-Galactose 1-phosphate = D-Glucose 1-phosphate + UDP-D-galactose ( Galactose metabolism )	2592
PC_3746	ethanol degradation IV	847	217	7306	224	79611	55902	84532
PC_3747	Signaling events mediated by Stem cell factor receptor (c-Kit)	5287	10603	8651	5170	2309	6591	3717	4286	9402	3265	2056	5894	4067	596	3815	7409	2241	2057	4254	867	6198	5595	5295	5777	6464	207	5605	6774	6772	6776	5290	4145	7006	5599	1399	2932	5728	2885	5604	5781	6654	2887	2549	5800	200734	161742	112476	1387	11184	572	1796	26228	10019
PC_3748	Heterotrimeric GPCR signaling pathway (through glutamate, G alpha q and PLC beta) ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	2793	10681	5894	5582	5579	369	673	2784	5578	5583	2915	5584	2776	5581	5588	5590	5580	2911
PC_3749	spermine biosynthesis	262	6611
PC_3750	(S)-Dihydro-orotic acid + H2O = N-Carbamoyl-L-aspartic acid ( Pyrimidine Nucleotides and Nucleosides metabolism )	790
PC_3751	G alpha s GDP-GTP exchange signaling ( GPCR signaling (cholera toxin) )	8326	2918	2793	10681	2916	8323	8324	1813	2784	1812	1815	1816	3577	3579	135	136	134	185	1814	2915	186	2778	2911	7855	2535	2912	2917	2913	2914	6608	8325	7976	8322	11211	8321
PC_3752	D-Glucosamine 6-phosphate + H2O = D-Fructose 6-phosphate + NH3 ( Fructose and Mannose metabolism )	10007
PC_3753	PAR4-mediated thrombin signaling events	2151	9475	9630	2147	4633	2767	2769	2776	54331	387	2782	5330	6093	10672	9002
PC_3754	NADPH + Cholesterol + O2 = NADP+ + 7-Hydroxy-cholesterol + H2O ( Steroids metabolism )	1581
PC_3755	D-Glucose 6-phosphate = D-Fructose 6-phosphate ( Fructose and Mannose metabolism )	2821
PC_3756	BMP signaling in Drosophila (dorsal midline) ( BMP signaling in Drosophila )	7490	6597	2033	84441	9794	1387	55534
PC_3757	Heterotrimeric GPCR signaling pathway (through Dopamine and G alpha s) ( GPCR Dopamine D1like receptor signaling pathway )	785	2793	10681	2906	10368	778	1385	2784	5566	1812	1816	5568	5567	5518	5519	5501	784	781	2778	5521	1020	776	782	2902	5523	786	783	2903	2904	5527	779	775	5528	2905	5525	5526	5524	5529	59283	59285	27092	27091	5522	28227	10369
PC_3758	Canonical Wnt signaling pathway	1855	1856	8395	8312	4040	324	2869	1499	2931	2932	89780	857	7855	8452	5525	59349	1857	85409	55361	8498	53944
PC_3759	Downstream signaling in nave CD8+ T cells	4772	8320	2353	4893	3265	3845	7124	3439	3440	3446	3444	3452	3442	3448	3451	3458	3559	925	5894	915	3105	3443	3441	3449	3725	5579	916	917	3002	926	5551	3560	673	8061	3454	5578	3726	1958	2002	919	5595	5594	3561	3445	5778	5605	5290	7293	5599	5601	356	3455	3558	567	801	5581	5604	5588	1961	3604	4775	4773	6775	8784
PC_3760	UTP + D-Glucose 1-phosphate = Pyrophosphate + UDP-D-glucose ( Glycolysis and Gluconeogenesis )	7360
PC_3761	beta-alanine degradation I	18	4329
PC_3762	NAD+ + L-Glutamic acid + H2O = NADH + 2-Oxo-glutaric acid + NH3 ( Glutamic acid and Glutamine metabolism )	2746	2747
PC_3763	Heterotrimeric GPCR signaling pathway (through Adenosine G alpha s) ( GPCR Adenosine A2A receptor signaling pathway )	2793	10681	1385	2784	5566	5568	5567	135	2778
PC_3764	RXR and RAR heterodimerization with other nuclear receptor	19	7040	7124	5914	596	5915	7067	7068	7421	5916	6256	3164	6198	6257	6720	5468	6258	7376	5467	5465	10062	5469	8648	84498	9971	9612
PC_3765	Neurotrophic factor-mediated Trk receptor signaling	9743	10755	23263	10817	25	4893	3265	3845	4803	4914	4804	5335	4908	5921	627	595	5595	5295	5594	6464	4909	6774	5584	5290	4145	1398	1399	10287	998	5908	387	5906	2885	5879	6993	391	25759	5604	1759	5590	5781	6654	7074	2549	8878	2889	5923	1793	4916	2532	4915	10818	53358	9844	6016	9093	23327	6014	30844	55179	57498	9846	9500
PC_3766	Raf activation signaling (through Grb2 and Sos) ( B cell receptor signaling )	4893	3265	3845	5894	369	673	2885	6654	6655
PC_3767	Beta catenin degradation signaling (Drosophila) ( Drosophila Wingless/Wnt signaling pathway Diagram )	8454
PC_3768	D-Glucosamine 6-phosphate + H2O = D-Fructose 6-phosphate + NH3 ( Aminosugars metabolism )	10007
PC_3769	NAD+ + CoA + (S)-Methyl-malonate semialdehyde => NADH + Propanoyl-CoA + CO2 ( Propanoate metabolism )	4329
PC_3770	D-Glucose 6-phosphate = D-Fructose 6-phosphate ( Glycolysis and Gluconeogenesis )	2821
PC_3771	NADH + 1,3-Bisphospho-D-glyceric acid = NAD+ + D-Glyceraldehyde 3-phosphate + Orthophosphate ( Glycolysis and Gluconeogenesis )	26330	2597
PC_3772	Canonical Wnt signaling pathway ( Canonical Wnt signaling pathway Diagram )	375790	7480	7476	7483	7484	6885	9672	4041	2239	4040	22943	7481	7471	7472	960	6382	10971	6385	7529	2810	6383	2817	1499	6932	7474	7473	89780	54361	7477	7532	7531	7534	3339	7533	6424	79412	2487	7482	7479	6423	83999	80326	7478	81029	83439	6934	56998	51701	27122	27121	27123	51384	51176	25776	11197	7475
PC_3773	PLK2 and PLK4 events	10733	10769
PC_3774	Acetyl-CoA + Dihydro-lipoamide = CoA + 6-S-Acetyl-dihydro-lipoamide ( Butanoate metabolism )	8050	1737
PC_3775	p38 cascade ( TGF-beta signaling(through TAK1) )	5603	6885	1386	5606	5608	6300	5600	1432
PC_3776	ATP + dIDP = ADP + dITP ( Purine nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3777	Nephrin/Neph1 signaling in the kidney podocyte	2151	8976	8440	4868	3725	2534	4690	5335	5295	207	409	5584	5290	5291	5599	5601	6416	5602	2885	5879	5590	7082	572	55243	7827	50855	7225	23607
PC_3778	CD28 signaling ( CD4 T cell receptor signaling (JNK cascade) )	940	941	942
PC_3779	AKT(PKB) activation signaling ( PDGF signaling pathway )	5293	5170	207	208	5290	5291	10000
PC_3780	3-phosphoinositide biosynthesis	5293	5286	5296	5287	10423	8395	23396	5288	5295	5290	5291	5297	5294	8396	138429	146850	5289	55300	23533	9896	8503	30849	8394	55361	22908	5298	200576
PC_3781	D-Ribose 1-phosphate = D-Ribose 5-phosphate ( Pentose phosphate cycle )	5236
PC_3782	VEGF signaling pathway ( VEGF signaling pathway )	658	8317	5293	5609	3551	1147	5603	5170	3656	9175	6885	8767	5565	2277	3717	10298	1956	4342	5894	4914	5582	5579	3643	3932	2534	983	3480	4804	4233	5159	369	5573	3815	2260	1019	6714	5576	673	7422	5156	5336	5578	5566	2321	5335	2263	2264	2261	5568	5567	6198	3716	5583	1017	156	92	5595	5295	5594	4058	7297	7465	5575	5577	207	208	2868	6259	2869	157	2324	3791	5605	657	91	7046	94	7048	1445	1326	5584	5290	5291	2475	7006	2870	7535	6850	5599	5601	6416	5606	1452	1453	9261	1024	102800317	7423	7424	2931	2932	1022	1025	3654	6197	902	4331	3718	5608	5347	6300	5602	5571	5563	2674	1455	4293	1018	1021	1020	5581	5604	4294	5588	90	5747	5590	5580	695	3702	5871	7786	5562	5058	5607	5598	5062	4214	5593	8737	816	818	817	93	659	5592	9641	2185	6196	6195	5600	1432	4296	7867	269	84451	8491	8550	131890	572	9020	4217	4215	8569	1263	53944	9047	106821730	51135	57144	51701	6199	53632	51422	27330	238	815	10000	10746	5564	11035	8517	1456
PC_3783	AKT(PKB)-Bad signaling ( IL-7 signaling(JAK1 JAK3 STAT5) )	658	8317	5609	3551	1147	5603	5170	3656	9175	6885	8767	5565	3717	10298	1956	4342	5894	4914	5582	5579	3643	3932	2534	983	3480	4804	4233	5159	369	5573	3815	2260	1019	6714	5576	673	5156	5578	5566	2321	2263	2264	2261	5568	5567	6198	3716	5583	1017	156	92	10971	5595	5594	4058	7297	7465	5575	5577	207	208	2868	6259	2869	157	2324	3791	5605	657	91	7046	94	7048	1445	1326	5584	2475	7006	2870	7535	6850	5599	5601	6416	5606	1452	1453	9261	1024	102800317	2931	2932	1022	1025	3654	6197	902	4331	3718	5608	5347	6300	5602	5571	5563	2674	1455	4293	1018	1021	1020	5581	5604	4294	5588	90	5747	5590	5580	695	3702	5871	7786	5562	5058	5607	5598	5062	4214	5593	8737	816	818	817	93	659	5592	9641	2185	6196	6195	5600	1432	4296	7867	269	84451	8491	8550	131890	572	9020	4217	4215	8569	1263	53944	106821730	51135	57144	51701	6199	53632	51422	27330	238	815	10000	10746	5564	11035	8517	1456
PC_3784	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	8326	1855	1856	8312	8323	8324	4041	23401	4040	324	1499	102800317	2932	7855	2535	10023	1857	8325	7976	8322	11211	8321	8313
PC_3785	HIV-1 Nef	317	5609	1147	8837	9530	7124	596	7132	4790	919	355	4792	836	835	5599	356	840	842	839	637	8738	54205	5970	7186	7185	8772	330	8737	841	8717	9020	4217	1616
PC_3786	glycogen degradation III	8972	5836	2548	5834	5837	178	5236	5239	55276
PC_3787	UDP-N-acetyl-D-galactosamine biosynthesis II	5238	2821	2645	10007	2582	6675	80201	132789	64841
PC_3788	sulfate activation for sulfonation	9061	9060
PC_3789	sucrose degradation V (mammalian)	226	229	6476	3795	7167	130589
PC_3790	Wnt secretory pathway (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	7480	7476	7483	7484	7481	7471	7472	7474	7473	89780	54361	7477	7482	7479	80326	7478	81029	51384	7475
PC_3791	L-Arginino-succinic acid = L-Arginine + Fumaric acid ( Arginine and Proline metabolism )	435
PC_3792	Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	1956	5340	5328	7040	2243	2244	2266	2335	7448	3690	3689	5054	3688	3685	1991	4314	1511	3678	5159	3684	6714	3082	4318	3693	4691	2357	2359	2358	3675	4321	4322	1398	9564	5879	2822	7436	5329	4035	1793	11330	80310	9622
PC_3793	tRNA charging	123283	4677	10667	2058	3035	1615	7453	6897	7407	2617	3376	5859	16	833	23438	6301	5917	8565	4141	23395	3735	124454	57505	57176	57038	55157	25973	92935	79731	80222	79587	54938	10056	55699	51520	10352	2193	51067
PC_3794	Succinyl-CoA + Dihydro-lipoamide = CoA + S-Succinyl-dihydro-lipoamide ( Citrate cycle )	1743
PC_3795	NAD+ + 3,4-Dihydroxy-phenyl-ethyleneglycol = NADH + 3,4-Dihydroxy-mandelaldehyde ( Tyrosine metabolism )	125	126	124	127	128	130	131	137872
PC_3796	Toll-like receptor signaling pathway (through JNK cascade)(Canonical) ( Toll-like receptor signaling pathway (through JNK cascade) )	7099	6885	929	3929	3654	7334	387522	10454	4615	54472	51135	23118	7189	23643
PC_3797	Negative regulation of gene expression ( Insulin receptor signaling (Mammal) )	2309	207	208	4303	2308	10000
PC_3798	IL2-mediated signaling events	8835	9021	8651	9046	10254	2353	4609	4893	3265	3845	3458	3559	5894	3725	5579	3932	2534	596	3560	5921	3716	1017	5595	5295	5594	6464	3561	3667	5605	6774	6772	6776	5290	6850	5599	5601	9261	6777	3718	3558	387	2885	5581	5604	5781	6654	2185	5600	1432	8027	1154	22806	9846	8660
PC_3799	GDP-mannose biosynthesis	5373	2821	4351	5372	29926	29925
PC_3800	L-dopachrome biosynthesis	7299
PC_3801	IL-7	2309	2534	3574	3575	3716	5595	5295	5594	6464	207	3561	3667	5605	6774	6772	6776	2931	2932	6777	3718	1213	5604	2308	868	2185	8027	572	8660
PC_3802	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	10423	8395	23396	9651	5336	5335	5297	5305	5333	8396	5330	5331	5332	23007	138429	89869	113026	79837	55300	8394	84812	55361	23236	51196	5298
PC_3803	Propanoyl-CoA + Acceptor = Propenoyl-CoA + Reduced acceptor ( Propanoate metabolism )	34	84129
PC_3804	JNK cascade ( IL-1 signaling pathway (through JNK cascade) )	5609	6885	3725	5599
PC_3805	Gene expression by FOXO ( Insulin receptor signaling )	2309	4303	2308
PC_3806	guanine and guanosine salvage I	4860	3251
PC_3807	glutamine biosynthesis I	2752
PC_3808	NAD+ + (S)-Malic acid = NADH + Pyruvic acid + CO2 ( Glycolysis and Gluconeogenesis )	4199	10873
PC_3809	NAD+ + (R)-Lactic acid = NADH + Pyruvic acid ( Glycolysis and Gluconeogenesis )	197257
PC_3810	FOXA transcription factor networks	3169	3171	3170
PC_3811	NAD+ + L-Glutamic acid + H2O = NADH + 2-Oxo-glutaric acid + NH3 ( Arginine and Proline metabolism )	2746	2747
PC_3812	Alpha6 beta4 integrin-ligand interactions	3911	3912	3915	3691	3655	3908	284217	3913	3914	3918	3909
PC_3813	(S)-3-Hydroxy-butanoyl-CoA = Crotonoyl-CoA + H2O ( Butanoate metabolism )	1892	3030	1962
PC_3814	ceramide biosynthesis	10558	9517	2531	123099	55304
PC_3815	Propanoyl-CoA + Acceptor = Propenoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	34	84129
PC_3816	Polo-like kinase signaling events in the cell cycle	10733	5347	1263	10769
PC_3817	Inositol phosphate metabolism ( Inositol phosphate metabolism )	5293	5286	3613	8395	8871	8821	3636	8867	23396	5336	5335	3706	3707	3612	3633	5290	5291	5297	5305	5294	3628	5333	5728	8396	5330	4952	5331	3632	5332	89869	113026	5289	253430	79837	23533	3631	8394	84812	51477	23236	51196	55586
PC_3818	CoA + ATP + Succinic acid = Succinyl-CoA + ADP + Orthophosphate ( Citrate cycle )	8803
PC_3819	IL-1_signaling(through_IKK-NFkB_cascade)(canonical) ( IL-1 signaling pathway (through NF-kappaB) )	7099	6885	3552	3553	3554	3654	7334	387522	10454	4615	54472	3556	51135	23118	7189
PC_3820	regulation of target gene expression by AP-1 ( IL-1 signaling pathway (through JNK cascade) )	3725	4790	5970
PC_3821	ATP + dTMP = ADP + dTDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	1841
PC_3822	AKT(PKB) activation signaling ( PDGF signaling pathway )	5293	5170	207	208	5290	5291	10000
PC_3823	Class I PI3K signaling events mediated by Akt	1147	5170	2309	9882	5894	3320	6714	6517	5566	10971	207	208	7529	2810	1026	2475	1027	2931	2932	3836	842	7532	7531	7534	5591	4303	7533	598	2308	253260	572	4217	79109	64223	10000
PC_3824	Beta catenin degradation signaling (Mammal) ( Mammalian Wnt signaling pathway Diagram )	8312	324	1499	2932	6500	8454	8945	8313
PC_3825	NAD+ + 3,4-Dihydroxy-mandelaldehyde + H2O = NADH + 3,4-Dihydroxy-mandelic acid ( Tyrosine metabolism )	218	221	220
PC_3826	IL4-mediated signaling events	9021	8651	9046	3717	9655	4049	5284	1277	7070	972	383	3690	3565	3567	2208	2242	6667	1278	4602	4603	1959	2113	246	6403	3159	1051	6688	3586	867	6198	3716	3566	5295	5777	6464	959	207	3561	4988	3667	604	6778	6776	5290	2475	6356	6777	3718	2885	3597	7033	598	3598	3662	1432	54625	6361	2971	3635	84666	57379	10344	8660
PC_3827	Insulin receptor signaling ( Insulin receptor signaling )	5293	5296	8471	5565	4893	3265	3845	3630	5894	3643	1977	369	6517	673	10971	5295	6464	5518	5519	7529	2810	3667	5290	5291	2475	7249	2932	5571	5563	7532	7531	2280	2885	7534	25759	5521	7533	5523	6654	6655	5562	5527	1978	5528	5525	5526	5524	5529	53358	53632	51422	5522	5564	8660	28227
PC_3828	sphingomyelin metabolism	6610	6609	339221	259230	166929	142891	55627	55512
PC_3829	Gli processing signaling ( Hedgehog signaling pathway )	2737	5566	5568	5567	1026	1029	1030	1031	1027	2932	1028	1032	6500	8454	8945
PC_3830	NADH repair	2597	55739	128240
PC_3831	Regulation of Androgen receptor activity	8805	7113	5152	25803	11143	2908	3725	354	3320	367	6714	7181	5451	1958	6256	3817	2316	2624	6257	3301	5599	6416	6258	7182	1050	2932	6595	190	5608	10399	4193	5966	6736	2033	2308	3065	10499	8648	5585	1432	10498	83637	51564	10513	1387	10481	8850	6599	10524	6605	23411	10919	25898	29843
PC_3832	serotonin degradation	10720	125	217	445329	445329	4128	4129	130	7365	6817	6799	224
PC_3833	G alpha q GDP-GTP exchange signaling ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	2793	10681	2784	2915	2776	2911
PC_3834	BMP signaling in Drosophila ( BMP signaling in Drosophila )	7490	6597	2033	84441	9794	1387	55534
PC_3835	CDC42 signaling events	2151	8976	8611	5609	10095	10109	10094	10092	10298	3265	5894	3725	7525	4633	999	6714	673	1386	867	6198	1072	324	5080	5595	5295	5594	1495	1499	5290	2475	5599	5601	6416	5606	8826	2932	5608	396	7410	3984	3985	9564	10093	998	10096	10097	5879	5581	5590	10188	2059	1739	7074	5058	5062	4214	5337	5923	8874	4735	9459	1432	4296	388585	8476	128239	55740	50855	81624	23265	10458
PC_3836	Prostaglandin and Leukotriene metabolism ( Prostaglandin and Leukotriene metabolism )	9536	247	27306	874	240	4048	246	873	239	2678	5742	6916	5743	2687	5730	8644	8529	4051	91227	5740	4056	80142
PC_3837	Nicotinate D-ribonucleotide + ATP = Deamido-NAD+ + Pyrophosphate ( Nicotinate and Nicotinamide metabolism )	23057	64802
PC_3838	Aurora B signaling	10403	6790	332	699	7813	6867	10112	10592	4869	7431	3925	1674	4691	5921	5684	5037	5501	23468	1058	387	3020	9493	54888	8452	5528	23397	9918	4638	55143	151648	1731	9212	11004	64151	29127	3619	10051	55958	90293	6795
PC_3839	dTMP de novo biosynthesis	1719	7298	6470	6472
PC_3840	Caspase8 activation signaling ( TNFR1 signaling pathway )	8772	841
PC_3841	XMP + Pyrophosphate = Xanthine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	3251
PC_3842	SHP2 signaling	10817	3717	1956	4893	3265	3845	5155	1950	4803	3458	3559	5894	4914	3479	3569	3932	3480	2773	3570	5159	3560	3459	7422	5566	4908	2263	2261	3716	627	5295	6464	4846	3561	4909	6383	3667	3791	5605	3572	6772	5290	3718	4301	3558	387	8543	2885	2770	5604	7010	5781	6654	2549	284	4916	4915	10818	2909	55824	9846
PC_3843	asparagine degradation I	80150	374569
PC_3844	Notch secretory pathway (Mammal) ( Notch signaling pathway Diagram )	5045	4851
PC_3845	IL23-mediated signaling events	9021	3717	242	8807	7124	3458	3553	920	4353	3569	916	2919	6347	4790	4792	3675	5295	3593	7297	4843	6774	6772	6776	5290	3594	3558	5970	4283	11009	8809	3606	6775	3605	149233	112744	51561	29949
PC_3846	ERK cascade ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	5894	369	673	5595	5594	5605	5604
PC_3847	putrescine degradation III	217	4128	6303	4129	219	218	221	224	112483
PC_3848	gluconeogenesis I	8789	26330	5230	226	2597	229	2023	2821	5232	669	2026	2203	1462	2027	5224	5223	4200	5105	4190	4191	4199	10873
PC_3849	Inosine + Orthophosphate = Hypoxanthine + D-Ribose 1-phosphate ( Purine nucleotides and Nucleosides metabolism )	4860
PC_3850	FAS (CD95) signaling pathway	5609	3551	1147	8837	5170	6714	7430	6609	355	5295	207	5981	5290	5291	836	6850	5599	5601	356	5608	5602	637	1213	695	5783	8772	4214	330	329	8737	841	5600	1432	843	23017	8517
PC_3851	NADP+ + 5,6-Dihydro-thymine = NADPH + Thymine ( Pyrimidine Nucleotides and Nucleosides metabolism )	1806
PC_3852	lactose degradation III	2720	112937
PC_3853	PKA activation signaling ( GPCR signaling (cholera toxin) )	112	109	115	111	5573	5576	5566	5568	5567	5575	5577	114	113	2778	108	107	196883	55811
PC_3854	Beta2 integrin cell surface interactions	3491	2159	5328	5327	718	3827	2243	2244	2266	5624	7070	3689	3383	2811	3684	2212	3384	7412	3683	3687	959	3385	5329	3681	3386	7045	10417	83700	50848
PC_3855	anandamide degradation	2166	158584
PC_3856	JNK cascade ( TNFR1 signaling pathway )	5609	5599	5601	6416	5602	83737	4217
PC_3857	D-Glycerate 2-phosphate = D-Glycerate 3-phosphate ( Glycolysis and Gluconeogenesis )	669	5224	5223
PC_3858	Ceramide signaling pathway	1147	8575	9530	9448	9131	4609	1950	7124	5894	5154	3479	5925	1509	596	6609	7132	5610	4790	4792	5595	5594	207	5605	5599	6416	637	8738	54205	5604	5970	5590	5580	581	7186	8772	4214	330	427	8737	841	8717	8844	8567	8439	572	5074	83939	56848	55512
PC_3859	EPO signaling pathway	9021	3717	3265	2056	4067	596	5336	5335	2057	4790	867	5295	5777	6464	6772	6776	7006	5599	1399	6777	7410	5906	2885	5781	695	598	6654	2549	2889	1432	3635	10019	8660
PC_3860	GMP + Pyrophosphate = Guanine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	3251
PC_3861	ATP + dGDP = ADP + dGTP ( Purine nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3862	TCR signaling in nave CD4+ T cells	3551	1147	2533	5170	27040	9402	10125	8915	4893	3265	3845	920	3122	3123	915	5579	3932	2534	916	5788	917	940	7409	4690	5578	5335	919	2316	867	5777	6464	207	941	1445	1326	942	5290	7454	7535	5728	998	5906	2885	6452	5581	5588	5781	6654	3702	3937	6786	10235	83593	3635	11184	84876	9020	84433	55503	84174	55824	10892	27347	28988	9846	7189	8517
PC_3863	Regulation of Ras family activation	5924	10156	10125	8437	4893	3265	3845	5579	3956	6237	5578	3958	5921	4763	801	2885	5581	5590	6654	6655	816	9610	5923	5922	153090	10235	112476	25780	115727	8831	51196	27342
PC_3864	2-Oxo-glutaric acid + L-Aspartic acid = L-Glutamic acid + Oxaloacetic acid ( Alanine,Aspartic acid and Asparagine metabolism )	2806	2805
PC_3865	Hedgehog	10284	50846	10001	2735	2736	2737	6497	891	5566	156	207	409	6383	1499	1024	2619	7531	1859	5727	3549	6469	5469	4086	374654	50937	55733	55582	1387	9968	64399	25942	6608	91653	27148	51715	9439	51684	7101	8643
PC_3866	adenine and adenosine salvage III	4860	3251	100	113179
PC_3867	ErbB receptor signaling network	9542	2069	1956	1950	7039	2064	3320	374	2065	685	10718	3084	2066	145957	1839
PC_3868	NAD+ + 3-Methyl-imidazole acetaldehyde + H2O = NADH + 3-Methyl-imidazole-acetic acid ( Histidine degradation )	218	221	220
PC_3869	NAD+ + Dihydro-lipoamide = NADH + Lipoamide ( Pyruvate metabolism )	1738
PC_3870	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Pentose phosphate cycle )	5634	221823
PC_3871	Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )	8326	2918	28514	7480	7476	9542	2793	10681	2660	7483	7484	2069	2916	2255	112	8823	50846	2277	8822	109	8323	2661	115	8324	8817	10220	27302	111	9965	9210	7481	183	3827	5155	1950	7039	7040	4803	2796	4878	5020	551	5443	1081	7252	2488	3972	5617	2688	796	2641	7432	2691	5539	4852	3630	3481	2520	4049	7124	3439	3440	3446	3444	3452	3442	3448	3451	3456	3458	3552	3553	2056	5154	1437	7471	3467	3443	3441	3449	3479	3623	3565	3567	2246	3569	1906	885	1392	796	1622	2922	3624	2249	3562	2247	3625	7472	2695	6343	1440	5697	797	3576	7043	2251	2248	2250	650	652	651	4295	3574	1908	3082	1813	3976	3578	374	7422	2784	655	6863	7200	4908	1907	3589	4254	1812	2252	1815	1816	653	654	3586	51083	627	3577	3579	135	136	3592	3593	959	134	185	2254	3445	941	4909	656	685	3596	1814	2668	114	200081	7066	3600	3952	7474	2915	942	8200	356	7423	7424	186	8743	113	2253	3626	2662	7473	89780	54361	7477	10718	83729	6750	7042	2778	182	51052	4693	3084	108	107	2911	7855	3603	3606	2535	2912	3549	2917	2913	2914	6469	3605	392255	151449	196883	145957	2258	2256	2259	7482	7479	55811	4838	1839	6608	80326	8074	7478	81029	8325	27006	26281	7976	9573	54567	26291	10683	51384	6866	2658	8322	11211	8321	3714	7475
PC_3872	NAD+ + 4-Hydroxy-phenyl-acetaldehyde + H2O = NADH + 4-Hydroxy-phenyl-acetic acid ( Tyrosine metabolism )	218	221	220
PC_3873	tryptophan degradation X (mammalian, via tryptamine)	10327	1644	4128	4129	224
PC_3874	Succinic acid + Ubiquinone = Fumaric acid + Ubiquinol ( Tyrosine metabolism )	6390	6389
PC_3875	3-phosphoinositide degradation	8871	8821	3636	8867	3633	5728	4952	23203	8897	27124	93492	90809	55529	64419	114971	3635	3631	51763	56623	22908	22876
PC_3876	PDGFR-beta signaling pathway	8976	5609	9368	10095	10109	10094	10092	8440	81	3717	25	2353	4609	4893	3265	3845	5155	5894	3690	3725	3932	2534	3685	7525	4067	3055	5159	2268	6722	6714	673	4690	5578	3727	5771	5770	5335	2002	5610	5867	5868	5921	1901	867	10971	5595	5295	5594	6464	5518	7529	2810	5605	6774	1445	6772	6776	5290	5291	5599	5601	6416	1398	8826	5321	5294	1785	640	6777	6197	396	7410	5602	4301	9564	10093	5728	10096	10097	5908	387	7532	7531	59	5906	2885	5879	7534	5515	5521	6876	5581	5604	7533	5580	5781	6654	4035	5795	2059	5058	6503	2887	2549	5300	2889	2017	9351	146850	8844	10006	93649	9732	55845	9712	26999	6494	116985	1796	2909	55824	8877	10458	10787	10163
PC_3877	ATP + ADP = ADP + ATP ( Purine nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3878	TNF receptor signaling pathway	5609	3551	1147	6885	6610	9530	9448	7124	7295	6609	7132	4790	7133	7128	5584	6772	5606	10399	6868	857	5970	5590	5871	7186	7185	8772	4214	330	329	8878	8737	841	8717	10454	203447	8491	8567	117584	8439	4217	4215	1540	23118	23043	11183	8517
PC_3879	Positive regulation of (Transcription of SOCS by STAT dimer) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram )	658	8317	5609	3551	1147	5603	5170	3656	9175	6885	8767	5565	3717	10298	1956	4342	5894	4914	5582	5579	3643	3932	2534	983	3480	4804	4233	5159	369	5573	3815	2260	1019	6714	5576	673	5156	5578	5566	2321	2263	2264	2261	5568	5567	6198	3716	5583	1017	156	92	5595	5594	4058	7297	7465	5575	5577	207	208	2868	6259	2869	157	2324	3791	5605	657	91	7046	94	7048	6774	1445	1326	5584	6772	6778	6776	2475	7006	2870	7535	6850	5599	5601	6416	5606	1452	1453	9261	1024	102800317	2931	2932	1022	1025	3654	6777	6197	902	4331	3718	5608	6773	5347	6300	5602	5571	5563	2674	1455	4293	1018	1021	1020	5581	5604	4294	5588	90	5747	5590	5580	695	3702	5871	7786	5562	5058	5607	5598	5062	4214	5593	8737	816	818	817	93	659	5592	9641	2185	6775	6196	6195	5600	1432	4296	7867	269	84451	8491	8550	131890	9020	4217	4215	8569	1263	53944	106821730	51135	57144	51701	6199	53632	51422	27330	238	815	10000	10746	5564	11035	8517	1456
PC_3880	2-oxobutanoate degradation I	5095	5096	1738	1629	593	594	4594	84693
PC_3881	CXCR4-mediated signaling events	9146	5170	3717	9525	920	3122	3123	915	2771	3932	2534	916	7525	4067	389	5788	3055	2773	2775	917	2268	5911	5899	6714	4318	7409	2781	919	1072	156	5295	5777	207	409	407	6774	1445	6772	6776	5290	5291	2475	2870	1398	6387	5294	5829	640	6777	6773	3984	9564	54331	998	7852	5908	387	388	2782	5879	2770	10399	5330	5331	1759	5747	5590	5781	5996	2308	5058	2185	10672	146850	253260	54434	3635	572	83737	79109	64223	23236	55824	29979	27183
PC_3882	2-Methyl-propanoyl-CoA + Acceptor = 2-Methylprop-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	35
PC_3883	(R)-Methyl-malonyl-CoA = (S)-Methyl-malonyl-CoA ( Propanoate metabolism )	84693
PC_3884	ceramide degradation	56624
PC_3885	L-Glutamine + D-Fructose 6-phosphate = L-Glutamic acid + D-Glucosamine 6-phosphate ( Fructose and Mannose metabolism )	9945	2673
PC_3886	Insulin receptor signaling (Mammal) ( Insulin receptor signaling (Mammal) )	5293	5296	8471	5565	4893	3265	3845	3630	5894	3643	1977	369	673	10971	5295	5518	5519	207	208	7529	2810	3667	5290	5291	2475	7249	2932	5571	5563	7532	7531	2280	2885	7534	5521	7533	5523	6654	6655	5562	5527	1978	23770	5528	5525	5526	5524	5529	57521	84335	64223	53632	51422	10000	5522	5564	8660	28227
PC_3887	JNK cascade ( CD4 T cell receptor signaling )	2353	3725	8061	2355	5605	5599	5601	2354	5602	5604
PC_3888	dopamine degradation	445329	445329	4128	1312	4129	6817	6799	224
PC_3889	pyruvate fermentation to lactate	3939	3945	3948	160287	92483
PC_3890	Negative regulation of heterotrimeric GPCR signaling pathway (through G alpha s) ( GPCR signaling (G alpha s, PKA and ERK) )	112	109	115	111	2771	114	113	2770	108	107	196883	55811
PC_3891	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( Canonical Wnt signaling pathway Diagram )	8326	1855	1856	8312	8323	8324	4041	23401	4040	324	1499	102800317	2932	7855	2535	10023	1857	8325	7976	8322	11211	8321	8313
PC_3892	acetate conversion to acetyl-CoA	79611	55902	84532
PC_3893	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Pyrimidine Nucleotides and Nucleosides metabolism )	5634	221823
PC_3894	Toll-like receptor signaling pathway (p38 cascade) ( Toll-like receptor signaling pathway (p38 cascade) )	7099	6885	929	3929	3654	7334	387522	10454	4615	54472	51135	23118	7189	23643
PC_3895	Negative feedback regulation of FGF8 signaling by Sprouty2 (Mouse) ( FGF signaling pathway )	6654	6655
PC_3896	ERK cascade ( GPCR Adenosine A2A receptor signaling pathway )	673	5595	5594	5605	5604
PC_3897	NF-kB signaling ( IL-1 signaling pathway (through NF-kappaB) )	4794	3551	1147	6885	4790	4792	6500	5970	8454	4793	8945	8517
PC_3898	LPA receptor mediated events	5338	112	109	115	111	9630	1956	2353	3265	2771	3725	4067	4313	2773	2775	3576	4137	6714	4318	2781	5335	4790	4792	5295	2767	2769	207	147	114	5291	836	1398	5829	2932	2776	113	9564	54331	387	2782	5879	2770	5331	5581	2768	5970	5747	5580	108	107	7074	2549	2185	10672	5587	9351	7205	112476	196883	1902	9138	1839	2846	9170	23566
PC_3899	D-Fructose 1,6-bisphosphate = Dihydroxy-acetone phosphate + D-Glyceraldehyde 3-phosphate ( Pentose phosphate cycle )	226	229	230
PC_3900	ATP + dCDP = ADP + dCTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3901	Fas signaling pathway ( Fas signaling pathway )	5609	355	10971	7529	2810	5599	5601	6416	356	5602	637	7532	7531	7534	54205	7533	581	8772	841	4217	1616
PC_3902	PLC beta signaling ( GPCR signaling (G alpha q) )	2776	5330	5331	5332	23236
PC_3903	NADP+ + D-Sorbitol = NADPH + D-Glucose ( Fructose and Mannose metabolism )	231
PC_3904	3-Hydroxy-isopentyl-CoA = 3-Methylbut-2-enoyl-CoA + H2O ( Valine,Leucine and Isoleucine degradation )	1892	3030	1962
PC_3905	glutamate dependent acid resistance	2572	2571
PC_3906	Negative regulation of (Dimerization of STAT) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram )	6776	6777	5781
PC_3907	Nicotinamide D-ribonucleotide + ATP = NAD+ + Pyrophosphate ( Nicotinate and Nicotinamide metabolism )	23057	64802
PC_3908	Notch degradation signaling (Mammal) ( Notch signaling pathway Diagram )	4851	4853	55294	4855	4854
PC_3909	Retinoic acid receptors-mediated signaling	8841	5582	983	5947	5914	5915	7421	5916	5578	5566	6256	5595	5594	6257	207	5599	6258	8204	1022	902	4331	2033	3065	10499	8648	1432	1387	8850	9612	8202
PC_3910	(S)-3-Hydroxy-3-methyl-glutaryl-CoA = 3-Methyl-glutaconyl-CoA + H2O ( Valine,Leucine and Isoleucine degradation )	549
PC_3911	alanine biosynthesis II	2875	84706
PC_3912	pentose phosphate pathway	25796	9563	2539	7086	6888	22934	8277	5226	6120	84076
PC_3913	MAP kinase cascade	7529
PC_3914	TCR signaling in nave CD8+ T cells	3551	1147	5170	27040	9402	10125	8915	4893	3265	3845	925	915	3105	5579	3932	2534	916	5788	917	940	926	5551	7409	5578	5335	919	867	5777	6464	207	941	1445	1326	942	5290	7535	567	5906	2885	5581	5588	6654	3937	6786	10235	83593	84876	9020	84433	55503	55824	10892	7189	8517
PC_3915	Signaling without Wnt (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	6932	7088	7089	7090	7091	83439	6934	51176
PC_3916	UDP-N-acetyl-D-galactosamine biosynthesis I	2582
PC_3917	B-Raf activation signaling ( GPCR signaling (G alpha s, PKA and ERK) )	673	5908	5906
PC_3918	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	3705	253430	9562
PC_3919	AMP + Pyrophosphate = Adenine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	353
PC_3920	Wnt secretory pathway (Canonical) ( Mammalian Wnt signaling pathway Diagram )	7480	7476	7483	7484	7481	7471	7472	7474	7473	89780	54361	7477	7482	7479	80326	7478	81029	51384	7475
PC_3921	Signaling with Wnt (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	8326	607	7480	7476	7483	7484	8323	8324	4041	4040	7481	7471	7472	1499	6932	7474	6597	7473	89780	54361	7477	7088	7089	7090	7091	2033	7855	4089	2535	1387	7482	7479	90780	80326	7478	81029	8325	83439	7976	6934	51384	51176	8322	11211	8321	26108	7475
PC_3922	L-serine degradation	10993	113675
PC_3923	G alpha i GDP-GTP exchange signaling ( GPCR signaling (pertussis toxin) )	8326	2918	2793	10681	2916	8323	8324	2771	1813	2784	1812	1815	1816	3577	3579	135	136	134	185	1814	2915	186	2770	2911	7855	2535	2912	2917	2913	2914	6608	8325	7976	8322	11211	8321
PC_3924	ATP + L-Glutamic acid + NH3 = ADP + L-Glutamine + Orthophosphate ( Glutamic acid and Glutamine metabolism )	2752
PC_3925	Pyruvic acid + Enzyme N6-(lipoyl)lysine = [dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine + CO2 ( Pyruvate metabolism )	5160	5162	5161
PC_3926	Caspase3 activation signaling ( Fas signaling pathway )	836	841
PC_3927	geranylgeranyldiphosphate biosynthesis	9453
PC_3928	ATP + GDP = ADP + GTP ( Purine nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3929	IL8-mediated signaling events	3576
PC_3930	GTP + L-Fucose 1-phosphate = GDP-L-fucose + Pyrophosphate ( Fructose and Mannose metabolism )	8790
PC_3931	Sumoylation by RanBP2 regulates transcriptional repression	7514	8554	9063	8021	23636	5905	9972	5903	9759	5901	7341	7329	4193	3065	23225
PC_3932	methylglyoxal degradation III	57016	1571	231
PC_3933	ATP + dTDP = ADP + dTTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
PC_3934	PLK3 signaling events	11200	7157	898	995	472	1263
PC_3935	Histidine degradation ( Histidine degradation )	314	8854	216	217	3035	3067	26	4128	4129	219	3034	223	501	23438	3176	224	8639	84735
PC_3936	Propanoate metabolism ( Propanoate metabolism )	5095	5096	55902
PC_3937	Phospholipase C gamma signaling ( B cell receptor signaling )	5336	3710	3708
PC_3938	glycine biosynthesis I	6470	6472
PC_3939	Circadian rhythm pathway	406	8553	1111	8864	9575	5187	3162	9572	102800317	11091	545	4841	1407	1408	4862	8914
PC_3940	NAD+ + CoA + (S)-Methyl-malonate semialdehyde => NADH + Propanoyl-CoA + CO2 ( Valine,Leucine and Isoleucine degradation )	4329
PC_3941	L-Alanine + Glyoxylic acid = Pyruvic acid + Glycine ( Alanine,Aspartic acid and Asparagine metabolism )	189	64902
PC_3942	Canonical Wnt signaling pathway ( Xenopus axis formation Wnt signaling pathway Diagram )	375790	7480	7476	7483	7484	6885	9672	4041	2239	4040	22943	7481	7471	7472	960	6382	10971	6385	7529	2810	6383	2817	1499	6932	7474	7473	89780	54361	7477	7532	7531	7534	3339	7533	6424	79412	2487	7482	7479	6423	83999	80326	7478	81029	83439	6934	56998	51701	27122	27121	27123	51384	51176	25776	11197	7475
PC_3943	Signaling without Hh ( Hedgehog signaling pathway )	2735	2736	2737	5727	6608	51684	8643
PC_3944	L-carnitine biosynthesis	8424	223	55217
PC_3945	(S)-reticuline biosynthesis II	7299
PC_3946	ERK cascade ( B cell receptor signaling )	5894	369	673	5595	5594	5605	5604
PC_3947	Beta catenin degradation signaling (Canonical) ( Mammalian Wnt signaling pathway Diagram )	8312	324	1499	2932	6500	8454	8945	8313
PC_3948	(S)-Malic acid = Fumaric acid + H2O ( Tyrosine metabolism )	2271
PC_3949	tRNA splicing	283989	83707	80746	116461	79042
PC_3950	ATM pathway	4683	5884	9025	11200	25	3014	993	995	7529	672	4361	641	637	7334	4193	7158	10155	472	1487	7518	7156	9656	8243	7014	84142	64326	10111	10524	51720	64421	5883	5932	2177	9126
PC_3951	L-Tetrahydro-folic acid + L-Serine = 5,10-Methylene-tetrahydro-folic acid + Glycine + H2O ( Glycine and Serine metabolism )	6470	6472
PC_3952	sorbitol degradation I	6652
PC_3953	Regulation of RhoA activity	9743	9639	23263	9826	395	4983	7204	22899	4168	613	7409	1027	5910	396	397	7410	387	23779	393	7984	11214	29	394	4650	55200	84033	23370	10276	57522	115557	64283	25791	64411	9138	9181	116985	9828	10395	398	64333	50619	1894	55160	50650	2909	23365	10451	10160
PC_3954	methylmalonyl pathway	5095	5096	4594	84693
PC_3955	HIF-1-alpha transcription factor network	8553	7015	3939	1356	5230	2353	2056	7037	7018	226	3689	5054	1906	3725	2023	4869	6667	5243	3484	3162	5045	6513	6515	5315	2113	7422	1385	2022	5211	3098	4907	2235	2624	405	207	4843	133	6095	2645	5236	3952	3172	6387	3099	7852	4088	3398	7033	4170	2033	664	4089	10499	8648	3091	768	5209	51564	10397	1387	10987	123	10370	79365	54583	112399	9429
PC_3956	glutaryl-CoA degradation	30	38	3032	2639	39
PC_3957	Adenylate cyclase inactivation signaling ( GPCR signaling (G alpha i) )	112	109	115	111	2771	114	113	2770	108	107	196883	55811
PC_3958	AKT(PKB) activation signaling ( Insulin receptor signaling (D. melanogaster) )	5170
PC_3959	NAD+ + Dihydro-lipoylprotein = NADH + Lipoylprotein ( Glycine and Serine metabolism )	1738
PC_3960	AKT(PKB)-GSK3beta signaling ( Insulin receptor signaling )	2997	207	208	2932	2998	10000
PC_3961	Signaling with Wnt (Mammal) ( Mammalian Wnt signaling pathway Diagram )	8326	607	7480	7476	7483	7484	8323	8324	4041	4040	7481	7471	7472	1499	6932	7474	6597	7473	89780	54361	7477	7088	7089	7090	7091	2033	7855	4089	2535	1387	7482	7479	90780	80326	7478	81029	8325	83439	7976	6934	51384	51176	8322	11211	8321	26108	7475
PC_3962	D-Sedoheptulose 7-phosphate + D-Glyceraldehyde 3-phosphate = D-Ribose 5-phosphate + D-Xylulose 5-phosphate ( Pentose phosphate cycle )	7086	8277	84076
PC_3963	PAR1-mediated thrombin signaling events	2151	6643	9475	9630	2147	2771	5582	5579	2773	2775	4633	5578	2781	2149	5295	4846	2767	2769	157	5290	408	2776	7408	1785	396	54331	387	2782	2770	5330	5331	2768	1759	5580	11214	6093	6642	10672	7791	5585	9138	23236	7225
PC_3964	UDP-D-glucose = UDP-D-galactose ( Galactose metabolism )	2582
PC_3965	p53 pathway	10419	1111	4194	8493	11200	25	7157	890	1017	7528	207	5599	5601	6125	1452	1453	102800317	2932	7321	900	1434	9349	6135	5515	1455	4193	5580	2033	10155	6502	472	5300	545	5524	4738	1432	1877	10075	80204	91875	1029	64326	80854	10848	8445	1387	8850	10524	7874	25898	28996	84148	63970	53944	387893	56950	11186	1616	1456
PC_3966	GDP-L-fucose biosynthesis II (from L-fucose)	8790	197258
PC_3967	NAD+ + L-2-Amino-adipate 6-semialdehyde + H2O = NADH + L-2-Amino-adipic acid ( Lysine degradation )	60496
PC_3968	glycine degradation (creatine biosynthesis)	2628	2593
PC_3969	regulation of target gene expression by AP-1 ( Toll-like receptor signaling pathway (through JNK cascade) )	3725
PC_3970	LPA4-mediated signaling events	112	109	115	9252	111	1385	5566	2774	114	113	2778	5581	108	107	196883	2846
PC_3971	Cellular roles of Anthrax toxin	5609	7124	3553	2099	2908	5241	5045	7412	5595	5594	834	5605	6416	5606	5608	118429	1667	801	5604	3606	22861	84168
PC_3972	ATP + CDP = ADP + CTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4833	10201	4830	4831	8382	4832	29922
